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T h e  studies reported in this thesis sought to explore t w o  m a j o r  areas o f  concern in the 
care o f  the obese patient with type 2  diabetes: 1) the d e v e l o p m e n t  a n d  evaluation o f  a 
brief, effective intervention to i m p r o v e  lifestyle self-management in patients with type 
2 diabetes a n d  2) differences in diabetes-related attitudes a n d  beliefs o f  health care 
professionals a n d  patients with type 2  diabetes that m a y  h a v e  a negative im pa ct o n  
diabetes-related o u t c o m e s  a n d  intervention implementation a n d  effectiveness.
T o  address these issues, t w o  studies w e r e  conducted. T h e  first w a s  a ra n d o m i s e d  
controlled trial o f  a brief intervention to i m p r o v e  lifestyle self -m an ag em en t in patients 
with type 2  diabetes. O n e  h u n d r e d  patients a g e d  b e t w e e n  40-70 years w e r e  recruited 
at a  Diabetes Centre. Participants c o m p l e t e d  foil questionnaire a n d  physiological 
assessments at four time points, baseline, 3 months, 6  m o n t h s  a n d  1 year. A  
personalised self -m an ag em en t plan w a s  de ve lo pe d with participants in the 
intervention gr ou p w h o  also received follow-up telephone calls at 1 w e e k ,  3 w e e k s  
a n d  7  w e e k s  post initial assessment. T h e  se co nd study w a s  a  c o m p a r i s o n  o f  patients' 
a n d  health care professionals' diabetes beliefs a n d  attitudes. O n e  h u n d r e d  a n d  four 
health care professionals a n d  10 0 o f  their patients c o mp le te d questionnaires assessing 
diabetes-related beliefs a n d  attitudes. In addition, the 100 patients in the lifestyle 
intervention study also participated in this study, in order to test the hypothesis that 
patients with type 2  diabetes will regard their o w n  diabetes as less serious c o m p a r e d  
to diabetes in general.
K e y  findings f r o m  the r a n d o m i s e d  controlled trial suggest that the intervention w a s  
successful in helping patients in the intervention group to reduce their fat intake a n d
S U M M A R Y
increase their lifestyle physical activity levels. These self-reported changes in 
behaviour were reflected in the objective data with weight maintenance in the 
intervention group compared to the control group, together with a reduction in waist 
circumference but did not translate into improvements in the other physiological 
measures. A striking finding from the comparison o f patients' and health care 
professionals' diabetes beliefs and attitudes study was that health care professionals 
viewed type 2 diabetes as more serious than their patients, and participants in the 
intervention study viewed their own diabetes as a less serious condition compared to 
the seriousness of type 2 diabetes in general. A majority o f the health care 
professionals considered diabetes harder to treat compared with other chronic 
conditions and felt that they did not have adequate time and resources to treat their 
patients with diabetes effectively.
The implications o f the above for future research and practice were discussed.
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Chapter 1
1.1. Definition
T y p e  2  diabetes identifies patients w h o  d o  not d e p e n d  o n  e x o g e n o u s  insulin treatment 
to r e m a i n  alive, although u p  to 2 0 %  are treated with insulin to control b l oo d glucose 
levels. T h e  crucial biochemical distinction f r o m  type 1 diabetes is that insulin 
deficiency in type 1 is so severe that e v e n  the l o w  insulin levels required to prevent 
lipolysis, fatty-acid oxidation a n d  ketone-body formation cannot b e  sustained, thus 
leading to spontaneous ketoacidosis. B y  definition, type 2  diabetes is taken to 
exclude the a u t o i m m u n e  destruction o f  islet B-cells (type 1 diabetes), w h i c h  is the 
cause o f  m o s t  cases o f  type 1. T y p e  2  diabetes w a s  previously k n o w n  as ‘maturity- 
o n s e f  diabetes, to a c k n o w l e d g e  the fact that the disease is diagnosed m o s t  c o m m o n l y  
in middle-aged or elderly people. H o w e v e r ,  it is n o w  clear that type 2  m a y  develop 
in y o u n g  adults, especially in high-susceptibility populations, (e.g. the P i m a  Indians), 
a n d  the specific subtype o f  type 2  k n o w n  as ‘maturity onset’ has n o w  generally b e e n  
abandoned.
T h e  distinctions b e t w e e n  type 2 a n d  type 1 diabetes are not always clear-cut, 
especially in a  clinical setting. M a n y  patients with type 2  are treated with insulin 
because m a x i m a l  dosages o f  oral hy p o g l y c a e m i c  agents ha v e  p r o v e d  ineffective, a n d  
insulin is the only dr ug currently available that c a n  lo we r blood glucose levels into a n  
acceptable range. Ketoacidosis c a n  occasionally b e  precipitated in type 2  patients b y  
severe intercurrent infection or other illness, a n d  c a n  present m u c h  as in type 1
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patients. H o w e v e r ,  type 2  patients h a v e  demonstrable residual insulin, a n d  d o  not 
b e c o m e  ketoacidotic spontaneously, e v e n  w h e n  insulin is withdrawn.
T h e  c o m m o n  type o f  type 2 diabetes is d u e  to variable combinations o f  insulin 
resistance, i.e. impaired ability o f  the tissues to respond to the glucose-lowering a n d  
other actions o f  insulin, a n d  islet B-cell failure. A l t h o u g h  circulatory insulin levels 
m a y  not b e  greatly reduced, a n d  m a y  e v e n  b e  a b o v e  the non-diabetic range, they are 
inadequate to o v e r c o m e  the tissue insulin resistance a n d  are substantially lower than 
w o u l d  b e  f o u n d  in healthy subjects w h o s e  bl o o d  glucose levels w e r e  artificially raised 
to the s a m e  degree (Yki-Jarvinen, 1994; De F r o n z o ,  1988).
N o r m a l l y  in healthy subjects after glucose ingestion or infusion, the delicate balance 
b e t w e e n  tissue glucose uptake a n d  hepatic glucose output is disrupted a n d  the 
m a in te na nc e o f  n o r m a l  glucose homeostasis is dependent o n  three processes that 
occur in a coordinated a n d  tightly integrated fashion (Table 1.1). In response to 
glucose, pancreatic insulin secretion is stimulated a n d  the combination o f  
hyperinsulinemia plus hy perglycemia p r o m o t e s  glucose uptake b y  splanchnic (liver 
a n d  gut) a n d  peripheral (primarily muscle) tissues a n d  suppresses hepatic glucose 
production. It follows, therefore, that defects at the level o f  the B-cell, muscle, 
and/or liver c a n  lead to the d e v e l o p m e n t  o f  glucose intolerance or overt diabetes 
mellitus. T h e  full-blown s y n d r o m e  o f  type 2 diabetes requires the simultaneous 
presence o f  t w o  m a j o r  defects, insulin resistance a n d  impaired B-cell function. In 
m o s t  type 2 individuals impaired tissue (muscle and/or liver) sensitivity to insulin 
represents the primary or inherited defect. It is important to note that, w h ic he ve r 
defect, i.e. diminished insulin secretion or insulin resistance, initiates the 
d e v e l o p m e n t  o f  type 2  diabetes, it subsequently leads to the e m e r g e n c e  o f  the se co nd
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abnormality. Importantly, both defects m u s t  b e  present simultaneously before 
significant glucose intolerance will ensue ( D e F r o n z o  et al., 1992).
T a b l e  1.1. Fa ct or s responsible for the m a i n t e n a n c e  of n o r m a l  glucose tolerance 
in healthy subjects.
Insulin secretion 
Tissue G l u c o s e  U p t a k e
Peripheral (primarily muscle) 
Splanchnic (liver plus gut) 
Suppression o f  Hepatic G l uc os e Production
1.1.1. Diagnosis
Since the diagnosis o f  diabetes has important legal a n d  medical implications for the 
individual, the diagnosis m u s t  b e  established b e y o n d  reasonable doubt before 
labelling a person as diabetic for the rest o f  their lives. T h e  identification of 
hyperglycaemia is central to the diagnosis o f  diabetes, p r o v o k e d  b y  a  carbohydrate 
challenge if necessary. O n c e  the diagnosis is established, other clinical observations 
a n d  m e a s u r e m e n t s  are necessary to define the type o f  diabetes, w h i c h  in turn will 
determine its treatment. A c c o r d i n g  to the revised W o r l d  Health Organization ( W H O )  
criteria ( W H O ,  1999), the m e t h o d s  a n d  criteria for diagnosing diabetes mellitus 
include the presence o f  diabetes s y m p t o m s  (thirst, polyuria a n d  unexplained weight 
loss) plus a r a n d o m  v e n o u s  p l a s m a  glucose concentration > _ 1 1.1 m m o l / 1  or a  fasting
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p l a s m a  glucose concentration > 7 , 0  m m o l / 1  or 2  h o u r  p l a s m a  glucose concentration >
11.1 m m o l / 1  2  hours after 7 5 g  anhydrous glucose in a n  oral glucose tolerance test 
( O G T T ) .  Importantly, type 2  diabetes often presents with less intense 
hyperglycaemic s y m p t o m s  or weight loss than in type 1, a n d  s o m e t i m e s  n o n e  at all. 
W i t h  n o  s y m p t o m s ,  diagnosis is not b a se d o n  a single glucose determination but 
requires confinnatoiy p l a s m a  v e n o u s  determination. A t  least o n e  additional glucose 
test result o n  another d a y  with a  value in the diabetic range is essential, either fasting, 
f r o m  a  r a n d o m  s a m p l e  or f r o m  the t w o  ho u r  post glucose load. If the fasting or 
r a n d o m  values are not diagnostic the 2-hour value should b e  used.
1.2. E p i d e m i o l o g y
W o r l d w i d e ,  type 2  diabetes is a n  important a n d  c o m m o n  disease that is steadily 
b e c o m i n g  m o r e  c o m m o n .  In Europe, the U S A  a n d  m o s t  westernised countries, type 
2  accounts for u p  to 8 5 %  o f  total cases o f  diabetes, a n d  probably affects 5 - 7 %  o f  the 
population; it is likely that m a n y  cases (perhaps u p  to 5 0 % )  are currently un di ag no se d 
(Gatling, 1985; Z i m m e t ,  1982).
T h e  prevalence o f  type 2 diabetes is l o w  ( < 1 % )  in m a n y  developing societies a n d  very 
high ( 4 0 - 5 0 % )  in certain groups, e.g. the P i m a  Indians o f  Arizona a n d  the N a u r u a n s  
( Z i m m e t ,  1982; 1992). B o t h  o f  these societies h a v e  b e c o m e  westernised relatively 
rapidly during the last f e w  decades, a n d  this has b e e n  paralleled b y  a n  increase in the 
incidence o f  type 2  diabetes. Several k e y  aspects o f  the westernised lifestyle (‘coca- 
colonization’ Z i m m e t  1992) predispose to obesity, insulin resistance a n d  type 2 
diabetes, notably a  high intake o f  energy-rich fatty foods a n d  physical inactivity. T h e  
diabetogenic effects of westernisation are also illustrated b y  the several-fold increases
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in the prevalence o f  type 2  seen in im m i g r a n t  populations, such as Ch in es e w h o  
m o v e d  to Mauritius, Japanese w h o  emigrated to Hawaii, a n d  Asians living in the U K  
or S o ut h Africa ( Z im me t, 1992; Mather, 1985).
T y p e  2  diabetes is predominantly, but not exclusively, a disease o f  the middle-aged 
a n d  elderly. In E u r o p e  a n d  the U S A ,  about 7 0 %  o f  patients are over 5 5  years o f  age 
a n d  the average age at diagnosis is 60  years. T h e  prevalence o f  type 2  increases 
m a r k e d l y  with age in all populations, a n d  in E u r o p e  a n d  the U S A  it probably affects 
1 0 %  or m o r e  o f  those over 7 0  years o f  age. T h e  true prevalence is difficult to judge 
because m a n y  cases h a v e  f e w  or n o  s y m p t o m s ,  a n d  are therefore undiagnosed; 
conversely, m a n y  type 2  patients are treated with insulin, often inappropriately 
(Rendell, 1983; C o h e n ,  1984). Overall, there appears to b e  a m a l e  preponderance 
(approximately 3:2, males:females).
T y p e  2  diabetes is a very costly disease, in individual, social a n d  e c o n o m i c  terms. 
A l t h o u g h  s o m e t i m e s  asymptomatic, it c a n  cause the s a m e  microvascular a n d  
macrovascular complications as type 1. Accelerated a n d  severe atherosclerosis is the 
m a j o r  p r o b l e m  a n d  results in m u c h  morbidity through angina, heart failure, 
claudication a n d  stroke; myocardial infarction, often at a  y o u n g  age, is the m o s t  
c o m m o n  cause o f  death in type 2  diabetes. Retinopathy, nephropathy a n d  neuropathy 
ca n all affect patients with type 2  diabetes. It cannot therefore b e  regarded as ‘m i l d ’ 
diabetes, e v e n  th ou gh bl oo d glucose levels m a y  b e  only moderately raised in m a n y  
cases a n d  patients will not die acutely if treatment is w i t h d r a w n  (Gill, 1986).
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1.3, Aetiology
Type 2 diabetes is a syndrome with many possible causes. This heterogeneity has 
hindered understanding of the pathogenesis of the various conditions that can lead to 
type 2 , although recent metabolic and genetic studies have begun to clarify these 
processes. Various animal syndromes have also helped to elucidate aspects of the 
human disease.
1.3.1. Genetic factors
A striking feature of the common type of type 2 diabetes is the strength of its genetic 
component, which is much greater than in type 1. Indeed, most of the susceptibility is 
probably genetically determined; the concordance rate for identical twins in various 
surveys has been 60-90%, while the lifetime risk for developing type 2 is increased up 
to 40% by having a first-degree relative with the disease (Yki-Jarvinen, 1994). 
Moreover, a positive family history of type 2 amplifies the diabetogenic potential of 
other risk factors, notably obesity (Bennett, 1990). The genetic factors involved are 
unknown; numerous candidate genes that could affect insulin secretion and/or insulin 
action have been investigated but none has yet been shown to account for more than a 
few per cent of the common type of type 2 diabetes.
It has been suggested that type 2 susceptibility genes might favour energy storage, 
perhaps by inducing insulin resistance selectively in liver and skeletal muscle; this 
would tend to raise insulin levels, which would promote triglyceride deposition in fat, 
provided that this process remained relatively sensitive to insulin. This ‘thrifty
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ge no ty pe’ w o u l d  confer survival advantages under harsh conditions or unpredictable 
fo o d  supply, a n d  so w o u l d  b e  selected in populations living in such a n  environment, 
but w o u l d  lead to obesity, insulin resistance a n d  perhaps type 2  diabetes un de r 
affluent conditions w h e r e  f o o d  is readily available (Walston et al., 1995; Hales et al., 
1992). This is suggested to explain the e m e r g e n c e  a n d  spread o f  type 2 diabetes in 
societies that adopt a  westernised lifestyle.
1.3.2. En viromnental factors
M u c h  evidence, including epidemiological findings, indicates that environmental 
factors are important in inducing type 2  diabetes to develop in people with genetic 
susceptibility. T h e  excessive energy intake a n d  sedentary lifestyle o f  urbanised 
westem-style societies greatly favour the d e v e l o p m e n t  o f  this disease. T h e  role o f  
physical inactivity has recently b e e n  e m p h a s i s e d  b y  the demonstration that regular 
exercise in early adult life c a n  significantly reduce subsequent susceptibility to type 2 
diabetes; it has b e e n  estimated that the risk o f  developing type 2  decreases b y  6 %  for 
every 5 0 0  kcal increase in daily energy expenditure through exercise (Helmrich et al., 
1991), T h e s e  factors predispose to obesity, w h i c h  in turn is a n  important risk factor 
for type 2, b y  increasing insulin resistance. T h e  w a y s  in w h i c h  a n  increased fat m a s s  
m i g h t  reduce sensitivity to insulin action in other tissues (primarily skeletal m u s c l e  
a n d  liver) are u n k n o w n  at present, although studies o f  obese, insulin-resistant Z u c k e r  
rats suggest that increased secretion o f  the cytokine T N F _ a  m a y  b e  involved. T N F  a 
is secreted b y  fat a n d  acts to inhibit intracellular signalling after insulin binds to its 
receptor (Hotamisligil et al., 1993). It is n o w  apparent that the distribution o f  b o d y  
fat, as well as its total mass, is a n  important determinant o f  risk for type 2  diabetes, as
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a ‘central5 or ‘truncal5 deposition of fat (particularly within the abdomen) 
substantially increases the susceptibility to the disease (Mayer-Davis et al., 2001; 
Bjomtorp, 1988). The physiological basis is unknown, but visceral fat appears to 
undergo lipolysis more readily, and increased free fatty acid levels in the bloodstream 
are known to increase insulin resistance through their metabolic effects in liver and 
muscle (Colberg et al, 1995).
Another environmental factor that may play a role is malnutrition in the first year of 
life and particularly in  utero. This hypothesis suggests that B-cell development is 
irreversibly damaged by inadequate nutrition (especially of proteins) during critical 
stages of fetal and infant development (Hales et al., 1992; Dahri et al., 1995).
1.3.3. Natural history of Type 2 diabetes
Type 2 diabetes is a heterogenous condition that affects predominantly older people 
with relatively short life expectancies; its natural history is therefore difficult to 
define. Resistance to the glucose-lowering action of insulin, due to genetic and/or 
environmental factors, would tend to lead to a slight increase in blood glucose levels, 
which stimulates insulin secretion and causes hyperinsulinaemia, which initially is 
able to overcome the effects of insulin resistance and maintain near-nonnal 
glycaemia. Ultimately, however, whether through worsening insulin resistance or 
progressive impairment of B-cell function, insulin secretion rises to a plateau, at 
which blood glucose levels begin to rise, first into the subclinical range of impaired 
glucose tolerance (IGT). Finally, when maximum insulin secretion can no longer be
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sustained, B-cell failure supervenes a n d  p l a s m a  insulin levels begin to fall, leading to 
hyperglycaemia that rises into the overtly diabetic range.
This process m a y  take several years a n d  is not necessarily irreversible; about 2 5 %  of 
people with I G T  progress to type 2  diabetes within 5 years, while the majority either 
r e m a i n  within that category ( 5 0 % )  or revert to n o r m a l  glucose tolerance (25%). 
Various interventions, such as weight loss a n d  increased physical activity a n d  also 
insulin-sensitising drugs, are able to reduce the likelihood o f  progression to overt type 
2 diabetes (Pickup et al., 1997).
1.4. Clinical features of T y p e  2  diabetes
T h e  clinical picture o f  type 2  diabetes differs f r o m  that o f  type 1 in several important 
aspects. T h e  older age o f  onset of m o s t  patients has already b e e n  mentioned. Just 
over 5 0 %  o f  cases present with classical hyperglycaemic s y m p t o m s ,  but with rare 
exceptions (e.g. during intercurrent illness) the features o f  diabetic ketoacidosis are 
absent. M a n y  type 2  patients d o  not c o m p l a i n  o f  obvious diabetic s y m p t o m s ,  a n d  
the disease is detected either opportunistically, for e x a m p l e  b y  screening at medical 
examinations or during hospital visits, or w h e n  patients present with intercurrent 
infections, usually genital candidiasis (particularly in w o m e n )  or o f  the urinary tract or 
skin. S o m e  present with complications o f  diabetes itself, such as myocardial 
infarction or peripheral vascular disease, or with microvascular disease, m o s t  
c o m m o n l y  retinopathy, w h i c h  m a y  b e  discovered b y  a n  optician during a  routine eye 
test. T h e  high proportion o f  incidental diagnoses in apparently a s y m p t o m a t i c  people 
em phasizes the fact that type 2  diabetes runs a n  insidious course; various studies ha v e  
estimated that significant hyperglycaemia is present o n  average for 5-7 years before
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the diagnosis is m a d e .  T h e s e  data also indicate that m a n y  patients with overt type 2 
diabetes still r e m a i n  undiagnosed, a n d  several surveys that ha v e  systematically 
screened defined populations suggest that u p  to 5 0 %  o f  all cases h a v e  not yet b e e n  
detected (Fujimoto, 1997).
Obesity is a  m a j o r  predisposing factor to insulin resistance a n d  is also a n  important 
obstacle to the effective m a n a g e m e n t  o f  type 2  diabetes. In the U K  a n d  other 
westernised countries, at least 5 0 %  o f  m e n  a n d  7 0 %  o f  w o m e n  are 1 2 0 %  o f  the ideal 
b o d y  weight at presentation ( U K P D S ,  1988); truncal obesity, w h i c h  is associated with 
hypertension, dyslipidaemia a n d  cardiovascular disease is particularly c o m m o n  
(Bjomtorp, 1988).
1.5. Chronic complications o f  T y p e  2  Diabetes
T y p e  2  diabetes carries the risk o f  long-term diabetic complications, including the 
microvascular diseases, retinopathy, nephropathy a n d  neuropathy that are specific to 
diabetes, a n d  the non-specific macrovascular p r o b l e m s  o f  occlusive atherosclerotic 
disease affecting ma i n l y  the heart, brain a n d  legs.
1.5.1. Ma cr ov as cu la r Complications
T h e  patient with type 2 diabetes is m o r e  likely to b e  affected b y  arterial disease, partly 
because type 2  diabetes generally appears at a  time o f  life w h e n  arteriosclerotic 
p r ob le ms are frequent e v e n  in the non-diabetic population. In addition, these patients 
frequently h a v e  m a n y  other adverse arteriosclerotic risk factors such as obesity,
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hyperlipidaemia, hypertension (w h i c h  is m o r e  c o m m o n  in diabetic people (Barrett- 
C o nn or , 1981)) a n d  smoking. T h e  grouping o f  these risk factors has long b e e n  
recognized a n d  has b e e n  given the title o f  ‘s y n d r o m e  X 5 b y  R e a v e n  (1988), w h o  has 
suggested that insulin resistance in various tissues ca n  explain its k e y  features.
C o r o n a r y  artery disease is the m a i n  complication o f  type 2 diabetes. A n g i n a  affects 
1 7 %  or m o r e  o f  patients (Gill, 1986) a n d  ultimately nearly 6 0 %  die f r o m  ischaemic 
heart disease as c o m p a r e d  with 1 5 %  o f  patients with type 1 diabetes ( M a r k s  et al., 
1971). My ocardial infarction is m o r e  c o m m o n  in diabetes a n d  also carries a  w o rs e 
prognosis (Rytter, 1985; Gwilt, 1984); the mortality rate is about twice that in n o n ­
diabetic subjects. Peripheral vascular disease m a y  cause intermittent claudication 
a n d  gangrene o f  the foot or leg, s o m e t i m e s  requiring amputation. Together with 
neuropathy, it is a m a j o r  cause o f  diabetic foot syndrome, a source o f  considerable 
morbidity a n d  cost to the health services. Cerebrovascular disease presents as 
transient ischaemic attacks or stroke, w h i c h  is m o r e  c o m m o n  a m o n g s t  diabetic 
patients a n d  carries a higher mortality than in the non-diabetic population (Marks, 
1971; Rytter, 1985).
1.5.2. Microvascular Complications
T h e  specific microvascular complications o f  diabetes m a y  b e  less pr om in en t in type 2 
than in type 1 but they still provide cause for concern. Retinopathy a n d  cataracts 
e a c h  affect about 1 5 %  o f  patients. M a c u l o p a t h y  is a n  especially c o m m o n  f o r m  of 
retinopathy in type 2 a n d  m a y  threaten vision (Watkins, 1987); it m a y  b e  very difficult 
to diagnose at routine fundoscopy. B y  contrast, proliferative retinopathy, the m o s t
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common cause of blindness in type 1 diabetes, is rare. Nephropathy is probably as 
likely to develop in type 2 as it is in type 1 , although its prevalence is lower because 
most type 2 patients being substantially older, have a shorter exposure to 
hyperglycaemia and therefore less opportunity to progress to end-stage nephropathy 
with renal failure. In addition, because type 2 diabetes is now so common, these 
patients constitute the majority of those requiring renal replacement therapy in many 
countries. Finally, neuropathy is a common complication and causes serious 
morbidity in a substantial proportion of type 2 patients, about 8% of whom have 
painful, rather than asymptomatic neuropathy (Gill, 1986). At least one-third of male 
type 2 patients, when directly questioned, have some degree of impotence (McCulloch 
et al, 1980).
1.5.3. Mortality in Type 2 Diabetes
Five-year mortality in type 2 diabetes is increased two-to-threefold, and age adjusted 
life expectancy is reduced by 5-10 years compared with the general population 
(Panzram, 1987; Goodkin, 1975). Interestingly, the mortality risk does not seem 
particularly related to the duration of the disease (Nathan, 1986); indeed, for type 2 
patients diagnosed over the age of 75 years, mortality is similar to that of their age- 
matched, non-diabetic counterparts (Williams, 1994).
1.5.4. Control and Complications
The natural history of microvascular and neuropathic complications in type 2 diabetes 
has been difficult to define because the disease may be present for many years before
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it is diagnosed, a n d  the incidence a n d  progression o f  complications m a y  b e  influenced 
b y  multiple co nfounding factors including age a n d  hypertension. Nevertheless, 
hyperglycaemia is clearly associated wi th the presence a n d  progression o f  
microvascular complications in type 2  diabetes (Klein et al., 1988; Li u  et al., 1992; 
Klein, 1995).
T h e  recently reported U K  Prospective Diabetes Study ( U K P D S ) ,  a  multicentre, 
prospective, r a n d o m i s e d  clinical trial, w a s  designed to determine w h et he r i m p r o v e d  
bl oo d glucose control w o u l d  prevent complications a n d  reduce morbidity a n d  
mortality in patients with n e w l y  diagnosed type 2  diabetes. Endpoints included 
m a j o r  clinical events that affect the life a n d  well-being o f  patients, su ch as stroke, 
angina, heart attack, blindness, renal failure a n d  amputations.
T h e  trial w a s  started in 1 9 7 7  a n d  recruited over 5 0 0 0  patients. All w e r e  treated 
initially b y  diet a n d  those w h o  r e m a i n e d  hyperglycaemic w e r e  r a n d o m l y  allocated to 
diet, sulphonylurea or insulin. O b e s e  patients w e r e  also r a n d o m i s e d  to metfonnin. 
Patients w h o  failed m o n o t h e r a p y  with sulphonylurea w e r e  further r a n d o m i s e d  to 
combination therapy; those w h o  failed m o n o t h e r a p y  with m e t f o r m i n  also received 
sulphonylurea, while those w h o  deve lo pe d hyperglycaemic s y m p t o m s  or fasting 
hyperglycaemia o n  m a x i m a l  oral therapy w e r e  transferred to insulin ( U K P D S ,  1998). 
Results indicate that lowering raised bl o o d  glucose a n d  blood pressure levels, with 
intensive use o f  existing treatments, substantially reduces the risk o f  heart disease, 
stroke a n d  death f r o m  diabetes-related diseases as well as diabetic eye disease a n d  
early kidney d a m a g e .  H o w e v e r ,  it is important to note that intensive treatment is not 
without side-effects. In the U K P D S ,  patients in the intensive group h a d  m o r e
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hypoglycaemic episodes compared to those in the conventional treatment group. In 
addition, weight gain w a s  significantly higher in the intensive group and patients 
assigned insulin had a greater gain in weight compared to those on oral 
hypoglycaemic medication.
1.6. M a n a g e m e n t  of Type 2 Diabetes
Type 2 diabetes is often difficult to manage, and is often poorly or insufficiently 
treated (Williams, 1994). T h e  treatment targets for patients with type 2 diabetes 
should be the s a m e  as for type 1, namely to abolish diabetic sy m p t o m s  and the risk of 
acute metabolic complications, to reduce the threat of chronic diabetic complications, 
to increase life expectancy to that of non-diabetic populations and to restore quality 
of life to normal. A t  present, none of these aims is m e t  in a substantial proportion of 
cases.
Lifestyle changes, especially dietary modification and increased physical activity are 
the starting point for all patients. Recommendations are that the high-fat, high- 
energy diets rich in refined carbohydrate should be replaced by a diet based on 
complex carbohydrates (accounting for over 5 0 %  of total energy intake), with a low 
fat content ( < 3 0 %  of total energy), especially saturated animal fats ( B D A ,  1992; 
A H A ,  2000). T h e  overweight majority are also encouraged to lose weight to bring 
their body-mass index (BM3) d o w n  to an acceptable level (<25kg/m2).
Unfortunately, lifestyle measures achieve adequate blood glucose control (fasting 
blood glucose levels < 7  mmol/1) in only 1 0 - 2 0 %  of cases ( U K P D S ,  1998).
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First-line drugs in type 2 diabetes are the sulphonylureas and the biguanides. Both 
types w o r k  only if the pancreas is still producing s o m e  insulin. T h e  sulphonylureas 
w o r k  principally by stimulating the islet cells of the pancreas to produce m o r e  insulin; 
they m a y  also have a beneficial effect on insulin sensitivity, enabling the insulin to 
w o r k  m o r e  effectively on cells. T h e  only biguanide n o w  used in the U K  is 
metformin. It is thought to act by enhancing uptake of glucose by individual cells 
and reducing the release of glucose by the liver (Williams, 1994; DeFronzo et al.,
1995). Sulphonylureas are considered to be m o r e  effective in non-obese patients, in 
w h o m  insulin deficiency m a y  play the dominant pathogenic role, while metformin is 
considered m o r e  appropriate for obese patients with marked insulin resistance. 
Neither drug lowers blood glucose levels by m o r e  than 2-3 mmol/1, and m a n y  patients 
therefore fail to be adequately controlled w h e n  they are used alone. E v e n  in patients 
w h o  respond initially, sulphonylureas and metformin m a y  later cease to be effective; 
it is not k n o w n  whether this ‘secondary failure’ is due to disease-related factors (i.e. 
declining B-cell function and/or worsening insulin resistance) or to poor patient 
adherence, although it is considered that the inevitable rise in blood glucose that 
occurs in patients with long-standing type 2 diabetes, irrespective of this m o d e  of 
treatment, argues in favour of the former (Lean et al., 1989).
M a n y  patients w h o  fail to respond to monotherapy with oral agents are treated with 
the combination of the two, and w h e n  this fails (as it ultimately does in most cases), 
with insulin. In the U K ,  1 5 - 2 0 %  of type 2 patients receive insulin (Lean, 1989). 
Various insulin regimens have been proposed, including once-daily injections of long- 
acting insulin, which relies o n  the patient’s remaining endogenous insulin to cover 
mealtime requirements, to multiple daily injections; the latter are needed particularly
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in patients w hose hyperglycaemia is driven mainly by insulin deficiency, towards the 
end of the natural history of type 2 diabetes.
Acarbose, an inhibitor of a-glucosidase in the gut wall and therefore of starch 
digestion, is used increasingly mainly as adjunctive treatment in patients w h o  are not 
controlled by sulphonylurea and/or metfonnin. Other treatments useful in obese 
patients include very-low-calorie diets and the weight-reducing drug Orlistat. Novel 
oral antidiabetic drugs currently undergoing clinical trials include the 
thiazolidinediones, which enhance insulin action. M a n y  of the decisions to be taken 
in managing type 2 diabetes are difficult. In particular m a n y  overweight patients w h o  
are poorly controlled m a y  not s h o w  any substantial improvement o n  insulin therapy 
and indeed m a y  gain further weight as a result, which in turn exacerbates the 
condition (Tattersall, 1987).
1.7. T h e  Challenge of T y p e  2 Diabetes
T h e  error in regarding type 2 as ‘mild diabetes5 (Gill, 1986) is n o w  well recognised, 
as is its importance as a major cause of disability and premature death. These 
problems are accentuated by the very large numbers of individuals concerned, 
considerably m o r e  than those with type 1. In 1997, approximately 14 million 
Americans had diabetes, with over 700 000 n e w  cases reported yearly (Harris et al.,
1998). A r o u n d  1.4 million people in the U K  today have diabetes. A t  least a million 
more, 'the missing million', are thought to have diabetes that has not yet been 
diagnosed (British Diabetic Association, 2000). This increasing prevalence is 
probably linked to the current obesity epidemic and the high levels of sedentary
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lifestyles in westernised societies and it is predicted to continue to increase sharply as 
the population ages (Laws et al., 1991).
Because type 2 diabetes is associated with such problematic comorbid conditions, 
including a substantially increased risk for cardiovascular disease, reducing risk 
factors such as obesity and physical inactivity through lifestyle modification, or at the 
very least limiting the disability associated with them, is crucial to the long-term 
health of individuals with type 2 diabetes (Albu et al., 1998). Although difficult to 
implement, lifestyle modification programmes also raise the possibility that such 
measures m a y  ultimately be able to contain the current epidemic of type 2 diabetes 
and limit the vast individual, social and financial d a m a g e  that it will otherwise cause.
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Chapter 2
2.1. Introduction
This review will focus predominantly on lifestyle modification interventions in type 2 
diabetes that aim to assess the effectiveness of dietary modification and exercise on 
changes in eating behaviour and physical activity patterns, body weight and other 
health outcomes in overweight and obese individuals with type 2 diabetes. Th e  
literature on interventions in overweight and obese individuals without type 2 
diabetes, in so far as it might inform this review, will also be considered. 
Consequently, the numerous other diabetes educational and psychosocial studies, 
m a n y  of which have been reviewed in two meta-analyses (Padgett, 1988; Brown,
1990) and a recent survey (Griffin et al., 1999) will be discussed only briefly for the 
following reasons: firstly, because m a n y  of these studies include subjects with both 
types of diabetes; secondly, because they do not usually have changes in eating 
behaviour and physical activity patterns as a primaiy outcome; thirdly, because the 
literature pertaining to these interventions has g r o w n  too large for inclusion. This 
focus has resulted in the literature for this review being organised into the following 
major areas: Behaviour change and psychological models, Role of behaviour in 
diabetes care, Educational and psychosocial interventions, Lifestyle modification 
interventions focusing on obesity and physical activity, Implications of the review 
findings for practice and future interventions in obese patients with type 2 diabetes.
2. Literature Review 011 Lifestyle modification interventions in type 2 diabetes
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2.2. Behaviour Change
H u m a n  behaviour and lifestyle account for m u c h  of the disease burden in western 
societies (Stamler, 1992). T h e  recognition that behaviour is a key component in both 
the generation and prevention of disease has led to numerous efforts to motivate 
individual patients and the public to change unhealthy habits. Accordingly, research 
has focused o n  the individuals’ beliefs and feelings about health and illness from a 
variety of different theoretical perspectives including the Health Belief M o d e l  ( H B M )  
(Rosenstock et al., 1988), Leventhal’s self-regulatory model (Leventhal et al., 1984), 
the transtheoretical model of behaviour change (Prochaska et al., 1984) and perceived 
self-efficacy (Bandura, 1977 ). There have been numerous clinical studies, reviews 
and theoretical papers on the subject of behaviour change (Ebrahim et al., 1997; 
Ashenden et al., 1997; Lawrence et al., 1996; Hjermann et al., 1981; Marlatt et al., 
1980) and Glanz et al. (1990) have reviewed over 50 models for understanding this 
complex phenomenon.
2.2.1. Psychological Models
T h e  Health Belief M o d e l  w a s  developed initially by Rosenstock in 1966 and further 
by Becker and colleagues throughout the 1970s and 1980s in order to predict 
preventative health behaviours and also the behavioural response to treatment in 
acutely and chronically ill patients. However, m o r e  recently the H B M  has been used 
to predict a wide variety of health-related behaviours (Champion, 1990; O ’Brien et 
al., 1990). T h e  H B M  predicts that behaviour is a result of a set of core beliefs, for 
example the individual’s perception of susceptibility to illness, the severity of the
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illness, the costs and benefits involved in carrying out the behaviour and cues to 
action which m a y  be internal or external to the individual. T h e  H B M  suggests that 
these core beliefs can be used to predict the likelihood that a behaviour will occur.
Leventhal and colleagues (1980; 1984) in the self-regulatory m o del of illness 
behaviour, defined illness cognitions as ca patient’s o w n  implicit c o m m o n  sense 
beliefs about their illness’. T h e y  proposed that these cognitions provide patients with 
a framework or schema for coping with and understanding illness or symptoms. Five 
cognitive dimensions of these beliefs were identified -  identity which refers to the 
label given to the illness and the s y m p t o m s  experienced, perceived cause which m a y  
be biological or psychosocial, time line which refers to beliefs about h o w  long the 
illness will last, consequences which refers to the patient’s perceptions of the possible 
effects of the illness on their lives and curability/controllability which refers to beliefs 
about whether the illness can be treated and cured and the extent to which the 
outcome of the illness is controllable either by themselves or by powerful others. 
Self-regulation is seen as emerging from a clinical tradition in psychology which sees 
the individual as involved in behaviour change efforts designed to eliminate 
dysfunctional patterns of thinking or behaviour (Bandura, 1982; Turk et al., 1986).
Prochaska and DiClemente (1982) developed the transtheoretical model of behaviour 
change (stages of change model) from a synthesis of 18 therapies describing the 
processes involved in eliciting and maintaining change. Th e y  suggested a model of 
behaviour change related to the individual’s state of readiness to change based on the 
following stages: precontemplation, i.e. not intending to m a k e  any changes, 
contemplation, i.e. considering changes in behaviour, preparation, i.e, getting ready to
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m a k e  changes, action, i.e. actively engaging in behaviour change and maintenance, 
i.e. sustaining the change for longer than 6 months. These stages were not considered 
to occur in a linear fashion, but rather the model describes behaviour change as a 
dynamic process, with the individual m o v i n g  back and forth between stages possibly 
several times before progressing to the action and maintenance stages. Thus, 
importantly the model incorporates the notion of lapse and relapse as part of the 
process of change. T h e  model also examines h o w  the individual weighs u p  the costs 
and benefits of a particular behaviour and suggests that individuals at different stages 
of readiness to change will differentially focus o n  either the costs of a behaviour or 
the benefits of a behaviour.
Bandura (1977) introduced the concept of perceived self-efficacy in the context of 
cognitive behaviour modification. According to the model, behavioural change is 
facilitated by a personal sense of control. If people believe that they can take action to 
solve a problem instrumentally, they b e c o m e  m o r e  inclined to do so and feel mo r e 
committed to this decision. Thus, perceived self-efficacy pertains to personal action 
control (Maddux, 1993; Bandura, 1992; Wallston, 1994). A  person w h o  believes in 
being able to cause an event can conduct a m o r e  active and self-determined life 
course. Self-efficacy levels can enhance or impede the motivation to act. Individuals 
with high self-efficacy choose to perform m o r e  challenging tasks. T h e y  set 
themselves higher goals and stick to t h e m  (Locke et al., 1990).
All of these models then provide a basis for understanding the determinants of 
behaviour and behaviour change and highlight important targets which interventions 
designed to change behaviour might focus upon if they are to be successful. Several
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specific behavioural strategies for example have consistently been found to be useful 
in the modification of dietary and physical activity patterns that lead to improvements 
in health outcomes.
2.2.2. Behavioural Strategies for Modifying Dietary and Physical Activity Patterns
Self-monitoring: Self-monitoring involves the systematic observation and recording of 
target behaviours, including the use of food and activity diaries to record caloric 
intake, fat grams, food groups, conditions or situations w h e n  overeating is c o m m o n ,  
and frequency, duration and/or intensity of exercise. Scales and body composition 
measures that record changes in weight or body fat also can be used (Foreyt et ai.,
1999).
While patients are not always accurate in their reporting of dietary and exercise 
behaviours, the primary purpose of self-monitoring is to increase patients’ awareness 
of their problematic dietary and activity patterns and the factors that influence h o w  
they behave (Lichman et al., 1992). Self-monitoring is associated consistently with 
improved treatment outcomes and patients report that it is one of the most helpful 
obesity m a n a g e m e n t  tools (Burke et al., 1995; Foreyt et al., 1996; Brownell et al.,
1995).
Stimulus control: Stimulus control involves identifying environmental cues that are 
associated with overeating and underactivity. Modification of these cues, and 
therefore changing the patient’s microenviromnent, m a y  increase success in 
sustaining dietary and activity behaviours (Foreyt et al., 1993; French et al., 1994).
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Controlling cues associated with overeating or inactivity can facilitate long-term 
maintenance because exposure to these cues m a y  precipitate relapse. There are 
numerous ways to implement this strategy, depending o n  the individual. Prompting 
patients to exercise through weekly telephone calls for example has been found to 
significantly enhance adherence to a walking p r o g r a m m e  (Lombard et al., 1995). In 
addition, eliminating the availability of snack foods in the house or restricting eating 
to particular rooms can be helpful.
Cognitive behaviour therapy (CBT):
Cognitive restructuring: Cognitive restructuring, a primary C B T  intervention, 
involves getting patients to address their thoughts and beliefs about themselves and 
their weight and teaching t h e m  to actively challenge and change aspects of their 
internal dialogue. This is particularly important because s o m e  obese individuals hold 
unrealistic beliefs about h o w  m u c h  weight they can lose and the benefits that weight 
loss will have on their lives. For example, Foster et al., (1997) found that patients in 
their obesity m a n a g e m e n t  study had weight loss expectations that were substantially 
different from what w a s  realistically achievable. While m a n y  patients lose about 
1 0 %  of their initial weight during treatment, reducing their risks for obesity related 
morbidity, this moderate amo u n t  of weight loss w a s  m u c h  less than the weight loss 
that these patients defined as an acceptable outcome (Foster et al., 1977; Institute of 
Medicine, 1995).
Stress management: Stress is a primary predictor of relapse and overeating and stress 
m a n a g e m e n t  and inoculation training are an important part of most C B T  programmes. 
Stress m a n a g e m e n t  and inoculation involve teaching patients methods for reducing 
stress and tension, including diaphragmatic breathing, progressive muscle relaxation
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or meditation ((Klem et al, 1997). In addition, stress inoculation involves having 
patients visualise stressful situations while practicing their relaxation skills, therefore 
allowing t h e m  to practice managing stressors in a safe enviromnent and improving 
their confidence in coping with stressful situations. These techniques are designed to 
reduce tension and associated sympathetic nervous system arousal in response to 
stressors and have been found to be very effective for numerous health-related 
problems (Everly, 1990; Lazar 1996; Lichstein, 1988; Mandle, 1996).
Relapse prevention: It is important to prepare patients for lapses in their lifestyle 
change programmes. Patients are taught that lapses are normal and that they need to 
recognise and anticipate situations that might cause a lapse. For example, m a n y  
studies have found that negative emotions and social situations, such as holidays or 
parties, are associated with lapses (Foreyt et al., 1994). Didactic training, modelling, 
role-playing and visualisation methods can be used to help patients develop coping 
strategies to m a n a g e  lapses and prevent full relapses (Marlatt et al., 1985).
Social support: Social support is an important component of successful lifestyle 
change. M a n y  studies have found that individuals with higher levels of social 
support tend to do better in weight m a n a g e m e n t  programmes ( K a y m a n  et al., 1990; 
K l e m  et al., 1997; Foreyt et al., 1991). Social support m a y  involve including the 
family in the intervention, participation in a community-based p r o g r a m m e  or 
involvement in any outside social activity. Peer and family support m a y  be 
particularly useful because it helps patients learn greater self-acceptance, develop n e w  
norms for interpersonal relationships and m a n a g e  stressful w o r k  or family related 
situations (Cousins et al., 1992).
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Barriers to change: It is important to identify perceived barriers to change. Obese 
diabetic patients have a higher risk for multiple comorbid medical conditions, which 
m a y  substantially increase their discomfort during activity and limit their endurance 
and flexibility (National Institutes of Health Report 1998). For example, Mattsson et 
al. (1997) found that severely obese w o m e n  (i.e.BMI>44) w h o  were tested during 
walking and cycling ergometry walked slower, had lower % V 0 2 m a x / k g  and higher 
V 0 2  and % V 0 2  m a x  than nonnal controls. In addition, they reported high degrees 
of perceived exertion and pain. These results suggest that walking, which is 
generally considered to be a moderate-intensity activity, m a y  actually be m o r e  intense 
for obese individuals due to the greater relative oxygen cost of walking associated 
with increased body mass.
Obese diabetic patients, therefore m a y  be m o r e  likely to perceive even moderate- 
intensity activity, such as walking, as exerting and painful which m a y  have a negative 
impact o n  adherence (Mattsson, 1997). Thus the presence or one or m o r e  comorbid 
medical conditions m a y  present a significant barrier to starting or maintaining a 
physical activity programme. Other barriers include those that affect any individual, 
such as lack of time, equipment, facilities, childcare or family support ( U S D H H S ,  
1996).
Similarly, other important barriers to lifestyle change in the obese diabetic patient 
m a y  be programme-based shortcomings. For example, the foundation of m a n y  
physical activity programmes is based on research that has focused on 
cardiopulmonary benefits (Brownell, 1995). This can have the unfortunate side 
effect of discouraging individuals from starting activity programmes because they
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m a y  mistakenly assume that small amounts of low-intensity activity, which is where 
most overweight and obese diabetic patients will begin, are not of any health value.
In addition, low to moderate-intensity physical activity programmes for obese diabetic 
patients initially m a y  be very helpful in improving psychological well-being, 
functional status and adherence, paving the w a y  for participation in m o r e  intense 
programmes (Foreyt et al., 1995; Blair et al., 1996; Slcender et al., 1996).
Strategies to promote adherence: There are several basic strategies that can be 
utilised to improve adherence to lifestyle modification programmes. First, 
developing good rapport with patients is very important. This can involve discussing 
barriers to treatment and providing patient education about the need for intervention 
and reviewing the expected course and outcomes.
Patient education is an important part of most interventions and works to address 
m a n y  patient and provider related barriers (Foreyt et al., 1996). Examples of patient 
education include ensuring that the patient understands the dietary and activity 
prescriptions by writing t h e m  down, discussing the patient’s beliefs about their 
diabetes and h o w  diet and physical activity m a y  benefit them, providing clear 
information about obesity and related conditions and h o w  lifestyle change m a y  be 
helpful in improving these conditions, and assessing the patient’s expectations. 
Building alliances with the patient is a very effective method of improving treatment 
adherence and addressing important psychosocial barriers to dietary change and 
physical activity for obese diabetic patients (Grilo, 1995).
In addition, treatment regimens can be modified so that they are m o r e  easily 
incorporated into the individual’s life. For example, the emphasis on moderate
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lifestyle activities is one w a y  to m a k e  physical activity initially m o r e  accessible to 
obese patients with type 2 diabetes (Blair, 1996). Including patients in the 
development of m a n a g e m e n t  goals and encouraging t h e m  to increase their activity 
intensity and duration gradually can be helpful. Giving feedback about progress and 
providing a w a y  for patients to monitor progress through self-monitoring is one of the 
most effective methods for enhancing activity and dietary adherence and promoting 
weight loss (Shah, 1996; Foreyt et al., 1994; K a y m a n  et al., 1990). Furthermore, the 
beneficial effect of social support has been demonstrated for physical activity, dietary 
change and the m a n a g e m e n t  of obesity (Burke et al., 1995;Cousins, 1992; Skender,
1996).
2.3. Role of Behaviour in Diabetes Care
Diabetes treatment predominantly involves self-management behaviours on the part of 
the patient, which include daily injections and medication taking, glucose testing, and 
the modification of physical activity and dietary habits. Problems in following 
diabetes regimens have been well documented (Glasgow, 1991; Johnson, 1994). 
Research has consistently found that while the various diabetes self-care behaviours 
are relatively independent of one another (Rubin, 1989) dietary aspects of the regime 
are experienced as the most difficult followed by physical activity (Fisher et al., 1997; 
Ar y  et al., 1986; Schlundt et al, 1994). M o s t  patients find medication taking to be 
the area in which they have the least difficulty (Glasgow, 1994) which m a y  be 
because this is the regimen area emphasised most by health care professionals and 
most associated with ‘managing an illness’ in the public’s perception.
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2.4. Educational and Psychosocial Interventions
Since implementing diabetes m a n a g e m e n t  lies largely with the patient’s daily efforts 
(Eakin, 1996; Anderson et al., 1991) numerous patient education interventions have 
been developed. These interventions were systematically reviewed in tw o  meta­
analyses (Padgett, 1988; Brown, 1990) and have been s h o w n  to improve self-care and 
health status, a finding that wa s  recently reinforced by a survey of educational and 
psychosocial interventions for people with diabetes (Griffin et al., 1999). Several 
patient activation interventions have reported strong and wide-ranging effects 
including improvements in self-efficacy, metabolic control, patient satisfaction and 
quality of life (Anderson, 1991, 1995;Greenfield et al., 1988). Controlled studies 
have demonstrated lasting improvements in quality of life as well as glycaemic 
control (Rubin et al., 1993; Clement, 1995). These benefits have also been 
accomplished with minority and older type 2 patients (Glasgow et al.,1992; Anderson, 
1991). In addition, tailored nutrition messages have been s h o w n  to be effective in 
promoting dietary fat reduction (Campbell et al., 1994) and physical activity (Bull et 
al., 1999). Computer-tailored interventions are also proving increasingly efficient and 
effective in motivating people to adopt health-promoting behaviours (Glasgow et al., 
1996; Brug et al., 1999).
2.5. Lifestyle Modification Interventions in Type 2 Diabetes
Lifestyle modification interventions in type 2 diabetes, which focus on changing 
behaviours which are thought to contribute to, or maintain, obesity and inactivity, 
have their roots in behavioural modification and include several of the techniques 
described above, including the use of self-monitoring and goal setting, stimulus
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control and modification of eating style and habits, the use of reinforcement of 
healthy behaviours, cognitive behavioural therapy interventions that focus on 
identifying barriers to change and improving coping skills, relapse prevention training 
and maintenance, and the use of social support. All of these strategies focus on 
changing the diabetic individual’s problematic dietary habits and physical inactivity in 
order to reduce obesity and increase physical activity both of which have been s h o w n  
to improve health outcomes in type 2 diabetes.
2.5.1. Obesity
Accumulating scientific evidence indicates that the risk of death from cardiovascular 
disease and all causes increases throughout the range of overweight ( B M I > 2 5  kg/m2) 
and obesity ( B M I > 3 0  kg/m2) across the adult lifespan (Stevens et al., 1998; Calle et 
al., 1999). Calle et al. (1999) reported the B M I  range associated with the lowest 
mortality to be between 22.0 and 23.4 kg/m2 for w o m e n  and 23.5 and 24.9 kg/m2 for 
men, whereas Stevens et al. (1998) found the range to be between 19.0 and 21.9 
k g / m 2  for both genders. It is notable that the incidence of cardiovascular and 
metabolic disease begins to increase at a B M I  well below 25 k g /m2 ( M o k a d  et al., 
1999; American Heart Association, 1998; Willet et al., 1999). Accordingly, adults of 
all ages are r e c o m m e n d e d  to strive for a healthy normal weight consistent with a B M I  
between 18.5 and 24.9 kg/m2 ( W H O ,  1998). Table 2.1 shows the W o r l d  Health 
Organisation classification scheme for overweight and obesity by B M I  with 
associated disease risk. Given the increased prevalence of obesity in industrialised 
countries, most adults fall outside the desirable B M I  range associated with a normal 
weight.
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Table 2.1. World Health Organisation classification scheme for overweight and 
obesity by the body mass index with associated disease risk 1998.
Classification Obesity class B o d y  mass index (kg/n
Underweight <18.5
N o r m a l 18.5-24.9
Overweight 25.0-29.9
Obesity I 30.0-34.9
n 35.0-39.9
Extreme obesity HI >4 0
2.5.2. Obesity and Type 2 diabetes
Obesity is one of the biggest obstacles to the m a n a g e m e n t  of type 2 diabetes. 
Although obesity does not necessarily lead to the development of type 2 diabetes, 
epidemiological studies have s h o w n  that the risk of type 2 diabetes increases 
exponentially with body mass index (BMI) over 28 kg/m2 (Colditz et al., 1995). For 
example, the risk is 80 fold greater in an individual with morbid obesity ( B M I>40)  
compared with an individual with a B M I < 2 2 .  T h e  life-time risk of acquiring type 2 
diabetes is approximately 5 0 %  in subjects with morbid obesity and central obesity is 
considered to be particularly diabetogenic.
There is evidence for a causal link between obesity and type 2 diabetes. Obesity 
worsens insulin resistance, one of the fundamental causes of type 2 diabetes, although 
the pathophysiological mechanisms remain uncertain (DeFronzo, 1992). There are 
particularly strong links with visceral fat; high levels of free fatty acids generated by 
intra-abdominal fat depots m a y  act directly on the liver to interfere with glucose 
handling, insulin clearance and other vital homeostatic metabolic processes.
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Obesity m a k e s  a significant contribution to the morbidity and mortality associated 
with type 2 diabetes, largely through its contribution to cardiovascular disease. In 
non-diabetic subjects, obesity is c o m m o n l y  associated with hypertension, 
dyslipidaemia and ultimately with atherogenesis and premature death from 
cardiovascular disease. These risks appear to be accentuated in diabetic subjects.
For example, the risk of premature death is 10 fold greater in a diabetic person with a 
B M I  >36, compared with a non-obese diabetic patient.
M a n a g i n g  a patient with type 2 diabetes and obesity can be seen as a conflict of 
interests, because the most effective treatments for type 2 diabetes, that is insulin and 
sulphonylureas, frequently lead to weight gain. This is one of the problems of the 
conventional approach to the m a n a g e m e n t  of type 2 diabetes in which the disease and 
its associated complications are considered separately. T h e  side effects and metabolic 
effects of drugs used to m a n a g e  type 2 diabetes frequently exacerbate the other 
complications. For example, if the physician focuses on achieving control of blood 
glucose levels with insulin or sulphonylurea therapy, this can lead to weight gain 
which in turn m a y  worsen insulin resistance and other aspects of the metabolic 
syndrome. Exacerbation of hypertension and dyslipidaemia m a y  then arise.
In contrast to these approaches, recent studies have s h o w n  that addressing the problem 
of obesity first can lead to an improvement in blood glucose control which can be 
accompanied by a decrease in blood pressure, an increase in insulin sensitivity and 
favourable changes in blood lipid profiles. Swedish and American studies of patients 
undergoing bariatric gastric surgery for example, found that of the 5 0 %  of patients 
w h o  had type 2 diabetes or were glucose intolerant before surgery, most patients
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developed normal glucose tolerance within 5-6 years of surgery (Pories et al., 1995). 
Thus, the successful loss of a substantial a m o u n t  of weight improved glucose 
tolerance dramatically.
Other studies have s h o w n  that a loss of 5 - 1 0 %  of body weight can produce 
statistically significant benefits. Several studies have reported that patients achieving a 
loss of body weight of 5 %  or greater achieved a small but significant decrease in 
H b A l c  levels, and that clinically meaningful improvements in H b A l c  can be obtained 
with a > 1 0 %  decrease in body weight ( U K P D S ,  1990; W i n g  et al., 1987). This is 
comparable, for example, to the improvement in glycaemic control anticipated 
following the addition of a second oral antidiabetic agent.
Weight loss in obese patients with type 2 diabetes can therefore significantly improve 
their clinical condition. A s  already emphasised, the multiple beneficial effects of 
weight loss on several features of the metabolic syndrome that contribute to atheroma 
m e a n  that weight reduction is a rational and conceptually attractive option in the 
m a n a g e m e n t  of type 2 diabetes. Indeed, in theory at least, it could be preferable to 
using several different drugs to treat the individual disorders of this syndrome.
2.5.3. Weight Loss Interventions
H o w  then is weight loss achieved and maintained? Beginning with the purely 
theoretical applications of Skinnerian principles to changing eating behaviour in the 
1960s (Ferster et al., 1962; Stuart, 1967), behavioural treatment has since b e c o m e  the 
principal m e a n s  of managing mild to moderate obesity in both diabetic and 
nondiabetic populations. M o r e  than 150 studies have been conducted on this topic,
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including comparisons of both behavioural and non-behavioural treatments and 
studies analysing the effectiveness of specific behavioural interventions (for example 
Wing, 1989). Behavioural treatments are based on the assumption that changing an 
individual’s intake and/or exercise behaviours can produce weight loss. Detailed 
descriptions of behavioural treatments have been published b y  W a d d e n  and Bell 
(1990) and W i n g  (1989).
Brownell et al. (1987) reviewed the results of behavioural weight-control studies 
published from 1974 to 1986. T h e y  reported that weight losses achieved in 
behavioural interventions had improved markedly over time, increasing from a m e a n  
weight loss of 3.86 k g  in 1974 to a m e a n  weight loss of 10.0 kg in 1986. A  major 
determinant of the improved outcome w a s  that over the years treatments had b e c o m e  
longer and m o r e  intensive and weight loss w a s  correspondingly greater. Although 
most of the behavioural treatment studies involved only short-tenn evaluation of 
effectiveness, follow-up duration had increased. Brownell et al. reported that the 
average length of follow-up for a sample of studies appearing in several major 
psychology journals w a s  15.5 weeks in 1974. In 1986, the average length of follow- 
up w a s  44 weeks. T h e  duration of treatments provided and the amo u n t  of weight loss 
achieved increased over the s a m e  period, although the n u m b e r  of pounds lost per 
w e e k  did not change dramatically (Brownell et al., 1987). Thus, the lengthening of 
treatment w a s  regarded as probably the most important factor in the improvement in 
results.
T h e  maintenance of weight loss w as also reported to have improved over time. In 
1974, the average length of follow-up w a s  only 15.5 weeks, and subjects maintained a
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weight loss of 4 kg over this time. In 1986, the average length of follow-up w a s  44 
weeks. Overall weight loss from pre-treatment to follow-up averaged 6.6 kg.
F e w  early studies however included follow-up periods >1 year. K r a m e r  et al. (1989) 
reviewed 13 behavioural studies with follow-up >1 year and found that the m e a n  
weight loss decreased from 7.3 kg at posttreatment to 5.8 kg at 1 year, 5.0 kg at 2 
years, 3.6 kg at 3 years and 3.4 k g  at 5 years. These results suggest that the long- 
tenn outcome of these programmes indicates a trend towards weight regain.
Later behavioural studies were distinguished by the inclusion of longer, m o r e  intense 
maintenance programmes. M o s t  notably, Perri et al. (1988, 1989) found that patients 
w h o  were treated in a 20 w e e k  behavioural p r o g r a m m e  with no maintenance 
programme, lost 10.8 kg initially and maintained a weight loss of 3.6 kg at 18-months 
follow-up. In contrast, patients given the s a m e  behavioural programme, with an 
intensive 18 months maintenance p r o g r a m m e  involving biweekly treatment meetings, 
structured aerobic exercise, and social influence strategies, lost 13.67 k g  initially and 
maintained a loss of 13.54 kg at 18-months follow-up.
W i n g  et al. have conducted the most systematic research in this area, focusing on 
intensive, structured behavioural group and individual weight loss studies with 
individuals with type 2 diabetes. Table 2.2 presents the results of eight controlled 
studies of behavioural weight loss with type 2 patients conducted by these 
investigators from 1985-1991.
T h e  patients in the W i n g  et al. studies were recruited through newspaper 
advertisements and physician referrals. Eligibility criteria varied slightly across the
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studies, but typically patients were 3 0 - 1 0 0 %  above ideal body weight, 30-70 years of 
age, and had blood glucose levels that m e t  the diagnostic criteria for type 2 diabetes. 
S o m e  of the studies included patients on insulin, while others did not; in exercise 
studies, patients were required to be able to walk for exercise, and in studies with very 
l ow calorie diets (VLCDs), patients could not have any medical conditions that would 
m a k e  the use of such diets contraindicated.
T h e  patients entering the studies averaged 53 years of age, with a 6-year history of 
diabetes. A t  entry, B M I  averaged 35-38 across studies, and H b A l  averaged 10-15%. 
All behavioural treatments used in these studies were executed in groups, conducted 
by a team of therapists that included at least one behaviourally trained clinician and a 
nutritionist. Prog r a m m e s  m e t  weekly for 10-20 weeks, with the exception of studies 
3 and 5 (1988), in which patients m e t  2-3 times/week during the first 10 weeks of the 
programme, and study 8 (1991) which used a m u c h  longer treatment format i.e. 50 
weeks of treatment. In the majority of these programmes, a calorie-counting diet wa s  
used, with calories set at 1000-1500 kcal/day. Exercise in the form of walking was  
stressed, with patients encouraged to gradually increase their exercise to a goal of a 2- 
mile walk 5 days/week. T h e  behavioural programmes included training in self­
monitoring, stimulus control techniques, preplanning, assertion, cognitive 
restructuring, and relapse prevention.
A s  can be seen from Table 2.2, results have gradually improved over time and W i n g  
et al. have achieved results with diabetic patients that are comparable to those 
obtained with nondiabetic subjects. However, long-tenn outcomes for these studies
35
still remain modest and results suggest a trend towards weight regain, findings which 
are consistent with the earlier findings reported above.
Table 2.2. Behavioural intervention in Type 2 diabetes (Wing et al., 1993)
Weight Loss (Kg)
Study E n d  of 1 year
(Reference) Treatment Condition Treatment Follow-up
1(1985) Nutrition Education (monthly meetings) 2.9 3.4
Nutrition Education (weekly meetings) 3.9 3.8
B T  (weekly meetings) 6.3 1.8
2(1986) B T  plus S M B G 5.8 4.1
B T 6.8 8.2
3 (1988) Diet plus placebo Exercise 7.3 4.0
Diet plus structured Exercise 8.5 7.8
4 (1988) B T  plus S M B G 7.0 3.8
B T  plus S M B G  plus self-regulation 5.1 3.6
5 (1988) Diet only 5.6 3.8
Diet plus structured Exercise 9.3 7.9
6(1991) Couples p r o g r a m m e  -  alone 9.0 5.3
Couples p r o g r a m m e  -  with spouse 8.6 3.2
7(1991) B T 10.1 6.8
B T  plus 1 V L C D 18.6 8.6
8(1991) B T  -  full year p r o g r a m m e 12.3 10.5
B T  plus 2 V L C D s  -  full year p r o g r a m m e 16.4 14.0
B T = B e h a v io ra l  T h e ra p y , S M B G = S e lf -M o n ito r in g  o f  B lo o d  G lu c o s e , V L C D = V e iy - L o w - C a lo r ie  D ie t
Glenny et al. (1997) identified two further studies by W i n g  and colleagues for 
inclusion in a systematic review of the literature o n  the prevention and treatment of 
obesity. T h e  first of these reviewed a four-month behavioural p r o g r a m m e  in which
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two different types of diet (calorie restriction versus calorie and fat restriction) were 
analysed in participants either with type 2 diabetes or with a family history of type 2 
diabetes (Pascale et al., 1995). Participants with type 2 diabetes achieved a m e a n  
weight loss of 5.2 kg with the calorie and fat restricted diet at the end of the eight 
m o n t h  follow-up compared to 0.96 for calorie restriction alone. This difference wa s  
statistically significant (p<0.05). For those with a family history of type 2 diabetes, 
there were no significant differences with respect to the diet received. In a further 
study, W i n g  et al. (1994) compared a 12-month continuous low calorie diet (LCD; 
1000-1200 kcals/d) to a lo w  calorie diet with intermittent periods of a very low calorie 
diet ( V L C D ;  400-600 kcals/d). At both one and two year follow-up, there w a s  no 
significant difference between the tw o  groups for weight loss, and weight regain 
occurred in both groups. Similar findings were again reported by W i n g  et al. (1998) 
in a lifestyle intervention, which included a highly restricted diet, carried out over 2 
years, in overweight individuals with a parental history of diabetes. Although 
initially successful, the interventions in this study were not effective in producing 
long-term changes in behaviour, weight or physiological parameters in this study 
group. Furthermore, while W i n g  et al. suggest that long-tenn interventions 
continuing over periods as long as 2 years m a y  be required to produce substantial 
weight loss in this population, this study experienced marked decreases in attendance 
over time, a major problem for future research attempting to replicate these 
interventions.
In contrast to these studies and the call for longer, m o r e  intensive inteiventions, 
Gla s g o w  and colleagues have been developing brief on-going self-management 
interventions that can be integrated into routine patient visits, and have demonstrated
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short-term success in improving self-care a m o n g  older patients with type 2 diabetes 
(1992). Further studies have also demonstrated (Glasgow et al., 1996; 1997) that a 
brief, low-cost computer-assisted dietary intervention conducted during routine 
outpatient visits produced sustained changes at 12-month follow-up in fat intake and 
cholesterol levels, but not weight loss.
In a comprehensive review of the literature, G a m e r  and W o o l e y  (1991) questioned the 
appropriateness of behavioural and dietary treatments of obesity in light of 
overwhelming evidence that they are ineffective in producing lasting weight loss.
T h e y  suggest that decades of research o n the biology of weight regulation m a k e  clear 
the unlikelihood of success with dietary treatment, information which the health 
professions have been slow to integrate, and r e c o m m e n d  improving lifestyle and 
health risk factors as important goals of treatment without requiring weight loss. 
Similarly, Wilson (1994) in a further review, points out that while over the years 
treatments have b e c o m e  longer and m o r e  intensive, often being combined with 
V L C D s ,  as highlighted by the W i n g  et al. (1998) study above, and weight loss has 
been correspondingly greater, the fundamental problem noted at the outset has 
remained: ‘the inexorable pattern of relapse irrespective of diverse attempts to 
improve long-tenn maintenance’.
2.5.4. S u m m a r y  and conclusions
Research indicates therefore that lifestyle modification interventions for obesity, in 
both diabetic and nondiabetic populations, appear to be able to demonstrate moderate 
success in promoting at least s o m e  short-tenn weight loss. However, there is
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virtually no evidence that clinically significant weight loss can be maintained over the 
long-term by the vast majority of people and Glenny et al. (1997) conclude that the 
majority of the studies included in their systematic review demonstrate weight regain 
either during treatment or post-inteivention. Although most patients maintain weight 
loss for at least a year, five-year follow-ups have s h o w n  that virtually everyone 
returns to their baseline weight (Wadden, 1989). Furthermore, research suggests that 
weight fluctuation m a y  have profound effects on health, with reports suggesting an 
association between weight fluctuation and mortality and morbidity from coronary 
heart disease ( H a m m  et al., 1989; Lissner et al., 1991). Repeated failed attempts at 
weight loss therefore m a y  be m o r e  detrimental to physical health than remaining 
statically obese. In 1958, it w a s  said that “M o s t  obese persons will not stay in 
treatment for obesity. O f  those w h o  stay in treatment most will not lose weight and 
of those w h o  do lose weight, most will regain it “ (Stunkard, 1958). In the intervening 
decades, little appears to have changed in the treatment of obesity.
2.6. Physical activity
Since the early w o r k  of Morris et al. (1958) on the role of physical inactivity in the 
development of coronary artery disease, population-based studies on physical activity 
and health have led to the consensus that sedentary living leads to coronary artery 
disease, type 2 diabetes and other health problems. T h e  physiological (Blair et al., 
1989; Paffenbarger et al., 1986) and psychological (Scully et al., 1998; Folkins et al., 
1981; Pauly et al., 1982; Taylor et al, 1985) benefits of physical activity are well 
documented. However, although the quality and quantity of physical activity 
r e c o m m e n d e d  for improving cardiovascular fitness (American College of Sports 
Medicine, 1990), and promoting health (Blair et al., 1992) and psychological well­
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being (Lluch et al., 2000) have been described, m o r e  than 7 0 %  of adult populations in 
both Europe and the U S  are not participating in regular physical activity ( Pescatello 
et al., 2000; Hill, 1999; Blair, 1988; Caspersen, 1986).
2.6.1. Physical activity and Ty p e  2 Diabetes
T h e  possible benefits of increased physical activity for the patient with type 2 diabetes 
are substantial, and recent studies strengthen the importance of long-term exercise 
programmes for the treatment of this illness. Physical activity can improve overall 
metabolic control, independent of weight or weight loss (Wallberg-Henriksson, 1992) 
and improved metabolic control m a y  lead to fewer type 2 complications and greater 
longevity (Hazard, 1995). Improved metabolic control occurs within days or even 
hours of physical activity (Rogers et al., 1988).
T h e  mechanisms responsible for increased glucose uptake and insulin sensitivity in 
response to bodily m o v e m e n t  are complex, but theoretically, increased muscle activity 
produces an increase in muscle blood flow, which leads to increased glucose and 
insulin delivery to the muscle. Next, muscle contraction results in an increase in 
m e m b r a n e  permeability to glucose, which m a y  be facilitated by an increase in the 
insulin sensitivity of the muscle (Wallberg-Henriksson, 1992). Importantly, this 
increased permeability can last for m a n y  hours after the cessation of muscle 
contraction and works in an additive fashion with insulin. Perseghin et al. (1996) 
recently s h o w e d  that physical activity performed at 5 5 - 7 0 %  of m aximal heart rate 
four times per w e e k  for 6 weeks led to increased insulin sensitivity through a twofold 
increase in insulin-stimulated glycogen synthesis in muscle, which w a s  due to an
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increase in insulin-stimulated glucose transport phosphorylation. This process w a s  
apparent a m o n g  people with and without type 2 diabetes.
2.6.2. Physical Activity Interventions
Observational studies have consistently supported theoretically expected associations 
between physical activity and prevention of type 2 diabetes (Laws et al., 1990; 
Regensteiner et al., 1991; Rew e r s  et al., 1994). Prospective cohort studies have 
s h o w n  that the incidence of type 2 diabetes is lower a m o n g  those w h o  report regular 
physical activity (Powell et al., 1994; Helmrich et al., 1991; L y nch et al, 1996),
These observational studies occurred over 2-14 years of follow-up and relied on self- 
reported physical activity levels, m a k i n g  estimates of dose response imprecise. 
Nonetheless, several studies have documented an expected pattern of decreased 
incidence with greater physical activity (Helmrich et al., 1991; L ynch et al., 1996).
Intervention studies have s h o w n  that physical activity plays an important role in 
glucose tolerance and insulin sensitivity both with and without weight loss (Perseghin 
et al., 1996; M a n s o n  et al, 1996; Eriksson et al., 1991). O n e  study demonstrated a 
3 6 %  reduction in plasma glucose concentration in an oral glucose tolerance test after 
1 w e e k  of intense physical activity a m o n g  seven m e n  with mild type 2 diabetes and 
three m e n  with IGT, while no changes in weight occurred over this period (Rogers et 
al.,1988). Another study demonstrated a 1 5 %  drop in H b A l c  a m o n g  20 m e n  with 
type 2 diabetes after just 6 weeks of moderate-intensity physical activity thr ee times 
per w e e k  for 30 minutes per session (Schneider et al., 1984). Stuart (1991) showed a 
significant reduction in H b A l c  after 12 weeks of moderate-intensity physical activity 
performed three times per w e e k  a m o n g  five w o m e n  with type 2 diabetes.
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Intervention studies with long-term follow-up have been few, and the f ew have 
generally included both physical activity and diet in the inteivention. At least one 
study of aerobic exercise alone did not find long-term improvements in glycemic 
control, but another study of resistance exercise alone showed a 1 0 %  improvement in 
H b A l c  (Eriksson et al., 1997). Kaplan et al. (1987) showed a 1 6 %  drop in H b A l c  
(9.2 to 7.7) over an 18-month diet with a moderate-intensity physical activity 
intervention program a m o n g  type 2 diabetes individuals, with no changes in weight. 
Eriksson et al. (1991) demonstrated that an intervention consisting of 6 months of 
supervised diet and physical activity training led to significant improvements in 
glucose tolerance at the 5-year follow-up a m o n g  41 Swedish m e n  with mild type 2 
diabetes at baseline. O f  these 41 subjects, 4 4 %  no longer reached glucose levels 
diagnostic for diabetes at the 5-year follow-up. Furthermore, Y a m a n o u c h i  et al.
(1995) found that patients assigned to a dietary p r o g r a m m e  augmented with moderate 
physical activity demonstrated significantly greater changes in glucose infusion and 
metabolic clearance rates compared to patients undergoing the diet p r o g r a m m e  alone.
However, it is well established that the benefits that accompany physical activity are 
initially obtained and subsequently retained only if individuals maintain appropriate 
exercise regimens over the long term (American College of Sports Medicine, 1990). 
Typically, 5 0 %  of the individuals w h o  begin an exercise p r o g r a m m e  stop within the 
first 6 months (Blair,1988; Dishman,1982; Leith, 1992). Results have been 
remarkably similar in studies with children (Epstein et al., 1982, 1984), college 
students (Dishman et al., 1981; Epstein et al., 1980), young and middle-aged m e n  and 
w o m e n  (Martin et al., 1984; Sallis et al., 1986) and older individuals (King et al.,
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1988; Kriska et al., 1986). Similar adherence patterns have been observed in primary 
prevention studies (Illmarinen et al., 1989; Morris et al., 1980), secondary prevention 
treatment programmes (Shephard, 1986; Oldridge et al., 1983), and worksite settings 
(Wieretal., 1989; Shephard, 1992).
2.6.3. S u m m a r y  and conclusions
These studies highlight the important role of physical activity in the prevention and 
m a n a g e m e n t  of type 2 diabetes. Physical activity programmes demonstrate 
significant and persistent benefits in terms of improvements in glycaemic control, 
insulin sensitivity and cardiovascular risk factors w h e n  they are regular and of at least 
moderate intensity ( B u e m a n n  et al., 1996; Eriksson et al., 1997; K a n g  et al. 1996; 
Young, 1995). In addition, physical activity not only significantly improves insulin 
sensitivity and glycaemic control in patients with type 2 diabetes, but it is an 
important predictor of weight loss maintenance ( B u e m a n n  et al., 1996; Eriksson et al., 
1997; Young, 1995; K a y m a n  et al., 1990; Foreyt et al., 1994). While physical 
activity alone m a y  not produce substantial weight losses, the improvements in 
psychological functioning that result from exercise, for example improved body 
image, psychological well-being and eating self-efficacy m a y  help obese and 
overweight diabetic patients better cope with and be less reactive to stressful 
situations and reduce overeating and the resultant negative emotions that lead to 
relapses (Foreyt et al., 1995; Grilo, 1995).
However, m o r e  effective approaches for maintaining adherence to physical activity 
programmes are needed in order to improve health outcomes. T h e  traditional
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structured exercise prescription for becoming physically fit has failed dismally in 
motivating most adults to b e c o m e  habitually physically active ( U S D H H S ,  1996).
T h e  fitness oriented exercise prescription advocated participation in 20-60 minutes of 
continuous aerobic exercise for three to five days a w e e k  performed at 6 0 - 8 5 %  
m a x i m a l  oxygen consumption (V02m a x ) ,  which is equivalent to 7 0 - 9 0 %  of the 
m a x i m u m  age predicted heart rate or 7-10 metabolic energy equivalents ( M E T s ;  Pate 
et al., 1995). M o s t  people do not ordinarily exert themselves beyond 3 0 - 3 5 %  of the 
V 0 2 m a x  (Hardman, 1999). In recent year's, it has b e c o m e  evident that the quantity 
of exercise needed for health benefit is considerably less than that needed to achieve 
physical fitness ( U S D H H S ,  1996; Pate et al., 1995). In addition, participation in 
vigorous activity is associated with increased risk of injury and death for irregular 
exercisers and those with disease (Giri et al., 1999; Shaper et al., 1994) which are 
c o m m o n  features of those with type 2 diabetes w h o  are overweight and obese.
44
T h e  care of the obese individual with type 2 diabetes requires a perspective that 
acknowledges the complex, chronic nature of this condition. Since there is as yet no 
‘cure’ for obesity, care should be viewed in terms of long-term m a n a g e m e n t  as in the 
treatment of other chronic conditions, replacing short-term interventions that 
emphasise idealistic goals of weight loss with a continuous-care model that focuses on 
the achievement of realistic objectives (Perri et al., 1993,1992). This review 
highlights that treatment goals stated in terms of ideal weights or specific numbers of 
pounds to be lost should be abandoned. Since obese diabetic individuals do not have 
direct control over h o w  m u c h  weight they lose, treatment goals should be framed in 
tenns of behaviours that they can control, such as the quality of the food that they 
c o n s u m e  and the amounts and types of physical activity they perform.
This model could offer a n e w  and even optimistic perspective on treatment.
Successful outcome can then be viewed not solely in terms of weight loss, but in 
beneficial changes in risk factors and improvements in quality of life (Foreyt et al., 
1994; Atkinson, 1993; Kaplan, 1990), which represent important indicators of 
success. Improvements in the quality of the diet should be a component of care 
independent of weight reduction (Hill et al., 1993). Reductions in amounts of dietary 
fats, for example, can improve health as well as assist in small amounts of weight 
loss. Restrictive dieting on the other hand has been associated with adverse effects on 
control of food intake, increasing both binge eating and emotional eating (Polivy et 
al., 1986; Wardle, 1987; Telch et al., 1994) and the caloric deficits c o m m o n  to m a n y  
treatment programmes m a y  lead to feelings of restriction and the relapse which is 
frequently reported. In contrast to these findings, Insull et al. (1990) have s h o w n  that
2.7. Implications for practice and future interventions
45
subjects in their studies have maintained reductions in the amount of fat in their diet 
without feelings of deprivation, with a resultant loss in weight. In addition, focusing 
on weight m a y  reinforce the pressures o n  patients caused by the social stigma of being 
overweight. Such a focus, given the likelihood of weight regain, m a y  only add to the 
psychological burden already experienced by the obese diabetic patient. Similarly, 
increased physical activity and a decrease in sedentary lifestyle can represent 
beneficial components of long-term care irrespective of the impact this m a y  have on 
weight loss (Perri, 1988).
Given the evidence already cited, the maintenance of stable weight and the prevention 
of weight gain should be recognized as a legitimate treatment option. Individuals 
w h o  have failed to lose weight using dietary and behavioural treatments are unlikely 
to lose weight in a repeated effort using the s a m e  approach (Smith et al., 1991). 
Moreover, in light of findings regarding potential negative effects of weight loss, 
maintenance of stable weight m a y  represent a preferred option for m a n y  individuals 
(Blair et al., 1993; Higgins et al., 1993), and physical activity has been demonstrated 
repeatedly to be an important predictor of weight maintenance ( B u e m a n n  et al., 1996; 
Eriksson et al., 1997; Young, 1995; K a y m a n  et al., 1990; Foreyt et al., 1994).
In terms of physical activity, findings such as those reported in this review have led 
physical activity and behavioural scientists to investigate innovative ways to 
encourage our predominantly physically inactive society to b e c o m e  less sedentary and 
m o r e  physically active. O n e  encouraging approach in this regard has been the 
emergence of lifestyle physical activity. D u n n  et al. (1998) have defined lifestyle 
physical activity as the daily accumulation of at least 30 minutes of self-selected
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activities including leisure, occupational and household activities that are at least 
moderate in their intensity. These activities m a y  be planned or unplanned, structured 
or unstructured, and are part of the routine tasks of everyday life, the underlying aim 
being to get ‘m o r e  people m o r e  active m o r e  often5 (Health Education Authority,
1994).
Finally, it is widely acknowledged that the obese diabetic patient poses a formidable 
therapeutic challenge (Garrow, 1992; Wilson, 1994; Wardle, 1989) and recent reviews 
document the failure of all obesity treatment approaches, behavioural, dietetic or 
pharmacological, to achieve significant and long-lasting weight loss ( G a m e r  et al, 
1991; Wilson, 1994;Brown et al., 1996; Glenny et al., 1997). A  m o r e  successful 
approach to treatment might be to take a ‘disability limitation5 approach as outlined 
above in which obesity is conceptualised as a chronic condition with a range of 
associated adverse consequences. While recognising that the ideal solution w o uld be 
to prevent or treat the basic weight problem, until efficacious treatments are available, 
the alternative is to help patients to limit the associated physical and psychological 
costs and most importantly to ensure that the treatment itself does not c o m p o u n d  their 
difficulties.
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Chapter 3
3. Randomised Controlled Trial of a brief Lifestyle Self-Management 
Intervention
3.1. Rationale
Type 2 diabetes is one of the most c o m m o n  of the chronic disorders and accounts for 
approximately 8 0 %  of all diagnosed cases, affecting over one in ten older people in 
the United K i n g d o m  ( U K )  (Marks 1996). Diabetes complications markedly affect 
the quality of life experienced b y  these patients. Cardiovascular disease (CVD), for 
example, is the leading cause of mortality a m o n g  people with type 2 diabetes with 75- 
8 0 %  of adult diabetic patients dying from coronary heart disease (CHD), 
cerebrovascular disease, and/or peripheral vascular disease. Diabetes is also the 
leading cause of blindness a m o n g  adults, and it accounts for 5 0 %  of all patients w h o  
require renal dialysis for kidney failur e. Diabetes can produce nervous system 
damage, leading to pain and loss of sensation. In severe cases, amputation of the 
extremities, such as toes and feet, is required. A s  a consequence of these manifold 
complications, individuals with diabetes have a considerably shorter life expectancy 
than do nondiabetic individuals and several recent studies have s h o w n  that in diabetic 
patients, the C H D  mortality is 4 - 5 times greater (e.g., U K P D S  1999; Bierman 1992).
T h e  role of lifestyle and behavioural factors in the development of this chronic illness 
is n o w  widely acknowledged. Evidence from cross-sectional and prospective studies 
demonstrates the role of obesity, particularly central (abdominal) obesity, and a 
sedentary lifestyle as major risk factors for the development of type 2 diabetes 
(Harris et al., 1998). Estimates suggest for example, that as m a n y  as 8 0 %  of people 
with type 2 diabetes are obese at the time of diagnosis and the incidence of type 2
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increases exponentially with the degree of obesity (Tuomilheto, 1989). In addition, 
Perry et al. (1995) sho w e d  that the risk of diabetes progressively decreased with 
increasing levels of physical activity, with the risk of diabetes reduced by m o r e  than 
5 0 %  in m e n  w h o  took moderately vigorous exercise.
It is increasingly recognised, therefore, that the m a n a g e m e n t  of type 2 diabetes must 
involve not only medication but also lifestyle change since s o m e  of the risk factors 
associated with type 2 diabetes, which are responsible for at least part of the raised 
cardiovascular risk, are k n o w n  to be amenable to lifestyle change (Eriksson et al.,
1991). Barnard et al. (1994) suggests that lifestyle modification to control diabetes 
and coronary heart disease risk factors m a y  be effective in the long term for reducing 
the tremendous medical and personal costs of this chronic illness and its 
complications. Furthermore, lifestyle modification consisting of diet, regular aerobic 
exercise, and normalization of body weight has been emphasized by the American 
Diabetes Association (1998) and the British Diabetic Association (1992) as being 
important factors in the treatment of type 2 diabetes.
Attempts to modify lifestyle are well established as a m e a n s  of improving people's 
health and a n u m b e r  of studies have been published highlighting the beneficial effects 
of interventions for people with diabetes (Glasgow et al., 1996; Campbell et al., 
1994). However, diabetes intervention efforts have also been criticized for focusing 
predominantly on either newly diagnosed patients, especially those w h o  are insulin- 
dependent (Brown, 1990; Coonrod et al., 1994), or on patients w h o  are sufficiently 
motivated and able to attend a series of intensive and broad-based diabetes education 
classes (Glasgow, 1991). In addition, differential effects of these interventions on 
self-regulation behaviours and lifestyle modification have been demonstrated. 
Diabetes education, for example, has been s h o w n  to be effective in promoting such 
self-regulation behaviours as self-monitoring of blood glucose and insulin adjustment 
but not lifestyle change such as dietary modification and increasing physical activity
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(Rubin et al., 1991). Diabetes dietary self-management and weight control 
interventions have been found unsuccessful unless they are veiy intensive and 
continued over long periods of time (Funnell, 1995) and even then these interventions 
suffer from high attrition rates at follow-up and poor maintenance of changes m a d e  
into the longer term (Wing, 1993).
While such diabetes interventions have played an important role, there is a pressing 
need for brief, practical, ongoing lifestyle self-management interventions, which are 
tailored to the individual, involve the patient in the decision-making process and can 
be integrated into routine usual care so that they are capable of reaching a broader 
audience. In light of the evidence already cited, the goal of lifestyle intervention 
should be reformulated from simple 'weight loss' to 'weight management' 
incorporating control of long-term weight gain and risk factor reduction, with success 
judged by the effect on the overall health and well-being of participants.
3.2. A i m s
T h e  aims of the present study were:
1) T o  develop such a brief, tailored, self-management intervention to improve 
adherence to r e c o m m e n d e d  lifestyle changes in type 2 diabetes by adapting a 
computer-assisted intervention developed in the United States (Glasgow et al.,
1996). This involved the development of paper-and-pencil self-completion 
questionnaires instead of the computer-assisted assessment and extending the 
study to include a physical activity component, smoking status, alcohol intake 
and a wider range of eating patterns and physiological indices;
2) T o  implement and evaluate the intervention in a randomised controlled trial to 
assess its impact on helping patients to adopt l o w  fat eating patterns and 
increased physical activity levels.
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3.3. Hypotheses
It wa s  expected that:
1) Patients in the personalized intervention group would s h o w  greater reductions 
in high-fat eating patterns compared to the usual care control group;
2) Patients in the personalized intervention group would s h o w  increased physical 
activity levels compared to the usual care control group;
3) These changes might be reflected in physiological indices such as 
improvements in body mass index (BMI), waist circumference, glycosylated 
haemoglobin (HbAlc) and blood lipid profiles.
3.4. Methodology
3.4.1. Design
This study w a s  a randomised controlled trial in which participants were allocated to 
either an intervention group or a usual care control group. T h e  study consisted of a 
between-subjects repeated measures design with comparisons between the two 
groups. T h e  study protocol w a s  approved by the South W e s t  Surrey Local Research 
Ethics Committee, the Chichester Research Ethics Committee and the University of 
Surrey Research Ethics Committee.
3.4.2. Participants
100 people aged 40-70 years with type 2 diabetes, a B M I  >  25, with or without 
hyperlipidemia, w h o s e  condition wa s  stable but sub-optimal and w h o  were well
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enough to participate in a regular walking p r o g r a m m e  were recruited at a Diabetes 
Centre. Those individuals with a history of an eating disorder or mental illness were 
not included in the study.
Subject numbers were detennined from past research (Glasgow et al., 1996) and G  
Power, version 2 (Erdfelder et al., 1996). It w a s  estimated that 100 subjects would 
have power of .70 to detect m e d i u m  effects at alpha =  .05 using F  tests to compare 
means.
3.4.2.1. Participation rate
Five hundred and seventy three patients, identified from the database as eligible to 
participate, were sent an initial letter of approach inviting th e m  to participate in the 
study. There were 357 replies, giving an overall response rate to the initial letter of 
62.3%. O f  these, 5 7 . 7 %  (n =  206) were interested in participating. These 206 
patients underwent further telephone screening for inclusion. Forty were excluded 
because they were too ill to participate. A  further 66 patients declined participation, 
the most frequent reasons being feeling that they did not have a problem with diabetes 
self-management (n=29), being too busy (n=9), going through other life stresses at the 
present time (n=l 1) and non-retumed questionnaires (n=17). This resulted in 100 
patients being randomised into the study giving a participation rate of 6 0 . 2 %  of 
eligible patients w h o  were interested in participating.
3.4.3. Recruitment
Eligible patients were identified via the computer database at the Diabetes 
Centre. This method of recruitment from a k n o w n  population w a s  chosen to enable 
participation rates and representativeness of the resulting sample to be determined. 
Those patients w h o  m e t  the inclusion criteria were sent an initial letter of approach 
and an information sheet telling t h e m  about the study and inviting t h e m  to participate.
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Patients were asked to indicate on a reply slip whether they would like to be contacted 
and those w h o  replied positively were contacted by telephone for further screening to 
ensure eligibility for inclusion in the study. A  fuller description of what w a s  involved 
in the study w a s  given to patients at this point including information regarding 
randomisation into tw o  groups, so that informed consent for participation 
in the study could be obtained. Patients were invited to ask questions and assured of 
confidentiality regarding any information that they might give to the study.
T h e  first questionnaire pack and consent forms, together with a F R E E P O S T  envelope 
for return were then sent to interested participants.
Randomisation, using a computer generated r a n d o m  numbers table, took place on 
return of the completed questionnaire pack and consent forms. All participants were 
then contacted by telephone to arrange the first assessment appointment at the 
Diabetes Centre.
3.4.4. Measures
Table 3.1. summarises the measures contained in the mailed questionnaire pack. All 
questionnaire packs followed the s a m e  format and order of presentation (Appendix 1). 
T h e  other questionnaire measures were administered to patients on arrival at the 
Diabetes Centre (Appendix 2).
3.4.4.1 Measures in mailed questionnaire pack
Personal Models o f Diabetes: Personal Models of Diabetes were assessed using a 
brief questionnaire version of the Personal Models of Diabetes Interview, which has 
been validated in both adult ( H a m p s o n  et al., 1990, 1995,2000; G l a s g o w  et al., 1997) 
and adolescent samples (Copp et al., 1998). This is an 8-item instrument that assesses
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two constructs - beliefs about the seriousness of diabetes (3 items) and beliefs about 
treatment effectiveness (5 items). E a c h  item has a five-point Likert scale response 
option (ranging from l=not at all serious/important/likely to help, to 5=extremely 
serious/important/likely to help). In the present study internal reliability of the scales 
as assessed by Cronbach's alpha w a s  .64 for the Seriousness construct and .84 for 
Treatment Effectiveness at baseline.
Diabetes self-management: Diabetes self-management wa s  assessed using the 
S u m m a r y  of Diabetes Self-Care Activities Questionnaire (Toobert &  Glasgow, 1994) 
which has been validated in previous studies (Toobert &  Glasgow, 1994; B o n d  et al., 
1992; Palardy et al., 1998). This 8-item instrument assessed two areas of diabetes 
self-management over the preceding 7 days- dietary self-care activities (5 items) and 
physical activities (3 items). E a c h  item has a five-point Likert scale response option 
(ranging from l=none/never, to 5=all/always). In the present study internal reliability 
of the scales as assessed by Cronbach's alpha w a s  .69 for the Diet construct and .79 
for the Physical Activity construct at baseline.
Dietary measures:
a) T h e  ICristal F o o d  Habits Questionnaire (FHQ; Kristal et al., 1990) is a 20-item 
instrument, which measures four dimensions of fat related dietary habits, substituting 
low-fat for high-fat foods (7 items), modifying meat choices (4 items), avoiding 
frying foods (4 items), avoiding adding fat as flavouring or seasoning to food (5 
items). Responses are on a 4-point Likert scale (l=usually to 4=rarely/never). In the 
present study internal reliability of the scales as assessed by Cronbach's alpha w a s  .70, 
.62, .64 and .69 for each of the scales respectively at baseline.
b) T h e  Block Fat Screener (Block et al., 1989) w a s  used to identify those individuals
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with a high daily intake of dietary fat. This 15-item validated measure has been 
s h o w n  to successfully discriminate individuals on a high (40%) and those on a low 
(20%) fat diet and to perform as well as a four-day diet record in correctly identifying 
those individuals. A  correlation of r =  0.58 w a s  reported (Block et al., 1989) between 
grams of total fat as estimated by the Screener and grams of total fat as calculated 
from the m e a n  of four-day diet records a m o n g  w o m e n .  Participants respond to the 
question 'Over the past 3 months, h o w  often did you eat...' on an 8-point scale 
ranging from 0 =  N e v e r  or less than once a month' to 8 =  '2 or m o r e  times a day'. 
Participants also indicate h o w  big a serving they usually ate on a 3-point scale ranging 
from 1 =  Small to 3 =  Large compared to a picture that they are s h o w n  indicating a 
m e d i u m  sized serving.
Eating Behaviour: Binge eating w a s  assessed using the Binge Eating Scale (BES; 
Gormally et al., 1982). This 16-item questionnaire assesses behavioural 
manifestations (for example, eating large amounts of food, eating in secret) and 
feelings/cognitions surrounding a binge episode (for example, feelings of lack of 
control, guilt after a binge) and successfully discriminates between 'No', 'Moderate' or 
'Severe' binge eating problems. Scores range from 0 -  64, with a score of 27 or 
above being indicative of meeting the D S M  HI criteria for bulimia (Marcus et al.,
1988). Scores in obese clinical samples average around 17, with about 1 0 %  scoring 
above the clinical cut-off (Sherwood et al., 1999).
Stages o f change for dietary fat reduction: Stages of change for dietary fat reduction 
were assessed using the previously validated measure of L a m b  and Sissons Joshi
(1996). This instrument consists of 6-items and has been s h o w n  to successfully 
discriminate respondents in terms of their fat intake. Respondents are asked to 
classify themselves by selecting one of six staging statements ranging from 0 =  1
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haven't given the matter of the fat in m y  diet any thought at all' (precontemplation), to 
5 =  1 have been consciously avoiding fat in m y  diet for longer than the last 6 months' 
(maintenance).
Physical activity measures:
Stages o f  change fo r  physical activity: Stages of change for physical activity was 
assessed using the previously validated 11-item Physician-based Assessment and 
Counseling for Physical Activity ( P A C E ;  L o n g  et al., 1996) measure. Respondents are 
asked to classify themselves by selecting one of 11 staging statements ranging from 0 
=  'I do not exercise or walk regularly now, and I do not intend to start in the near 
future' (precontemplation) to 11 =  'I do vigorous exercise 6 or m o r e  times per w e e k  
for over 6 months' (maintenance).
Pase: T h e  Physical Activity Scale for the Elderly Questionnaire (PASE; W a s h b u r n  et 
al., 1993) w a s  used to assess the n u m b e r  of days and amount of time spent in leisure 
time, household and w o r k  related physical activity over the past 7 days. This is a 10- 
item measure to which participants respond on a 4-point Likert scale (l=less than 1 
hour to 4 = m o r e  than 4 hours). T h e  initial studies report construct validity in the 
range r =  0.25 to 0.42 with test-retest reliability over a 3-7 w e e k  interval estimated at
0.75.
Barriers to healthy eating and physical activity: Barriers to healthy eating were 
assessed using the Barriers to Diabetes Self-care scale (Glasgow, 1994). This is a 21- 
item scale to which participants respond on a 4-point Likert scale ('not at all', 'a little', 
'a moderate amount', a great deal') depending on the extent to which they feel a 
suggested situation prevents t h e m  from following a healthy eating plan. In the present 
study internal reliability of the scale as assessed by Cronbach's alpha w a s  .85 at 
baseline. Barriers to physical activity were assessed using the Barriers to Diabetes
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Self-care scale (Glasgow, 1994). This is a 10-item scale to which participants respond 
o n a 4-point Likert scale ('not at all', 'a little', 'a moderate amount', a great deal') 
depending on the extent to which they feel that a situation prevents t h e m  from being 
as physically active as they would like to be. In the present study internal reliability of 
the scale as assessed by Cronbach's alpha w a s  .71 at baseline.
Self-efficacy: A  2-item measure w a s  constructed to assess individual self-efficacy for 
performing physical activity (1-item) and cutting d o w n  on intake of high fat food (1- 
item), based on Lorig et al. (1996) 'Outcome measures for Health Education and other 
Health Care Interventions'. Participants were asked to rate, on a 10-point Likert scale 
(ranging from l=not at all confident to 10=extremely confident) h o w  confident they 
were that they could take part in moderate intensity physical activity such as brisk 
walking 3-4 times a w e e k  and cut d o w n  on their intake of high fat food.
Quality o f life: A  general measure of functioning, the Medical O u t c o m e s  Study 
( M O S )  SF-12 Health Survey (12 items) wa s  used to assess quality of life. T h e  SF-12 
(Ware et al., 1996) w a s  developed as part of the Medical Outcomes Study and is 
designed to measure quality of life and to be appropriate for assessing c o mmunity  
samples and individuals recovering from illness or surgery. T h e  tw o  components 
(physical and mental) are derived from responses to 12 items, which assess subjective 
well-being, the extent to which pain or physical disability interferes with daily life, 
and the extent to which the respondents have restricted their activities as a result of 
emotional distress. T h e  two component scales, physical and mental, are determined 
by weighting and combining responses to the 12 items according to algorithms 
provided by W a r e  et al. (1996).
Self-esteem: Self-esteem w a s  measured using the Rosenberg Self-Esteem Scale (RSE; 
Rosenberg, 1965). This is a 10-item scale which measures global self-esteem to
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which participants respond on a 4-point Likert-type scale of agreement ( strongly 
agree, agree, disagree, strongly disagree) with a range of possible scores of 10-40. In 
the present study internal reliability of the scale as assessed by Cronbach's alpha was 
.88.
Profile and demographic characteristics: A  demographic and profile questionnaire 
assessed marital status, housing, employ ment status, occupation, ethnicity, education, 
h o m e  ownership, age, height, (9 items) and weight history (8 items).
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Table 3.1. Summary of measures contained in mailed questionnaire pack
Instrument O u t c o m e  measured
Personal Models of Diabetes Beliefs about their diabetes - 2 
constructs, seriousness (3 items) 
and treatment effectiveness (5 items)
T h e  S u m m a r y  of Diabetes Self-Care Self-care activities over the past
Activities Questionnaire 7 days- dietary activities (5 items) 
and physical activities (3 items)
T h e  ICristal F o o d  Habits 4 dimensions of fat-related dietary
Questionnaire ( F H Q ) habits: substituting low-fat foods, 
modifying meat, avoiding frying, 
avoiding adding fat as flavouring or 
seasoning (20 items)
T h e  Block Fat Screener Estimated daily grams of fat (15 items)
T h e  Gormally Binge Eating Scale Binge eating severity (16 items)
Stages of C h a n g e  for Fat Reduction Stages of change for dietary fat 
reduction (6 items)
T h e  Physician-based Assessment and Stage of change for physical
Counseling for Physical Activity ( P A C E ) activity (11 items)
T h e  Physical Activity Scale N u m b e r  of days and a m o u n t  of time
for the Elderly Questionnaire spent in leisure time, household and
( P A S E ) w o r k  related physical activity over past 
7 days (10 items)
Barriers to Diabetes Self-care Barriers to healthy eating (21 items) and 
physical activity (10 items)
O u t c o m e  Measures for Confidence in performing physical
Health Education activity and diet behaviours (2 items)
T h e  Medical O u t c o m e s  Study 
SF-12 Health Survey
Quality of life (12 items)
Rosenberg Self-Esteem Scale Self-esteem (10 items)
Demographic/Profile questionnaire Marital status, housing, employment 
status, occupation, ethnicity, education, 
h o m e  ownership, age, height, (9 items) 
and weight history (8 items)
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3.4.4.2. Measures administered at the Diabetes Centre
Family history: Five questions were used to assess family history of cardiovascular 
disease, stroke, obesity, diabetes and diabetes in pregnancy.
Health related behaviour histoty: Responses to one question on smoking w a s  used to 
categorize respondents as never-smokers, ex-smokers and current smokers. O n e  
question on alcohol intake w a s  used to categorize respondents as non-drinkers (do not 
drink alcohol), low-risk drinkers (those w h o  drank less than 21 units per week) or 
moderate to high-risk drinkers (those w h o  drank over 21 units per week). O n e  
question w a s  used to assess regular daily eating patterns for breakfast, lunch, evening 
meals and snacks. O n e  question w a s  used to assess subjective ratings of the 
frequency of bingeing/overeating to which participants responded o n  an 8-point Likert 
scale (0 =  never to 8 =  2 or m o r e  times per day).
Physiological measures: Weight w a s  measured on the Soehnle electronic weighing 
scale, model 7300, 150 kg x  100 g. B o d y  mass index (BMI) w as calculated from 
weight (kg)/height ( m 2). Waist circumference w a s  measured m i d w a y  between the 
lower rib margin and the iliac crest, using standardized procedures, and recorded to 
the nearest centimeter ( V a n  der K o o y  et al., 1993).
Fasting lipids and glycosylated haemoglobin(HbAlc): Total serum cholesterol, total 
H D L - C ,  L D L - C  and triglycerides were measured after an overnight fast using the 
Reflotron solid phase reagent system. Basic information on the Reflotron instrument 
and the reagent carriers have been described elsewhere (for example, Stahler, 1983). 
H b A l c  w a s  assayed using the Tosoh Haemoglobin A l e  2.2 analyzer in the Clinical 
Pathology Laboratory, St. Richard's Hospital, Chichester, Sussex.
Blood pressure: Blood pressure w a s  measured using the O M R O N  7 0 5 C P  fully
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automatic blood pressure monitor.
3.4.5. Procedure
3.4.5.1. Baseline Assessment
Prior to the initial assessment visit to the Diabetes Centre, scoring of the F o o d  Habits 
Questionnaire ( F H Q )  (Kristal et al., 1990), the Block Fat Screener (Block et al,
1989), and the Barriers to Healthy Eating and Physical Activity Questionnaires 
(Glasgow, 1994) w a s  completed so that the interventionist could prepare a draft of the 
personalised self-management plan for each participant in the intervention group.
W h e n  participants arrived at the Diabetes Centre, they were asked to complete the 
following: a form giving consent to the donation of blood, a family history of 
cardiovascular disease, diabetes and obesity, the frequencies of their smoking 
behaviours and alcohol intake and regular eating/binge eating questionnaire 
(Appendix 2). Patients were then escorted to an examination r o o m  to complete 
baseline physiological measures - blood pressure, weight, waist circumference, 
complete plasma lipid profile and H b A l c .  Patients were then given refreshments 
since they arrived fasting for the blood analysis, and those in the usual care control 
group were thanked for their participation. Patients in the intervention group 
remained at the Diabetes Centre and m e t  individually with the interventionist to 
develop their personalized self-management programme.
3.4.5.2. Meeting with Interventionist
T h e  key features of the intervention were assessment, patient participation in goal 
setting, selecting personalised strategies to overcome barriers and follow-up including 
evaluation and problem solving. T h e  assessment used the self-report measures
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outlined above to assess the patient's eating patterns and level of physical activity. 
These measures established the patient's current lifestyle, identified the most 
problematic areas, and identified the patient's barriers to making lifestyle changes. 
This information w a s  then used to guide discussion with the patient to help develop 
discrepancy between current status and desired goals. T h e  discrepancy between a 
participant's stated goals and current behaviour w a s  examined to increase motivation 
for change by emphasizing participant-generated benefits of change and reducing the 
perceived costs of change. Following the principles of brief motivational interviewing 
(Miller et al., 1991) ambivalence about behaviour change w a s  explored, personal 
goals and self-motivational statements were elicited and a personalised p r o g r a m m e  
w a s  formulated in which manageable goals for decreasing fat intake and increasing 
physical activity were negotiated, and specific intervention strategies to increase self- 
efficacy and decrease barriers to change were developed. T h e  patient received a copy 
of the goal setting form (see Figure 3.1.) and an appointment wa s  m a d e  for a follow- 
up telephone call in one w e e k  to monitor progress. T h e y  were then asked to complete 
a ten-point self-efficacy scale to indicate h o w  confident they were that they could 
achieve the eating and physical activity goals that had been set. Before patients left 
they received booklets that had been specially prepared for this inteivention 
reinforcing the essentials of healthy eating and the importance of increasing physical 
activity.
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GOAL:
T o  stop eating fatty foods between meals.
PROBLEMS IN ACHIEVING GOAL:
1. Feel like snacking in front of television in the evening.
2.1 have 'junk' food around the house.
STEPS FOR ACHIEVING GOAL:
1. H o w  will you recruit support? 
e.g. Tell a friend, relative, colleague, partner.
Get whoever lives with you to join in.
2. H o w  will you change your enviromnent? 
e.g. Clear the cupboards and fridge of fatty between meal snacks. 
Take 2 pieces of fruit to w o r k  every day.
3. W h a t  do you need to buy to achieve your goal? 
e.g. N e e d  to buy plenty of fruit and extra bread.
4. W h e n  will you do this? 
e.g. I will do this tomorrow.
5. At what time of day do you need to change your eating pattern? 
e.g. If you k n o w  evenings are a 'danger time', m a k e  sure yo u  fill up on 
healthy starchy foods at your meal, or change your routine to keep
your m i n d  off food.
6. D o  you need to substitute in another food/drink? Is it a suitable low-fat
substitute?
e.g. Semi-s k i m m e d  milk instead of whole milk.
Flora light instead of butter.
CHECKLIST: Tick each one w h e n  completed.
1.......  2 ....  3 ...... 4 ...... 5 ...... 6 ......
Figure 3.1. Goal setting example sheet for intervention group.
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3.4.5.3. Follow-up Phone Calls
Maintenance issues were addressed by follow-up telephone calls m a d e  by the 
interventionist w h o  m e t  with the patient at the assessment visit, at one week, three 
weeks and seven weeks post assessment. These calls generally lasted for about 10 
minutes and focused o n  the extent to which patients had achieved their goals since last 
contact. Patients were reinforced or assisted in problem-solving additional strategies 
as appropriate.
3.4.5.4. Twelve, 24 and 52 w e e k  assessments
Further full assessments following the s a m e  procedure as outlined above, took place 
for both groups at twelve, twenty-four and fifty-two weeks. At these visits, 
intervention subjects m e t  with the interventionist and were helped to review what had 
worked, set further goals if they were achieving the initial goals and were helped to 
develop n e w  problem-solving strategies for situations with which they had not coped 
successfully. Patients also received additional written materials focusing on lapse and 
relapse, key targets for changing eating and physical activity patterns, and the 
importance of physical activity in diabetes management.
A  diagrammatic representation of recruitment into the study and the assessment 
procedure is s h o w n  in Figure 3.2.
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Figure 3.2. Procedure for intervention study.
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Statistical analysis wa s  carried out using S P S S  version 9 for Windows. T h e  results 
were analysed in the following ways:
1. Chi-square and independent t tests were used to evaluate comparability of 
groups at baseline on profile and demographic characteristics, family history 
of co-morbid diseases and health-related behaviour history.
2. Descriptive statistics were used to describe the participants’ self-reports of 
daily eating patterns, bingeing/overeating and dieting history.
3. Prim ary outcomes: A  series of repeated measures multivariate analyses of 
variance ( M A N O V A )  with a within-subject factor of time (3 levels) and a 
between-subject factor of group (2 levels) were conducted to evaluate 
intervention effects o n  dietary behaviour, physical activity, BMI/waist, 
physiological outcomes and self-care activities. Univariate analyses of 
variance ( A N O V A )  were conducted on each dependent variable as follow-up 
tests to the M A N O V A s  to identify specific variables on which there wa s  
differential change. Post hoc m a i n  effect analyses to the univariate A N O V A s  
following a significant interaction consisted of conducting independent 
samples and paired samples t tests to evaluate the between groups and within 
groups differences at each time point on those variables identified as differing 
significantly. Familywise error rate across these tests w a s  controlled for using 
H o l m ’s sequential Bonferroni approach.
3.4.6. Statistical analyses
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4. Secondary outcomes: A  series of repeated measures M A N O V A s  with a 
within-subject factor of time (3 levels) and a between-subject factor of group 
(2 levels) were conducted to evaluate intervention effects on personal models 
of diabetes, quality of life, self-esteem and binge eating frequency. A N O V A s  
were conducted on each dependent variable as follow-up tests to the 
M A N O V A s  to identify specific variables on which there wa s  differential 
change. Post hoc m a i n  effect analyses to the univariate A N O V A s  following a 
significant interaction consisted of conducting independent samples and paired 
samples t tests to evaluate the within groups differences at each time point on 
those variables identified as differing significantly. Familywise error rate 
across these tests w a s  controlled for using H o l m ’s sequential Bonferroni 
approach.
5. Predictors o f outcome: A  series of partial correlations were conducted a m o n g  
participants in the intervention group to identify patient characteristics 
predictive of outcome. Correlations were calculated between a set of 
baseline predictor variables and six key outcome measures, controlling for 
baseline scores on the relevant dependent variable. Predictor variables 
included profile and demographic characteristics, health status and baseline 
psychosocial variables. T h e  six key outcome measures were the F o o d  Habits 
Questionnaire (FHQ), the Block Fat Screener, the Physical Activity Scale for 
the Elderly (PASE), B M I ,  Cholesterol and HbAlc.
6. T h e  bivariate correlations for the variables in each M A N O V A  are s h o w n  in 
Appendix 3.
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4. Results: Three and Six months follow-up data
4.1. Profile and demosraphic characteristics
Table 4.1 shows the m e a n s  and standard deviations for the intervention and control 
groups in terms of profile and demographic characteristics. There were no significant 
differences between the two groups in terms of age, height, sex, weight, B M I ,  
duration of diabetes, current medication at baseline, n u m b e r  of co-morbid diseases, 
occupation, ethnicity, marital, educational and employment status.
Chapter 4
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Table 4.1. Profile and demographic characteristics
Intervention Group(n=50) Control Group(n=50) 
Characteristic M  S D  M  S D
A g e 59.16 8.84 59.72 6.47
Height 1.63 0.07 1.63 0.07
Sex (n(%))
M e n 29 (58) 29 (58)
W o m e n 21 (42) 21 (42)
Weight (kg) 102.72 25.60 94.54 18.9
B M I * 31.6 3.99 30.54 4.39
Years diagnosed 7.28 5.25 8.08 4.70
Medication (n(%))
Insulin only 9(18) 11 (22)
Tablets only 31 (62) 28 (56)
Both insulin &  tablets 3 (6) 3(6)
Co-morbidity (n(%))
C H D * 15 (30) 10 (20)
Hypertension 28 (56) 21 (42)
A s t h m a 4(8) 5(10)
Stroke 1(2) 4(8)
Arthritis 3(6) 5(10)
Other 18(36) 13 (26)
Occupational status (n(%))
Professional 10 (20) 10 (20)
Managerial 11(22) 12 (24)
Skilled manual/
N o m n a n u a l 16 (32) 14 (28)
Partly skilled/
Unskilled 13 (26) 14 (28)
Ethnicity (n(%))
White 50 (100) 49 (98)
Asian 0(0) 1(2)
Marital status (n(%))
Married/cohabiting 40 (80) 37 (74)
Single 3(6) 4(8)
Separated/divorced/
W i d o w e d 13 (26) 9(18)
Education (n(%))
Basic education 24 (48) 21 (42)
‘ATevels/vocational 17 (34) 23 (46)
Graduate/postgraduate 9(18) 6(12)
E m p l o y m e n t  status (n(%))
Full time 14 (28) 13 (26)
Part time 12 (24) 12 (24)
U n e m p l o y e d 1(2) 2(4)
Retired 23 (46) 23 (46)
'■'13+11 = B o d y  m a s s  in d e x  (w e ig h t(k g )/h e ig h t(m  ) s e lf- r e p o r t) , C H D  = C o r o n a ry  H e a r t D is e a s e
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There were no significant differences between the tw o  groups for family history of 
coronary heart disease (CHD), stroke, overweight, diabetes and diabetes in pregnancy 
(see Table 4.2).
4.2. Family history
Table 4.2. Family history
Intervention G r oup Control
(n=50) (n=50)
n % n %
C H D 17 34 21 42
Stroke 14 28 13 26
Overweight 27 54 19 38
Diabetes 17 34 22 44
Diabetes in pregnancy 2 4 3 6
4.3. Health-related behaviour history
There were no significant differences between the groups in terms of their smoking 
behaviour, alcohol intake, daily eating patterns, bingeing/overeating and dieting 
history at baseline (see Table 4.3).
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Table 4.3. Health-related behaviour history
Intervention group 
(n=50) 
n  %
Control group 
(n=50) 
n  %
S m o k i n g
Current 10 20 10 20
Former 34 68 37 74
Never 16 32 12 24
Alcohol consumption*
non-drinker 12 24 11 22
<21 units/week 26 52 32 64
>21 units/week 12 24 6 12
Daily eating patterns
Breakfast 49 98 47 94
L u n c h 47 94 47 94
Evening meal 47 94 48 96
Snacks 31 62 28 56
Mean SD Mean SD
Bingeing/overeatingA 2.62 2.11 2.04 \.7t
Dieting history* 3.00 1.27 3.14 1.3(
41 one unit=one glass of wine/one measure o f spirits/halfpint o f beer 
KLikert scale, l=once a month, 7=once a day
M ikert scale, l=never, 5=more than 10 times lost and regained 5 kg in weight
4.4. O u t c o m e  Analyses at 6 m o n t h s  follow-up
4.4.1. Prim ary Outcomes
Dietary behaviour: Primary outcome results for dietary behaviour are s h o w n  in Table
4.4. Using the multivariate criterion of Wilks’ lambda (A), the M A N O V A  indicated 
a significant ma i n  effect of Time, A=.21, F(10,84)=30.90, p=.000, and a significant 
Gr o u p  x  T i m e  interaction effect, A =  72, F(10,84)=3.24, p =  001. Univariate analyses 
conducted to follow up the significant interaction sho w e d  that this w a s  due to
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significant interactions for the F H Q  subscales ‘substituting low-fat foods’, 
F(2,163)=l 1.97, p=.000 and ‘avoiding adding fat as flavouring to food’, 
F(2,182)=4.884, p=.009. T h e  interaction for the Block fat screener w as also 
significant F(2,142)=3.68,p=.038, however after applying the Bonferroni correction 
procedure, this result w as no longer significant (see Figure 4.1).
Figure 4.1. Change in scores fo r the Block Fat Screener between intervention and 
control groups.
Post hoc analyses showed that for the F H Q  subscale ‘substitute’, both groups showed 
significant improvement over time with the greatest improvement for both groups 
occurring between T i m e  1 and T i m e  2. However, the intervention group improved 
significantly m o r e  than the control group. T h e  difference between the intervention 
and control group m e ans wa s  significant at T i m e  2, t (97) =  -2.594, p  =  .011, and at 
T i m e  3 t (96) =  -3.680, p  =  .000. There w as no significant difference between the 
groups for the F H Q  subscale 'substitute' at T i m e  1, t (98) =  1.256, p  =  .212. For the 
intervention group, the m e ans for the ‘substitute’ subscale were significantly different 
between Times 1 and 2, t (49) =  12.687, p  =  .000, and between Times 1 and 3, t (49) =  
12.253, p  =  .000. There wa s  no significant difference between the m e a n s  at Times 2 
and 3, t (49) =  0.543, p  =  .590. For the control group, there were significant 
differences between the m e ans at Times  1 and 2, t (49) =  7.373, p  =  .000 and Times 1
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and 3, t (47) =  6.737, p  =  .000. There w a s  no significant difference between the means 
at Times 2 and 3, t (47) =  -0.774, p  =  .443 (see Figure 4.2).
Figure 4.2. Change in the Food habits questionnaire (FH Q ) subscale ‘substitute ’ 
between intervention and control groups.
There were no significant differences between the two groups for the 'avoid fat as 
flavouring' subscale at T i m e  1, t (98) =  1.256, p  =  .212, T i m e  2, t (98) =  .160, p  =  
.874, or T i m e  3, t (97) =  -1.358, p  =  .178. Only the intervention group changed 
significantly over time for this subscale. For the intervention group, the m e ans for 
the ‘avoid fat as flavouring’ subscale were significantly different between Times 1 
and 2, t (49) =  3.608, p  =  .001, and between Times 1 and 3, t (49) =  6.218, p  =  .000. 
There wa s  no significant difference between the m e ans at Times 2 and 3, t (49) =  
2.077, p  =  .043. For the control group, there were no significant differences between 
the m e a n s  at Times 1 and 2, t (48) =  1.560, p  =  .125, Times 2 and 3, t (47) =  0.210, p  
=  .834 or Times 1 and 3, t (47) =  1.961, p  =  .06 (see Figure 4.3).
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Figure 4.3. Change in Food habits questionnaire (FHQ) subscale *avoid fa t as 
flavouring 9 between intervention and control groups.
These results suggest that intervention but not control participants m a d e  significant 
reductions in their fat-related eating habits between the baseline and three months 
assessments and that these changes were maintained at the six months assessment.
Table 4.4. Primary outcome results for dietary behaviour
Measure Group T i m e  1 
Baseline 
M  S D
T i m e  2 
3-months 
M  S D
T i m e  3 
6-months 
M  S D
Dietarv Behaviour 
FH Q !i 
- Substitute Intervention 2.60 0.62 1.35***a 0.58 1 30««b 0.59
Control 2.43 0.70 1.68***a 0.68 1.76***b 0.63
-Avoid fat as Intervention 2.42 0.37 2.10***a 0.53 1.93***b 0.52
flavouring Control 2.23 0.47 2.08 0.61 2.08 0.54
Block Fat Screener 1 Intervention 34.41 18.78 23.62 14.13 19.86 13.62
Control 31.67 23.34 26.03 18.78 26.00 17.72
***p<0.001
1=h ig h e r  s c o re s  w o r s e  $F H Q = F o o d  h a b its  q u e s t io n n a ir e
u s ig n if ic a n t d if fe re n c e  b e tw e e n  T im e  1 a n d  T im e  2 , b s ig n if ic a n t d if fe re n c e  b e tw e e n  T im e  1 a n d  T im e
3
Physical activity: Primary outcome results for physical activity are s h o w n  in Table
4.5. T h e  results for the repeated measures A N O V A  on the P A S E  measure of physical
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activity indicated no significant main effects of Time, A=.996,_F(2,93)=0.201, p=.819, 
or G roup x T i m e  interaction, A=.966, F(2,93)= 1.631, p=.201.
Table 4.5. Primary outcome results for physical activity
Measure G r oup T i m e  1 T i m e  2 T i m e  3
Baseline 3-months 6-months
___________________________________ M  S D  M  S D  M  S D
Physical Activity
-PASE2* Intervention 254.30 95.23 272.60 108.83 273.86 120.21
Control 260.05 100.31 246.10 79.96 250.87 94.24
2= h ig h e r  s c o re s  b e t te r
*PASE=Physical activity scale for the elderly
BMl/Waist: Primary outcome results for BMI/Waist variables are s h o w n  in Table 6. 
Using the multivariate criterion of Wilks’ lambda, the M A N O V A  for the BMI/Waist 
variables indicated a significant G r oup x T i m e  interaction effect, A = . 90, 
F(4,92)=2.80, p=.031. Univariate analyses conducted to follow up the significant 
interaction showed that this wa s  due to a significant interaction for waist 
measurements, F(2,190)=5.86, p=.005. There were no significant univariate effects 
for B M I  (see Figure 4.4).
3 3 .0
3 2 .5
3 2 .0  
1  3 1 .5
3 1 .0
3 0 .5
3 0 .0
T1 72 T3
Measurement Time
Figure 4.4. Change in BMI between intervention and control groups.
Control
Intervention
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Post hoc analyses showed waist measurement did not differ significantly between the 
two groups at Time 1, t (98) = 1.232, p = .221, Time 2, t(97)= 1.037, p = .302, or 
Time 3, t (97) = 0.407, p = .685. Only the intervention group changed significantly 
over time on waist measurement. For the intervention group the means for waist 
measurement were significantly different between Times 1 and 2, t (49) = 3.062, p = 
.004, and between Times 1 and 3, t_(49) = 3.148, pj= .0030. There was no significant 
difference between the means at Times 2 and 3, t (49) = 0.385, p = .702. For the 
control group, there were no significant differences between the means at Times 1 and 
2, t (48) = 0.732, p = .468, Times 2 and 3, t (46) = -0.557, p = .581 or Times 1 and 3, t 
(46) = -1.066, p= .292 (see Figure 4.5).
105.0
104.0 
^  103.0 
•5 102.0 
^  101.0
100.0 
99.0
T1 T2 T3 
Measurement Time
Figure 4.5. Change in Waist measurement between intervention and control 
groups.
These results suggest that waist measurements for participants in the intervention 
group were significantly lowered between the baseline and three months assessments 
and that these changes were maintained at the six months assessment.
Control
Intervention
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Table 4.6. Primary outcome results for BMI/Waist
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
M SD M SD M SD
B M  dce/m2) 1 Intervention 32.40 4.49 32.26 4.47 32.18 4.38
Control 31.30 5.01 31.34 5.08 32.87 4.95
W a is t (c m ) Intervention 104.22 10.46 102.90**a 10.35 1027i-b 9.72
Control 101.25 11.44 101.60 11.01 101.84 11.28
*p<0.01
1 = h i g h e r  s c o r e s  w o r s e
a  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2, b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1  a n d  T i m e  
3
P h y s io lo g ic a l o u tc o m e s : Primary outcome results for physiological variables are 
shown in Table 4.7. The M A N O V A  for the five physiological variables (cholesterol, 
UDL, LDL, Triglycerides, HbAlc) indicated no significant main effects of Time, 
A=.885,JF(10,86)=1.463, p=. 167, or Group x Time interaction, A= 930, 
F(10,86)=0.643, p=773.
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Table 4.7. Primary outcome results for Physiological variables
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
M SD ‘ M SD M SD
Phvsioloeical variables 
C h o le s te r o l (m m o l/l)1 Intervention
Control
5.52
5.90
1.06
1.17
5.60
5.83
0.75
0.89
5.53
5.75
0.66
0.83
H D L ( m m o l / l)2a Intervention
Control
1.06
1.16
0.42
0.40
1.08
1.13
0.43
0.47
1.02
1.18
0.30
0.50
L D U m m o l / l)lb Intervention
Control
3.46
3.70
1.04
1.12
3.35
3.81
1.01
0.84
3.57
3.70
0.74
0.86
T r i H v c e r  ides (m m o l/l)lcIntervention
Control
2.28
2.30
1.23
1.35
2.08
2.07
1.08
1.37
2.12
3.90
1.28
12.33
H b A l c  ( % ) ld Intervention
Control
8.50
8.40
1.61
1.76
8.40
8.40
1.64
1.64
8.54
8.26
1.72
2.10
^ h i g h e r  s c o r e s  w o r s e ,  2 = h i g h e r  s c o r e s  b e t t e r  ^ C h o l e s t e r o l ,  d e s i r a b l e  l e v e l  = <  5 . 2 0  m m o l / 1  
a  H D L = H i g h  d e n s i t y  l i p o p r o t e i n ,  d e s i r a b l e  l e v e l  = > 1 . 0  m m o l / 1  
b  L D L = L o w  d e n s i t y  l i p o p r o t e i n ,  d e s i r a b l e  l e v e l  =  <  4 . 0  m m o l / 1  
c  T r i g l y c e r i d e s ,  d e s i r a b l e  l e v e l  =  <  2 . 0  m m o l / 1  
H b A l c  =  G l y c o s y l a t e d  h a e m o g l o b i n ,  n o r m a l  r a n g e  =  4 - 6 %
S u m m a r y  o f  s e lf-c a re  a c tiv itie s : Primary outcome results for the summary of self- 
care activities are shown in Table 4.8. Using the multivariate criterion of Wilks’ 
lambda, the M A N O V A  for the summary of self-care activities indicated a significant 
main effect of Time, A= 632, F(4,93)=13.554, p=.000, and a significant Group x 
Time interaction effect, A=.832, F(4,93)=4.708, p=.002. Univariate analyses 
conducted to follow up the significant interaction showed that this was due to 
significant interactions for the two subscales Diet F(2,192)= 4.471, p=. 013 and 
Physical Activity F(2,192)= 6.169, p=.005.
Post hoc analyses showed that there were no significant differences between the two 
groups for the Diet subscale at Time 1, t (98) = -0.733, g = .465, or Time 3, t (97) = 
0.382, p = .703. There were, however, significant differences between the two groups
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at Time 2, t (98) = 2.171, p = .032, with the intervention group making significant 
improvements in their diabetes dietary self-management. Only the intervention group 
changed significantly over time for the Diet subscale. For the intervention group the 
means for the Diet subscale were significantly different between Times 1 and 2, t (49) 
= -4.056, p = .000, and between Times 1 and 3, t (49) = -3.353, p = .002. There was 
no significant difference between the means at Times 2 and 3, t (49) = 1.174. p = .246. 
For the control group, there were no significant differences between the means at 
Times 1 and 2, t (48) = -0.515, p = .609, Times 2 and 3, t (47) = -1.549, p = .128 or 
Times 1 and 3, t (47) = -2.095, p = .043 (see Figure 4.6).
Figure 4.6. Change in the Summary of self-care *Diet * subscale between 
intervention and control groups.
Post hoc analyses showed that there were no significant differences between the two 
groups for the Physical Activity subscale at Time 1, t (98) = -0.733, p = .465, or Time 
3, t (97) = 0.382, p = .703. There were, however, significant differences between the 
two groups at Time 2, t (97) = 2.401, p = .018, with the intervention group making 
significant increases in their Physical Activity self-management. For the intervention 
group the means for the Physical Activity subscale were significantly different 
between Times 1 and 2, t (49) = -5.517, p = .000, and between Times 1 and 3, t (49) = 
-3.935, p = .000. There was no significant difference between the means at Times 2
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and 3, t (49) = 2.077, g = .043. For the control group, there was a significant 
difference between the means at Times 1 and 2, t (48) = -3.213, g = .002, but no 
significant differences between the means at Times 2 and 3, t (47) = 1.193, g =. 128 or 
Times 1 and 3, t (47) = -1.0325, g = .308 (see Figure 4.7).
Figure 4.7. Change in the Summary of self-care ‘Physical Activity ’ subscale 
between intervention and control groups.
These results suggest that participants in the intervention group significantly increased 
their dietary and physical activity self-management activities between the baseline 
and three months assessments and that these changes were maintained at the six 
months assessment.
Table 4.8. P rim ary  outcome results for Self-care activities
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
M SD M SD M  SD
Self-care Activities2
- D i e t Intervention 3.72 0.57 4.06***a 0.57 4.00**b 0.52
Control 3.80 0.56 3.83 1.11 3.93 0.48
-P h y s ic a l A c t i v i t y Intervention 2.37 1.21 3.40***a 1.11 3.10***b 1.12
Control 2.51 1.28 2.83 1.16 2.71 1.08
p < 0 . 0 0 1 ,  p < 0 . 0 1
2 = h i g h e r  s c o r e s  b e t t e r
a  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  3
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P e r s o n a l m o d e ls  o f  d ia b e te s : Secondary outcome results for Personal models of 
diabetes are shown in Table 4.9. The results for the M A N O V A  on the two constructs 
(seriousness, importance of self-management) of Personal models of diabetes 
indicated a nonsignificant Group x Time interaction effect, A= 976, F(4,93)=0.575, 
p=.681, therefore no further follow-up analyses were conducted.
These results suggest that there were no significant changes in participants’ personal 
models about the seriousness of diabetes and the importance of diabetes self­
management between the two groups during the course of this study.
4.4.2. Secondary Outcomes
Table 4.9. Secondary outcome results for Personal models of diabetes
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
M SD M SD M SD
Personal models
- S e rio u s n e ss 2 Intervention 2.62 0.71 2.77 0.78 2.76 0.66
Control 2.74 0.71 2.72 0.81 2.84 0.70
-Im p o r ta n c e  o f
s e lf-m a n a s e m e n t2 Intervention 3.85 0.52 3.98 0.57 3.97 0.57
2 i.. _ t. .. .
Control 3.76 0.51 3.86 0.53 3.84 0.38
2 = h i g h e r  s c o r e s  b e t t e r
Q u a l i t y  o f  l i f e : Secondary outcome results for the SF-12 quality of life measure are 
shown in Table 4.10. The results for the M A N O V A  on the two components (physical 
and mental) of the SF-12 quality of life measure indicated a nonsignificant Group x 
Time interaction effect, A=.975, F(4,93)=0,587, p=.673, therefore no further follow- 
up analyses were conducted. These results suggest that there were no significant 
changes in participants’ subjective perceptions of quality of life status in terms of 
physical or mental health between the two groups during the course of this study.
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Table 4.10. Secondary outcome results for the SF-12 components
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
___________________________M  SD M  SD M  SD
SF-122
- P h y s ic a l  H e a lt h Intervention 35.78 14.76 30.12 9.91 29.18 8.84
Control 32.11 15.27 27.85 10.17 25.30 10.01
- M e n t a l  H e a lt h Intervention 32.10 25.04 40.56 20.91 43.87 18.67
Control 35.72 20.85 44.38 20.24 44.96 19.77
2 = h i g h e r  s c o r e s  b e t t e r
S e lf-e s te e m : Secondary outcome results for the Self-esteem measure are shown in 
Table 4.11. The results for the repeated measures A N O V A  on the self-esteem scale 
indicated a nonsignificant Group x Time interaction effect, A-968, F(2,95)=1.590, 
p=.209, therefore no further follow-up analyses were conducted. These results 
suggest that there were no significant changes in participants’ subjective perceptions 
of self-esteem between the two groups during the course of this study.
Table 4.11. Secondary outcome results for the Self-esteem scale
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
___________________________M  SD M  SD M  SD
Self-esteem scale2
Intervention 31.82 5.47 31.08 4.52 32.88 4.92
Control 30.82 5.22 30.28 4.50 31.06 5.38
2 = h i g h e r  s c o r e s  b e t t e r
B in g e  e a tin g : Secondary outcome results for the Binge Eating Scale are shown in 
Table 4.12. The results for the repeated measures A N O V A  on the binge eating scale 
indicated a nonsignificant Group x Time interaction effect, A=.988, F(2,95)=0.548, 
p=.580, therefore no further follow-up analyses were conducted. These results
82
suggest that there were no significant changes in participants’ subjective perceptions 
of binge eating frequency between the two groups during the course of this study.
Table 4.12. Secondary outcome results for the Binge Eating Scale
Measure Group Time 1 
Baseline 
M  SD
Time 2 
3-months 
M  SD
Time 3 
6-months 
M  SD
Binge eating scale2
Intervention 6.75 6.14 5.30 5.91 3.62 5.26
2 t - ______
Control 6.04 6.86 5.14 6.50 5.06 6.50
2 = h i g h e r  s c o r e s  w o r s e
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Results of these analyses are shown in Table 4.13.
Partial correlations were calculated between a set of baseline predictor variables and 6 
key outcome measures at 6-month follow-up, partialling out baseline scores on the 
relevant dependent variable. Potential predictor variables included demographic 
(age, sex, education level), health status (duration of diabetes, insulin-taking status, 
number of other chronic diseases), and baseline psychosocial variables (personal 
models of diabetes, summary of self-care activities, and perceived barriers to and self- 
efficacy for dietary self-care and physical activity). The six key outcome measures 
were the Food Habits Questionnaire (FHQ), the Block Fat Screener, the Physical 
Activity Scale for the Elderly (PASE), BMI, Cholesterol and HbAlc. Ten of the 
predictor variables were significantly associated with outcome on at least one of the 
measures, and these correlations ranged from -0.29 to 0.45. No predictor variable 
was consistently associated with outcome. Higher levels of physical activity were 
associated with lower levels of education (r = -0.51), shorter duration of diabetes (r = 
-0.29), higher baseline scores on physical activity self-management (r = 0.37) and 
greater self-confidence in ability to increase physical activity (r = 0.27). Higher 
cholesterol levels were associated with younger participants (r = -0.30) who were not 
taking insulin (r = 0.45), women improved less than men on changing fat intake habits 
(r =0.25) and those with fewer comorbid diseases at baseline showed less 
improvement on the Block Fat Screener (r = -0.45). Higher HbAlc was related to 
lower baseline scores on dietary self-management (r = -0.32) and higher baseline 
barriers to healthy eating (0.38).
4.4.3. Predictors of outcome
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Table 4.13. Predictors of outcome among intervention subjects.
Outcome measure (n=50)
Baseline predictor Food Block Fat Pase BMI Cholesterol HbAlc
variable Habits Screener
Age .00 .08 .17 -.16 -0.30* -.09
Sex (1=M, 2=F) .25* -.15 -.04 -.14 -.00 .02
Education level .02 -.09 -.51*** .00 -.01 -.04
Duration of diabetes -.15 .03 -.29* .23 .14 -.03
Insulin (l=yes, 2=no) -.03 -.04 -.20 .23 .45*** -.20
No. of comorbid diseases 
Personal models
-.12 -0.40** -.17 .04 .13 -.11
-Seriousness -.16 -.04 -.05 .02 .11 .24
-Importance
Self-care
-.24 -.17 -.22 .10 -.03 -.17
-Diet -.01 -.02 .22 .06 .15 -0.32*
-Physical activity 
Barriers
-.11 .07 .37* .07 -.02 .02
-Diet .04 .04 -.17 .01 -.09 .38"
-Physical activity 
Self-efficacy
.13 .13 .06 -.06 .02 -.00
-Diet -.07 -.10 .10 -.06 -.02 -.09
-Physical activity .04 .02 .27* .08 .10 .03
* * > < 0 . 0 0 7 ,  **p<0.01, *p<0.05
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A  series of repeated measures M A N O V A s  with a within-subject factor of time (3 
levels) and a between-subject factor of group (2 levels) were conducted to evaluate 
intervention effects on the process variables related to changes in dietary behaviour 
and physical activity. ANOVAs were conducted on each dependent variable as 
follow-up tests to the M A N O V A s  to identify specific variables on which there was 
differential change. Post hoc main effect analyses to the univariate ANOVAs 
following a significant interaction consisted of conducting independent samples and 
paired samples t tests to evaluate the between groups and within groups differences at 
each time point on those variables identified as differing significantly. Familywise 
error rate across these tests was controlled for using Holm’s sequential Bonferroni 
approach.
D i e t a r y  b e h a v io u r  p ro c e s s  v a r ia b le s : R esults for the analyses of process variables for 
dietary behaviour are shown in Table 4.14. Using the multivariate criterion of Wilks’ 
lambda, the M A N O V A  indicated a significant main effect of Time A=. 62, F (6,89)= 
8.860, p_= 000, as well as a significant Group x Time interaction effect, A= 735, 
F(6,89)= 5.341, p_=.000, for the Stages of Change for dietary fat reduction(SOCF), 
barriers to healthy eating (BHE) and self-efficacy for lowering fat intake measures. 
Univariate analyses showed that this was due to a significant interaction for the SOCF 
F(2,188) = 13.688, p = 0.000. There was a significant univariate interaction effect for 
BHE F(2,188) = 3.662, p_= 0.031, however after applying the Bonferroni correction 
procedure, this result was no longer significant (see Figure 4.8).
4.4.4. Process analyses
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Figure 4.8. Change in the Barriers to healthy eating (BHE) measure between 
intervention and control groups.
There were no significant differences between the two groups on univariate follow up 
analysis for self-efficacy.
Post hoc analyses showed that there were no significant differences between the two 
groups for SOCF at Time 1, t (98) = -2.036, p = .05, or Time 2, t (97) = 1.976, p = 
.051. There were, however, significant differences between the two groups at Time 3, 
t (97) = 2.401, p = .006, with the intervention group making significant changes to 
their SOCF perceptions. Only the intervention group changed significantly over time 
in their perceptions of SOCF. For the intervention group the means for the SOCF 
were significantly different between Times 1 and 2, t (49) = -4.877, p = .000, between 
Times 2 and 3, t_(49) = -3.000, p = .004 and between Times 1 and 3, t (49) = -6.370, p 
= .000. For the control group the means for the SOCF did not differ significantly 
between Times 1 and 2, t (49) = -0.141, p = .888, between Times 2 and 3, t_(49) = - 
0.795, p = .431 and between Times 1 and 3, t (48) = -0.805, p = .425 (see Figure 4.9).
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Figure 4.9. Change in the Stages o f Change for dietary fat reduction (SOCF) 
measure between intervention and control groups.
Results from the analyses of dietary behaviour process variables suggest that the 
perceptions of participants in the intervention group but not the control group of their 
stage of change for dietary fat reduction changed from contemplation to action and 
that this was associated with decreased barriers to healthy eating but not with 
increased self-efficacy.
Table 4.14. Process variable results for d ietary behaviour
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
M SD M SD M SD
Dietarv Behaviour
S O C F 11 Intervention
Control
2.88
3.50
1.56
1.44
3.96*"a
3.52
0.64
1.38
4.30"*b
3.63
0.67
1.37
b h e 2& Intervention
Control
40.70
37.88
9.81
8.08
37.20
37.12
9.48
8.94
35.44
36.46
9.90
9.42
S e lf-e ffic a c v 1 Intervention
Control
3.82
3.66
1.04
1.31
4.16
3.60
1.06
1.20
4.24
3.75
1.04
1.10
"><0.001
' ^ h i g h e r  s c o r e s  b e t t e r ,  2 = h i g h e r  s c o r e s  w o r s e
8 s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e
3
$ S O C F = S t a g e s  o f  c h a n g e  f o r  d i e t a r y  f a t  r e d u c t i o n  <£B H E = B a r r i e r s  t o  h e a l t h y  e a t i n g
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P h y s ic a l  a c tiv ity  p ro ce s s  v a r ia b le s : Results for the analyses of process variables for 
physical activity are shown in Table 4.15. Using the multivariate criterion of Wilks’ 
lambda, the M A N O V A  indicated a significant main effect of Time A=. 72, F 
(6,91)=5.69, pj=.000, as well as a significant Group x Time interaction effect, A=.83, 
F(6,91)=3.11, p_=.008, for the Stage of change for physical activity (PACE), barriers 
to physical activity (BPA) and self-efficacy for physical activity measures.
Univariate analyses showed that this was due to significant interaction effects for the 
PACEF(2,192) = 3.727, p = 0.028, andBPAF(2,192) = 4.186, £_= 0.023. There 
were no significant differences between the two groups on univariate follow up 
analysis for self-efficacy.
Post hoc analyses showed that there were no significant differences between the two 
groups for the PACE at Time 1, t (98) = -1.371, p = .174, Time 2, t (97) = 0.429, p = 
.669 or Time 3, t (97) = 0.932, p = .354. For the intervention group the means for the 
PACE were significantly different between Times 1 and 2, t (49) = -3.219, p = .002, 
and between Times 1 and 3, t (49) = -2.983, p = .004. There was no significant 
difference between the means at Times 2 and 3, t (49) = .306, p = .761. For the 
control group the means for the PACE did not differ significantly between Times 1 
and 2, t (49) = -0.755, p = .454, between Times 2 and 3, L(49) = -1.583, p =. 120 and 
between Times 1 and 3, t (48) = 0.511, p = .612 (see Figure 4.10).
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Figure 4.10. Change in the Stages of Change for physical activity measure (PACE) 
between intervention and control groups.
Post hoc analyses showed that there were no significant differences between the two 
groups for the BPA at Time 1, t (98) = 1.627, p = . 107, Time 2, t (97) = 0.293, p = 
.770 or Time 3, t (97) = -0.708, p = .480. For the intervention group the means for the 
BPA were significantly different between Times 1 and 2, t (49) = 2.084, p = .042, and 
between Times 1 and 3, t (49) = 3.407, p = .001. However, after applying the 
Bonferroni correction procedure, the difference between the means at Times 1 and 2 
was no longer significant. There was no significant difference between the means at 
Times 2 and 3, t (49) = .306, p = .761. For the control group the means for the BPA 
were not significantly different between Times 1 and 2, t (49) = 0.445, p = .658,
Times 2 and 3, t (49) = -0.681, p = .499 or Times 1 and 3, t (48) = -0.145, p = .885 
(see Figure 4.11).
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Figure 4.11. Change in the Barriers to physical activity measure (BPA) between 
intervention and control groups.
Results from the analyses of physical activity process variables suggest that the 
perceptions of participants in the intervention group but not the control group of their 
stage of change for physical activity changed from contemplation to action and that 
this was associated with decreased barriers to physical activity but not with increased 
self-efficacy.
Table 4.15. Process variable results for physical activity
Measure Group Time 1 Time 2 Time 3
Baseline 3-months 6-months
M SD M SD M SD
Phvsical Activitv
P A C E  15 Intervention
Control
4.70
5.27
2.44
2.07
5.64**a
5.47
2.00
1.96
5.60*’b
5.17
2.19
1.97
B P  A  2& Intervention
Control
19.08
17.49
5.27
5.29
17.52**a
17.25
4.78
5.25
16.70***b
17.42
4.43
5.53
S e lf-e fT ic a c v 1 Intervention
Control
3.64
3.98
1.30
1.22
3.74
3.64
1.21
1.39
3.26
3.33
1.50
1.38
p < 0 . 0 0 1 ,  p < 0 . 0 1
' ^ h i g h e r  s c o r e s  b e t t e r ,  2 = h i g h e r  s c o r e s  w o r s e
s P A C E = S t a g e s  o f  c h a n g e  f o r  p h y s i c a l  a c t i v i t y  & B P  A = B a r r i e r s  t o  p h y s i c a l  a c t i v i t y  
a  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e
3
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Chapter 5
5.1. A ttrition
Six participants in total were lost to final follow-up in the study, two from the 
intervention group (one who is deceased and one who felt unable to continue with the 
study because of other life stresses), and four from the control group (two who are 
deceased, one who moved away from the area and one who had a major heart attack 
and was unable to continue with the study). Since the majority of these participants 
were lost to the study between the six and twelve months assessments (n=5), 
statistical analysis for the twelve months follow-up data was conducted on an 
intention-to-treat basis.
5.2. Outcom e Analyses a t 12 months follow-up
5.2.1. Primary Outcomes
D i e t a r y  b e h a v io u r : Primary outcome results for dietary behaviour are shown in Table
5.1. Using the multivariate criterion of Wilks’ lambda (A), the M A N O V A  indicated 
a significant main effect of Time, A = 24, F(10,89)=27.91, p= 000, and a significant 
Group x Time interaction effect, A —.7 2 , F(10,89)=3.36, p= 001. Univariate analyses 
conducted to follow up the significant interaction showed that this was due to 
significant interactions for the FHQ subscale ‘substituting low-fat foods’, 
F(2,196)=7.59, p=.001 and the Block fat screener, F(2,196)=6.94, p=.002. The 
interaction for the FHQ subscale 'modifying meat' was also significant F(2,196)=3.82,
5. Results: Twelve months follow-up data
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p=.031, however after applying the Bonferroni correction procedure, this result was 
no longer significant (see Figure 5.1).
Control
Intervention
T1 T2 T4
Measurement Time
Figure 5.1. Change in Food habits questionnaire (FHQ) subscale ‘modify meat ’ 
between intervention and control groups.
Post hoc analyses showed that for the FHQ subscale ‘substitute’, both groups showed 
significant improvement over time with the greatest improvement for both groups 
occurring between Time 1 and Time 2. However, the intervention group improved 
significantly more than the control group. The difference between the intervention 
and control group means was significant at Time 2, t (98) = -2.639, p = .010, and at 
Time 4 t ((98) = -2.083, p = .040, however after applying the Bonferroni correction 
procedure, the Time 4 result was no longer significant. There were no significant 
differences between the two groups at Time 1, t (98) = 1.256, p = .212. For the 
intervention group, the means for the ‘substitute’ subscale were significantly different 
between Times 1 and 2, t (49) = 12.687, p = .000, and between Times 1 and 4, t (49) = 
11.792, p = .000. There was no significant difference between the means at Times 2 
and 4, t (49) = -0.185, p = .854. For the control group, there were significant 
differences between the means at Times 1 and 2, t (49) = 7.373, p = .000 and between 
Times 1 and 4, t (49) = 7.422, p = .000. There was no significant difference between 
the means at Times 2 and 4, t (49) = 0.692, p = .492 (see Figure 5.2).
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* — Control
Intervention
T1 T2 T4
Measurement Time
Figure 5.2. Change in the Food habits questionnaire (FHQ) subscale ‘substitute9 
between intervention and control groups.
Post hoc analyses for the Block fat screener showed that there were no significant 
differences between the intervention and control group means at Time 1, t (98) = 
0.765, p = .446 or at Time 2, t (98) = -0.645, p = .520. There were however significant 
differences between the means at Time 4, t (98) = -2.736, p = .007, with the 
intervention group improving significantly more than the control group. Only the 
intervention group changed significantly over time for the Block fat screener. For the 
intervention group, the means for the Block fat screener were significantly different 
between Times 1 and 2, t (49) = 5.206, p = .000, and between Times 1 and 4, t (49) = 
6.034, p = .000. There was no significant difference between the means at Times 2 
and 4, t (49) = 1.515,p = .136. For the control group, there were no significant 
differences between the means at Times 1 and 2, t (49) = 1.964, p = .055, Times 2 and 
4, t (49) = -1.947, p= .057 or Times 1 and 4, t (49) = -0.014, p = .989 (see Figure
5.3).
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Figure 5.3. Change in scores for the Block Fat Screener between intervention and 
control groups.
These results suggest that intervention but not control participants made significant 
reductions in their fat-related eating habits and their daily total intake of fat between 
the baseline and three months assessments and that these changes were maintained at 
the twelve months assessment.
Table 5.1. P rim ary  outcome results for d ietary  behaviour
Measure Group Time 1 
Baseline 
M  SD
Time 2 
3-months 
M  SD
Time 4 
12-months 
M  SD
Dietary Behaviour 
F H Q 11 
- Substitute Intervention 2.60 0.62 1.35***a 0.58 1.36***b 0.58
Control 2.43 0.70 1 68***a 0.68 1.62***b 0.66
- Modify Intervention 1.85 0.93 1.08 0.50 1.21 0.60
meat Control 1.74 0.93 1.40 0.72 1.44 0.65
B lo c k  F a t  S c re e n e r 1 Intervention 34.41 18.78 23.62***a 14.13 2o 97»*b 12.97
Control 31.67 23.34 26.03 18.78 31.24 23.14
***P<0.001
1=:h i g h e r  s c o r e s  w o r s e  $ F H Q = F o o d  h a b i t s  q u e s t i o n n a i r e
3 • •  ^ ^
s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 ,  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e
4
P h y s ic a l a c t iv it y : Primary outcome results for physical activity are shown in Table
5.2. The results for the repeated measures A N O V A  on the PASE measure of physical
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activity indicated no significant main effects of Time, A= 991,_F(2,97)=0.455, p=.636, 
or Group x Time interaction, A= 951, F(2,97)=2.499, p=.087.
Table 5.2. P rim ary  outcome results for physical activity
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
___________________________M  SD M  SD M  SD
Physical Activity
- P A S E 2' Intervention 254.30 95.23 275.78 110.05 281.35 114.84
Control 260.05 100.31 241.36 85.60 246.60 92.82
2 = h i g h e r  s c o r e s  b e t t e r
* P A S E = P h y s ic a l  a c t iv i ty  s c a le  f o r  t h e  e ld e r ly
B M / W a i s t : Primary outcome results for BMVWaist variables are shown in Table 5.3. 
Using the multivariate criterion of Wilks’ lambda, the M A N O V A  for the BMI/Waist 
variables indicated a significant Group x Time interaction effect, A-64, 
F(4,95)=T2.82, p=.000. Univariate analyses conducted to follow up the significant 
interaction showed that this was due to a significant interaction for both BMI 
F(2,196)=35.154, p=.000 and waist measurements F(2,1956)=l4.254, p=.000.
Post hoc analyses for the BMI variable showed that there were no significant 
differences between the two groups at Time 1, t (98) = 1.272, p = .207, Time 2, t (98) 
= 1.140, p = .257 or Time 4, t (98) = -0.726, p = .470. For the intervention group 
there were no significant differences between the means at Times 1 and 2, t (49) = 
1.225, p = .227, at Times 2 and 4, t (49) = 1.237, p = .222 or at Times 1 and 4, t_(49) = 
1.743, p_= .088. However, post hoc analyses for the BMI variable for the control 
group showed that although there were no significant differences between the means 
at Times 1 and 2, t (49) = 0.159, p = .875, the means were significantly different
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between Times 2 and 4, t (49) = -8.106, p = .000 and Times 1 and 4, t_(49) = -6.440, p 
= .000 (see Figure 5.4).
33.0
30.5 -I-------- 5— ---- \-----
T1 72 74
Measurement Time
Figure 5.4. Change in BMI between intervention and control groups.
These results suggest that while intervention participants maintained their BMI 
between baseline and the twelve months assessment, BMI increased significantly for 
control participants over the same time period.
Post hoc analyses showed that waist measurement did not differ significantly between 
the two groups at Time 1, t (98) = 1.232, p = .221, Time 2, t (98) = 0.481, p = .632, or 
Time 4, t (98) = -0.426, p = .671. Only the intervention group improved significantly 
over time on waist measurements. Post hoc analyses for the intervention group 
showed that the means for waist measurement were significantly different between 
Times 1 and 2, t (49) = 3.062, p = .004, and between Times 1 and 4, t£49) = 3.317, p 
= .002. There was no significant difference between the means at Times 2 and 4, t 
(49) = 0.434, p = .666. For the control group, there was no significant difference 
between the means at Times 1 and 2, t (49) = -0.807, p = .424. There were however 
significant differences between the means at Times 2 and 4, t (49) = -3.380, p = .001 
and Times 1 and 4, t (49) = -3.587, p = .001 (see Figure 5.5).
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Figure 5.5. Change in Waist measurement between intervention and control 
groups.
These results suggest that waist measurements for participants in the intervention 
group were significantly lowered between the baseline and three months assessments 
and that these changes were maintained at the twelve months assessment, while waist 
measurements for the control group increased significantly from baseline to the 
twelve months assessment.
Table 5.3. P rim ary  outcome results for BM I/W aist
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
M SD M SD M SD
B M I  (kg /m 2) ' Intervention 32.40 4.49 32.26 4.47 32.06 4.30
Control 31.30 5.01 31.34 5.08 32.72***b 4.77
W a ist (c m)1 Intervention 104.22 10.46 102.90**a 10.35 102.70**b 10.25
Control 101.25 11.44 101.87 10.86 103.60 10.63
*’ *p<o.ooi,**p<o.oi
' ^ h i g h e r  s c o r e s  w o r s e
d s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e
4
P h y s io lo g ic a l o u tc o m e s : Primary outcome results for physiological variables are 
shown in Table 5.4. The M A N O V A  for the five physiological variables (cholesterol,
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HDL, LDL, Triglycerides, HbAlc) indicated a non significant Group x Time 
interaction effect, A= 893, F(10,89)=1.064, p= 399.
Table 5.4. Primary outcome results for Physiological variables
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
M SD M SD M SD
Physiological variables 
C h o le s te r o l (m m o l/l) v Intervention
Control
5.52
5.90
1.06
1.17
5.60
5.83
0.75
0.89
5.25
5.66
0.88
0.83
H D L f m m o l / l)2a Intervention
Control
1.06
1.16
0.42
0.40
1.08
1.13
0.43
0.47
1.01
1.12
0.30
0.40
L D L f m m o l / l)lb Intervention
Control
3.46
3.70
1.04
1.12
3.37
3.82
1.01
0.83
3.35
3.72
0.83
0.83
T rig ly c e r id e s  (m m o l/l)lc Intervention
Control
2.28
2.30
1.23
1.35
2.08
2.07
1.08
1.37
2.07
1.84
1.23
0.88
H b A l c  ( % ) ld Intervention
Control
8.50
8.40
1.61
1.76
8.40
8.40
1.64
1.64
8.38
8.26
2.35
1.41
1 = h i g h e r  s c o r e s  w o r s e ,  2 = h i g h e r  s c o r e s  b e t t e r  " C h o l e s t e r o l ,  d e s i r a b l e  l e v e l  = < 5 . 2 0  m m o l / 1  
a  H D L = H i g h  d e n s i t y  l i p o p r o t e i n ,  d e s i r a b l e  l e v e l  = > 1 . 0  m m o l / 1  
L D L = L o w  d e n s i t y  l i p o p r o t e i n ,  d e s i r a b l e  l e v e l  =  <  4 . 0  m m o l / 1  
0  T r i g l y c e r i d e s ,  d e s i r a b l e  l e v e l  =  <  2 . 0  m m o l / I  
H b A l c  =  G l y c o s y l a t e d  h a e m o g l o b i n ,  n o r m a l  r a n g e  =  4 - 6 %
S u m m a r y  o f  s e lf-c a re  a c tiv itie s : Primary outcome results for the summaiy of self-
care activities are shown in Table 5.5. Using the multivariate criterion of Wilks’
lambda, the M A N O V A  for the summary of self-care activities indicated a significant
main effect of Time, A=.650, F(4,95)=12.808, p=.000, and a significant Group x
Time interaction effect, A=.823, F(4,95)= 5.101, p=.001. Univariate analyses
conducted to follow up the significant interaction showed that this was due to a
significant interaction for the subscale Physical Activity F(2,196)= 6.568, p= 002.
There were no significant univariate effects for the Diet subscale (see Figure 5.6).
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Figure 5.6. Change in the Summary of self-care ‘Diet’ subscale between 
intervention and control groups.
Post hoc analyses for the Physical Activity subscale showed that there were no 
significant differences between the two groups at Time 1, t (98) = -0.733, p = .465. 
There were however significant differences between the two groups at Time 2, t (98)
= 2.118, p = .037 and Time 4, t (98) = 2.348, p = .021, with the intervention group 
making significant improvements compared to the control group. For the 
intervention group the means for the Physical Activity subscale were significantly 
different between Times 1 and 2, t (49) = -5.517, p = .000, and between Times 1 and 
4, t (49) = -4.124, p = .000. There was no significant difference between the means at 
Times 2 and 4, t (49) = 0.676, p = .503. For the control group, there was a significant 
difference between the means at Times 1 and 2, t (49) = -3.207, p = .002. There were 
however no significant differences between the means at Times 2 and 4, t (49) =
1.735, p = .089 and Times 1 and 4, t (49) = -0.340, p = .735 (see Figure 5.7).
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Figure 5.7. Change in the Summary of self-care ‘Physical Activity’ subscale 
between intervention and control groups.
These results suggest that participants in the intervention group significantly increased 
their physical activity self-management activities between the baseline and three 
months assessments and that these changes were maintained at the twelve months 
assessment, while participants in the control group reverted to baseline levels at the 
twelve months assessment.
Table 5.5. P rim ary  outcome results for Self-care activities
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
M SD M SD M SD
Self-care Activities2 
- D i e t Intervention 3.72 0.57 4.06"*a 0.57 3.82 0.52
Control 3.80 0.56 3.83 0.48 3.64 0.98
- P h y s ic a l A c t i v i t y Intervention 2.37 1.21 3.40"*a 1.11 3.24"*b 1.47
Control 2.51 1.28 2.83 1.16 2.57 1.38
* " p < 0 . 0 0 1
2= h i g h e r  s c o r e s  b e t t e r
a  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  4
5.2.2. Secondary Outcomes
P e r s o n a l m o d e ls  o f  d ia b e te s : Secondary outcome results for Personal models of 
diabetes are shown in Table 5.6. The results for the M A N O V A  on the two constructs
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(seriousness, importance of self-management) of Personal models of diabetes 
indicated a nonsignificant Group x Time interaction effect, A=.961, F(4,95)=0.964, 
p= 431, therefore no further follow-up analyses were conducted.
These results suggest that there were no significant changes in participants’ personal 
models about the seriousness of diabetes and the importance of diabetes self­
management between the two groups during the course of this study.
Table 5.6. Secondary outcome results for Personal models of diabetes
Measure Group Time 1 
Baseline 
M  SD
Time 2 
3-months 
M  SD
Time 4 
12-months 
M  SD
Personal models
- S e rio u s n e s s2 Intervention 2.62 0.71 2.77 0.78 2.80 0.82
Control 2.74 0.71 2.72 0.81 2.86 0.94
-Im p o r ta n c e  o f  
s e lf-m a n a g e m e n t2 Intervention 3.85 0.52 3.98 0.57 3.92 0.88
2.i-i______i. ... ..
Control 3.76 0.51 3.86 0.53 3.57 0.95
2 = h i g h e r  s c o r e s  b e t t e r
Q u a l i t y  o f  l i f e : Secondaiy outcome results for the SF-12 quality of life measure are 
shown in Table 5.7. The results for the M A N O V A  on the two components (physical 
and mental) of the SF-12 quality of life measure indicated a nonsignificant Group x 
Time interaction effect, A=.952, F(4,95)=1.203, p=.315, therefore no further follow- 
up analyses were conducted. These results suggest that there were no significant 
changes in participants’ subjective perceptions of quality of life status in terms of 
physical or mental health between the two groups during the course of this study.
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Table 5.7. Secondary outcome results for the SF-12 components
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
M SD M SD M SD
SF-122
- P h y s ic a l H e a lt h Intervention 35.78 14.76 30.12 9.91 37.70 14.31
Control 32.11 15.27 28.21 10.12 32.44 15.85
- M e n t a l  H e a lt h Intervention 32.10 25.04 40.56 20.91 30.42 20.56
2 i - _ i
Control 35.72 20.85 43.30 21.09 28.50 20.24
- h i g h e r  s c o r e s  b e t t e r
S e lf-e s te e m : Secondary outcome results for the Self-esteem measure are shown in 
Table 5.8. The results for the repeated measures A N O V A  on the self-esteem scale 
indicated a nonsignificant Group x Time interaction effect, A=.979, F(2,97)=1.026, 
p~ 362, therefore no further follow-up analyses were conducted. These results 
suggest that there were no significant changes in participants’ subjective perceptions 
of self-esteem between the two groups during the course of this study.
Table 5.8. Secondary outcome results for the Self-esteem scale
Measure Group Time 1 
Baseline 
M  SD
Time 2 
3-months 
M  SD
Time 4 
12-months 
M  SD
Self-esteem scale2
Intervention 31.82 5.47 31.08 4.52 32.80 5.48
2 1- i. .. 1. ..
Control 30.82 5.22 30.48 4.66 31.06 5.43
2= h i g h e r  s c o r e s  b e t t e r
B in g e  e a tin g : Secondary outcome results for the Binge eating scale are shown in 
Table 5.9. The results for the repeated measures A N O V A  on the binge eating scale 
indicated a nonsignificant Group x Time interaction effect, A=.989, F(2,97)=0.519, 
p= 60, therefore no further follow-up analyses were conducted. These results suggest
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that there were no significant changes in participants’ subjective perceptions of binge 
eating frequency between the two groups during the course of this study.
Table 5.9. Secondary outcome results for the Binge Eating Scale
Measure Group Time 1 
Baseline 
M  SD
Time 2 
3-months 
M  SD
Time 4 
12-months 
M  SD
Binge eating scale2
Intervention 6.75 6.14 5.30 5.91 4.62 5.61
Control 6.04 6.86 5.14 6.50 5.10 6.03
2 = h i g h e r  s c o r e s  w o r s e
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Results of these analyses are shown in Table 5.10.
Partial correlations were calculated between a set of baseline predictor variables and 6 
key outcome measures at 12-month follow-up, partialling out baseline scores on the 
relevant dependent variable. Potential predictor variables included demographic 
(age, sex, education level), health status (duration of diabetes, insulin-taking status, 
number of other chronic diseases), and baseline psychosocial variables (personal 
models of diabetes, summary of self-care activities, and perceived barriers to and self- 
efficacy for dietary self-care and physical activity). The six key outcome measures 
were the Food Habits Questionnaire (FHQ), the Block Fat Screener, the Physical 
Activity Scale for the Elderly (PASE), BMI, Cholesterol and HbAlc. Nine of the 
predictor variables were significantly associated with outcome on at least one of the 
measures, and these correlations ranged from -0.27 to 0.36. No predictor variable 
was consistently associated with outcome. Higher levels of physical activity were 
associated with lower levels of education (r = -0.27), fewer comorbid diseases at 
baseline (r = -0.27), higher baseline scores on physical activity self-management (r =
0.27) and greater self-confidence in ability to increase physical activity (r = 0.36). 
Those with fewer comorbid diseases at baseline showed less improvement on 
changing fat intake habits (r = 0.27), as did participants who regarded their diabetes as 
less serious (r = -0.31) and did not believe in the importance of diabetes self­
management (r = -0.27). Higher HbAlc was related to lower baseline scores on 
dietary self-management (r = -0.32) and higher baseline barriers to healthy eating 
(0.27).
5.2.3 Predictors of outcome
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Table 5.10. Predictors of outcome among intervention subjects.
Outcome measure (n=50)
Baseline predictor Food Block Fat Pase BMI Cholesterol HbAlc
variable Habits Screener
Age .00 -.11 -.14 -.18 -.10 -.04
Sex (1=M, 2=F) .05 -.08 -.12 -.11 .14 -.06
Education level .09 -.02 -.27* -.13 -.06 -.13
Duration of diabetes -.17 .21 -.15 .19 .19 .10
Insulin (l=yes, 2=no) .02 .04 -.17 .12 .23 .10
No. of comorbid diseases -.27* .06 -.27* .06 .01 .12
Personal models
-Seriousness -.31* -.14 .10 .07 .11 .11
-Importance -.27* -.12 -.23 -.02 -.06 -.01
Self-care
-Diet .17 -.23 .14 .07 .14 -.32*
-Physical activity -.06 .00 .27* .02 -.11 .09
Barriers
-Diet -.22 -.21 -.04 .18 -.09 .27*
-Physical activity -.02 -.09 .10 -.06 .03 -.01
Self-efficacy
-Diet -.08 -.12 .10 -.24 -.09 -.05
-Physical activity .12 -.03 .36** -.20 -.20 -.18
" p < 0 . 0 1 ,  * p < 0 . 0 5
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A  series of repeated measures M A N O V A s  with a within-subject factor of time (3 
levels) and a between-subject factor of group (2 levels) were conducted to evaluate 
intervention effects on the process variables related to changes in dietary behaviour 
and physical activity. ANOVAs were conducted on each dependent variable as 
follow-up tests to the M A N O V A s  to identify specific variables on which there was 
differential change. Post hoc main effect analyses to the univariate ANOVAs 
following a significant interaction consisted of conducting independent samples and 
paired samples t tests to evaluate the between groups and within groups differences at 
each time point on those variables identified as differing significantly. Familywise 
error rate across these tests was controlled for using Holm’s sequential Bonferroni 
approach.
D i e t a r y  b e h a v io u r  pro ce ss v a r ia b le s : R esults for the analyses of process variables for 
dietary behaviour are shown in Table 5.11. Using the multivariate criterion of Wilks’ 
lambda, the M A N O V A  indicated a significant main effect of Time, A= 496, F (6,93)= 
15.745, p_= 000, as well as a significant Group x Time interaction effect, A=.726, 
F(6,93)= 5.848, p_=.000, for the Stages of Change for dietary fat reduction(SOCF), 
barriers to healthy eating (BHE) and self-efficacy for lowering fat intake measures. 
Univariate analyses showed that this was due to a significant interaction for the SOCF 
F(2,196) = 17.502, p = 0.000. There was a significant univariate interaction effect for 
BHE F(2,196) = 3.54, p_= 0.045, however after applying the Bonferroni correction 
procedure, this result was no longer significant (see Figure 5.8).
5.2.4. Process analyses
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Figure 5.8. Change in the Barriers to healthy eating (BHE) measure between 
intervention and control groups.
There were no significant differences between the two groups on univariate follow up 
analysis for self-efficacy.
Post hoc analyses showed that there were no significant differences between the two 
groups for SOCF at Time 1, t (98) = -2.036, p = .05, or Time 2, t (97) = 1.976, p =
.051. There were, however, significant differences between the two groups at Time 4, 
t (98) = 4.646, p = .000, with the intervention group making significant changes to 
their SOCF perceptions compared to the control group. Only the intervention group 
changed significantly over time in their perceptions of SOCF. Post hoc analyses for 
the intervention group showed that the means for the SOCF were significantly 
different between Times 1 and 2, t (49) = -4.877, p = .000, between Times 2 and 4, t 
(49) = -7.236, p = .000 and between Times 1 and 4, t (49) = -7.530, p = .000. For the 
control group there were no significant differences between the means at Times 1 and 
2, t (49) = -0.141, p = .888, Times 2 and 4, t (49) = -1.460, p = .151 and Times 1 and 
4, t (49) = -1.720, p = .092 (see Figure 5.9).
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Figure 5.9. Change in the Stages o f Change for dietary fat reduction (SOCF) 
measure between intervention and control groups.
Results from the analyses of dietary behaviour process variables suggest that the 
perceptions of participants in the intervention group but not the control group of their 
stage of change for dietary fat reduction changed from contemplation to action and 
that this was associated with decreased barriers to healthy eating but not with 
increased self-efficacy. These results were maintained and increased at the twelve 
months assessment.
Table 5.11. Process variable results for d ietary  behaviour
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
M SD M SD M SD
Dietary Behaviour
S O C F 11 Intervention
Control
2.88
3.50
1.56
1.44
3.96*“a
3.52
0.64
1.38
4.72***b
3.80
0.57
1.27
b h e 2& Intervention
Control
40.70
37.88
9.81
8.08
37.20
37.12
9.48
8.94
33.74
34.52
9.36
9.39
S e lf-e ffic a c y  ' Intervention
Control
3.82
3.66
1.04
1.31
4.16
3.60
1.06
1.20
4.30
3.70
1.00
1.14
1 = h i g h e r  s c o r e s  b e t t e r ,  2 = h i g h e r  s c o r e s  w o r s e
a  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  
4
s  S O C F = S t a g e s  o f  c h a n g e  f o r  d i e t a r y  f a t  r e d u c t i o n  ^ B H E ^ B a r r i e r s  t o  h e a l t h y  e a t i n g
“ *p < 0.001
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P h y s ic a l a c tiv ity  pro ce ss v a r ia b le s : Results for the analyses of process variables for 
physical activity are shown in Table 5.12. Using the multivariate criterion of Wilks’ 
lambda, the M A N O V A  indicated a significant main effect of Time, A=. 810, F 
(6,93)=3.627, p_=003, as well as a significant Group x Time interaction effect,
A= 80, F(6,93)=3.729, p_=.002, for the Stage of change for physical activity (PACE), 
barriers to physical activity (BPA) and self-efficacy for physical activity measures. 
Univariate analyses showed that this was due to significant interaction effects for the 
PACE F(2,196) = 6.939, p = 0.001. There were no significant differences between 
the two groups on univariate follow up analysis for BPA or self-efficacy.
Post hoc analyses showed that there were no significant differences between the two 
groups for the PACE at Time 1, t (98) = -1.371, p = .174, Time 2, t (98) = 0.554, p = 
.581 or Time 4, t (98) = 2.076, p = .041. Post hoc analyses for the intervention group 
showed that the means for the PACE were significantly different between Times 1 
and 2, t (49) = -3.219, p = .002, and between Times 1 and 4, t (49) = -4.906, p = .000. 
There was no significant difference between the means at Times 2 and 4, t (49) = - 
1.124, p = .266. For the control group the means for the PACE did not differ 
significantly between Times 1 and 2, t (49) = -0.432, p = .668, Times 2 and 4,1(49) = 
1.084, p = .284 or between Times 1 and 4, t (49) = 0.806, p = .424 (see Figure 5.10).
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Figure 5.10. Change in the Stages of Change for physical activity measure (PACE) 
between intervention and control groups.
Results from the analyses of physical activity process variables suggest that the 
perceptions of participants in the intervention group but not the control group of their 
stage of change for physical activity changed from contemplation to action and that 
this was associated with decreased barriers to physical activity but not with increased 
self-efficacy. These results were maintained at the twelve months assessment.
Table 5.12. Process variable results for physical activity
Measure Group Time 1 Time 2 Time 4
Baseline 3-months 12-months
M SD M SD M SD
Physical Activity
P A C E  IJ Intervention
Control
4.70
5.27
2.44
2.07
5.64*’a
5.42
2.00
1.97
5.94***b
5.08
2.19
1.93
B P A  2& Intervention
Control
19.08
17.49
5.27
5.29
17.52**8
17.10
4.78
5.27
17.50
17.68
9.97
5.94
S e lf-e ffic a c y 1 Intervention
Control
3.64
3.98
1.30
1.22
3.74
3.70
1.21
1.39
3.56
3.32
1.51
1.42
* * * p < 0 . 0 0 1 , " p < 0 . 0 1
1 = h i g h e r  s c o r e s  b e t t e r ,  2 = h i g h e r  s c o r e s  w o r s e
s P A C E = S t a g e s  o f  c h a n g e  f o r  p h y s i c a l  a c t i v i t y  & B P A = B a r r i e r s t o  p h y s i c a l  a c t i v i t y
,l s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e  2 , b  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  T i m e  1 a n d  T i m e
4
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Chapter 6
The present study aimed to develop a brief, tailored, self-management intervention to 
improve lifestyle self-management in patients with type 2 diabetes, and to evaluate the 
impact of the intervention on helping patients to adopt low fat eating patterns and 
increased physical activity levels. This study is one of the very few randomised 
controlled trials of lifestyle interventions in type 2 diabetes to be conducted in the UK, 
incorporating both dietary and physical activity components. With increasing 
numbers of older people and the increase in risk factors for developing type 2 
diabetes, notably overweight, obesity and physical inactivity, the prevalence of type 2 
diabetes is likely to increase. In light of spiraling health care costs and the fact that 
patients with diabetes consume a disproportionate amount of health care expenditure 
(Marks, 1996), preventive self-management interventions in health care settings of the 
type described here are urgently needed.
Six participants in total were lost to final follow-up in the study. These very low 
attrition rates suggest that this brief intervention was acceptable to a broad cross- 
section of patients and indeed participants reported that the personalised, tailored 
aspects of the intervention, which have proved efficient and effective in other areas of 
health promotion (Rimer et al., 1999; Prochaska et al., 1993), were more helpful to 
them than previous attempts to alter their eating and physical activity patterns. 
Collaborative problem-solving and mutually negotiated goals were generated that 
actively involved patients in the decision making process. Individual involvement of
6. Discussion
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this kind, which reflects current trends towards increasing patient empowerment 
(Anderson, 1995), needs to be developed especially within the primary care setting, 
which is where the majority of patients with type 2 diabetes are treated. Indeed, 
Diabetes U K  has emphasised such a patient centred approach to diabetes care as a 
priority in a position statement for the Diabetes National Service Framework 
(NSF)(Diabetes U K  Position Statement, 2000).
The intervention was effective in producing change in a number of important dietary 
behaviours. Intervention participants made significant reductions to their fat-related 
eating habits by substituting low fat for high fat foods and avoiding adding fat as 
flavouring to foods between the baseline and three months assessments. These 
changes were maintained at the six months assessment for both subscales and for the 
substituting low fat for high fat foods subscale at the twelve months assessment. In 
addition, the significant reductions made to total daily intake of fat by intervention 
participants between the baseline and three months assessments were maintained and 
increased at the twelve months assessment.
These results have important implications for practice. Fat reduction has been 
identified as the most difficult of the dietary recommendations for diabetic patients to 
follow. These reductions therefore in both fat-related eating habits and total intake of 
fat were encouraging in light of recent recommendations for healthy eating in patients 
with type 2 diabetes (BDA, 1992; AHA, 2000) and the suggested link between high- 
fat diets and coronary heart disease (CHD), obesity and type 2 diabetes (Pang, 1994; 
BDA, 1992). In addition, since weight loss is an important goal of treatment in type 
2 diabetes, a reduction of the total fat content of the diet can be seen as an important
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step in reducing total energy intake, which is of benefit in both weight maintenance 
and ultimately weight loss.
In terms of physical activity, the major public health problem of sedentary living is 
concentrated in the least active and unfit 20-30% of the adult population, with an 
estimated increased mortality of at least twofold for this group. Risk can apparently 
be substantially reduced if these individuals become at least somewhat active and 
moderately fit. Participation in moderate-intensity activities, such as walking instead 
of driving a short distance, climbing stairs, parking away from the destination, and 
getting off the bus early and walking, impart significant health benefits (Blair et al., 
1989; Leon et al., 1987; Sallis et al., 1986). In addition, total energy expenditure over 
time may be more important than the duration of the exercise session itself when 
considering the effect on longevity and premature mortality (Blair et al., 1992; 
Paffenbarger et al., 1986). Importantly, physical activities of light to moderate 
intensity that can be built into the normal daily routine, may be more sustainable and 
may be the most effective and least costly approach for increasing energy expenditure 
in the largest number of people (Shephard, 1992; Pescatello, 2000).
Accordingly it can be concluded that some activity is better than none and that low- to 
moderate intensity activity is better than remaining sedentary. In the present study 
therefore, although the overall PASE score for occupational, household and leisure 
activities was not significantly different between the two groups, the means for the 
intervention group were in the right direction at all time points compared to the 
control group, and were approaching significance for the Time 2 and Time 4 data, 
suggesting that intervention participants were increasing their physical activity levels.
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One possible explanation for the lack of significance may be that the study sample 
was too small to provide enough statistical power to detect intervention effects. This 
highlights the issue of the difficulty of computing power for intervention studies with 
multiple outcomes. In the present study, subject numbers were determined from the 
effect sizes of Glasgow et al. (1996) upon which the intervention was closely 
modelled. Accordingly, effect sizes for self-reported dietary behaviour and 
cholesterol were used but Glasgow et al. did not incorporate a physical activity 
component in their intervention. Indeed, there are no comparable studies in the 
literature incorporating both dietary and physical activity components in a brief 
intervention such as in the present study.
A  further explanation for the lack of significant results may lie in the mode of 
administration of the questionnaire. In this study the PASE was administered by mail 
and was therefore self-report, which can be affected by recall difficulties and possible 
overestimation or underestimation of frequency or duration. Furthermore, many 
participants reported uncertainty as to how to respond to some of the categories in the 
questionnaire and this may have resulted in under-reporting of some activities and 
possibly double reporting of others. Washburn et al. (1993) report that PASE scores 
were nearly 18 points higher, on average, when the PASE was administered by mail 
compared to telephone. In a telephone version where the interviewer could probe in 
response to questionable information, this did not occur. However, it is important to 
note that interviewer probing may also introduce inconsistency in the responses.
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Consistent with the above results on dietary and physical activity behaviour, 
intervention subjects also reported significantly increased dietary and physical activity 
self-care behaviours compared to the control group over the preceding 7 days, at the 
three and six months assessments, and these results were maintained for the physical 
activity subscale at the twelve months assessment.
An important consideration is that all of the above changes were self-reported. Self- 
report measures are used most frequently to assess adherence to treatment, perhaps 
because they are the most easily administered and the least expensive. Interviews, 
structured questionnaires and daily diaries are the three most commonly used formats. 
However, patient self-reports concerning regimen adherence have traditionally been 
considered suspect; what patients say they do may bear little resemblance to actual 
behaviour, because patients may for example be influenced markedly by what they 
believe the health care professional wants to hear (Glanz, 1990). Issues that concern 
all self-report measures include validity, sources of respondent error (that is, 
nondeliberate error in recall), and deliberate errors or misreporting (Gibson, 1990).
Accordingly, the finding that the above self-reported behaviour changes were 
reflected in the objective data with a small but significant difference between the two 
groups in tenns of BMI and waist measurements was reassuring. This effect resulted 
primarily from a significant drop in the waist measurement for intervention subjects 
between the baseline and three months assessments which was maintained at six and 
twelve months. In addition, these self-reported changes were also reflected in weight 
maintenance in the intervention group between the baseline and the twelve months
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assessment, while BMI increased significantly for the control group over the same 
time period.
These findings are particularly important and support those of previous studies (for 
example, Lehmann et al., 1995). It is now apparent that the distribution of body fat, 
as well as its total mass, is an important determinant of risk for type 2 diabetes, as a 
'central' or 'truncal' deposition of fat (particularly within the abdomen) substantially 
increases the susceptibility to the disease (Mayer-Davis et al., 2001; Bjomtorp, 1988). 
The physiological basis is unknown, but visceral fat appears to undergo lipolysis more 
readily, and increased free fatty acid levels in the bloodstream are known to increase 
insulin resistance through their metabolic effects in liver and muscle (Colberg et al., 
1995). This is the critical reason why it is essential to obtain an accurate waist 
circumference on every patient yet this measurement is often neglected from clinical 
practice and indeed research with patients with type 2 diabetes. Seidell (1995) 
reviewed anthropometric methods to assess abdominal fat, concluding that waist 
circumference alone was probably the most practical measurement for use in health 
promotion. Waist circumference relates closely to intra-abdominal fat mass (Pouliet 
M-C et al, 1994; Ross et al., 1993; Seidell et al., 1988) and changes in waist 
circumference, as repoited in the present study, reflect changes in cardiovascular risk 
factors even in the absence of significant weight loss (Lehmann et al., 1995; 
Sonnichsen et al., 1992; Wing et al., 1992; Wing et al., 1995; Hellenius et al., 1993; 
Barlow, 1995).
Extensive clinical and epidemiological research has found the waist circumference to 
be the best anthropometric indicator of both total body fat and intra-abdominal fat
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mass, compared with laboratory reference methods of underwater weighing and 
magnetic resonance imaging (MRI). A  further benefit is that the waist is very easily 
measured, and is the most easily reproducible statistic. It is also better than waist/hip 
ratio, which is a complicated term and somewhat ambiguous, because the ratio 
involves two variables and a small or large hip circumference may result in a false 
interpretation (Depres et al., 1990). Furthermore, while waist/hip ratio is not always 
responsive to weight loss or weight gain, body mass index and waist circumference 
obviously are (Krotkiewski, 1988).
It is important to note that measuring waist circumference does not claim to offer 
major advantages over BMI in tenns of predicting health problems. They have 
similar power, but a large waist circumference is able to detect some individuals 
whose BMI is not yet over the conventional cut-offs (25 or 30 kg/m2), but who need 
weight management because of central fat deposition, an important consideration in 
the preventive management of patients with type 2 diabetes. Indeed, several studies 
have shown that the greatest benefit from weight loss occurs in subjects with central 
fat predominance.
Applied correctly, therefore, the waist circumference can be used as a simpler 
alternative to BMI. The main value is in health promotion, to warn people of their 
health risks and their need to take action. The immediacy of waist circumference 
presents a better opportunity than BMI to reach those people with type 2 diabetes who 
currently regard themselves as within the 'normal' range, as part of an "overweight 
population in a toxic environment of high-fat food and inactivity" (Lean et al.,1998)
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The finding that BMI increased significantly for the control group between the 
baseline and twelve months assessments is of particular concern. Achievement and 
maintenance of a healthy body weight rely on strategies that are mostly independent 
of the desired or healthy body weight to be achieved. Because weight gain 
accompanies aging, and because weight gain is independently associated with 
coronary heart disease and stroke, prevention of weight gain should be a high priority 
in this population group. In general, relative caloric restriction sufficient to produce 
weight reductions of between 5% and 10% can significantly improve the clinical 
condition in type 2 diabetes. However, the generally poor long-term success of 
programmes that encourage such weight reduction supports an approach as 
highlighted in the present study, which may be more effective over the long term in 
promoting the behavioural changes needed to promote weight maintenance should 
any weight loss occur and importantly to prevent weight gain. In this regard, the 
results for BMI for the intervention group compared to the control group in the 
present study are very encouraging.
It was disappointing that the behaviour changes did not translate into significant 
differences between the two groups in terms of reductions in HbAlc or improvements 
in the other physiological measures (cholesterol, HDL, LDL, triglycerides) at any of 
the assessment time points. This is in contrast to the Glasgow et al. (1996) study, 
which reported significant reductions in serum cholesterol for inteivention 
participants. The findings of the present study however, are not unusual and reflect 
those of previous research. Watts et al. (1991) for example, found that 60% of 
patients who lost 9 kg or more did not have improvement in plasma glucose levels. 
Further, these findings support those of Denke (1995) and others that some
119
individuals exhibit almost no response or even a paradoxical response to a 
cholesterol-lowering diet: their cholesterol levels actually increase on a cholesterol- 
lowering diet (DHFS, 1968; Hunninghake et al., 1993).
Studies by both Glasgow (1989) and Johnson (1992) have found that the relations 
between behaviour change and physiological measures of diabetes control are at best 
often modest and definitely complex. There are numerous patient factors (age, 
gender, history of diabetes), medical status variables (insulin status, comorbidities, 
other medications), patient provider interaction factors (appropriateness of regimen 
prescription) and issues pertaining to timing and sequence of behaviour changes and 
physiological change that can potentially condition and moderate these relationships. 
Larger scale and more complex studies are needed to address these issues and to 
identify subgroups of patients whose diabetes and physiological status is more and 
less responsive to behaviour change (Wing,1990; Glasgow et al.,1992; Denke, 1995).
In tenns of the process of change, intervention subjects perceived themselves to be 
significantly more ready, at the three months and six months assessments to increase 
their physical activity levels and reduce their fat intake and moved from a stage of 
precontemplation to action, for example, a) from exercising or walking infrequently to 
doing moderate physical activity 3 times a week, b) from meaning to do something to 
lessen the fat in their diets but not actually getting around to it, to consciously 
avoiding fat in their diets for the last 6 months. These results were maintained at the 
twelve months assessment. These changes in eating behaviour and physical activity 
levels were accompanied by a trend towards decreased barriers to change but not 
increased self-efficacy. These results support those of Glasgow et al. (1992; 1996)
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and suggest that the collaborative problem-solving and patient empowerment aspects 
of the intervention may have equipped participants in the intervention group with 
relatively enduring skills to cope with the continuously changing array of barriers to 
lifestyle self-management in diabetes care (Irvine, 1990; Glasgow, 1986).
Given the significant behaviour changes and previous findings in diabetes (Kingery et 
al., 1989; Crabtree, 1987), and other areas (Bandura, 1977; 1986) that self-effieacy 
often mediates or at least predicts behaviour change, it was surprising that there were 
not significant results for self-efficacy. This finding may well be explained by the 
fact that participants in the present study had quite high self-efficacy scores at 
baseline, which may have precluded the ability to detect further significant increases. 
Importantly, however, high self-efficacy scores at baseline have been shown 
(Bandura, 1992) to be an important determinant of programme continuation, and the 
low attrition rates in the present study would support these findings.
Quality of life (QoL) is increasingly recognized as an important health outcome in its 
own right, and has been said to represent the ultimate goal of all health interventions 
(Rubin, 2000). More than 50 years ago, the World Health Organisation stated that 
health was defined not only by the absence of disease and infirmity, but also by the 
presence of physical, mental and social well-being (WHO, 1952). Most studies 
report worse quality of life for people with diabetes compared to the general 
population, especially regarding physical functioning and well-being (Rubin et al., 
1999; Peyrot et al, 1997). Snoek (2000) suggests that one of the most intriguing 
findings from QoL research is the relatively weak association between patients' 
objective health status and their subjective life quality. Where diabetes is concerned,
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quality of life may bear no relation to biomedical measures of diabetes control 
(Bradley, 1994). Indeed, studies examining the relationship between diabetes control 
(HbAlc) and subjective well-being find low correlations if any, (Nerenz et al., 1992; 
Sonnaville et al., 1998; Weinberger et al, 1994), although there is evidence to suggest 
that patients suffering from diabetes-related complications on average report lower 
levels of QoL compared to patients without secondary complications (Klein, 1998).
In the present study, there were no significant differences between the two groups on 
perceptions of quality of life or self-esteem. However, it may have been unrealistic to 
expect such impacts from a brief intervention directed in particular at two aspects of 
diabetes self-management. A  second explanation may be that the particular QoL 
measure selected (the SF-12 short form from the Medical Outcomes Study) was not 
sufficiently sensitive to the changes produced or that not enough time had elapsed for 
the behavioural changes to translate into functioning and QoL differences. In 
addition, in contrast to the findings of others (Woodcock et al., 1999; Frasure-Smith et 
al., 1995), while the intervention did not result in an improvement in participants’ 
subjective ratings of quality of life or self-esteem, at least it did not result in making it 
worse. This finding is important given the lifestyle adjustments required, especially 
dietaiy change, which are frequently rated by both patients and health care 
professionals as being the most difficult aspects of the regime to follow (Fisher et al., 
1997; Schlundt et al. 1994; Ary et al., 1986). Furthermore, an encouraging result 
regarding future implementation is that there was no sign of an increase in either 
binge eating or emotional eating as a result of the dietary modification element of this 
brief intervention.
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Understanding the behaviour of persons with diabetes requires some knowledge of 
their beliefs and attitudes towards diabetes and its treatment. Beliefs and attitudes are 
a major component of health behaviour, and previous research has demonstrated 
associations with diabetes management (Cerkoney et al., 1980; Polly, 1992; Fitzgerald 
et al., 1995). Hampson et al., (1996; 1995) suggest that beliefs about treatment 
effectiveness followed by beliefs about seriousness appear to be most strongly 
associated with self-management and patient's personal models of diabetes are useful 
predictors of self-care behaviour. In the context of the above findings, therefore, it 
was of particular concern to find that, in contrast to previous research (for example 
Glasgow et al., 1996), patients in the present study perceived their diabetes as only 
slightly serious and were only slightly worried about its threat to their future health. 
Participants did however believe in the value of treatment for diabetes, and beliefs 
about the value of treatment were somewhat stronger than beliefs about the 
seriousness of one's disease. In addition, participants’ personal models of diabetes 
and the importance of self-management did not alter significantly throughout the 
course of the study for either the intervention or the control group.
This result was disappointing since it was hoped that as the intervention group 
engaged more with their diabetes self-management, they might begin to regard their 
diabetes as the very serious disease that it is and appreciate the very significant threat 
that it poses to their future health. However, these findings are consistent with the 
commonly held myth amongst both health care professionals and the public in general 
that type 2 diabetes is a relatively mild disease, which is easily managed, and that 
complications either won't happen because it occurs in older patients or are inevitable 
because they are already present at diagnosis. A  second explanation may be that the
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majority of these patients were not taking insulin and research has shown that those 
who are taking insulin regard their diabetes as more serious than those who are not 
(Hampson et al, 1990).
Regarding generalisability of this intervention, and given concerns about the 
applicability of many interventions in diabetes care to subgroups such as less- 
educated patients, the elderly, type 2 patients and high-risk patients with other chronic 
diseases, it was encouraging to see that these factors were not related to treatment 
outcome in the present study. In general, the intervention appears relatively robust 
and applicable to most patients with diabetes since no single predictor was 
consistently associated with outcome on any of the key outcome measures.
6.1. Strengths of the Study
One of the methodological strengths of this study was the inclusion of a broader range 
of outcome measures compared to most diabetes studies, which often assess only 
improvements in knowledge and glycaemic control (Brown, 1990; Glasgow et al., 
1992). Including a broader selection of measures together with other behaviour 
change indices and process measures allows better understanding of how the 
intervention works.
It is well known that maintenance and preventing relapse is an important challenge for 
lifestyle behaviours (Marlatt et al., 1985). Accordingly, a further strength of the 
present study was the recognition that maintenance of behaviour change should be 
conceptualised as a process in itself rather than merely as the last step in the behaviour
124
change process, with a shift in focus to include not only relapse prevention but also 
importantly, relapse management. This was facilitated by reviewing with 
intervention participants at each assessment time point what had worked or not so far, 
the generation of alternative choices, the decision-making and action process, 
followed by appraisal of the outcome. Use of this problem-solving approach as a 
component of relapse prevention and management teaches participants to become 
their own therapists in dealing with future problematic situations. The results of the 
present study, which show that participants were generally successful in maintaining 
or even enhancing changes made over the twelve months follow-up period, suggest 
that this component of the intervention was successful in facilitating adherence to the 
difficult lifestyle changes recommended for these patients as part of their medical 
regimen.
Telephone contact to provide support and prevent relapse was also incorporated. This 
has been demonstrated by others to be both efficient and cost-effective in improving 
maintenance of behaviour change (Piette et al., 2001; Wasson et al., 1992; Estey et al., 
1990) and patients reported that it was preferable compared, for example, to weekly 
attendance at group meetings, which may also have resulted in high attrition rates.
6.2. Limitations of the Study
In addition to the limitations already discussed, a further limitation of this study is that 
a research psychologist rather than diabetes centre staff administered the intervention. 
However, since this was an initial 'feasibility' study and many procedures were being 
tested for the first time, this was considered appropriate. Later research will have to
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test the effectiveness of the intervention using diabetes care team members, for 
example nurses or dieticians, as interventionists.
The use of paper-and-pencil self-completion questionnaires for tailoring is also a 
limitation. Resources were not available to use a computerised assessment, as in the 
Oregon Research Institute's version of this intervention. However, the measures 
could easily be converted to a computer format, which would permit automated 
scoring and make less work for those involved in delivering the intervention. 
Computer-tailored interventions for health behaviour are proving efficient and 
effective (Brug et al., 1999) and this type of intervention lends itself to a more 
automated approach.
A  further consideration relates to administration of the Physical Activity Scale for the 
Elderly, which might have been better administered by telephone or individual 
interview with each participant. In addition, an objective measure of physical fitness 
might have facilitated a clearer understanding of intervention effects and changes over 
time on increasing physical activity levels.
It is also possible that the quality of life scale used (SF-12) was not the best measure 
for this population. The use of a diabetes specific quality of life measure, such as the 
ADDQoL (Bradley et al., 1995), may have been more sensitive to change and may 
have provided a more patient centred analysis of the impact of type 2 diabetes on 
individual quality of life. In addition, the Type 2 Diabetes Symptom Checklist (DSC- 
Type 2; Grootenhuis et al., 1994) which measures both the occurrence and the 
perceived burden of physical and psychological symptoms related to type 2 diabetes 
and its possible complications, would have enabled the measurement of differences in 
symptom severity between patients and changes over time within patients, which are 
important factors in perceived quality of life.
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6.3. Implications of the Study
This study has important implications for practice and future research in the care of 
people with type 2 diabetes. It has been argued (Glasgow, 1999a) that the message 
that diabetes and its management is much more than HbAlc, and that cardiovascular 
outcomes are at least as important in terms of morbidity, mortality, costs and public 
health outcomes as glycemie control and microvascular complications , has not been 
nearly as widely accepted as has the message that 'metabolic control matters' 
emphasised by the DCCT (1994). The results of the recently reported UKPDS study 
(1999), and epidemiologic and cost data showing that cardiovascular disease 
complications are the greatest killers and responsible for the majority of health care 
costs among persons with type 2 diabetes (ADA, 1993; ADA, 1998; DHHS, 1996) 
suggest a convincing case for interventions such as the one reported here which focus 
on reducing cardiovascular disease risk factors such as high fat diets, physical 
inactivity and central abdominal obesity. Future research needs to address these 
issues.
A  related concern is that to date there has been a reliance on very intensive 
interventions delivered in tertiary care settings by leading experts and 
multidisciplinary teams with highly selected, motivated and uncomplicated patients. 
While this type of research has produced important information on what it is possible 
to accomplish under ideal circumstances with the patients most ready to change, it 
does not tell us what types of interventions will appeal to patients, health care 
professionals and health care settings, be practical to implement when applied under 
real-world conditions with limited resources and diverse, and less motivated patient 
groups. Key features of the intervention described are that a highly personalised 
intervention, which addresses the important influences on lifestyle self-management 
in type 2 diabetes, can be conducted in a brief period of time. The intervention can 
potentially be integrated into routine patient care in general practice, thus reaching a
127
broader audience. This approach could also be extended to other patient groups who 
would benefit from lifestyle changes, for example those with coronary heart disease or 
arthritis.
An important conceptual shift in diabetes research is also indicated to incorporate the 
recognition of behavioural outcomes as appropriate in their own right, not only 
because behaviour change is probably a necessary precursor to subsequent biological 
or clinical endpoints, but also because 'doing well' reflects ordinary everyday 
behavioural functioning and the congruence between self-management practices, 
emotional status and quality of life as well as metabolic control and clinical status. 
Behavioural outcomes are therefore of interest and worth evaluating in their own 
right.
The finding that participants in the present study regarded their diabetes as only fairly 
serious is of particular concern and that this may be related to attitudes and beliefs of 
the health care professionals involved in their care clearly warrants further 
exploration, in light of growing evidence that differences in the concepts and 
perspectives of patients and practitioners exist and may be important factors affecting 
treatment behaviour and health outcomes for patients with type 2 diabetes. 
Furthermore, patient-centered, motivational interviewing, and patient 
activation/empowerment approaches, of the type described here, have consistently 
been found to produce beneficial effects, yet such strategies are seldom employed in 
either primary care or specialist settings. There is a compelling need for future 
research to address these issues, and the implementation of and barriers to the 
application of the behavioural sciences in these health care settings.
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7. Com parison of patients’ and health  care  professionals’ diabetes beliefs and 
attitudes
7.1. Rationale for the present study
This exploratory cross-sectional study was undertaken to investigate an important 
issue highlighted in the intervention study that might act as a barrier to future 
interventions being effective and implementation of interventions by health care 
professionals. The issue highlighted was that patients’ personal models of diabetes 
suggested that they did not regard their diabetes as ‘serious’. In contrast to this, 
discussions with health care professionals involved in their care revealed that they 
regard diabetes as ‘very serious’. This study was designed therefore to investigate 
more fully this discrepancy in diabetes-related attitudes and beliefs of health care 
professionals and patients with type 2 diabetes and to ascertain whether patients' 
personal models of diabetes in the lifestyle intervention study differed to their 
diabetes-related attitudes in general.
7.2. Background
Diabetes is a lifelong chronic illness in which patients deliver over 95% of their own 
care. Type 2 diabetes in particular is a serious and growing health problem affecting 
all sectors of the population and accounts for approximately 80% of diagnosed cases 
of diabetes. Effective management of diabetes requires complex, continual and 
demanding self-care behaviours: diet control, exercise, self-monitoring of blood sugar 
levels, and taking medications several times a day. However, achieving effective
Chapter 7
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management of type 2 diabetes has proven to be very difficult. Much research during 
the past several years has attempted to address this issue, but despite this extensive 
research attention, achieving adequate control of glucose levels in type 2 diabetes 
patients remains elusive (UKPDS, 1999; Johnson, 1992; Kurtz, 1990).
Understanding the behaviour of persons with diabetes requires some knowledge of 
their attitudes towards diabetes and its treatment (Anderson et al, 1988). 
Psychological models such as the Health Belief Model and the Self-Regulation Model 
of illness behaviour emphasise that attitudes and beliefs are a major component of 
health behaviour, and constructs from these models have been associated with 
diabetes management. Cerkoney et al. (1980) for example found that beliefs about 
the seriousness of diabetes and responding to cues to action were associated with 
adherence to treatment. Polly (1992) reported that perceived severity was associated 
with metabolic control and perceived barriers were associated with adherence to 
treatment in older type 2 patients. Fitzgerald et al. (1995) found that type 2 patients 
with higher adherence acknowledged the seriousness of diabetes and recognised the 
relation between glucose control and complications.
Hampson et al. (1996,1995, 1994,1990) have systematically assessed the five 
components of illness representation explicitly using the Leventhal et al. (1985) 
framework and then related patients' illness representations to the various aspects of 
their self-management of diabetes. Results from these studies suggest that beliefs 
about treatment effectiveness followed by beliefs about seriousness appear to be most 
strongly associated with self-management and that patients' personal models of 
diabetes are useful predictors of self-care behaviour.
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Attitudes to diabetes also influence the behaviour of health care professionals (Ajzen 
et al., 1980; Weinberger et al., 1984). Since patient education is largely a process of 
communication between health care professionals and their patients it is important to 
understand the similarities and differences in their attitudes towards diabetes and its 
treatment. Health care providers bring to their encounters a professional worldview 
that influences the way they interpret diabetes, explain its causes and progression, 
understand its symptoms, and orchestrate methods of treatment. This professional 
perspective may also differentiate providers from patients with respect to diabetes 
management goals and expectations. Although differences in perspective are not 
inherently problematic, they frequently become so when patients do not meet the 
goals and expectations of their health care providers. In these instances, patients are 
likely to be labelled ‘nonadherent’, a term that might be seen to imply a moral failure 
to behave properly. Anderson (1985) suggests that this blaming behaviour stems 
from the belief on the part of health care providers that the correct view of diabetes 
and its management is that of the clinicians.
The problem with trying to understand patients’ behaviour in this way is that it 
seldom leads to an in-depth exploration of the reasons for the behaviour or a rational 
approach to changing it. In contrast to this, a better understanding of the behaviour of 
patients might well result from finding out their attitudes and beliefs about the illness 
and the psychosocial contexts in which they care for their diabetes, rather than by 
making judgements about their self-care behaviours. For example, the choices that 
patients make appear quite sensible if one understands the demand characteristics of 
their enviromnent (Anderson, 1998). In this way we can shed light on the causes of
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undesirable diabetes care and therapeutic outcomes as well as the dissatisfaction that 
often results from a provider or patient’s failure to meet the other’s diabetes 
management expectations.
A  major problem in treating diabetes is that patients often fail to appropriately carry 
out recommended treatment behaviours. High rates of nonadherence to treatment 
regimens have often been noted among type 2 diabetes patients (for example, Cox et 
al., 1992). Efforts to understand the basis of this nonadherence commonly focus on 
patient knowledge and motivation, addressing the underlying questions: Why don’t 
patients do what they should, and how can we get them to do it? (Cox et al., 1992; 
O ’Connor et al., 1992). This emphasis on patient characteristics may be 
inappropriate. There is growing evidence that differences in the concepts and 
perspectives of patients and practitioners exist (Snoek, 2000; Lang et al., 2000) and 
may be important factors affecting treatment behaviour (Golin, 1996; Hernandez, 
1995; Kleimnan, 1980).
A  number of studies have examined these differences in tenns of differences in 
understanding of common tenns and concepts used in diabetes care. Aufseesser et al. 
(1995) for example examined diabetes patients' understanding of eight medical terms 
concerning retinopathy. Results indicated that patients' understanding of the terms 
was quite diverse and that most patients had a poor understanding of terms commonly 
used in an ophthalmology consultation. Furthermore, both the physician and the 
patient were certain that the patient understood these terms. Importantly in this 
study, sociodemographic factors did not have an effect on patient understanding.
More recently, Hunt et al. (1998) in a qualitative study contrasting patient and
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practitioner perspectives in diabetes management indicated that the concept of 
'diabetes control’ had very different meanings for health care professionals and 
patients. Practitioners' primary means of evaluating control of diabetes is on 
objective clinical indicators. Patients, on the other hand, are much more complex in 
their assessments and focus more on how they feel, how much the illness disrupts 
their normal life and their assessments of the impact of their actual behaviours on 
their illness.
Other studies have focused on differences in explanatory models of diabetes between 
health care professionals and patients. Kleinman (1980) for example, has argued that 
individuals vary in their explanatory models of illness and health, which are based on 
distinct sets of meanings and that these meanings importantly influence how 
individuals act regarding treatment. He has argued that by learning to elicit patients' 
explanatory models, clinicians can work toward negotiating the discrepancies between 
their models and patients' models, thereby improving compliance, satisfaction, and 
subsequent use of the health care system. Based on this framework, Cohen et al. 
(1994) have characterized patient and practitioner explanatory models of diabetes. 
They found practitioners' and patients' models were least congruent regarding 
aetiology, pathophysiology and symptom onset, and they conclude that patients and 
practitioners focus on different domains. Patients for example, were found to 
emphasize difficulties in the social domain and the impact of diabetes on their lives, 
whereas practitioners see diabetes as a pathophysiological problem and are most 
concerned with its physical impact. They suggest that this difference between patient 
and practitioner perspectives may be an important contributory factor to poor 
management of diabetes.
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A  related concern is that while there is some literature on patient beliefs and attitudes 
that affect adherence to recommended treatment regimens (Hampson et al., 1996; Cox 
et al., 1992), little is known about provider beliefs and attitudes that may interfere 
with their adherence to current standards of care (Anderson, 1991,1992; Weinberger, 
1984; Marteau et al., 1984). Contradictions noted in the literature on the diabetes- 
related beliefs and behaviours of health care providers merit further inquiry.
Although physicians generally agree that tight glucose control is important in diabetes 
(Anderson, 1991), their practice behaviours are inconsistent with this belief (Jacques 
et al.,1991;Kenny et al., 1993; Stolar et al., 1995). Belfiglio et al. (2001) for 
example, in the context of the larger QuED project, conducted a survey to investigate 
the relationship between target fasting blood glucose (FBG) levels adopted by Italian 
physicians and the level of metabolic control obtained in patients with type 2 diabetes 
in their charge. Results suggest that doctors adopt extremely heterogeneous target 
FBG levels in patients with type 2 diabetes, which in turn represent an important 
independent predictor of metabolic control. This study demonstrates the crucial role 
of physicians' attitudes and beliefs in determining patient outcomes. The risk of poor 
metabolic control was strongly related to physicians' beliefs, and more than one-third 
of the cases with HbAlc levels >7.0% could be attributed to physicians' FBG target
These findings may be attributable to the different perception about the risk of 
hypoglycaemia in an aged population and to the belief that even low levels of 
metabolic control could exert a positive effect in preventing complications of 
diabetes. On the other hand, lack of adherence to guidelines for both glycemic 
control and complication screening may relate to the belief that diabetes
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complications are inevitable and cannot be prevented (NIH,1994) or that type 2 
diabetes is not a serious disease requiring aggressive treatment. In fact, Kenny et al. 
(1993) report that physician adherence to consensus recommendations for 
complication screening is lower for patients with type 2 diabetes than for patients with 
type 1 diabetes.
It has been demonstrated that increasing the knowledge of a patient with diabetes does 
not necessarily lead to enhanced diabetes self-management (Norris et al., 2001;
Griffin et al., 1999). The above findings would suggest that it is equally true that 
increasing the knowledge base of providers through continuing medical education 
and/or guidelines (for example, UKPDS) is unlikely to result in a significant 
improvement in the diabetes care they provide (Belfiglio et al., 2001; Larme et al. 
1998).
These findings then suggest that it is particularly important to understand the attitudes 
of primary care providers and patients about the treatment of type 2 diabetes. Of 
diabetic patients, over 80% suffer from type 2 diabetes (Marks,1996; Harris, 1995), a 
majority of patients with diabetic end-stage renal disease have type 2 diabetes (Pugh, 
1995) and some of the complications of diabetes (for example, cardiovascular disease) 
are more common in older type 2 patients ((Kenny, 1993). Primary care providers 
have the most negative attitudes to diabetes (Anderson, 1991) yet they provide a 
major part of all diabetes care (Harris, 1995) particularly for patients with type 2 
diabetes. If attitudes and behaviours are linked, as research suggests, then 
understanding why health care professionals and patients think and act the way they 
do is an important step in the development of effective interventions and continuing
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professional development programmes to enable health care professionals and patients 
to manage diabetes more effectively.
7.3. Aims of the present study
This study aimed to examine attitudes to diabetes of health care professionals and 
patients with diabetes and to explore discrepancies in those attitudes, which may act 
as barriers to effective diabetes care and therapeutic outcomes for patients with type 2 
diabetes. Accordingly, building on the work of Anderson et al. (1998,1989, 
1990,1991), it was decided to use the third version of the Diabetes Attitude Scale 
(DAS-3), The DAS-3 represents a generalized measure of patients' attitudes towards 
diabetes and is designed to facilitate comparisons between patients and the health care 
professionals (HCPs) involved in their care. A  comparison of the attitudes of HCPs 
and patients provides an opportunity to identify differences in opinion that could 
interfere with the quality of the patient-HCP relationship and ultimately affect the 
management and treatment of the disease. Doctors, nurses and dietiticans were 
recruited for the present study since they are the HCPs most involved in the care of 
patients with type 2 diabetes and also those involved in the previous Anderson et al. 
studies (for example 1990,1991).
A  further aim of this study was to gain a more detailed understanding of health care 
provider attitudes to diabetes and its treatment, compared to other chronic illnesses, 
that may negatively impact diabetes care and function as barriers to intervention 
implementation in a variety of health care settings. Accordingly, as previously
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investigated by Larme et al. (1998), an additional survey was included for completion 
by HCPs addressing specific practice behaviours and attitudes towards diabetes.
7.4. Hypotheses
It was expected that:
1) Patients with type 2 diabetes will not see their diabetes as serious as the health 
care professionals involved in their care;
2) Health care professionals who spend more of their work time involved in 
diabetes care will view diabetes as more serious than those who spend less 
time;
3) Patients with type 2 diabetes will regard their own diabetes as less serious 
compared to diabetes in general.
7.5. Method
7.5.1. Design
This study consisted of a cross-sectional design comparing and contrasting differences 
in attitudes to diabetes between health care professionals and patients with type 2 
diabetes.
7.5.2. Participants
One hundred and four health care professionals and 100 of their patients participated 
in this study. Subject numbers were determined using G  Power, version 2 (Erdfelder 
et al., 1996). It was estimated that a total sample size of 180 participants would have
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pow er o f 0.80 to  detect m edium  effects at a lpha =  .05 using F tests to  com pare means. 
The health  care professionals consisted o f  nurses, general p ractitioners and d ie titians  
w ho w ere a ll responsible fo r d ire c t care o f  patients w ith  diabetes. The patients had 
been diagnosed w ith  type 2 diabetes fo r m ore than one year, were aged 40-70 years 
and had no m a jo r im pa irm en t due to  diabetes.
In  a d d itio n  to  the above partic ipan ts , the 100 patients in  the life s ty le  in te rven tion  
study also pa rtic ipa ted  in  th is  study, in  order to  test the hypothesis tha t patients w ith  
type 2 diabetes w ill regard th e ir ow n diabetes as less serious com pared to  diabetes in  
general.
7.5.3. R ecru itm ent
The hea lth  care professionals w ere a ttend ing  a B ritis h  D iabe tic  A ssocia tion  
conference on diabetes care in  P rim ary Care and were approached as they registered 
fo r the conference and in v ite d  to  pa rtic ipa te  in  the study. Those w ho agreed were 
then g iven a fu lle r descrip tion  o f  w hat was in vo lve d  in  the study and asked i f  they 
w ou ld  also be w illin g  to  re c ru it a t least 5 o f th e ir patients fo r in c lu s io n  in  the study 
and any o f th e ir colleagues no t in  attendance at the conference. They were then g iven 
verba l and w ritte n  deta ils o f  the ine lus ion /exc lus ion  c rite ria  fo r the pa tien t 
partic ipan ts, a pack con ta in ing  y e llo w  questionnaires to  be g iven to  th e ir patients, a 
pack con ta in ing  b lue questionnaires to  be g iven  to  th e ir colleagues, together w ith  
FREEPOST envelopes fo r th e ir re turn. The hea lth  care professionals were 
encouraged to  com plete th e ir questionnaires and hand them  back to  the investiga to r 
w h ile  s t ill at the conference. Those w ho were unable to  do so were g iven FREEPOST 
envelopes fo r th e ir re turn. T h is  m ethod o f recru itm en t was undertaken firs tly  to  ensure 
tha t as diverse and 'na tionw ide ' a sam ple o f  partic ipan ts as possible were ta k in g  part in  
th is  study and secondly because, as others have noted (Anderson et a l., 1991; M aheux
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et a l., 1989) i t  is  ve ry  d iff ic u lt to  ob ta in  an adequate num ber o f  returns w hen 
questionnaires are m a iled  to  hea lth  care professionals and patients.
7.5.4. M easures
The tw o  groups o f new ly  recru ited  pa rtic ipan ts  w ere asked to  com plete questionnaires 
re la tin g  to  dem ographic and p ro file  characteristics and the D iabetes A ttitu d e  Scale -  
3rd version  (D A S  -3 ; A nderson et a l., 1998).
The 100 patients in  the life s ty le  in te rve n tio n  study w ere asked to  com plete the D AS-3 
at the 3 m onths assessment v is it.
Diabetes Attitude Scale: The D A S -3 has been shown to  be a v a lid  and re lia b le  
general measure o f d iabetes-re lated attitudes, su itab le  fo r com parisons across d iffe re n t 
groups o f  hea lth  care professionals and patients (Anderson et a l., 1998). I t  consists o f  
33 L ik e rt scale item s (5= strong ly  agree, l= s tro n g ly  disagree) and fiv e  discrete 
subscales. The subscales measure attitudes to  the fo llo w in g :
1. The need for special training in education - Assesses the respondent's a ttitude  about 
the need fo r hea lth  care professionals w ho care fo r patients w ith  diabetes to  have 
special tra in in g  in  teaching, counse lling , and behaviour change techniques.
2. Seriousness o f type 2 diabetes -  Assesses the respondent's a ttitude  about the 
seriousness o f type 2 diabetes.
3. The overall value o f tight glucose control in diabetes care — Assesses the 
respondent's a ttitude  about w hether the po ten tia l b ene fit o f tig h t glucose co n tro l is  
ju s tifie d  in  term s o f the cost to  the patients.
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4. Psychosocial impact o f diabetes on patients -  Assesses the respondent's a ttitude  
tow ard  the psychosocia l im pact o f diabetes on the lives o f  people w ith  the disease.
5. Attitude towards patient autonomy -  Assesses the respondent's a ttitudes about 
w hether patients should be the p rim a ry  decis ion  m akers regard ing the d a ily  self-care 
o f  th e ir diabetes.
The hea lth  care professionals w ere asked to  com plete add ition a l questions re la tin g  to  
p rio r tra in in g  in  diabetes care, how  the treatm ent o f diabetes com pared w ith  the 
treatm ent o f  fiv e  other chron ic cond itions (l= d ia b e te s  easier, 10=diabetes harder), 
th e ir b e lie fs  about the effectiveness o f  trea tm ent o f  hyperglycaem ia in  preventing  
diabetes com plica tions (T reatm ent is e ffe c tive , l= s tro n g ly  agree, 10=strong ly 
disagree), confidence in  th e ir ow n therapeutic actions (l= s tro n g ly  agree, 10=strongly 
disagree) and w hether they had enough tim e  and resources to  e ffe c tiv e ly  trea t th e ir 
patients w ith  diabetes (l= s tro n g ly  agree, 10=strong ly disagree). The com plete 
questionnaire pack fo r the hea lth  care professionals is  shown in  A ppend ix  4.
The patients were asked to  com plete add ition a l questions re la tin g  to  p rio r diabetes 
education and th e ir cu rren t understanding o f diabetes and its  treatm ent. The com plete 
questionnaire pack fo r the patients is  shown in  A ppend ix  5.
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S ta tis tica l analysis was carried  ou t using SPSS version  10 fo r W indow s. The results 
w ere analysed in  the fo llo w in g  ways:
1. D escrip tive  sta tistics were used to  describe the p ro file  and dem ographic 
characteristics o f  bo th  groups (patients and hea lth  care professionals).
2. Cronbach's alpha was used to  determ ine scale re lia b ility  fo r each o f the fiv e  
subscales o f the D iabetes A ttitu d e  Scale (D A S ).
3. Pearson's product-m om ent co rre la tions w ere used to  exam ine the corre la tions 
between the fiv e  D A S  subscales.
4. M u ltiv a ria te  analysis o f variance (M A N O V A ) was conducted to  exam ine 
d iffe rences in  attitudes on the fiv e  D A S  subscales between fo u r groups, patients, 
doctors, nurses and d ie titians. Analyses o f variances (A N O V A ) on each dependent 
va riab le  w ere conducted as fo llo w -u p  tests to  the  M A N O V A . Post hoc m ain  e ffec t 
analyses to  the un iva ria te  A N O V A s consisted o f conducting  independent-sam ples t 
tests to  determ ine spec ific  group d iffe rences fo r each a ttitude  scale. F am ilyw ise  e rro r 
rate across these tests was con tro lled  fo r  using H olm 's sequential B on fe rron i 
approach.
5. M u ltip le  regression analysis was conducted to  id e n tify  p red ictors o f a ttitude  on the 
fiv e  D A S  subscales. For the patients, p re d ic to r variab les consisted o f p ro file  and 
dem ographic characteristics, du ra tion  o f  diabetes and m ed ica tion -tak ing  status. For
7.6. Statistical analyses
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the hea lth  care professionals, p re d ic to r variab les consisted o f p ro file  and dem ographic 
characteristics, du ra tion  o f  years w o rk in g  in  diabetes care, percentage o f  w o rk  tim e  
devoted to  diabetes care, w o rk  se tting  (fo r exam ple, p rim ary care, secondary care) and 
w hether o r no t they had received specia lis t tra in in g  in  diabetes care. For bo th  groups, 
the c rite rio n  variables were the fiv e  D A S  subscales: need fo r specia lis t tra in in g , 
seriousness o f  type 2 diabetes, value o f  tig h t b lo o d  glucose con tro l, psychosocia l 
im pact o f type 2 diabetes and the need fo r pa tien t autonom y. A ll non-continuous 
variab les were converted to  a set o f d ichotom ous variables (num bering one few er than 
the num ber o f d iscrete categories) b y  dum m y va riab le  cod ing w ith  Is  and Os.
6. D escrip tive  sta tistics were used to  describe firs tly , the health  care professionals 
a ttitudes tow ards the d iffic u lty  o f treatm ent fo r diabetes com pared to  o ther ch ron ic 
illnesses and secondly, th e ir b e lie fs  about diabetes treatm ent. A ll pa rtic ipan ts were 
categorized and the p ro p o rtio n  o f  respondents above (fo r the com parisons w ith  other 
ch ron ic illnesses) and be low  (fo r leve ls o f agreem ent w ith  the statem ents about 
diabetes treatm ent) the m id p o in t o f  the scales was calculated.
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8. Results
Chapter 8
Table 8.1 shows the means and standard deviations fo r the pa tien t group in  term s o f 
p ro file  and dem ographic characteristics. These patients were 60 years o ld , the 
m a jo rity  were w h ite  (97% ), m en (58% ), w ho were ta k in g  o ra l hypoglycaem ic 
m ed ica tion  (55% ). In  term s o f  occupationa l status, they m ostly  belonged to  the 
s k ille d  m anual group (28% ) and w hen asked i f  they had ever attended 'a diabetes 
pa tien t education program m e o r a series o f  classes o r a group', 85%  rep lied  
negative ly. O f those w ho had attended diabetes pa tien t education classes (n=T5), the 
m a jo rity  (n=12) attended these at a diabetes centre.
8.1. Profile and demographic characteristics o f patients
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Table 8.1. Profile and demographic characteristics of newly recruited patients
(N=100)
C haracte ris tic M ean o r N SD
Age 60.00 7.77
H e igh t 1.63 0.09
W eigh t 87.36 19.54
Sex
M en 58
W om en 42
Years D iagnosed 9.14 7.08
M e d ica tion
In su lin  o n ly 16
Tablets on ly 55
B o th  in s u lin  &  tablets 23
N one 6
D iabetes P atien t E ducation  
Program m e
N o 85
Yes 15
Type -  D iabetes C entre 12
P ractice N urse 3
E th n ic ity
W h ite 97
B la ck  A fric a n 2
A sian 1
O ccupational status
P rofessional 18
M anageria l 20
S k ille d  m anual/
N onm anual 28
P a rtly  sk ille d 14
U n sk ille d 20
144
8.2. Profile and demographic characteristics o f health care professionals (h=104)
Table 8.2 shows the means and standard devia tions fo r the health  care professionals in  
tenns o f p ro file  and dem ographic characteristics. O f the partic ipan ts, 81%  were 
w om en and 78%  were e ithe r nurses o r d ie titians . M ost o f the hea lth  care 
professionals were w h ite  (96% ), w o rk in g  in  the p rim a ry  care setting  (55% ). F o rty- 
three percent reported devo ting  at least h a lf o f th e ir w o rk  tim e  to  trea ting  people w ith  
diabetes and the m a jo rity  (69% ) had attended a special tra in in g  course fo r health  
professionals invo lve d  in  diabetes care.
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Table 8.2. Profile and demographic characteristics of health care professionals
(N=T04)
C haracte ristic M ean(S D ) o rN (% )
Age 40.64 (8 .33)
Sex
M en 20(19.2% )
W om en 84(80.8% )
P rofession
D octo r 22(21.15% )
N urse 48(45.11% )
D ie titia n 34(32.70% )
W ork tim e  devoted to  diabetes
0-24% 35(33.7% )
25-49% 24(23.1% )
50-74% 18(17.3% )
75-100% 27(26.0% )
W ork  setting
P rim ary care 57(54.8% )
C om m unity 14(13.5% )
Secondary care 10 ( 9.6% )
A ll o f  above 23(22,1% )
E th n ic ity
W h ite 100(96.2% )
A sian 4( 3.8% )
Special tra in in g  cour se
N o 32(30.8% )
Yes 72(69.2% )
Type -E N B  course' 28(26.9% )
Conferences 6( 6.0% )
Study Days 15(14.4% )
O ther
*
23(22.1% )
E n g l i s h  N u r s i n g  B o a r d  s p e c i a l  t r a i n i n g  c o u r s e  f o r  n u r s e s  i n  d i a b e t e s  c a r e
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Table 8.3 shows descrip tive  sta tistics fo r the fiv e  D A S  subscales. The m ean score 
ranged fro m  3.33 (psychosocia l im pact o f  diabetes) to  4.33 (need fo r special tra in ing ). 
The re lia b ilitie s  o f the subscales ranged fro m  0.60 (va lue o f tig h t b lood  glucose 
co n tro l) to  0.81 (seriousness o f type  2 diabetes).
T a b le  8.3. D e sc rip tive  s ta tis tic s  fo r  D A S  subscales fo r  h e a lth  ca re  p ro fessiona ls 
and n e w ly  re c ru ite d  p a tie n ts  (N =204)
N um ber Cronbach's
8.3. Descriptive statistics for DAS subscales
Subscale* o f  item s M SD Range A lpha
N eed fo r special tra in in g 5 4.33 0.44 1.00-5.00 0.66
Seriousness o f type 2 diabetes 7 4.13 0.63 2.29-5.00 0.81
V alue o f  tig h t con tro l 7 3.76 0.38 2.43-5.00 0.60
Psychosocial im pact o f  diabetes 6 3.33 0.49 1.75-5.00 0.63
P atien t autonom y 8 3.82 0.57 1.00-5.00 0.70
*  S c a l e  r a n g e  5  =  s t r o n g l y  a g r e e ,  1  =  s t r o n g l y  d i s a g r e e
8.4. Correlations between the DAS subscales
Table 8.4 presents the corre la tions betw een the D A S  subscales. The corre la tions 
ranged from  a h igh  o f  0.58 (seriousness o f type 2 diabetes and pa tien t autonom y) to  a 
lo w  o f  0.23 (va lue o f tig h t b lood  glucose co n tro l and pa tien t autonom y). The 
co rre la tion  betw een the subscales 'tig h t co n tro l' and 'psychosocial im pact o f  diabetes' 
was no t s ign ifican t.
147
Table 8.4. Pearson's product-moment correlations between DAS subscales
Special Seriousness T ig h t Psychosocial P atient
T ra in in g type 2 diabetes C on tro l im pact autonom;
Special tra in in g - - - - -
Seriousness type 2 0.44* - - - -
V alue o f tig h t con tro l 0.28* 0.50* - - -
Psychosocial im pact 0.32* 0.42* -0.05 - -
Patient autonom y 0.45* 0.58* 0.23* 0.36* -
*p<0.01
8.5. Attitudinal differences on the five DAS subscales
R esults fo r the m u ltiva ria te  analysis o f  variance (M A N O V A ) conducted to  exam ine 
ove ra ll a ttitu d in a l d ifferences on the fiv e  D A S  subscales among patients, doctors, 
nurses and d ie titia n s  are shown in  Table 8.5. U sing  the m u ltiva ria te  c rite rio n  o f 
W ilk s ' lam bda (A ), the M A N O V A  ind ica ted  a s ig n ifica n t m ain e ffe c t o f  G roup, 
A = .43 , F(15,541)=12.60, p=.000. U n iva ria te  analyses conducted to  fo llo w  up the 
s ig n ifica n t m ain e ffe c t showed a s ig n ifica n t e ffe c t fo r group on a ll o f  the fiv e  
subscales 'need fo r special tra in in g ', F (3,200)=6.35, p=.000, 'seriousness o f type 2 
diabetes',
F (3,200)=50.01, p=.000, 'value o f tig h t b lood  glucose con tro l', F (3,200)=9.55, p=.000, 
'psychosocial im pact o f diabetes', F (3,200)=9.75, p=.000 and 'pa tien t autonom y', 
F (3,200)=37.31, p= 000 .
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Table 8.5. Subscale scores for health care professionals and patients
Patient D octo r Nurse D ie titia n
(n= 100) (n="22) (n=48) (n=34)
Subscale M SD M SD M SD M SD
Need fo r special tra in in g 4.24 0.44 4.15 0.40 4.80 0.43ac 4.50 0.34M
Seriousness o f type 2 diabetes 3.71 0.57 4.35 0.33e 4.61 0.40ac 4.54 0.36b
V alue o f tig h t con tro l 3.62 0.42 3.85 0.30e 3.90 0.3 l a 3.92 0 .27b
Psychosocial im pact o f diabetes 3.16 0.51 3.40 0.31 3.60 0 .4 2 a 3.43 0 .4 6 b
Patient autonom y 3.48 0.45 3.40 0 .4 3 e 4.27 0 .4 5 ac 4.08 0 .5 3 b
a  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  p a t i e n t s  a n d  n u r s e s  p < 0 . 0 1  
b s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  p a t i e n t s  a n d  d i e t i t i a n s  p < 0 . 0 1  
Cs i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  d o c t o r s  a n d  n u r s e s  p < 0 . 0 1  
d  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  d o c t o r s  a n d  d i e t i t i a n s  p < 0 . 0 1  
e s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  p a t i e n t s  a n d  d o c t o r s  p < 0 . 0 1
Post hoc analyses fo r each o f the subscales suggests the fo llo w in g :
Need for special training: There were no s ig n ifica n t d ifferences between the means 
fo r the patients and doctors t_(120)=0.89, p_=.378 o r the nurses and d ie titia n s  L (80)=  
-0.341, p_=.734. H ow ever, the means were s ig n ific a n tly  d iffe re n t between the 
patients and nurses t_(146)=-2.947, p_=.004, patients and d ie titians  t_(132)=-3.095, 
P_=.002, doctors and nurses t_(68)=-2.900, p_=.005 and doctors and d ie titia n s  t_(54)= 
-3.438, p_= 001.
These results suggest tha t doctors, w ho had the low est score (4 .15) fo r th is  subscale, 
d iffe re d  s ig n ifica n tly  from  both o f the other health  care professional groups but not 
patients, and that nurses and d ie titia n s  d iffe re d  s ig n ific a n tly  from  the patients but not 
from  each other on the a ttitude  tha t hea lth  care professionals need special tra in in g  to  
care fo r ind iv id u a ls  w ith  type 2 diabetes (see F igure 8.1).
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Figure 8.1. Mean scores fo r  subscale 'need fo r  special training'for patients, 
doctors, nurses and dietitians.
Seriousness o f type 2 diabetes: The means fo r th is  subscale were s ig n ifica n tly  
d iffe re n t between the patients and doctors t_(120)=-5.000, p_=.000, patients and nurses 
t_(146)=-9.727, p_=.000, patients and d ie titia n s  t_(132)=-7.849, p_=.000 and doctors 
and nurses t_(68)=-2.671, p_=.009. There were no s ig n ifica n t d iffe rences between the 
means fo r doctors and d ie titia n s  t_ (54 )= -l .983, p_=.052 o r nurses and d ie titians  
L (80)=0 .825 ,p_=412 .
These results suggest tha t the attitudes o f  a ll o f the health care professionals tow ards 
the seriousness o f type 2 diabetes d iffe re d  s ig n ific a n tly  from  those o f the patients and 
tha t the nurses also d iffe re d  s ig n ific a n tly  to  the doctors but not the d ie titia n s  fo r th is  
subscale. O ve ra ll, a ll groups agreed tha t type 2 diabetes is a serious disease but the 
patients scored low est fo r th is  subscale (see F igure 8.2).
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Figure 8.2. Mean scores fo r  subscale 1seriousness o f type 2 diabetes' fo r  patients, 
doctors, nurses and dietitians.
Value o f tight blood glucose control: The means fo r th is  subscale were s ig n ifica n tly  
d iffe re n t between the patients and doctors t_(120)=-2.461, 015, patients and nurses
t_(146)=-3.950, p_=.000 and patients and d ie titia n s  L(132)= -3 .833, p_= 000. There 
were no s ig n ifica n t d iffe rences between the means fo r doctors and nurses t_(68)=- 
0.482, p_=. 631, doctors and d ie titia n s  t_(54)=-0.829, p_=.411 o r nurses and d ie titians  
t_(80)=-0.362, p_=.718.
These results suggest tha t a ll o f  the health  care professionals d iffe re d  s ig n ifica n tly  
from  the patients, bu t not from  each other, in  th e ir a ttitudes tow ards the value o f tig h t 
b lood  glucose con tro l fo r patients w ith  type 2 diabetes. O ve ra ll, a ll groups agreed that 
there is a re la tionsh ip  between leve l o f b lood  glucose con tro l and the developm ent o f 
com p lica tions o f diabetes, but not at a very strong leve l o f agreem ent w ith  the 
statem ent (see F igure 8.3).
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Figure 8.3. Mean scores fo r  subscale ’value o f tight control’fo r  patients, doctors, 
nurses and dietitians.
Psychosocial impact o f type 2 diabetes: There were no s ig n ifica n t d ifferences 
between the means fo r the patients and doctors t_(120)=-2.028, p_=.045, doctors and 
nurses t_(68)= -1.887, g_=.063, doctors and d ie titia n s  t_(54)=-0.353, p_= 725 o r nurses 
and d ie titia n s  t_ (80 )= l .535, p_=. 129. H ow ever, the means were s ig n ific a n tly  d iffe re n t 
between the patients and nurses t_(146)=-4.957, p_=.000 and patients and d ie titians  
t_(132)=-2.727,p_=007.
These results suggest tha t patien t v iew s on the psychosocial im pact o f  type 2 diabetes 
d iffe re d  s ig n ifica n tly  from  those o f nurses, w ho held the strongest view s, and 
d ie titia n s  but not doctors. The view s o f  the health care professionals ove ra ll d id  not 
d iffe r s ig n ifica n tly  from  each other (see F igure 8.4).
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Figure 8.4. Mean scores fo r subscale 'psychosocial impact o f diabetes' fo r  patients, 
doctors, nurses and dietitians.
Patient autonomy: The means fo r th is  subscale were s ig n ifica n tly  d iffe re n t between 
the patients and doctors t_(120)=-4.688, p_=.000, patients and nurses t_(146)=-9.931, 
P_=.000, patients and d ie titia n s  t_(132)=-6.377, j)= .0 0 0  and doctors and nurses 
t_(68)=-2.559, p/=.013. There were no s ig n ifica n t d ifferences between the means fo r 
doctors and d ie titia n s  L (54)= -0 .764 , p_=.448 o r nurses and d ie titians  t_(80)=1.744, 
P_=.085.
These results suggest tha t pa tien t view s on the need fo r patient autonom y in  diabetes 
self-m anagem ent d iffe re d  s ig n ific a n tly  from  a ll o f the health care professiona l groups, 
w ith  nurses expressing the strongest view s. The nurses also d iffe re d  s ig n ific a n tly  in  
th e ir v iew s com pared to  the doctors bu t not the d ie titia n s  (see F igure 8.5).
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Figure 8.5. Mean scores fo r subscale 1patient autonomy' for patients, doctors, 
nurses and dietitians.
8.6. Predictors o f attitudes
M u ltip le  regression analysis was conducted to  id e n tify  predictors o f  a ttitude  on the 
fiv e  D AS subscales. For the patients, po ten tia l p red ic to r variab les inc luded p ro file  
and dem ographic characteristics (age, sex: 1 =  fem ale versus 0 =  non-fem ale, w eight, 
occupation: 1 =  professiona l/m anageria l versus 0 =  non-professional/m anageria l), 
dura tion  o f diabetes and m ed ica tion -tak ing  status (1 =  in su lin  versus 0 =  non -insu lin ,
1 =  tablets versus 0 =  non-tablets). For the health care professionals, p red ic to r 
variab les inc luded p ro file  and dem ographic characteristics (age, sex: 1 =  fem ale 
versus 0 =  non-fem ale, occupation: 1 =  docto r versus 0 =  non-doctor, 1 =  nurse versus 
0 =  non-nurse), dura tion  o f years w o rk in g  in  diabetes care, percentage o f w o rk  tim e 
devoted to  diabetes care, w o rk  se tting (1 =  p rim ary care versus 0 =  non-prim ary care), 
and w hether o r not they had received specia lis t tra in in g  in  diabetes care (1 =  tra in in g  
versus 0 =  non-tra in ing ). For both groups, the c rite rio n  variables were the fiv e  DAS 
subscales, need fo r specia lis t tra in in g , seriousness o f type 2 diabetes, value o f tig h t 
b lood  glucose con tro l, psychosocia l im pact o f type 2 diabetes and the need fo r patien t 
autonom y.
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Patients: R esults o f these analyses are show n in  Table 8.6. There were no 
s ig n ifica n t pred ictors o f  'need fo r special tra in in g ' am ong the pa tien t group. F o r the 
subscale 'seriousness o f type 2 diabetes', o n ly  sex was a s ig n ifica n t p red ic to r, w ith  
m en m ore lik e ly  than w om en to  regard type 2 diabetes as a serious disease, R 2=  0.04, 
adjusted R 2=  0.03, F (l,9 8 )= 3 .9 4 7 , p=0.05. F o r the subscale 'value o f  tig h t b lood  
glucose con tro l', du ra tion  o f  diabetes and w e igh t w ere s ig n ifica n t p red icto rs, R 2=
0.14, adjusted R2=  0.12, F (2,97)=7.646, p=0.001, w ith  those w ho had had diabetes fo r 
a shorter du ra tion  and were overw e igh t expressing stronger agreem ent w ith  the 
statem ent. For the subscale 'psychosocial im pact o f diabetes', m ed ica tion -tak ing  
status was the o n ly  s ig n ifica n t p red ic to r, R 2=  0.05, adjusted R 2=  0.04, F (l,9 8 )= 5 .5 4 6 , 
p= 0 .0 2 ,w ith  those patients using in s u lin  expressing strongest agreem ent tha t diabetes 
had a negative im pact on pa tien t lives. F o r the subscale 'pa tien t autonom y', dura tion  
o f  diabetes was the on ly  s ig n ifica n t p red ic to r, R 2=  0.05, adjusted R 2=  0.04, 
F (l,9 8 )= 5 .2 1 3 , p=0.025, w ith  those w ho had had diabetes fo r a longer du ra tion  
expressing strongest agreem ent w ith  the need fo r pa tien t autonom y in  diabetes se lf­
management.
155
Table 8.6. Predictors of patients' attitudes on the DAS subscaies
Subscale Predictors B t P R 2 A d j.R 2 F P
Seriousness .04 .03 3.95 < 0 5
Sex -.20 -2.00 <.05
Age -.07 -.76 n.s.
W eigh t .04 .35 n.s.
O ccupation -.06 -.60 n.s.
D u ra tion -.08 -.77 n.s.
In su lin .12 1.23 n.s.
Tablets -.17 -1.73 n,s.
T ig h t C o n tro l .14 .12 7.65 < 0 0 1
D ura tion -.30 -3.20 < 0 0 2
W eigh t .22 2.37 < 0 2
Age .15 1.54 n.s.
O ccupation -.17 -1.75 n.s.
Sex -.14 -1.40 n.s.
In su lin -.07 -.78 n.s.
Tablets .08 .73 n.s.
Im p a c t .05 .04 5.55 <.02
In su lin .23 2.36 <.02
Age .04 .38 n.s.
W e igh t .04 .40 n.s.
O ccupation .15 1.46 n.s.
Sex -.06 -.66 n.s.
D u ra tio n .16 1.65 n.s.
Tablets .06 .52 n.s.
A u to n o m y .05 .04 5.21 < 0 2 5
D ura tion .26 2.30 < 0 2 5
Age -.15 -1.47 n.s.
W e igh t .11 1.16 n.s.
O ccupation .03 .32 n.s.
Sex .04 .40 n.s.
In su lin -.14 -1.45 n.s.
Tablets .15 1.57 n.s.
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Health care professionals: R esults o f  these analyses are shown in  Tab le  8.7. For the 
subscale 'need fo r special tra in in g ', sex was the o n ly  s ig n ifica n t p red ic to r, R 2=  0.10, 
adjusted R 2=  0.09, F (l,1 0 2 )= 1 0 .7 9 4 , p=0.001, w ith  wom en expressing stronger 
agreem ent w ith  the a ttitude  th a t hea lth  care professionals need special tra in in g  to  care 
fo r persons w ith  diabetes. For the subscale 'seriousness o f type 2 diabetes', percentage 
o f w o rk tim e  devoted to  diabetes care was the o n ly  s ig n ifica n t p red ic to r, R 2=  0.19, 
adjusted R 2=  0.17, F (2 ,1 0 1 )= l 1.375, p=0.000, w ith  those w ho devoted m ore o f th e ir 
w o rk tim e  trea ting  in d iv id u a ls  w ith  diabetes v ie w in g  type 2 diabetes as a serious 
cond ition . F o r the subscale Value o f  tig h t b lo o d  glucose con tro l', du ra tion  o f  years 
w o rk in g  in  diabetes care and w o rk  se tting  w ere the on ly  s ig n ifica n t p red icto rs, R 2=  
0.09, adjusted R 2=  0.07, F (2 ,101)=5.027, p=0.008, w ith  those w ho have w orked fo r 
longer in  diabetes care and those w ho w o rk  in  a secondary care se tting  expressing 
stronger agreem ent w ith  the a ttitude  th a t the p o ten tia l bene fit o f  tig h t glucose con tro l 
is  ju s tifie d  in  term s o f the cost to  the  patients. For the subscale 'psychosocial im pact 
o f diabetes', percentage o f  w o rk tim e  devoted to  diabetes care was the o n ly  s ig n ifica n t 
p red ic to r, R 2=  0.05, adjusted R 2=  0.04, F (2 ,101 )= 5 .176, p=0.025, w ith  those w ho 
devoted m ore o f th e ir w o rk tim e  trea ting  in d iv id u a ls  w ith  diabetes expressing stronger 
agreem ent th a t diabetes had a negative im pact on pa tien t lives. For the  subscale 
'pa tien t autonom y', sex was the o n ly  s ig n ific a n t p red ic to r, R 2=  0.07, adjusted R 2=  
0.06, F (l,1 0 2 )= 6 .9 2 1 , p=0.010, w ith  w om en expressing stronger agreem ent w ith  the 
need fo r pa tien t autonom y in  diabetes self-m anagem ent.
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Table 8.7. Predictors of health care professionals’ attitudes on the DAS subscales
Subscale Predictors B t p R 2 Adj.R2 F p
S pecia l tra in in g .20 10.80 <.001
Seriousness
T ig h t C o n tro l
Im p a c t
A u to n o m y
Sex .31 3.28 < 0 0 1
Age .01 .15 n.s.
D iabcare .11 1.85 n.s.
W orktim e .15 1.53 n.s.
S etting .18 1.90 n.s.
T ra in in g -.01 -.10 n.s.
D octo r .02 .12 n.s.
N urse -.01 -.15 n.s.
W ork tim e .40 4.23 < 0 0 0
Age .05 .50 n.s.
Sex .80 .00 n.s.
D o c to r -.11 -.96 n.s.
Nurse .09 1.01 n.s.
D iabcare .09 1.00 n.s.
Setting .08 .77 n.s.
T ra in in g .02 .23 n.s.
.
D iabcare .22 2.29 < 0 2 4
S etting -.21 ■-2.22 < 0 2 9
Age .14 1.34 n.s.
Sex -.05 -.46 n.s.
D octo r .06 .50 n.s.
N urse .06 .63 n.s.
W ork tim e .11 1.00 n.s.
T ra in in g -.06 -.61 n.s.
W ork tim e .22 2.28 < 0 2 5
Age .16 1.70 n.s.
Sex .06 .60 n.s.
D octo r -.03 -.15 n.s.
Nurse .15 1.56 n.s.
D iabcare .05 .55 n.s.
S etting -.10 -.97 n.s.
T ra in in g .09 .91 n.s.
Sex .25 2.63 < 0 1 0
Age .13 1.36 n.s.
D octo r .12 .06 n.s.
N urse .15 1.45 n.s.
D iabcare .06 .65 n.s.
W orktim e .11 1.14 n.s.
Setting .10 .92 n.s.
T ra in in g -.04 -.43 n.s.
.19 .17 11.37 < .000
,09 .07 5.03 <.008
.05 5.18 <.025
.06 6.92 <.010
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8 .7. Health care professionals attitudes towards the treatment o f diabetes
These results are shown in  Table 8.8. M o s t o f the  hea lth  care professionals 
considered diabetes harder to  trea t com pared w ith  other ch ron ic cond itions. D iabetes 
was rated as harder to  trea t than hypertension (76.9% ), hype rlip ide m ia  (72.9% ) and 
angina (63.4% ). F ifty -fo u r percent o f  pa rtic ipan ts  also rated diabetes as harder to  
trea t than a rth ritis  (53.7% ) w h ile  57.7%  rated diabetes as easier to  trea t than heart 
fa ilu re .
The vast m a jo rity  o f hea lth  care professionals (91.4% ) agreed tha t the  con tro l o f 
hyperglycaem ia prevented com p lica tions and 90%  agreed tha t th e ir therapeutic 
actions and advice were e ffe c tive  in  im p ro v in g  d iabe tic  outcom es. There was m uch 
less agreem ent w ith  the statem ent 'I  have adequate tim e  and resources to  trea t m y 
d iabe tic  patients e ffe c tive ly ' w ith  69.2%  disagreeing w ith  th is  statem ent.
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T a b le  8.8. H e a lth  ca re  p ro fess iona ls  a ttitu d e s  to  th e  tre a tm e n t o f d iabe tes: scale 
re su lts  (n=104)
<5.5
( % m
>5.5*
(% (n ))
C om parison o f d iffic u lty  o f treatm ent 
fo r diabetes w ith  tha t o f o ther ch ron ic 
illnesses (l= e a s ie r, 10=harder)
-Hypertension 23.1(24) 76.9(80)
-HyperI ipidem ia 27.1(28) 72.9(76)
-Angina 36.6(38) 63.4(66)
-Arthritis 46.3(48) 53.7(56)
-Heart Failure 57.7(60) 42.3(44)
B e lie fs  about diabetes treatm ent 
(l= s tro n g ly  agree, 10=strong ly disagree)
-Treatment effective 91.4(95) 8.6(9)
-Confidence in abilities 89.5(93) 10.5(11)
-Enough time and resources 30.8(32) 69.3(72)
* 5 . 5 = m i d p o i n t  o f  s c a l e
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8.8. Attitudinal differences on the five DA S subscales for a) lifestyle intervention
participants and bHifestvle intervention participants versus newly recruited patients 
(NRP)
a)Lifestvle intervention participants: These results are shown in  Table 8.9. There were 
no s ig n ifica n t d ifferences between the means fo r the in te rven tion  and con tro l groups 
in  the life s ty le  in te rve n tio n  study, on any o f  the fiv e  D A S  subscales.
T a b le  8.9. Scores on th e  fiv e  D A S  subscales fo r  life s ty le  in te rv e n tio n  p a rtic ip a n ts
In te rven tion  C on tro l
(n=50) (n=48)
Subscale M SD M SD
N eed fo r special tra in in g 4.20 0.38 4.17 0.42
Seriousness o f  type 2 diabetes 3.91 0.53 3.80 0.91
V alue  o f tig h t con tro l 3.77 0.38 3.66 0.35
Psychosocial im pact o f diabetes 3.03 0.51 3.03 0.52
P atient autonom y 3.55 0.38 3.54 0.69
There was a s ig n ifica n t d iffe rence  betw een the means fo r partic ipan ts in  the life s ty le  
in te rve n tio n  study fo r the Personal m odels o f diabetes subscale 'seriousness' 
(M ean=2.86,S D =0.87) and the D A S  subscale 'seriousness o f  type 2 diabetes' 
(M ean=3.86,S D =0.52), t_(98)=-11.094, g_=000. There was also a s ig n ifica n t 
d iffe rence  between the means in  response to  the questions 'H ow  serious is  your 
diabetes' (M ean=2.66,SD =0.91) and 'Type 2 diabetes is  a serious cond ition ' 
(M ean=3.62,SD =0.88), t  (94)=7.710, g  =  .000. B o th  item s had id e n tica l response 
scales (l= S tro n g ly  disagree/N ot a t a ll serious, 5=S trong ly agree/Extrem ely serious) 
and the assessment o f personal m odels at one year (T im e  4) was used fo r th is  
com parison. These results suggest tha t pa rtic ipan ts  v iew ed th e ir ow n diabetes as a
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less serious co n d itio n  com pared to  th e ir v iew s about the seriousness o f type 2 diabetes 
in  general.
b)Lifestvle intervention participants versus newly recruited patients: There were no 
s ig n ifica n t d ifferences between the means fo r  the partic ipan ts in  the life s ty le  
in te rve n tio n  study and the new ly  recru ited  patients on any o f the fiv e  D A S  subscales. 
These results are shown in  Table 8.10.
T a b le  8.10. Scores on th e  fiv e  D A S  subscaies fo r  life s ty le  in te rv e n tio n  
p a rtic ip a n ts  and n e w ly  re c ru ite d  p a tie n ts  (N R P )
In te rven tion N R P
(n==98) (n=T00)
Subscale M SD M SD
N eed fo r special tra in in g 4.18 0.40 4.24 0.44
Seriousness o f  type 2 diabetes 3.86 0.52 3.71 0.57
V alue o f tig h t con tro l 3.71 0.37 3.62 0.42
Psychosocial im pact o f diabetes 3.03 0.51 3.26 0.51
P atient autonom y 3.54 0.55 3.48 0.45
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T h is  study aim ed to  exam ine attitudes to  diabetes o f  patients w ith  diabetes and the 
hea lth  care professionals invo lve d  in  th e ir care, and to  explore discrepancies in  those 
attitudes w h ich  m ay act as barriers to  e ffe c tive  diabetes care and therapeutic outcom es 
fo r patients w ith  type 2 diabetes. There is g row ing  evidence tha t d iffe rences in  the 
concepts and perspectives o f patients and p ractitione rs  ex is t and m ay be im portan t 
factors a ffe c tin g  treatm ent behaviour (B e lfig lio  et a l., 2001; G o lin , 1996; Hernandez, 
1995; K le inm an , 1980). A cco rd in g ly , i t  was an tic ipa ted  tha t th is  study w ou ld  
fa c ilita te  a clearer understanding o f  the perspectives tha t bo th  health  care 
professionals and patients b rin g  to  th e ir consulta tions w h ich  m ig h t e lucidate  firs tly , 
the causes o f undesirable diabetes care and therapeutic outcom es and secondly, the 
d issa tis faction  tha t o ften  arises fro m  a hea lth  care professional's o r patient's fa ilu re  to  
m eet the other's diabetes m anagem ent expectations.
The h ighest leve ls o f agreem ent am ong patients and health  care professionals 
concerned the need fo r specia l tra in in g  in  order to  p rovide  diabetes care. A ll o f  the 
groups agreed w ith  the need fo r hea lth  care professionals to  have special tra in in g  in  
order to  trea t in d iv id u a ls  w ith  diabetes and th is  was re flec ted  in  the fa c t th a t 69%  o f 
the hea lth  care professiona l respondents ind ica ted  tha t they had attended some fo rm  o f 
special tra in in g . H ow ever, i t  is  in te res ting  to  note tha t doctors were the least 
supportive, d iffe rin g  s ig n ific a n tly  fro m  bo th  o f  the other health  care professiona l 
groups, w h ile  nurses w ere the m ost supportive , fo llo w e d  by the d ie titia n s  and then 
patients.
Chapter 9
9. Discussion
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In  th is  study a ll o f the doctors w ho pa rtic ipa ted  w o rk  fo r the m ost pa rt in  the p rim a ry  
care se tting  and as such trea t a w ide  va rie ty  o f  cond itions. Indeed 64%  o f the doctors 
ind ica ted  tha t they spent less than 25%  o f th e ir w o rk  tim e  devoted to  diabetes care. 
They are therefore by tra in in g  and p ractice  generalists, and i t  is p robab ly no t 
su rp ris ing  tha t they expressed the least support fo r the need fo r special tra in in g  in  
o rder to  trea t in d iv id u a ls  w ith  diabetes. Indeed, in  a recent survey o f diabetes care in  
general p ractice  in  E ngland and W ales, P ierce et a l. (2000) found th a t approxim ate ly 
f if ty  percent o f th e ir general p ra c titio n e r respondents had attended o n ly  a h a lf day 
approved course on diabetes as th e ir diabetes re la ted educational a c tiv ity  w ith in  the 
past three years.
H ow ever, w ith  increasing num bers o f  people be ing diagnosed w ith  type 2 diabetes, 
m ore and m ore patients are be ing treated by th e ir general p ractitione rs in  the p rim ary 
care setting. T h is issue there fore  becomes increas ing ly  im portant. The treatm ent o f 
diabetes is becom ing ever m ore com plex, no t o n ly  through the use o f m ore 
sophisticated in s u lin  d e live ry  systems and b lood  glucose m on ito rin g  technologies but 
also w ith  the c a ll fo r m ore in tensive  treatm ent o f type 2 diabetes fo llo w in g  the 
recen tly  reported U KPD S (1999). A cco rd in g ly , i t  is  extrem ely lik e ly  tha t general 
p rac titione rs  are go ing to  requ ire  m ore and m ore specia lis t tra in in g  and in p u t in  order 
to  e ffe c tiv e ly  trea t th e ir patients w ith  diabetes.
The fin d in g  tha t the attitudes o f a ll o f  the hea lth  care professionals tow ards the 
seriousness o f  type 2 diabetes d iffe re d  s ig n ific a n tly  fro m  those o f the patients in  the 
present study is  o f p a rticu la r in te rest and th is  discrepancy between hea lth  care 
pro fessiona l and pa tien t perceptions is re flec ted  in  previous research. Larm e and
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Pugh (1998) fo r exam ple suggest th a t p ro v id e r urgency to  con tro l diabetes contrasts 
sharp ly w ith  pa tien t experience and awareness. I t  is  suggested th a t the la ck  o f 
d ram atic sym ptom s to  'scare* patients and the la ck  o f  p u b lic  hea lth  cam paigns to  b rin g  
the seriousness o f  diabetes to  patien ts' a tten tion  (such as fo r hypertension, cholestero l 
and sm oking), com bined w ith  c u ltu ra l and econom ic barriers, m ean th a t patients 
ne ithe r take diabetes seriously no r lis te n  to  th e ir hea lth  care professionals. I t  is also 
possib le th a t patients' v iew s m ay re fle c t the m anner in  w h ich  hea lth  care professionals 
w ho w ish  to  m a in ta in  a therapeutic re la tionsh ip  w ith  patients, w h ich  is  reassuring and 
encouraging, convey in fo rm a tio n  about the seriousness o f type 2 diabetes. A  num ber 
o f o ther possible explanations fo r th is  d iscrepancy in  perceptions o f the seriousness o f 
diabetes have also been suggested. For exam ple, the hea lth  care professionals' sense 
o f urgency to  con tro l diabetes is heightened by th e ir know ledge tha t the consequences 
are devastating i f  patients do no t fo llo w  th e ir recom m endations, especia lly  about 
life s ty le  changes, and they are aware th a t they are trea ting  an unde rly ing  co n d itio n  
a ffe c tin g  the en tire  body, and no t ju s t trea ting  sym ptom s.
W h ile  the patients agreed th a t type 2 diabetes was a serious disease, the strength o f 
th e ir agreem ent was re la tiv e ly  weak. T h is  fin d in g  has im portan t im p lica tio n s  fo r 
pa tien t education and in te rven tion . The lite ra tu re  on adherence to  diabetes treatm ent 
regim ens fo r exam ple suggests tha t be lie fs  about the seriousness o f type 2 diabetes are 
s trong ly  re la ted  to  adherence to  treatm ent (C erkoney et a l., 1980), m e tabo lic  con tro l 
(P o lly , 1992) and self-m anagem ent behaviours (Ham pson et a l., 1996). Type 2 
diabetes requires d iffic u lt and long -las ting  behaviour changes on the pa rt o f patients 
and i t  is  u n lik e ly  tha t such changes w ill be m ade and sustained unless bo th  patients 
and hea lth  care professionals are in  agreem ent about the serious nature o f  th is  illness.
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In  the present study the hea lth  care professionals d iffe re d  s ig n ific a n tly  fro m  the 
patients, bu t no t fro m  each other, in  th e ir a ttitudes tow ards the va lue o f  tig h t b lood  
glucose con tro l fo r patients w ith  type 2 diabetes. O vera ll, a ll groups agreed tha t there 
is a re la tionsh ip  between leve l o f b lood  glucose con tro l and the developm ent o f 
com p lica tions o f diabetes. H ow ever, i t  is o f in te rest to  note tha t d ie titia n s  agreed 
m ost strong ly, fo llo w e d  by  nurses and doctors, and fin a lly  patients, w ho were the least 
supportive o f  the concept tha t hyperg lycaem ia contributes to  the developm ent o f 
com plica tions. A ga in , th is  fin d in g  has im po rtan t im p lica tio n s  fo r pa tien t education 
and in te rven tion . W h ile  the hea lth  care professiona ls' b e lie f in  the re la tionsh ip  
between b lood  glucose co n tro l and the com p lica tions o f  diabetes can be view ed as a 
p os itive  fin d in g , the fa c t th a t the patients expressed re la tive ly  w eak agreem ent w ith  
the concept is  o f concern. I t  has been c le a rly  dem onstrated tha t im p ro v in g  m etabo lic 
con tro l o f diabetes reduces com p lica tions and hosp ita lisa tions (U K P D S , 1999; 
V in ico r,1 9 9 4 ; C la rk  et a l., 1996; D C C T , 1993) and tha t patients w ho repo rt h igh 
leve ls o f  adherence tend to  have a ttitudes m ore in  accord w ith  diabetes experts and 
recognize the re la tionsh ip  betw een glucose co n tro l and com p lica tions (Anderson et 
a l., 1993). T h is fin d in g  also supports e a rlie r research (fo r exam ple H un t et a l., 1998) 
w h ich  suggests tha t the concept o f 'diabetes co n tro l' has d iffe re n t m eaning fo r 
patients and p ractitione rs , w ith  p rac titione rs  focusing  p rim a rily  on ob jective  c lin ic a l 
ind ica to rs , w h ile  patients focus m ore on how  they fee l, how  m uch the illness  d isrupts 
th e ir nonna l life  and the im pact o f th e ir actua l behaviours on th e ir illness.
P atien t view s on the psychosocia l im pact o f type 2 diabetes d iffe re d  s ig n ific a n tly  
fro m  those o f  nurses, w ho he ld  the strongest view s, and d ie titians  bu t no t doctors.
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The view s o f the health  care professionals o ve ra ll d id  no t d iffe r s ig n ific a n tly  fro m  
each other. T h is  fin d in g  th a t patients d id  no t strong ly support the perceived negative 
im pact tha t diabetes has on th e ir live s  m ay re fle c t the fa c t tha t m ost o f the patients in  
th is  study were no t ta k in g  in s u lin  (n=61). P revious research has ind ica ted  tha t 
patients w ho use in s u lin  express stronger agreem ent w ith  the concept th a t diabetes has 
a negative im pact on a patient's life  (A nderson et a l., 1993) com pared to  those w ho do 
not.
Nurses and d ie titia n s  expressed the strongest agreem ent w ith  the b e lie f th a t patients 
should m ake th e ir ow n decisions about the d a ily  treatm ent o f diabetes. D octors were 
s ig n ific a n tly  w eaker in  th e ir support fo r th is  concept. There are a num ber o f possible 
explanations fo r th is  fin d in g . D iabetes care, especia lly  w hen i t  invo lves the 
adm in is tra tion  o f in su lin , requires tha t the pa tien t be able to  m ake com plex d a ily  
treatm ent decisions. A cco rd in g ly , having the pa tien t m ake treatm ent decisions m ay 
be co u n te r-in tu itive  fo r doctors w ho have been tra ined  to  m ake such decisions 
them selves. H is to ric a lly , w estern hea lth  care systems have been designed p rim a rily  
fo r rap id  response to  acute illness (G lasgow , 1995; E tzw ile r, 1997; V o n  K o r ff et a l.,
1997). W ith  chron ic illnesses such as diabetes, the ro le  o f the hea lth  care 
pro fessiona l and the hea lth  care system sh ifts  fro m  p ro v id in g  d ire c t m edica l care to  
fa c ilita tin g  m anagem ent o f  the disease by patients and fa m ilie s  (E tzw ile r, 1997; V on  
K o r ff et a l., 1997). O ur hea lth  care system , in c lu d in g  how  we tra in  our hea lth  
professionals, has ye t to  m ake th is  sh ift. D iabetes self-care o ften  requires a h igh  
degree o f pa tien t autonom y and hea lth  psychology m ay have an im portan t ro le  to  p lay 
in  educating and fa c ilita tin g  the de legation o f  re sp o n s ib ility  fo r m aking  treatm ent 
decisions fro m  doctors to  patients.
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In  term s o f  the pred ictors o f  a ttitudes, there w ere no s ig n ifica n t pred icto rs o f'n e e d  fo r 
special tra in in g ' am ong the pa tien t group and sex was the o n ly  s ig n ifica n t p red ic to r 
fo r the hea lth  care professionals group, w ith  w om en expressing stronger agreem ent 
w ith  the a ttitude  tha t hea lth  care professionals need special tra in in g  to  care fo r persons 
w ith  diabetes. For the subscale 'seriousness o f type 2 diabetes', m en patients were 
m ore lik e ly  than wom en patients to  regard type 2 diabetes as a serious disease as were 
those hea lth  care professionals w ho devoted m ore o f th e ir w o rk tim e  trea ting  
in d iv id u a ls  w ith  diabetes. D u ra tio n  o f  diabetes and w e igh t w ere s ig n ifica n t pa tient 
pred icto rs fo r the subscale 'value o f tig h t b lo o d  glucose con tro l' as were du ra tion  o f 
years w o rk in g  in  diabetes care and w o rk  setting  fo r the hea lth  care professionals. 
A cco rd in g ly , in d iv id u a ls  w ho have had type 2 diabetes fo r a shorter du ra tion  and are 
overw e igh t expressed stronger agreem ent w ith  the statem ent. In  add ition , those 
hea lth  care professionals w ho have w orked  fo r longer in  diabetes care and those w ho 
w o rk  in  a secondary care se tting  expressed stronger agreem ent w ith  the  a ttitude  tha t 
the po ten tia l b ene fit o f tig h t glucose co n tro l is  ju s tifie d  in  tenns o f  the cost to  the 
patients.
U sing  in su lin  was the o n ly  s ig n ifica n t pa tien t p re d ic to r fo r the subseale 'psychosocial 
im pact o f  diabetes' as was percentage o f  w o rk tim e  devoted to  diabetes care fo r the 
hea lth  care professiona l group. T h is resu lt supports the find ings o f previous research 
(fo r exam ple Anderson et a l., 1993) tha t type 1 patients express the strongest 
agreem ent w ith  the idea tha t diabetes has a negative im pact on a patient's life , 
fo llo w e d  by type 2 patients w ho use in su lin . I t  appears tha t the use o f in su lin  
conveys to  patients a message about the seriousness o f  the disease. F o r the  subscale
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'pa tien t autonom y', du ra tion  o f diabetes was the o n ly  s ig n ifica n t pa tien t p re d ic to r and 
sex was the o n ly  s ig n ifica n t p red ic to r fo r the hea lth  care professiona l group, w ith  
w om en expressing stronger agreem ent w ith  the need fo r pa tien t autonom y in  diabetes 
self-m anagem ent.
I t  is  im po rtan t to  note how ever th a t none o f the s ig n ifica n t pred icto rs fo r e ithe r the 
pa tien t o r the hea lth  care professionals accounted fo r a very large percentage o f  the 
variance on any o f  the subscales, w h ich  suggests th a t these m ay no t have been the 
best pred ictors. Possible a lte rnatives, w h ich  m ay have been bette r pa tien t pred ictors, 
inc lude  health  status (num ber o f  o ther ch ron ic  diseases, presence o f  com p lica tions) 
and psychosocia l variab les (personal m odels o f  diabetes, barriers to  and se lf-e ffica cy  
fo r diabetes self-care). For the hea lth  care professionals, better p red icto rs m ay have 
been be lie fs  about diabetes treatm ent, confidence in  th e ir ow n a b ilitie s  to  carry out 
trea tm ent recom m endations and con textua l factors ( fo r exam ple, tim e  and resources). 
In  add ition , i t  is o f  in te rest to  note th a t the resu lts o f  the regression analyses do no t 
re fle c t the d ifferences am ong the hea lth  care professionals reported in  the ea rlie r 
analyses o f  variance and t tests. H ow ever, th is  m ay be a ttribu tab le  to  the d iffe rence  in  
the w ay the variance is pa rtitio n e d  ou t fo r  the analysis o f variance com pared to  the 
regression. In  the regression, hea lth  care professiona l group does no t add anyth ing to  
the p red ictions over and above the other independent variables.
There were no s ig n ifica n t d iffe rences betw een the in te rven tion  and co n tro l groups in  
the life s ty le  in te rven tion  study on any o f  the  fiv e  D A S  subscales. In  add ition , there 
were no s ig n ifica n t d iffe rences betw een the partic ipan ts in  the life s ty le  in te rven tion  
study and the new ly  recru ited  patients on any o f  the fiv e  D A S  subscales. H ow ever,
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there w ere s ig n ifica n t d iffe rences betw een life s ty le  partic ipan ts ' responses to  the 
personal m odels o f  diabetes subscale 'seriousness' and the D A S  subscale 'seriousness 
o f  type 2 diabetes'. Furtherm ore, the responses to  the questions 'H ow  serious is your 
diabetes' and 'Type 2 diabetes is a serious co n d itio n ' d iffe re d  s ig n ific a n tly  and suggest 
tha t partic ipan ts v iew ed th e ir ow n diabetes as a less serious co n d itio n  com pared to  
th e ir v iew s about the seriousness o f  type 2 diabetes in  general.
These fin d in g s  are p a rtic u la rly  im p o rta n t and re fle c t those o f previous studies.
M u rphy et al. (1995) fo r exam ple in  a q u a lita tive  study explored perceptions o f the 
seriousness o f  diabetes in  in te rv iew s w ith  in d iv id u a ls  w ith  type 2 diabetes and found 
tha t respondents were genera lly re fe rrin g  to  com p lica tions in  d iscussing the 
seriousness o f  diabetes and va ried  in  the extent to  w h ich  they saw them selves as 
'candidates fo r com p lica tions ’. Respondents distanced them selves fro m  candidacy 
w ith  phrases such as 'o n ly  a m ild  fo rm ' to  describe th e ir ow n diabetes o r expressed 
confidence in  'advances in  m odem  m ed icine ' to  prevent com plica tions. N um erous 
other studies have dem onstrated th a t people tend to  be lieve tha t th e ir ow n risks are 
less than the risks o f th e ir peers (H oorens, 1993; Schwarzer, 1994; W einste in , 1980,
1998) and th is  tendency to  be lieve  tha t one's ow n ris k  o r illness is less serious than 
tha t o f others m ay reduce in te rest in  hea lth -p ro tective  behaviours. Indeed, research 
on hea lth  behaviour has dem onstrated tha t people w ho believe th a t th e ir ow n ris k  is 
lo w  o r people w ho th in k  tha t th e ir ris k  is  lo w e r than th e ir peers are less lik e ly  to  take 
precautions than those w ho acknow ledge personal ris k  (W einste in  et a l., 1999; Conner 
&  N orm an, 1996; D avidson &  P rkach in , 1997; K le in , 1997). Th is reluctance 
there fore  to  acknow ledge personal v u ln e ra b ility  in  term s o f  the seriousness o f th e ir
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diabetes m ay be a m a jo r reason w hy in d iv id u a ls  w ith  type 2 diabetes fa il to  adhere to  
treatm ent recom m endations.
M ost o f  the health  care professionals considered diabetes harder to  trea t com pared 
w ith  other chron ic cond itions. There are a num ber o f possible explanations fo r th is. 
As m entioned p reviously, the tra in in g  o f hea lth  care professionals has tra d itio n a lly  
focused on the treatm ent o f acute cond itions, no t chron ic ones re q u irin g  a h igh  degree 
o f pa tien t p a rtic ip a tio n  and behaviour change. D iabetes m ay be regarded as harder to  
trea t there fore  because its  successful m anagem ent re lies to  a greater extent on life s ty le  
change and pa tien t self-m anagem ent, aspects o f treatm ent w h ich  hea lth  care 
professionals have rece ived in s u ffic ie n t tra in in g  fo r and w h ich  are outside o f  th e ir 
'con tro l'. In  add ition , the sym ptom s associated w ith  diabetes are o ften  an un re liab le  
guide to  the severity o f  the disease fo r patients and to  the e ffica cy  o f  treatm ent fo r 
hea lth  care professionals. D iabetes sym ptom s are subtle and last over such a long  
period  o f tim e  tha t patients do no t fee l in  im m edia te  danger and o ften  neglect to  
fo llo w  treatm ent recom m endations (G o lin  et a l., 1996). Further, diabetes treatm ents, 
fo r exam ple fin g e r sticks fo r glucose m o n ito rin g  and in s u lin  in jec tions , o ften  cause 
pa in  o r indeed create sym ptom s ra ther than a lle v ia tin g  them . D iabetes m edications 
fo r exam ple, m ay som etim es resu lt in  hypoglycaem ia o r are associated w ith  w e igh t 
gain. Because o f th is , hea lth  care professionals o ften  have d iffic u lty  conv inc ing  
patients to  fo llo w  th e ir treatm ent recom m endations, especia lly i f  those patients are not 
experiencing uncom fortab le  sym ptom s.
Larm e and Pugh (1998) suggest th a t constant flu c tua tion s  in  g lycaem ic con tro l m ay 
also cause patients to  perceive diabetes as 'on and o ff, day by day', so they becom e la x
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about fo llo w in g  treatm ent regim ens, m aking  the w o rk  o f hea lth  care professionals 
m ore d iffic u lt. H un t e t al. (1998) in  a q u a lita tive  study on how  patients adapt 
diabetes self-care recom m endations in  everyday life  report tha t patients ro u tin e ly  
custom ize treatm ent recom m endations to  f i t  th e ir spec ific  circum stances and p rio ritie s  
w h ich  they suggest is a necessary aspect o f  any attem pt to  app ly the p rin c ip le s  o f  se lf- 
care to  the pa rticu la rs  o f  d a ily  life . Im p o rta n tly  how ever, such custom isation  m ay no t 
be in  accord w ith  hea lth  care professiona ls' treatm ent recom m endations.
The fin d in g  th a t a lm ost 70%  o f hea lth  care professionals fe lt th a t they d id  no t have 
adequate tim e  and resources to  trea t th e ir patients w ith  diabetes e ffe c tive ly  m ust also 
con tribu te  to  the perception th a t diabetes is  especia lly  hard to  trea t and have an 
im portan t im pact on jo b  satisfaction . E x tra  hea lth  care professiona l tim e  and e ffo rt 
are requ ired to  trea t diabetes and to  cover a ll aspects o f  com prehensive diabetes care. 
Y e t frequen tly  the ty p ic a l c lin ic  se tting  does no t support longer o r few er 
appointm ents, there is  in s u ffic ie n t s ta ff to  educate patients o r a lack  o f  resources fo r 
re fe rra ls  to  o ther specia lists w hen requ ired , fo r exam ple psycho log ica l expertise. For 
these reasons, hea lth  care professionals fre q u e n tly  fee l tha t they have to  com prom ise 
the q u a lity  o f  care they o ffe r to  th e ir patients w h ich  leads to  a sense o f fru s tra tio n  on 
th e ir part and m ay account fo r the la ck  o f  adherence to  gu ide line  im p lem enta tion  by 
hea lth  care professionals, p a rticu la rly  p rim a ry  care providers, noted in  the  lite ra tu re  
(fo r exam ple, Jacques et a l., 1991; K enny et a l., 1993; Peters et a l., 1996). Indeed, as 
G lasgow  (1995) notes, such con textua l factors in  the care o f people w ith  diabetes 
m ust be addressed o r p ractice  gu ide lines are u n lik e ly  to  be fo llow ed .
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9.1 Strengths and Limitations of the Study
T h is  study has bo th  m ethodo log ica l strengths and lim ita tio n s . Strengths inc lude  the 
use o f the D A S -3 , w h ich  is a general measure o f diabetes-related a ttitudes fo r use by 
both  patients and hea lth  care professionals in vo lve d  in  th e ir care. T h is  a llow s fo r 
d ire c t com parisons and exam ination  o f  the d iabetes-re lated a ttitudes o f  both groups 
and provides an oppo rtun ity  to  id e n tify  d iffe rences in  op in io n  tha t cou ld  in fluence  the 
q u a lity  o f pa tien t-p ro fessiona l com m unication , thereby a ffe c tin g  the m anagem ent o f 
the disease. L im ita tio n s  inc lude  the absence o f  a s ig n ifica n t p ro p o rtio n  o f  c u ltu ra lly  
d iverse partic ipan ts, the sm all num ber o f doctors p a rtic ip a tin g  and the fa c t tha t m ost 
o f  the hea lth  care professionals w ere w om en, w ho were e ithe r nurses o r d ie titians. 
H ow ever, i t  is im po rtan t to  note tha t th is  is n o t unique to  the present study and the 
d iffic u ltie s  o f re c ru itin g  hea lth  care professionals, especia lly doctors, to  pa rtic ipa te  in  
th is  k in d  o f research have also been noted by others (fo r exam ple Anderson et a l., 
1993). Nevertheless, th is  was a convenience sam ple and as such m ay no t be 
representative w h ich  o f  course lim its  gene ra lisa b ility  o f find ings.
9.2 Im p lica tio n s  o f the S tudy
T h is study has im portan t im p lica tio n s  fo r p ractice  and fu tu re  research in  the care o f 
people w ith  type 2 diabetes. Patients are no t passive rec ip ients o f m ed ica l advice. 
R ather they are active  in terpre ters and at tim es th e ir in te rp re ta tions lead them  to  qu ite  
d iffe re n t responses fro m  those advocated by the hea lth  care professionals invo lve d  in
173
th e ir care. To understand and appropria te ly  in fluence  self-care choices, c lin ic a l 
encounters should inc lude  an open dia logue w ith  patients. H ea lth  care professionals 
should no t assume tha t ignorance o r a la ck  o f  m o tiva tio n  underlies poor outcom es. 
They should exp lore  w hat patients are do ing  and w hy they are do ing  i t  tha t w ay, 
recogn izing  tha t self-care behaviour is reasoned behaviour, fro m  the patient's 
perspective (Hernandez, 1995). T h is  w ill he lp  m ove the m anagem ent o f type 2 
diabetes away fro m  the fru s tra tio n  o f b lam ing  patients fo r fa ile d  treatm ent tow ards 
he lp ing  patients m ake adequate and appropria te  illness  m anagem ent choices, 
re fle c tin g  current trends in  diabetes care tow ards increasing pa tien t em pow erm ent, 
enabling patients to  m ake in fo rm ed  decisions about th e ir ow n care (A nderson et a l., 
1991).
I t  is  im portan t to  rem em ber th a t w h ile  hea lth  care professionals m ay have a 
consu lta tion  w ith  a pa tien t fo r o n ly  15 m inutes every 3 to  6 m onths, patients m ust 
m ake self-care decisions m any tim es each day. H ea lth  care professionals w ho 
establish an open dia logue w ith  patients w ill become aware o f how  patients ac tua lly  
transla te these b r ie f encounters in to  action. T h is  a llow s them  to  engage in  an 
in te rac tive  process w ith  th e ir patients to  he lp  im prove  th e ir behavioura l decisions and 
even tua lly  im prove  th e ir outcom es. S e lf-m ed ica tion  adjustm ent, d ie ta ry 
experim enta tion , and response to  sym ptom s a ll can be reasonable strategies w hen 
done w ith  s u ffic ie n t pro fessiona l support. H ea lth  care professionals w ho begin a 
d ia logue w ith  th e ir patients w ith  type 2 diabetes to  ascertain th e ir be lie fs  and attitudes 
to  th e ir illness can he lp  assure th a t th e ir p ra c tica l decisions about se lf-care are 
c lin ic a lly  sound.
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Furtherm ore, over re liance on the pow er o f  m edications m ay be u n in te n tio n a lly  
re in fo rced  by health care professionals w ho emphasise m edications in  consultations. 
D iscussing w ith  patients w hat they can and cannot expect in  the longer te rm  from  
th e ir m edications m ay be an e ffe c tive  w ay to  encourage greater re liance  on 
behavioura l changes. I t  m ay also be usefu l to  discuss w ith  type 2 patients fro m  the 
start th a t in su lin  use is  som ething tha t is a rea l p o s s ib ility  fo r them  in  the fu tu re . Th is 
m ay he lp  firs tly , to  im press upon them  the seriousness o f th e ir co n d itio n  g iven  the 
fin d in g s  o f the association o f in s u lin  use w ith  perceptions o f seriousness o f th e ir 
co n d itio n  and secondly, to  rem ove the association o f in s u lin  usage w ith  a sense o f 
fa ilu re  and poor con tro l.
The fin d in g  tha t a m a jo rity  o f hea lth  care professionals in  the present study fe lt tha t 
they d id  no t have adequate tim e  and resources to  trea t th e ir patients w ith  diabetes 
e ffe c tiv e ly  is o f  p a rticu la r concern and tha t th is  m ay be re la ted to  jo b  sa tis faction  
c le a rly  w arrants fu rth e r research. D iM a tte o  et al. (1993) have dem onstrated tha t how  
c lin ic ia n s  fee l about th e ir w o rk  can have a p o s itive  e ffe c t on patients' general 
adherence and lin k  p h ys ic ia n s 'jo b  sa tis faction  w ith  pa tien t actions th a t are c r itic a l to  
the m anagem ent o f th e ir ch ron ic  diseases. Such find ings have im po rtan t im p lica tio n s  
fo r organ iza tiona l and personal changes a t the hea lth  care professiona l le ve l to  
im prove  hea lth  care fo r patients w ith  type  2 diabetes.
G lasgow  (1995) and V on  K o r ff e t al. (1997) propose ways to  e n lis t pa tien t, c lin ic  and 
com m un ity  support in  diabetes m anagem ent to  lig h te n  the load fo r hea lth  care 
professionals and im prove diabetes outcom es. C om m unication  and m o tiva tio n a l 
techniques b ene fic ia l to  d iabe tic  patients inc lude  using patient-focused dia logue to
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id e n tify  barrie rs to  self-care and assess pa tien t readiness, focusing on a spec ific  
p rob lem , estab lish ing re a lis tic  ob jectives, nego tia ting  an action  p lan, and frequent 
fo llow -ups. A ctions at the c lin ic  le ve l inc lude  a team  approach to  diabetes care, 
rem inder systems to  prom pt screening and re fe rra ls , longer appoin tm ent tim es fo r 
patients w ith  diabetes and a focus on pa tien t education.
M ed ica l education and con tinu in g  education program m es fo r hea lth  care professionals 
have an im portan t ro le  to  p lay in  p rom oting  pos itive  attitudes tha t encourage the 
e ffe c tive  and com passionate treatm ent o f  diabetes (Anderson et a l., 1992; W einberger 
et a l., 1984). T h is includes he lp ing  hea lth  care professionals to  m ake the s h ift from  
an acute to  a ch ron ic m odel o f  m ed ica l care and fro m  the ro le  o f p rim a ry  decision­
m aker to  th a t o f  teacher and fa c ilita to r. T o date, these program m es have been 
m in im a lly  e ffec tive  in  changing p rov ide r behaviour in  diabetes care. T h is m ay be 
because they are generally based on the transfe r o f  new  m edica l know ledge.
H ow ever, research has repeatedly ind ica ted  th a t increased know ledge does no t 
necessarily resu lt in  changes in  behaviour in  e ithe r p ractitioners o r patients and tha t 
be lie fs  and a ttitudes, no t know ledge d e fic its , m ay be the m a jo r barrie rs to  e ffec tive  
p ractice  and therapeutic outcom es fo r people w ith  diabetes. C on tinu ing  education 
program m es fo r health  care professionals tha t address attitudes and be lie fs  in  add ition  
to  know ledge are lik e ly  to  be m ore e ffe c tive  than tra d itio n a l program m es in  changing 
practice  behaviours and im p ro v in g  d iabe tic  outcom es.
In  conclusion , there is a g row ing  body o f research th a t is ca llin g  fo r p ractitione rs  to  
s h ift fro m  a ttem pting to  d icta te  behaviours in  an au tho rita tive  m ode to  fo rm in g  
co llabo ra tive  a lliances w ith  patients w ith  jo in tly  id e n tifie d  goals and strategies
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(G lasgow  et a l., 1996; M a rtinez, 1993). T h is  study ind icates tha t an im po rtan t part o f 
fo rm in g  such co llabo ra tio n  w ill be to  recognize the d is tin c tio n  between p ra c titio n e r 
and pa tien t perspectives. In  the case o f ch ron ic  illnesses lik e  type 2 diabetes, 
behavioura l choices m ay be be tte r understood as m u ltip le  and ongoing, h ig h ly  
dependent on the circum stances o f patients' lives , and w ith  an im pact on disease status 
th a t is d iffu se  and o ften  uncerta in , ra ther than s tra igh tfo rw ard .
Researchers are becom ing increas ing ly  aware tha t attitudes to  and be lie fs  about illness 
have considerable im pact on q u a lity  o f  care and are thus im portan t to  address, no t 
o n ly  fo r the developm ent o f e ffe c tive  in te rven tions fo r both patients and hea lth  care 
professionals bu t also im p o rta n tly  to  in fo rm  m edica l and ongoing education and 
pro fessiona l developm ent program m es fo r the hea lth  care professions. T h is  study 
makes a s ig n ifica n t co n trib u tio n  to  e luc ida tin g  these issues, since lit t le  is  know n about 
con trasting  pa tien t and p ra c titio n e r perspectives in  type 2 diabetes m anagem ent in  the 
U K , w h ich  m ay lead to  d iffe re n t goals and expectations o f treatm ent in  diabetes care.
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Chapter 10
10.1 In tro d u c tio n
D iabetes is a g loba l hea lth  p rob lem  th a t is  expected to  present one o f the 21st century's 
b iggest m edica l challenges. The num ber o f people w ith  diabetes is escalating bo th  in  
the U K  and w o rldw ide  and type 2 diabetes in  p a rticu la r is  increasing at an a lann ing  
rate. A round  1.4 m illio n  people in  the U K  today have diabetes. A t least a m illio n  
m ore -  'the m issing m illio n ' -  are though t to  have diabetes tha t has no t ye t been 
diagnosed. There are cu rren tly  16 m illio n  A m ericans w ith  diabetes, bu t i t  is 
p ro jected  tha t w ith in  10 years, there w ill be 23 m illio n  Am ericans w ith  th is  disease. In  
Europe, the U S A  and m ost w esternised countries, type 2 accounts fo r up to  85%  o f 
to ta l cases o f  diabetes.
D iabetes is  also unique am ong ch ron ic illnesses in  the degree to  w h ich  pa tien t 
behaviour in fluences bo th  the a p p lica tio n  and outcom es o f therapy. Indeed, there is 
em erging evidence suggesting th a t in  order to  e ffe c tiv e ly  im p lem ent in tensive 
regim ens designed to  achieve o p tim a l g lycaem ic con tro l, i t  is necessary to  address a 
va rie ty  o f  behavioura l issues am ong in d iv id u a ls  w ith  diabetes.
The increase in  the prevalence o f diabetes is associated w ith  an im proved standard o f 
liv in g , w h ich  seems to  resu lt in e v ita b ly  in  life s ty le  changes th a t resu lt in  increased 
body w e igh t and reduced physica l a c tiv ity . I t  is  these life s ty le  changes tha t are 
considered m ost lik e ly  to  underlie  the w o rld w id e  increased prevalence o f th is  disease. 
S ince bo th  obesity and physica l in a c tiv ity  are s ig n ifica n t ris k  factors fo r diabetes, the
10. General Discussion
178
reduction  o r e lim in a tio n  o f  such factors appears to  be re la ted to  p revention  and 
m anagem ent o f th is  disease. In  add ition , coronary heart disease (C H D ) is  the m a jo r 
cause o f  m o rta lity  fo r in d iv id u a ls  w ith  diabetes. B o th  physica l a c tiv ity  and w e igh t 
loss have been shown to  reduce b lood  pressure, im prove  serum  lip id  leve ls and 
p o s itive ly  a ffe c t o ther C H D  ris k  factors (N H L B I, 1998). Thus, developm ent o f 
e ffe c tive  life s ty le  in te rve n tio n  strategies fo r  adoption  and m aintenance o f hea lthy 
eating, physica l a c tiv ity , and body w e igh t w o u ld  be s ig n ifica n t fo r the prevention  and 
treatm ent o f bo th  m o rb id ity  and m o rta lity  in  diabetes.
10.2. W eaknesses o f Past Research
T ra d itio n a lly , life s ty le  in te rve n tio n  program m es in  type 2 diabetes have focused on 
w e igh t loss as a p rim a ry  outcom e. The m ost successful o f these have com bined 
d ie ta ry re s tric tio n , exercise and behaviour m o d ifica tio n  and they have been shown to  
be m ost e ffe c tive  over the short term . C u rren tly , a pa tien t entering such an 
in te rven tion  program m e can expect to  lose 20 lbs on average (approx im ate ly  10% o f 
th e ir w e igh t) over the course o f20-26 weeks (W ing , 1997). H ow ever, long-te rm  
m aintenance o f w e igh t loss a fte r p a rtic ip a tio n  in  w e igh t con tro l in te rven tions rem ains 
elusive. A t the 1-year fo llo w -u p , patients have ty p ic a lly  regained 30%  o f th e ir in itia l 
w e igh t loss; the fe w  studies w ith  3 to  5 year fo llo w -u p  suggest tha t m ost patients are 
back to  baseline by th is  tim e  (W ilso n , 1994; W adden et a l., 1989). In  add ition , there 
is some evidence tha t d iabe tic  patients are less successful in  m a in ta in ing  long-term  
w e igh t loss than people w ith o u t diabetes (G uare et a l., 1995), a resu lt perhaps due to  
m etabo lic  d ifferences between these tw o  groups and com pounded by the effects o f 
treatm ent fo r those w ith  diabetes.
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Concern arises there fore  over the use o f short-te rm  w e igh t loss as the sole, o r even 
p rim ary , in d ica to r o f successful in te rve n tio n  outcom e. T h is is  p a rtly  because 
repeated loss and regain o f  w e igh t (w e ig h t cyc lin g ) m ay be m ore hazardous to  health  
and w e ll be ing than a h igh  bu t stable w e igh t (R od in  et a l., 1990; L issner e t a l., 1991; 
Haus et a l., 1994; Foster et a l., 1997)). Furtherm ore, d ie tin g  and d ie ta ry  restra in t has 
been im p lica ted  in  increasing eating  problem s (fo r exam ple, binge eating and 
em otiona l eating) and preoccupation w ith  w e igh t and shape (P o liv y  et a l., 1995; 
W ard le , 1987).
In  term s o f physica l a c tiv ity , the tra d itio n a l structured exercise p rescrip tion  fo r 
becom ing p h ys ica lly  f i t  has fa ile d  d ism a lly  in  m o tiva tin g  m ost adults to  becom e 
h a b itu a lly  phys ica lly  active  (U SD H H S, 1996). In  recent years, i t  has becom e evident 
th a t the quan tity  o f  exercise needed fo r hea lth  b e n e fit is  considerab ly less than tha t 
needed to  achieve physica l fitness (U SD H H S, 1996; Pate et a l., 1995). In  add ition , 
p a rtic ip a tio n  in  v igorous a c tiv ity  is associated w ith  increased ris k  o f in ju ry  and death 
fo r irre g u la r exercisers and those w ith  disease (G ir i et a l., 1999; Shaper et a l., 1994), 
w h ich  are com m on features o f  those w ith  type 2 diabetes w ho are overw e igh t and 
obese.
The shortcom ings o f tra d itio n a l treatm ents then and the neglect o f the psychosocia l 
aspects o f obesity and physica l in a c tiv ity  in  type 2 diabetes, has led  to  the emergence 
o f  a new  perspective on treatm ent w h ich  supports the v ie w  th a t a w id e r approach to 
ris k  m anagem ent in  type 2 diabetes is needed than one focusing  e n tire ly  on w e igh t 
loss (A D A , 1997; W H O , 1998). The goal o f  life s ty le  in te rven tion  should be 
re fo rm u la ted  fro m  sim ple w e igh t loss to  'w e ig h t management' in co rpo ra tin g  con tro l o f
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long -tenn  w e igh t ga in  and ris k  fa c to r reduction , w ith  success judged  by the e ffe c t on 
the o ve ra ll health  and w e ll-b e in g  o f partic ipan ts.
10.3. O verv iew  o f studies
10.3.1. R andom ised co n tro lle d  tr ia l o f a b r ie f life s ty le  self-m anagem ent in te rven tion
T o address these concerns and consistent w ith  th is  new  perspective o f w e igh t 
m anagem ent and ris k  fa c to r reduction , the developm ent, im p lem enta tion  and 
eva lua tion  o f a b rie f, ta ilo re d , self-m anagem ent in te rven tion  to  im prove  life s ty le  se lf­
m anagem ent in  patients w ith  type 2 diabetes in  a lo n g itu d in a l study was undertaken. 
T h is in te rven tion  incorpora ted pa tien t assessment, co llabo ra tive  goal setting, 
id e n tific a tio n  o f barriers to  these goals, personalized p rob lem -so lv ing  and fo llo w -u p  
support.
The results fro m  th is  study ind ica te  a num ber o f  key find ings. In te rven tion  
partic ipan ts w ere able to  m ake s ig n ifica n t reductions to  th e ir fa t-re la ted  eating habits 
and to ta l d a ily  in take  o f fa t, w h ich  were m ain ta ined fo r the m ost pa rt a t the tw e lve  
m onths assessment. These results have im p o rta n t im p lica tio n s  fo r practice. Fat 
reduction  has been id e n tifie d  as the m ost d iff ic u lt o f  the d ie ta ry  recom m endations fo r 
d iabe tic  patients to  fo llo w . These reductions therefore in  both fa t-re la ted  eating habits 
and to ta l in take o f fa t were encouraging in  lig h t o f  recent recom m endations fo r 
hea lthy eating in  patients w ith  type 2 diabetes (B D A , 1992; A H A , 2000) and the 
suggested lin k  between h ig h -fa t d iets and coronary heart disease (C H D ), obesity and 
type 2 diabetes (Pang, 1994; B D A , 1992). In  add ition , a reduction  o f  the to ta l fa t 
content o f  the d ie t can be seen as an im po rtan t step in  reducing to ta l energy in take,
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w h ich  is o f  b ene fit in  bo th  w e igh t m aintenance and u ltim a te ly  w e igh t loss. H ow ever, 
im provem ents in  the q u a lity  o f  the  d ie t should be a com ponent o f care independent o f  
w e igh t reduction  (H ill et a l., 1993). R eductions in  am ounts o f d ie ta ry  fa ts, fo r 
exam ple, can im prove hea lth  as w e ll as assist in  sm all am ounts o f w e igh t loss. 
R estric tive  d ie tin g  on the o ther hand has been associated w ith  adverse effects on 
con tro l o f food  in take, increasing bo th  b inge eating  and em otiona l eating (P o liv y  et 
a l., 1986; W ard le , 1987; T e lch  et a l., 1994) and the ca lo ric  d e fic its  com m on to  m any 
treatm ent program m es m ay lead to  fee lings o f re s tric tio n  and the relapse w h ich  is 
frequen tly  reported.
S im ila rly , increased physica l a c tiv ity  and a decrease in  sedentary life s ty le  can 
represent b e n e fic ia l com ponents o f  long -tenn  care irrespective  o f the im pact th is  m ay 
have on w e igh t loss (P e rri, 1988). P a rtic ip a tio n  in  m oderate-in tensity a c tiv itie s , such 
as w a lk in g  instead o f d riv in g  a short d istance, c lim b in g  stairs, pa rk ing  away fro m  the 
destination , and ge tting  o f f  the bus ea rly  and w a lk in g , im part s ig n ifica n t health 
benefits (B la ir et a l., 1989; Leon et a l., 1987; S a llis  et a l., 1986). In  add ition , to ta l 
energy expenditure over tim e  m ay be m ore im po rtan t than the du ra tion  o f  the exercise 
session its e lf w hen considering the e ffe c t on lo n g e v ity  and prem ature m o rta lity  (B la ir 
e t a l., 1992; Paffenbarger e t a l., 1986). Im p o rta n tly , physica l a c tiv itie s  o f  lig h t to  
m oderate in te n s ity  th a t can be b u ilt in to  the norm a l d a ily  rou tine , m ay be m ore 
sustainable and m ay be the m ost e ffe c tive  and least costly  approach fo r increasing 
energy expenditure in  the largest num ber o f people (Shephard, 1992; Pescatello, 
2000).
A cco rd in g ly  it  can be concluded tha t some a c tiv ity  is  better than none and tha t lo w - to  
m oderate in te n s ity  a c tiv ity  is be tte r than rem a in ing  sedentary. In  the present study
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there fore , a lthough the o ve ra ll PASE score fo r occupational, household and le isure 
a c tiv itie s  was no t s ig n ific a n tly  d iffe re n t betw een the tw o  groups, the means fo r the 
in te ive n tio n  group were in  the rig h t d ire c tio n  at a ll tim e  po in ts com pared to  the 
con tro l group, and were approaching s ign ificance  at the 6 m onths and 12 m onths 
assessments, suggesting tha t in te rve n tio n  pa rtic ipan ts were increasing th e ir physica l 
a c tiv ity  levels.
C onsistent w ith  the above fin d in g s , in te rve n tio n  subjects also reported, a t the  three 
and s ix  m onths assessments, s ig n ific a n tly  increased diabetes re la ted  se lf-care 
behaviours fo r both  the d ie ta ry  and physica l subscales, com pared to  the con tro l group, 
over the preceding 7 days, resu lts w h ich  were m a in ta ined fo r the physica l a c tiv ity  
subscale at the tw e lve  m onths assessment.
A  ve ry im po rtan t fin d in g  in  th is  in te rve n tio n  study was that the above se lf-reported 
behaviour changes were re flec ted  in  the ob jective  data w ith  a sm all bu t s ig n ifica n t 
d iffe rence  between the tw o  groups in  tenns o f B M I and w a is t measurements. T h is 
e ffe c t resu lted p rim a rily  fro m  a s ig n ific a n t drop in  the w a is t m easurem ent fo r 
in te rven tion  subjects between the baseline and three m onths assessments w h ich  was 
m ainta ined at s ix  and tw e lve  m onths. W a ist c ircum ference relates c lose ly  to  in tra ­
abdom inal fa t mass (P ou lie t M -C  et a l., 1994; Ross et a l., 1993; S e ide ll e t a l., 1988) 
and changes in  w a is t circum ference, o f  the size reported in  the present study, m ay 
p o te n tia lly  re fle c t changes in  card iovascula r ris k  factors even in  the absence o f 
s ig n ifica n t w e igh t loss (Lehm ann et a l., 1995; Sonnichsen et a l., 1992; W ing  et a l., 
1992; W ing  et a l., 1995; H e llen ius et a l., 1993; B a rlow , 1995).
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In  add ition , the se lf-reported  changes in  d ie ta ry  behaviour and physica l a c tiv ity  were 
also re flec ted  in  w e igh t m aintenance in  the in te rve n tio n  group between baseline and 
the tw e lve  m onths assessment, w h ile  B M I increased s ig n ific a n tly  fo r  the con tro l 
group over the same tim e  period. G iven the evidence already c ited , the m aintenance 
o f stable w e igh t and the p revention  o f w e igh t gain should be recognized as a 
le g itim a te  treatm ent goal. In d iv id u a ls  w ho have fa ile d  to  lose w e igh t using d ie ta ry 
and behavioura l treatm ents are u n lik e ly  to  lose w e igh t in  a repeated e ffo rt using the 
same approach (S m ith  et a l., 1991). M oreover, in  lig h t o f find ings regard ing po ten tia l 
negative effects o f w e igh t loss, m aintenance o f stable w e igh t, as dem onstrated fo r 
in te rven tion  partic ipan ts in  the present study, m ay represent a p re ferred op tion  fo r 
m any in d iv id u a ls  (B la ir et a l., 1993; H igg ins  et a l., 1993).
In  term s o f the process o f  change, in te rve n tio n  subjects w ere s ig n ific a n tly  m ore ready, 
at the three m onths and s ix  m onths assessments to  increase th e ir physica l a c tiv ity  
leve ls and reduce th e ir fa t in take  and m oved fro m  a stage o f p recontem p la tion to  
action. These results were m ain ta ined at the tw e lve  m onths assessment. Further, 
these changes in  eating behaviour and physica l a c tiv ity  leve ls were accom panied by a 
trend  tow ards decreased barrie rs to  change.
The fin d in g  tha t no sing le  p re d ic to r was consisten tly  associated w ith  outcom e on any 
o f  the key outcom e measures is im po rtan t and suggests tha t th is  in te rve n tio n  is 
generalisable and m ay be b road ly  app licab le  to  m ost patients w ith  diabetes. In  lig h t 
o f  concerns about the a p p lic a b ility  o f  m any in te rven tions in  diabetes care to  
subgroups such as the less-educated, the e lde rly , type 2 patients and h ig h -risk  patients 
w ith  o ther ch ron ic diseases, i t  was encouraging to  note tha t these factors were no t 
re la ted to  treatm ent outcom e in  the present study.
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U nderstand ing the behaviour o f persons w ith  diabetes requires some know ledge o f 
th e ir be lie fs  and a ttitudes tow ards diabetes and its  treatm ent. B e lie fs  and a ttitudes are 
a m a jo r com ponent o f hea lth  behaviour, and previous research has dem onstrated 
associations w ith  diabetes m anagem ent (C erkoney et a l., 1980; P o lly , 1992; F itzgera ld  
et a l., 1995; Ham pson et a l., 1996; 1995). A cco rd in g ly , the fin d in g  tha t partic ipan ts 
in  the in te rven tion  study regarded th e ir diabetes as o n ly  fa ir ly  serious is o f  p a rticu la r 
concern and tha t th is  m ay be re la ted  to  attitudes and be lie fs  o f the hea lth  care 
professionals invo lve d  in  th e ir care c le a rly  w arranted fu rth e r exp lo ra tion . There is 
increasing evidence tha t d iffe rences in  the concepts and perspectives o f patients and 
p ractitione rs ex is t and m ay be im po rtan t factors a ffe c tin g  no t o n ly  treatm ent 
behaviour bu t also in te rve n tio n  effectiveness and fu tu re  im p lem enta tion . The cross- 
sectional study was there fore  undertaken to  address these issues.
10.3.2. C om parison o f  patients' and hea lth  care professionals' diabetes be lie fs  and 
a ttitudes
T h is  exp lo ra to ry  study was undertaken to  investiga te  an im portan t issue h igh lig h te d  in  
the in te rve n tio n  study tha t m ig h t act as a b a rrie r to  fu tu re  in te rven tions be ing e ffe c tive  
and im p lem enta tion  o f in te rven tions by hea lth  care professionals. The issue 
h ig h lig h te d  was tha t pa tien ts’ personal m odels o f  diabetes suggested tha t they d id  no t 
regard th e ir diabetes as ‘ serious’ . In  contrast to  th is , discussions w ith  hea lth  care 
professionals in vo lve d  in  th e ir care revealed th a t they regard diabetes as ‘ve ry 
serious5. T h is study was designed there fo re  to  investigate m ore fu lly  th is  
discrepancy in  diabetes-re lated attitudes and b e lie fs  o f health care professionals and 
patients w ith  type 2 diabetes and to  ascerta in w hether patients' personal m odels o f
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diabetes in  the life s ty le  in te rve n tio n  study d iffe re d  to  th e ir d iabetes-re lated attitudes in  
general.
There is g row ing  evidence th a t d iffe rences in  the concepts and perspectives o f 
patients and p ractitioners ex is t (Snoek, 2000) and m ay be im portan t facto rs a ffe c tin g  
treatm ent behaviour (B e lfig lio  e t a l., 2001; G o lin , 1996; Hernandez, 1995; K le im nan , 
1980). A cco rd in g ly , i t  was an tic ipa ted  tha t th is  study w ou ld  fa c ilita te  a clearer 
understanding o f the perspectives tha t both  hea lth  care professionals and patients 
b rin g  to  th e ir consulta tions w h ich  m ig h t e lucidate  firs tly , the causes o f undesirable 
diabetes care and therapeutic outcom es and secondly, the d issa tis faction  tha t o ften 
arises fro m  a hea lth  care professional's o r patient's fa ilu re  to  m eet the other's diabetes 
m anagem ent expectations.
A  num ber o f key find in g s  resulted from  th is  study. The highest leve ls o f  agreement 
am ong patients and professionals concerned the need fo r special tra in in g  in  order to  
p rovide  diabetes care. A  s trik in g  fin d in g  was the s ig n ifica n t d iffe rence  between 
hea lth  care professionals' and patients' a ttitudes tow ards the seriousness o f type 2 
diabetes, w ith  hea lth  care professionals v ie w in g  type 2 diabetes as m ore serious than 
the patients. Furtherm ore, pa rtic ipan ts in  the in te rve n tio n  study view ed th e ir ow n 
diabetes as a less serious co n d itio n  com pared to  th e ir v iew s about the seriousness o f 
type 2 diabetes in  general. These results have im po rtan t im p lica tio n s  fo r pa tien t 
education and in te rve n tio n  effectiveness. The lite ra tu re  on adherence to  diabetes 
treatm ent regim ens fo r exam ple suggests tha t be lie fs  about the seriousness o f type 2 
diabetes are strong ly re la ted to  adherence to  treatm ent (C erkoney et a l., 1980), 
m e tabo lic  con tro l (P o lly  1992) and self-m anagem ent behaviours (Ham pson et a l., 
1996). Type 2 diabetes requires d iff ic u lt and long -las ting  behaviour changes on the
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part o f  patients and i t  is  u n lik e ly  th a t such changes w ill be made and sustained unless 
bo th  patients and health  care professionals are in  agreem ent about the serious nature 
o f th is  illness.
A no ther m ain fin d in g  was th a t a m a jo rity  o f  the hea lth  care professionals considered 
diabetes harder to  trea t com pared w ith  other ch ron ic cond itions and fe lt tha t they d id  
no t have adequate tim e  and resources to  trea t th e ir patients w ith  diabetes e ffe c tive ly . 
T h is  fin d in g  is p a rtic u la rly  im po rtan t and m ay in  pa rt exp la in  w hy patient-centered, 
m o tiva tio n a l in te rv ie w in g , and pa tien t activa tion /em pow erm ent approaches, o f  the 
type described here, w h ich  have consisten tly  been found to  produce b e n e fic ia l e ffects, 
are seldom  em ployed in  e ithe r p rim a ry  care o r specia lis t settings. There is  a 
com pe lling  need fo r fu tu re  research to  address these issues, and the im p lem enta tion  o f 
and barrie rs to  the a pp lica tio n  o f the behavioura l sciences in  these hea lth  care settings.
G lasgow  et al. (1999b) have in troduced the R E -A IM  m odel o f  research eva luation, a 
fram ew ork tha t focuses a tten tion  on im po rtan t a p p lic a b ility  issues and a rea l w o rld , 
effectiveness perspective o f in te rven tions. There are fiv e  com ponent dim ensions to  
the R E -A IM  m odel, w h ich  com bine to  determ ine the ove ra ll p u b lic  hea lth  im pact o f  
an in te rven tion : l)R each , o r the percent and representativeness o f  patients w ho are 
w illin g  to  pa rtic ipa te  in  a g iven procedure; 2 )E ffica cy , o r the im pact o f  an 
in te rve n tio n  on im portan t outcom es, in c lu d in g  behavioura l, b io lo g ic a l, q u a lity  o f life , 
and econom ic outcom es; 3) A dop tion , o r the percent and representativeness o f 
settings tha t are w illin g  to  adopt o r try  an in te rven tion ; 4 ) Im p lem enta tion , o r how  
consisten tly an in te rven tion  o r procedure is de live red  as intended; and 5)
M aintenance, o r the extent to  w h ich  a program m e o r p o lic y  becomes in s titu tio n a lise d
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or pa rt o f the rou tine  p ractice  o f m ed ica l settings. I t  is  suggested tha t these fiv e  
factors in te rac t to  detenn ine the ove ra ll ’population-based’ o r p u b lic  hea lth  im pact o f  a 
program m e o r in te rven tion .
A p p lie d  to  the present study, the reach results w ere encouraging. O ver 60%  o f 
e lig ib le  patients partic ipa ted  in  the study, and a lthough it  w ou ld  be desirable to  
increase th is  fig u re , th is  rate com pares favou rab ly  to  the sm all num ber o f o ther studies 
w ho have reported such data (fo r exam ple, G lasgow , 1996). I t  is  also encouraging 
tha t these partic ipan ts were representative o f  the popu la tion  o f type 2 diabetes at th is  
diabetes centre, g iven concerns th a t o n ly  hea lthy, m otiva ted  and lo w -ris k  persons w ill 
pa rtic ipa te  in  hea lth  p rom otion. Im p o rta n tly , o lde r patients and those w ith  m ore 
com orb id ities  and less education w ere as lik e ly  to  pa rtic ipa te  in  th is  in te rven tion  as 
other patients and no p a rtic ip a n t lis te d  ob jections to  such an in te rve n tio n  as a reason 
fo r non -partic ipa tion . In  general, the basic in te rve n tio n  was e ffe c tive  in  p roducing 
im provem ents in  self-m anagem ent behaviours in  th is  pa tien t group, in c lu d in g  the 
cha lleng ing  life s ty le  targets o f d ie ta ry and physica l a c tiv ity  patterns.
The status o f  the last three R E -A IM  outcom es, adoption, im p lem enta tion  and 
m aintenance are ye t to  be determ ined. A d d itio n a l research is ind ica ted  w ith  la rger 
num bers o f  health  care settings to  id e n tify  the characteristics o f settings w illin g  o r 
u n w illin g  to  adopt th is  and s im ila r in te rven tions and to  id e n tify  barrie rs to  adoption, 
im p lem enta tion  and m aintenance o f bo th  in te rve n tio n  de live ry  and p a rtic ip a n t 
behaviour change.
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10.4. Im p lica tio n s  o f the C om parison o f  patients' and health  care professionals' 
diabetes be lie fs  and a ttitudes study fo r fu rth e r developm ents o f the L ife s ty le  
In te rven tion
The com parison o f patients' and hea lth  care professionals' diabetes be lie fs  and 
a ttitudes has im portan t im p lica tio n s  fo r fu rth e r developm ents o f the life s ty le  
in te rven tion . C lea rly , since be lie fs  about the seriousness o f type 2 diabetes are 
strong ly  re la ted  to  adherence to  treatm ent and self-m anagem ent behaviours, health  
care professionals need to  ascertain patients' personal m odels o f  th e ir diabetes as part 
o f rou tine  p ractice  so tha t any discrepancies in  b e lie fs  about the seriousness o f  th e ir 
illness, as h igh ligh ted  in  the present study, can be addressed very ea rly  on in  the 
treatm ent process. T h is  m ay w e ll pave the w ay fo r increased in te rven tion  
effectiveness and adherence to  the d iff ic u lt life lo n g  self-m anagem ent regim en tha t 
these patients m ust sustain and m ay also serve to  lessen the fru s tra tio n  th a t is 
frequen tly  experienced by hea lth  care professiona ls w ho in  the present study 
considered diabetes harder to  trea t com pared w ith  other chron ic cond itions.
Furtherm ore, in  term s o f w idespread adoption  and im p lem enta tion  o f th is  in te rven tion  
by hea lth  care professionals, the fa c t th a t i t  was a b r ie f in te rven tion  th a t cou ld  
p o te n tia lly  be incorporated in to  rou tine  care is im portan t in  lig h t o f  the fin d in g  tha t 
the  hea lth  care professionals fe lt th a t they d id  no t cu rre n tly  have adequate tim e  and 
resources to  trea t th e ir patients w ith  diabetes e ffe c tive ly . T h is b r ie f in te rven tion  
there fore  m ay rem ove th is  im po rtan t b a rrie r to  fu tu re  adoption and im p lem enta tion  
and ce rta in ly  i f  incorpora ted in to  rou tine  usual care, th is  cou ld  becom e an e ffe c tive  
w ay fo r enhancing m aintenance o f life s ty le  changes over the longer term .
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A lth o u g h  the studies reported here have produced some in te resting  and im portan t 
fin d in g s , and the lim ita tio n s  have a lready been discussed in  d e ta il fo r each study, 
there are a num ber o f overarch ing considerations. F irs tly , the absence o f  a s ig n ifica n t 
p ropo rtion  o f c u ltu ra lly  d iverse pa rtic ipan ts lim its  gene ra lisa b ility  o f the find ings to  
e thn ic m in o ritie s  and other c u ltu ra l groups. Secondly, in  com m on w ith  s im ila r 
research, the m u ltip le  com ponents to  the life s ty le  in te rven tion  m ake i t  d iff ic u lt to  
determ ine the re la tive  co n trib u tio n  o f in d iv id u a l com ponents. In  add ition , there was 
o n ly  one in te rve n tio n is t and one diabetes centre invo lve d  in  the present in te rven tion  
study. Therefore po ten tia l d iffe re n tia l e ffects in vo lv in g  in te rven tion is ts  and c lin ics  
w ere no t addressed and fu tu re  research w ill need to  address issues o f  genera lisa tion 
and u n ifo rm ity  across in te rve n tio n  s ta ff and c lin ics .
The la ck  o f fo llo w -u p  beyond one year is  another lim ita tio n . I t  cannot be assumed 
th a t the w e igh t m aintenance and con tinu in g  reduction  in  w a is t c ircum ference evident 
in  the in te rven tion  group w o u ld  continue in d e fin ite ly  and fu tu re  research should be 
conducted to  rep lica te  these fin d in g s  and incorpora te  a longer fo llo w -u p . F in a lly , in  
the com parison o f patients' and hea lth  care professiona ls' diabetes be lie fs  and attitudes 
study, the sm all num ber o f doctors and the over-representation o f  w om en in  the 
sam ple are obvious lim ita tio n s . A lth o u g h  i t  was considered tha t approaching health  
care professionals in d iv id u a lly  w o u ld  ensure op tim a l p a rtic ip a tio n , i t  m ay w e ll be th a t 
m a ilin g  questionnaires to  a representative sam ple o f  hea lth  care professionals
10.5. Limitations and Implications for practice and future research
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in vo lve d  in  diabetes care w ou ld  have ensured a m ore representative sam ple o f 
partic ipan ts. Furtherm ore, conducting  in -depth  in te rv iew s w ith  the hea lth  care 
professionals m ay have com plem ented the quan tita tive  m ethods used in  th is  study and 
p rovided  a m ore in -depth  understanding o f hea lth  care professionals attitudes. 
H ow ever, resources were no t ava ilab le  in  the present study to  do e ithe r o f  these 
options.
N evertheless, the research reported in  the present thesis has im portan t im p lica tio n s  fo r 
p ractice  and fu tu re  research in  type 2 diabetes. F irs tly , the care o f the obese 
in d iv id u a l w ith  type 2 diabetes requires a perspective tha t acknow ledges the com plex, 
ch ron ic  nature o f th is  cond ition . S ince there is as ye t no ‘ cure ’ fo r obesity, care 
should be view ed in  term s o f long -tenn  m anagem ent as in  the treatm ent o f  other 
ch ron ic cond itions, rep lacing  short-tenn  in te rven tions w ith  a continuous-care m odel 
tha t focuses on the achievem ent o f re a lis tic  ob jectives (P erri et a l., 1991,1992). Since 
obese d iabe tic  in d iv id u a ls  do no t have d ire c t con tro l over how  m uch w e igh t they lose, 
treatm ent goals should be fram ed in  term s o f behaviours tha t they cou ld  con tro l, such 
as the q u a lity  o f the food  th a t they consum e and the am ounts and types o f physica l 
a c tiv ity  they perfonn .
T h is m odel o ffe rs  a new  and even o p tim is tic  perspective on treatm ent. Successful 
outcom e can then be view ed in  tenns o f b e n e fic ia l changes in  ris k  facto rs and 
im provem ents in  q u a lity  o f life  (Foreyt et a l., 1994; A tk inson , 1993; K ap lan, 1990), 
w h ich  represent im portan t ind ica to rs  o f success. G iven the evidence already cited , 
the m aintenance o f stable w e igh t and the prevention  o f w e igh t ga in should be 
recognized as a leg itim a te  treatm ent goal w ith  fu tu re  research addressing 
in te rven tions such as the one reported here w h ich  focus on reducing card iovascular
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disease ris k  factors such as h ig h  fa t d ie ts, physica l in a c tiv ity  and cen tra l abdom inal 
obesity.
Future versions o f  th is  in te rve n tio n  m ig h t also b e n e fit fro m  conversion to  a 
com puterised fo rm a t, w h ich  w o u ld  p e rm it autom ated scoring so tha t s ta ff cou ld  be 
tra ined  re la tiv e ly  easily and thereby fa c ilita te  easier im p lem enta tion  o f  the 
in te rven tion . In  add ition , an ob jective  m easure o f  physica l fitness w o u ld  fa c ilita te  a 
clearer understanding o f  in te rve n tio n  effects and changes over tim e  on increasing 
physica l a c tiv ity  levels. In  term s o f  the  im pact o f  the in te rven tion  on patients' q u a lity  
o f  life , the in c lu s io n  o f  m ore diabetes spec ific  measures, such as the A D D Q oL  
(B rad ley et a l., 1995), o r the Type 2 D iabetes Sym ptom  C hecklis t (D S C -Type 2; 
G rootenhuis et a l., 1994) w h ich  measures bo th  the occurrence and the perceived 
burden o f  physica l and psycho log ica l sym ptom s re la ted to  type 2 diabetes and its  
possible com plica tions, m ay p rov ide  a m ore pa tien t centred analysis o f  the  im pact o f 
type 2 diabetes on in d iv id u a l q u a lity  o f  life . A lso , since the pos itive  aspects o f the 
group experience have p rev ious ly  been dem onstrated in  other program m es both  fo r 
d ie ta ry  change (R apoport e t a l., 2000) and p o o rly  con tro lled  type 1 diabetes patients 
(Snoek et a l., 1999), fu tu re  in te rven tions m ig h t b e n e fit fro m  the in c lu s io n  o f 
in te rm itte n t group booster sessions w h ich  m ig h t address m aintenance and relapse 
issues and p rovide  socia l support fo r in te rve n tio n  partic ipants.
Secondly, patients are no t passive rec ip ien ts o f  m edica l advice. R ather they are active 
in terpre ters and at tim es th e ir in te rp re ta tions lead them  to  qu ite  d iffe re n t responses 
fro m  those advocated by the hea lth  care professiona ls invo lved  in  th e ir care. To 
understand and appropria te ly  in fluence  the self-care choices th a t patients w ith  type 2 
diabetes m ake, health  care professionals should exp lore  patients' be lie fs  and attitudes
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to  th e ir diabetes, and w hat patients are do ing  and w hy they are do ing  i t  th a t w ay, 
recogn iz ing  tha t self-care behaviour is reasoned behaviour, fro m  the patient's 
perspective.
The fin d in g  tha t a m a jo rity  o f  hea lth  care professionals in  the present study fe lt tha t 
they d id  no t have adequate tim e  and resources to  trea t th e ir patients w ith  diabetes 
e ffe c tive ly  is o f p a rticu la r concern and th a t th is  m ay be re la ted to  jo b  sa tis faction  
c le a rly  w arrants fu rth e r research. D iM a tte o  et al. (1993) have dem onstrated th a t how  
c lin ic ia n s  fee l about th e ir w o rk  can have a p os itive  e ffe c t on patients' general 
adherence and lin k  p h ys ic ia n s 'jo b  sa tis faction  w ith  pa tien t actions th a t are c ritic a l to  
the m anagem ent o f  th e ir ch ron ic  diseases. Such find ings have im po rtan t im p lica tio n s  
fo r organ iza tiona l and personal changes a t the hea lth  care professiona l le ve l to  ensure 
im proved hea lth  care fo r patients w ith  type 2 diabetes, and the im p lem enta tion  o f 
evidence-based practice.
10.6. Sum m ary and C onclusions
A  b rie f, behaviou ra lly  based life s ty le  self-m anagem ent in te rven tion , in co rpo ra ting  
both  d ie ta ry  and physica l a c tiv ity  com ponents appears m oderate ly e ffe c tive  in  
p rom oting  changes in  d ie ta ry  behaviour and physica l a c tiv ity  in  p rev ious ly  sedentary 
overw e igh t and obese persons w ith  type 2 diabetes. These find ings  are encouraging 
because th is  approach rem oves m any o f the com m only reported barrie rs to  life s ty le  
self-m anagem ent in  th is  pa tien t group.
Furtherm ore, com paring the d iabetes-re lated attitudes o f  health  care professionals and 
patients w ith  diabetes, the h ighest leve ls o f  agreem ent am ong patients and
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professionals concerned the need fo r specia l tra in in g  in  order to  p rovide  diabetes care. 
A  s trik in g  fin d in g  was the s ig n ifica n t d iffe rence  between hea lth  care professionals' 
and patients' a ttitudes tow ards the seriousness o f  type 2 diabetes, and tha t patients 
v iew ed th e ir ow n diabetes as less serious com pared to  type 2 diabetes in  general. In  
add ition , a m a jo rity  o f  the hea lth  care professionals considered diabetes harder to  trea t 
com pared w ith  o ther chron ic cond itions and fe lt tha t they d id  no t have adequate tim e  
and resources to  trea t th e ir patients w ith  diabetes e ffe c tive ly .
In  conclusion , i t  is im po rtan t to  develop and evaluate in te rven tions, such as the one 
o u tlin e d  in  th is  thesis, tha t are appropria te to  a p rim a ry  care setting and to  ensure tha t 
key messages regarding the ris k  factors o u tlin e d  re fle c t recent evidence on th e ir 
im portance in  the prevention  and m anagem ent o f type 2 diabetes. I t  is  equa lly  
im p o rta n t tha t add itiona l research is  undertaken w ith  la rger num bers o f  hea lth  care 
settings to  id e n tify  the characteristics o f  settings w illin g  o r u n w illin g  to  adopt th is  and 
s im ila r in te rven tions and to  id e n tify  barrie rs w h ich  m ay inc lude  be lie fs  and attitudes 
to  diabetes, bo th  at pa tien t and hea lth  care professiona l le ve l, to  adoption, 
im p lem enta tion  and m aintenance o f both  in te rve n tio n  d e live ry  and p a rtic ip a n t 
behaviour change.
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A p p e n d i x  1
M a i l e d  q u e s t i o n n a i r e  p a c k
P A T I E N T  I N F O R M A T I O N  S H E E T
The University is carrying out a study for people with diabetes. This 
study aims to help people change their eating patterns and increase their 
levels of physical activity, in order to improve their health.
All participants will fill in a series of questionnaires, sent in the post on 
three occasions, about yourself, your eating and level of physical activity. 
You will also be asked to attend the Chichester Diabetes Centre so that a 
small blood sample can be taken to measure the levels of fats 
(cholesterol) and sugars (glucose) in your blood at the same time, with no 
additional cost to you.
Some participants, selected at random, will be asked to meet with me, the 
Health Psychologist, on three occasions to discuss the information they 
have given us. At this meeting, which should last for approximately one 
hour, we will measure your weight and height and you will be asked to 
complete some additional questionnaires. The Health Psychologist will 
then monitor your progress by follow-up telephone calls.
We will need your permission to view your medical records to obtain 
information about your weight, height, blood pressure and blood test 
results. We will also need you to sign a consent form to say that you 
agree to take part in the study, as it has been explained to you. Both of 
these forms will be sent to you in the post with the questionnaires. We 
will also be informing your G.P. of your participation in the study.
Any information that you provide at any stage of the study will be kept 
totally confidential. If you have any further questions or would like 
some more information, please do not hesitate to contact me at the 
address or telephone number given below.
Marie Clark - Health Psychologist 
Department of Psychology 
University of Surrey 
Guildford GU2 5XH 
Tel. No.: 01483-300800 Ext. 2970
CONSENT FORM
Please return this form with the c o m pleted questionnaire
I have received and read a copy of the Patient Information Sheet. I have 
had the study explained to me and had the opportunity to ask questions 
about the study. I understand that my participation is voluntary and that I 
may withdraw from the study at any time. This will not affect, in any way, 
the usual care offered to me by my doctor. I agree to participate in this 
study as it has been described to me, and I understand that you will inform 
my G.P. of my participation.
Participant...........................................
Signature.................   Date
PERMISSION TO VIEW MEDICAL RECORDS
I give permission for Marie Clark, from the Psychology Department of the 
University of Surrey, to use certain information from my medical records.
I understand that information such as my weight, height, blood pressure 
and blood test results are needed for this study. Only information directly 
related to this study will be recorded, and this information will be kept 
strictly confidential.
Participant..........................................
Signature Date
UNIVERSITY OF SURREY AND 
THE CHICHESTER DIABETES CENTRE
Name:
Date of birth:
Address:
Telephone: Day
Evening
This questionnaire covers various aspects of your eating and physical activity 
patterns. Thank you for taking the time to complete it. All 
information will be treated in strictest confidence. If you have any questions or 
would like some more information, please do not hesitate to contact me.
Please return this questionnaire as soon as possible in the FREEPOST envelope 
provided.
M A R I E  C L A R K  
Health Psychologist 
Tel: 01483 300800 Ext. 2970.
B e l i e f s  a b o u t  D i a b e t e s
Please circle the answer that best describes how you feel about these questions:
1. H o w  serious is your diabetes?
N o t  a t  a l l  s e r io u s  S lig h t ly  s e r io u s  F a i r l y  s e r io u s  V e t y  s e r io u s  E x t r e m e ly  s e r io u s
2. H o w  worried are y o u  about developing complications of diabetes (like eye problems, foot ulcers or 
heart attacks)?
N o t  a t  a l l  w o r r ie d  S lig h t ly  w o r r ie d  F a i r l y  w o r r ie d  V e r y  w o r r ie d  E x t r e m e ly  w o r r ie d
3. H o w  important is following yo u r  self-care r e c o m m e n d a t i o n s  (for example, diet, exercise a n d  glucose 
testing) for controlling your diabetes?
N o t  a t  a l l  im p o r t a n t  S lig h t ly  im p o r t a n t  F a i r l y  im p o r t a n t  V e r y  im p o r t a n t  E x t r e m e ly  im p o r t a n t
4. H o w  frustrated d o  y o u  feel w h e n  trying to take care o f  yo ur diabetes?
N o t  a t  a l l  f r u s t r a t e d  S lig h t ly  f r u s t r a t e d  F a i r l y  f r u s t r a t e d  V e r y  f r u s t r a t e d  E x t r e m e ly  f r u s t r a t e d
5. H o w  important is controlling yo ur blood glucose levels for avoiding complications f r o m  diabetes? 
N o t  a t  a l l  im p o r t a n t  S lig h t ly  im p o r t a n t  F a i r l y  im p o r t a n t  V e r y  im p o r t a n t  E x t r e m e ly  im p o r t a n t
6 . H o w  m u c h  has having diabetes c h a n g e d  yo ur activities (that is your family a n d  social events, work, 
an d hobbies)?
N o n e  S lig h t ly  M o d e r a t e ly  A  lo t  C o m p le t e ly
7. H o w  important d o  y o u  believe healthy eating is for controlling yo ur diabetes?
N o t  a t  a l l  im p o r t a n t  S lig h t ly  im p o r t a n t  F a i r l y  im p o r t a n t  V e r y  im p o r t a n t  E x t r e m e ly  im p o r t a n t
8 . H o w  likely d o  y o u  think it is that healthy eating will prevent future complications of yo ur diabetes? 
N o t  a t  a l l  l ik e ly  S lig h t ly  lik e ly  F a i r l y  l ik e ly  V e r y  l ik e ly  E x t r e m e ly  l ik e ly
9 . H o w  important d o  y o u  believe physical activity is for controlling your diabetes?
N o t  a t  a l l  im p o r t a n t  S lig h t ly  im p o r t a n t  F a i r l y  im p o r t a n t  V e r y  im p o r t a n t  E x t r e m e ly  im p o r t a n t
10. H o w  likely d o  y o u  think it is that physical activity will prevent future complications of your diabetes? 
N o t  a t  a l l  l ik e ly  S lig h t ly  l ik e ly  F a i r ly  l ik e ly  V e r y  l ik e ly  E x t r e m e ly  l ik e ly
S u m m a r y  o f  D i a b e t e s  S e l f - C a r e  A c t i v i t i e s
The questions below ask you about your diabetes self-care activities over the 
7  days. If you were ill during the past 7 days, please think back the last 7 days 
that you were not ill. Please answer the questions as honestly and accurately 
as you can. Tick the answer that applies to you.
Eating Patterns
The first few questions ask about your eating patterns over the last 7 days. If you 
have not been given a specific diet by your doctor, nurse or dietician, answer 
Question 1 according to the general guidelines you have received.
1. How often did you follow your recommended diet over the last 7 days?
 1. Always ____ 2. Usually _____ 3. Sometimes  4. Rarely__________ 5. Never
2. What percentage of the time did you successfully limit your calories as 
recommended in healthy eating for diabetes control?
 o% (none) ____ 25% (1/4)   50% ( V z )  _____ 75% (3/4) _____ 100% (all)
3. During the past 7 days, what percentage of your meals included high fibre foods, 
such as fresh fruits, fresh vegetables, whole grain breads, dried beans and peas, 
bran?
 o% (none) ____ 25% (1/4)  50% ( V z )   75% (3/4)  100% (all)
4. During the past 7 days, what percentage of your meals included high fat foods 
such as butter, ice cream, oil, nuts and seeds, mayonnaise, avocado, deep-fried food, 
salad dressing, bacon and other meat with fat or skin?
 o% (none) ____ 25% (1/4) _____ 50% ( V z )   75% (3/4) _____100% (all)
5. During the past 7 days, what percentage of your meals included sweets and 
desserts such as pie, cake, jelly, soft drinks (regular, not diet drinks), cookies, 
biscuits?
 o% (none) ____ 25% (1/4) _____ 50% ( V z )   75% (3/4) ____ 100% (all)
Exercise
6. On how many of the last 7 days did you participate in at least 20 minutes of 
physical exercise? -
0 1 2 3 4 5 6 7
7. What percentage of the time did you exercise the amount suggested by your 
doctor or nurse (for example, if your doctor recommended 30 minutes of activity)?
   o% (none) ____ 25% (1/4)  50% (Vz)  75% (3/4)  100% (all)
8. On how many of the past 7 days did you participate in a specific exercise session 
other than what you do around the house or as part of your job?
0  1  2 3 4 5 6 7
Please think about your eating habits over the past three months. 
Circle the answer that best applies to you.
1. Over the past three months, did you cat chickenV
Yes No
I j  ‘ Y e s '.............
(a) How often was it fried?
Usually Often Sometimes Rarely/Never
(b) How often did you take off the skin?
Usually Often Sometimes Rarely/Never
1. Over the past three months, did you eat red meat such as beef, 
pork or lamb?
Yes No
If'Yes'....................
(a) How often did you trim off all the visible iai irom me meat: 
usually Often Sometimes Rarely/Never
3. Over the past three months, did you eat mince;
Yes No
i f ' r e s 1........
(a) How often did you choose extra lean mince, turkey or chicken 
minee?
E A T I N G  H A B I T S
Usually Often Sometimes Rarely/Never
4 . Over the past three months, did you eat fish?
Yes No
If'Yes'............
(a) How often was it fried?
Usually Often Sometimes Rarely/Never
5. Over the past three months, did you have at least one vegetarian 
dinner or main meal, that is, without meat, fish, eggs or cheese?
Yes No
If'Yes’.............
(a) How often did you have a vegetarian dinner?
Usually Often Sometimes Rarelv/Never
6 . Over the past three months, did you eat spaghetti, macaroni or 
pasta?
Yes No
I f Y e s 1.................
(a) How often did you have it without a sauce or without a meat 
sauce?
Usually Often Sometimes Rarely/Never
7. Over the past three months, did you eat cooked vegetables?
Yes No
I fYes1..............
(a) How often did you add butter, margarine or other fat?
Usually Often Sometimes Rarelv/Never
Usually Often Sometimes Rarely/Never
8 . Over the past three months, did you eat potatoes?
Yes No
I f ’Yes'..............
(a) How often were they fried, like chips, or roasted?
Usually Often Sometimes Rarely/Never
9. Over the past three months, did you eat boiled or baked potatoes?
Yes No
If'Yes'.............
(a) How often did you eat them without any butter, margarine, or 
cheese?
Usually Often Sometimes Rarely/Never
10. Over the past three months, did you eat green salads?
Yes No
If'Yes'...............
(a) How often did you use no dressing?
Usually Often Sometimes Rarely/Never
(b) How often did you use low-fat or non-fat dressing?
(b) I low often were the vegetables fried?
Usually Often Sometimes Rarely/Never
1 1. Over the past three months, did you eat bread, rolls or muffins?
Yes No
If'Yes'...................
(a) How often did you eat them without butter or margarine?
Usually Often Sometimes Rarely/Never
12. Over the past three months, did you drink milk or use milk on 
cereal?
Yes No
If'Yes'................
(a) How often was it semi-skimmed or skimmed milk?
Usually Often Sometimes Rarely/Never
13. Over the past three months, did you eat cheese, including cheese 
in sandwiches or in cooking?
Yes No
I fYes ' ..............
(a) How often was it specially made low-fat, or non-fat, chccse?
Usually Often Sometimes Rarely/Never
14. Over the past three months, did you eat dessert?
Yes No
If'Yes'..............
(a) How often did you eat only fruit?
Usually Often Sometimes Rarely/Never
15. Over the past three months, did you eat home-baked biscuits, 
cakes or pies?
Yes No
If'Yes'...............
(a) How often were they made with less butter, margarine or oil than 
the recipe called for?
Usually Often Sometimes Rarely/Never
16. Over the past three months, did you eat frozen desserts, for 
example ice-cream, arctic roll, viennetta?
Yes No
If'Yes' .................
(a) How often did you choose a low-fat version?
Usually Often Sometimes Rarely/Never
17. Over the past three months, did you eat snacks between meals?
Yes No
If'Yes'.....................
(a) How often did you eat raw vegetables or fresh fruit as a snack? 
Usually Often Sometimes Rarely/Never
18. Over the past three months, did you saute or fry any foods?
Yes No
If'Yes' ....................
(a) How often did you use a spray instead of adding the usual oil, 
m argarine or butter?
Usually Often Sometimes Rarelv/Never
19. Over the past three months, did you use mayonnaise or 
mavonnaisc-typc spread?
Yes No
I fYes ' ..................
(a) How often did you use a low-fat or non-fat version?
Usually Often Sometimes Rarely/Never
20. Over the past three months, how often did you eat cold or hot 
cereal for breakfast?
Usually Often Sometimes Rarely/Never
21. Over the past three months, how many servings a day did you eat 
of wholegrain foods such as wholemeal bread (one serving equals 2 
thin slices), rice, pasta (one serving equals 2 tablespoonfuls), potatoes 
(one serving equals 1 medium-sized potato)?
1 serving 2-4 5 - 8  9 or more
or less servings servings servings
22. Over the past three months, how often did you eat dried beans 
and peas (for example kidney beans, chick peas)?
Usually Often Sometimes Rarely/Never
23. Over the past three months, how often did you eat vitamin-c-rich 
fruits and vegetables (fruit juices, green pepper, strawberries, 
tomatoes, oranges)?
Usually Often Sometimes Rarely/Never
24. Over the past three months, how often did you eat dark  green or 
deep yellow fruits and vegetables (greens, carrots, peaches, squash)?
Usually Often Sometimes Rarely/Never
25. Over the past three months, how often did you eat vegetables in 
the cabbage family (cabbage, cauliflower, broccoli, Brussels 
sprouts)?
Usually Often Sometimes Rarely/Never
26. Over the past three months, how often did you eat vegetables 
from the onion family (onions, garlic, leeks, chives, spring onions)?
Usually Often Sometimes Rarelv/Never
27. Over the past three months, how often did you eat cured or 
smoked meats?
Usually Often Sometimes Rarely/Never
E a t i n g  H a b i t s
Think about your eating habits over the past th ree  m onths. Tick the box 
by the option that best describes the num ber of times you eat this food. 
Be sure to tick one box per question.
1. Over the past three months, how often did you eat.....
H a m b u r g e r ,  c h e e s e b u r g e r ?
□  2 or m ore tim es per day 8
n  once per day 7
D  5-6 tim es per week 6
n  3-4 tim es per week 5
n  2 tim es per week 4
E3 once per week 3
D  2-3 tim es per month 2
n  once per month ,
n  NEVER, or less than once per month 0
2. How big a serving did YOU usually eat?
n  Small □  M edium  til Large ,23
M edium  serving size:
3. O ver the past three m onths, how often did you ea t.....
B e e f  o r  l a m b ,  s u c h  a s  c h o p s ,  s t e a k s  o r  r o a s t s ?
□  2 or more tim es per day 
n  once per day
d  5-6 times per week 
O  3-4 times per week 
n  2 times per week 
n  once per week 
n  2-3 times per month 
D  once per month
□  NEVER, or less than once per month
4. How big a serving did YOU usually eat?
D  Small n  M edium  d  Large 
M edium serving size:
:. + Medium Serving s h o w n ;
P o r k ,  i n c l u d i n g  c h o p s  a n d  r o a s t s  ( n o t  h a m  o r  b a c o n ) ?
□  2 or more times per day 
d  once per day 
n  5-6 tim es per week 
D  3-4 tim es per week 
n  2 tim es per week 
n  once per week 
D  2-3 tim es per month 
n  once per month
C3 N EVER, or less than once per month
6 . How big a serving did Y O U  usually eat?
n  Small C3 M edium  C3 Large \2?
M edium  serving size:
5. Over the past three months, h o w  often did you eat...
7. O ver the past three m onths, how often did you eat
S a u s a g e s ,  f r a n k f u r t e r s ?
□  2 or more times per day 
tH once per day
tn 5-6 times per week 
tn 3-4 times per week 
tn 2 times per week 
tn once per week 
tn 2-3 tim es per month
□  once per month
□  NEVER, or less than once per month
8. How big a serving did YOU usually eat?
tn Small tn M e d i u m  tn Large
M e d i u m  serving size:
9. O ver the past three m onths, how often did you eat
H a m ,  l u n c h  m e a t s ?
□  2 or more tim es per day 
n  once per day
n  5-6 tim es per week 
D  3-4 tim es per week 
D  2 tim es per week 
n  once per week 
D  2-3 tim es per month 
D  once per month
□  N EVER, or less than once per month
10. How big a serving did YOU usually eat?
D  Small n  M e d i u m  d  Large
M e d i u m  serving size:
W h o l e  m i l k ?
11. Over the past three months, h o w  often did you eat
□  2 or more tim es per day «
D  once per day ?
D  5-6 times per week 6
D  3-4 times per week 5
D  2 times per week 4
D  once per week 3
C3 2-3  times per month 2
□  once per month 1
□  NEVER, or less than once per month 0
12. How big a serving did YOU usually eat?
D  Small C3 M edium  D  Large 123
M edium  serving size:
13. O ver the past three m onths, how often did you eat
C h e e s e  ( n o t  l o w  f a t ) ?
d  2 or more tim es per day 
O  once per day 
tn 5-6 tim es per week 
tn 3-4 tim es per week 
tn 2 tim es per week 
tn once per week 
tn 2-3 tim es per month 
tn once per month
□  NEVER, or less than once per month
14. How big a serving did YOU usually eat?
tn Small tn M e d i u m  tn Large
M e d i u m  serving size:
15. O ver the past three m onths, how often did you ea t.....
D o u g h n u t s ,  b i s c u i t s ,  c a k e s  o r  p a s t r i e s ?
(Not low fat)
□  2 or more times per day 
n  once per day
n  5-6 tim es per week 
n  3-4 tim es per week 
n  2 tim es per week 
D  once per week 
D  2-3 tim es per month 
n  once per month
□  NEVER, or less than once per month
16. How big a serving did YOU usually eat?
D  Small n  M e d i u m  D  Large
M e d i u m  serving size:
17. O ver the past three m onths, how often did you eat
E g g s ?
d  2 or more tim es per day 
tn  once per day 
tn  5-6 tim es per week 
tn  3-4 tim es per week 
tn  2 tim es per week 
t3 once per week 
tn  2-3 tim es per month 
tn  once per month
tn N EVER, or less than once per month
18. How big a serving did YOU usually eat?
tn Small tn M e d i u m  tn Large
M e d i u m  serving size:
19. O ver the past three m onths, how often did you eat.....
W h i t e  b r e a d  o r  r o l l s ,  b a g e l s ,  
I t a l i a n  b r e a d  ( i n c l u d i n g  s a n d w i c h e s ) ?
□  2 or more tim es per day 
D  once per day
D  5-6 times per week 
n  3-4 times per week 
n  2 tim es per week 
n  once per week 
n  2-3 times per month 
n  once per month
□  NEVER, or less than once per month
20. How big a serving did YOU usually eat?
D  Small n  M edium  D  Large 
M edium  serving size:
21. O ver the past three m onths, how often did you eat....
M a r g a r i n e  o r  b u t t e r  ( n o t  l o w  f a t ) ?
□  2 or more tim es per day 
D  once per day
D  5-6 tim es per week 
D  3-4 tim es per week 
O  2 tim es per week 
D  once per week 
O  2-3 tim es per m onth 
D  once per month
□  N EVER, or less than once per month
22. How big a serving did YOU usually eat?
D  Small D  M e d i u m  D  Large
M e d i u m  serving size:
23. O ver the past three months, how often did you eat.....
S a l a d  d r e s s i n g  o r  m a y o n n a i s e  ( n o t  l o w  f a t ) ?
d  2 or more tim es per day 
tn once per day 
tn 5-6 times per week 
t3 3-4 times per week 
t ]  2 tim es per week 
tn once per week 
tn 2-3 tim es per month 
tn once per month
□  NEVER, or less than once per month
24. How big a serving did YOU usually eat?
n  Small tn M e d i u m  tn Large
M e d i u m  serving size:
25. O ver the past three m onths, how often did you eat...
C h i p s ,  f r i e d  o r  r o a s t e d  p o t a t o e s ?
□  2 o r  more times per day 
d  once per day
d  5-6 tim es per week 
d  3-4 tim es per week 
d  2 tim es per week 
d  once per week 
d  2-3 times per month 
d  once per month
□  NEVER, or less than once per month
26. How big a serving did YOU usually eat?
d  Small d  M e d i u m  d  Large
M e d i u m  serving size:
'tv-
27. O ver the past three m onths, how often did you eat
B a c o n ?
□  2 o r  more tim es per day 
n  once per day
n  5-6 tim es per week 
D  3-4 tim es per week 
d  2 tim es per week 
n  once per week 
d  2-3 tim es per month 
D  once per month
□  NEVER, or less than once per month
28. How big a serving did YOU usually eat?
n  Small n  M edium  d  Large 
M edium  serving size:
29. O ver the past three m onths, how often did you eat
P o t a t o  c r i s p s ,  c o m  c h i p s ,  o r  p o p c o r n  
o r  s i m i l a r  s n a c k s  ( n o t  l o w  f a t ) ?
D  2 or more times per day 
□
once per day 
Cl 5-6 times per week 
d  3-4 times per week 
tn  2 times per week 
tn once per week 
tn 2-3 times per month 
tn  once per month
□  NEVER, or less than once per month
30. How big a serving did YOU usually eat?
tn Small tn M edium tn Large 
M edium  serving size:
I 2 3
Medium Serving shown <= 2 handfuls
E A T I N G  A S S E S S I M E N T  I
Below  a re  a  g ro u p  of n u m b e re d  s ta te m e n ts .  R ead  all th e  s ta te m e n ts  in e a c h
group and circle the one that best describes the way you feeh
1. I don't feel self-conscious about my weight or body size when I am with 
others.
2. I feel concerned about how I iook to others, but it normally does not 
make me feel disappointed with myself.
3. I do get self-conscious about my appearance and weight which makes 
me feel disappointed in myself.
4. I feel very self-conscious about my weight and frequently I feel intense 
shame and disgust for myself. I try to avoid social contacts because of 
my self-consciousness.
* ☆ <r tfr * ifr -6 ☆ & Cr
1. I don't have any difficulty eating slowly in the proper manner.
2. Although I seem to "gobble down" foods I don’t end up feeling stuffed 
because of eating too much.
3. At times, I tend to eat quickly and then feel uncomfortably full 
afterwards.
4. I have the habit of bolting down my food without really chewing it.
^  tt te tt tt t t  -Cr
1. I feel capable of controlling my eating urges when I want to.
2. I feel I fail to control my eating urges more than the average person.
3. I feel utterly helpless when it comes to feeling in control of my eating 
urges.
3. Because I feel so helpless about controlling my eating I have become
very desperate about trying to get in control.
1. I don’t have the habit of eating when I am bored.
2. I sometimes eat when I am bored, but I am often able to get busy and
get my mind off food.
3. I have a regular habit of eating when I am bored, but occasionally I can 
use some other activity to get my mind off eating.
4. I have a strong habit of eating when I am bored. Nothing seems to help 
me break the habit.
1 am usually physically hungry when I eat something.
Occasionally I eat something on impulse even though ium I Cany iiui 
hungry.
I have a regular habit of eating foods that I might not really enjoy, in 
order to satisfy a hungry feeling even though physically I don’t need the 
food.
Even though I am not really hungry I get a hungry feeling in my mouth 
which is only satisfied by food. Sometimes when I eat the food to satisfy 
my mouth hunger I then spit it out so I won’t gain weight.
I don’t feel guilt or self-hate after I eat.
After I overeat, occasionally I feel guilt or self-hate.
Almost all the time I experience strong guilt or self-hate after I overeat.
I don’t lose total control of my eating even after periods when I overeat. 
Sometimes when I eat "forbidden foods" on a diet, 1 feel like I "blew it" 
and 1 eat even more.
Frequently I have the habit of saying to myself, "I’ve blown it now, why 
not go all the way" when I overeat on a diet. When that happens I eat 
more.
I have a regular habit of starting strict diets for myself, but I break the 
diets by going on an eating binge. My life seems to be either a "feast" 
or a"famine\
I rarely eat so much food that I feel uncomfortably stuffed afterwards. 
Usually about once a month, I eat such a quantity of food ! end up 
feeling very stuffed. 
I have regular periods during the month when I eat large amounts of 
food, either at mealtimes or snacks. 
I eat so much food that I regularly feel quite uncomfortable and 
sometimes a bit nauseous.
My regular calorie intake does not go up very high or down very low on 
a regular basis.
Sometimes after 1 overeat, I will try to reduce my calorie intake to almost 
nothing to compensate for the excess calories I have eaten.
I have a reguiar habit of overeating during the night. It seems that my 
routine is not to be hungry in the-morning but overeat in the evening.
In my adult years I have had regular periods where I practically starve 
myself. This follows periods when I overeat.
& # it & tr
I am usually able to stop eating when I want to. 1 know when “enough 
is enough”.
Every so often, I experience a compulsion to eat which i can’t seem to 
control.
Frequently 1 experience a compulsion to eat which I seem unable to 
control, but at other times I can control my eating urges.
I feel incapable of controlling urges to eat. 1 have a fear of not being 
able to stop eating voluntarily.
<6* & & ^  'St •fir ^  ^
I don’t have any problem stopping eating when 1 am full.
I usually can stop eating when full but occasionally overeat leaving me 
feeling uncomfortably stuffed.
I have a problem stopping eating once I start and usually 1 feel 
uncomfortably stuffed after a meal.
Because 1 have a problem not being able to stop eating when 1 want, I 
sometimes have to induce vomiting to relieve my stuffed feeling.
& tS*&&&'& tSr © tSr
I seem to eat just as much when I am with others (family, social 
gatherings) as when I'm by myself.
Sometimes when 1 am with other people I am self- conscious about my 
eating.
Frequently I eat only a small amount of food when others are present 
because I am. embarrassed about my eating.
1 feel so ashamed about overeating that I pick times to overeat when I 
know no one will see me. I feel like a "closet eater".
I eat three meals a day and only an occasional snack.
I eat three meals a day, but 1 normally snack between meals.
When 1 am snacking heavily, I get in the habit of skipping regular meals. 
There are regular periods when 1 seem to be continually eating, with no 
planned meals.
I don’t think much about trying to control unwanted eating urges.
At least some of the time I feel my thoughts are pre-occupied with trying 
to control my eating urges.
I feel that frequently I spend much time thinking about how much I ate 
or about trying not to eat any more.
It seems to me that most of my waking hours are pre-occupied by 
thoughts about eating or not eating. I feel like I am constantly struggling 
not to eat.
I don’t think about food a great deal.
I have strong cravings for food but they last only for brief periods of time. 
I have days when 1 can’t think about anything but food.
Most of my days seem to be pre-occupied with thoughts about food. 1 
feel like I live to eat.
I usually know whether or not I’m physically hungry. I take the right 
portion of food to satisfy me.
Occasionally, I feel uncertain about knowing whether or not I'm 
physically hungry. At these times it’s hard to know how much food I 
should take to satisfy me.
Even though I might know how many calories I should eat, I have no 
idea what is a "normar amount of food for me.
Eating Habits
Please circle the answer that best applies to you:
0 I haven’t given the matter of the fat in my diet any thought at all
1 I think about the fat in my diet from time to time, and then put the matter out 
of my mind
2 I keep meaning to do something to lessen the fat in my diet, but don't actually 
get around to it
3 From time to time I avoid fat in my diet, but at other times I go back to eating 
too much fat
4 I have been consciously avoiding fat in my diet for the last 6 months
5 I have been consciously avoiding fat in my diet for longer than the last 6 
months
T o  w h a t  extent d o  the following situations k e e p  y o u  f r o m  following a healthy, low-fat 
eating plan?
Please circle the a n s w e r  that best applies to you.
1 .1 am bored or restless and feel like snacking
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
2. Family members eat high fat foods in my presence
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
3. M y nurse/doctor/dietician has not given me a realistic, practical eating plan 
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
4. There aren’t any low fat food choices at or near my work
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
5. Seeing advertisements for appetizing high fat foods makes me hungry 
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
6. The fat content of foods is not clearly labeled in grocery stores or restaurants 
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
7 .1 feel upset after an argument or disagreement
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
8 . 1 taste foods as I prepare them
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
9. Other family members make comments about my eating low-fat foods 
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
10. My nurse/doctor/dietician does not emphasize the importance of a low-fat 
eating plan
N o t  at all A  little A  m o d e r a t e  a m o u n t  A  great deal
BARRIERS T O  H E A L T H Y  EATING
11. Co-workers eat high-fat foods (desserts, snacks) in front of me
Not at all A little A moderate amount A great deal
12. There aren’t enough tasty low-fat menu choices in places that I eat out 
Not at all A little A moderate amount A great deal
13.1 hear contradictory news reports about what foods are actually bad for you 
Not at all A little A moderate amount A great deal
1 4 .1 feel down or low
Not at all A little A moderate amount A great deal
1 5 .1 feel pressure to eat when I'm at social events or other persons’ houses 
Not at all A little A moderate amount A great deal
16.1 do not have support from my doctor’s office between visits
Not at all A little A moderate amount A great deal
17. My schedule is not flexible enough to allow me time to prepare healthy foods 
Not at all A little A moderate amount A great deal
18. Low-fat food items cost more
Not at all A little A moderate amount A great deal
1 9 .1 do not know anyone else who is trying to eat low-fat food& with whom I can 
share ideas and support
Not at all A little A moderate amount A great deal
2 0 .1 have junk food around the house
Not at all A little A moderate amount A great deal
2 1 .1 have difficulty finding low-fat food items where I shop
Not at all A little A moderate amount A great deal
W h a t  is Y o u r  PACE SCORE?
T h i s  f o r m  will help y o u r  d o c t o r  u n d e r s t a n d  y o u r  level of physical activity. Please r e a d  the 
entire f o r m  a n d  t h e n  c h o o s e  the n u m b e r  b e l o w  that best describes y o u r  c u r r e n t  level of physical 
activity o r  y o u r  interest in physical activity. D o  n o t include activities that y o u  d o  as part of y o u r  
job.
“ V i g o r o u s ”  exercise includes activities like jogging, running, fast cycling, aerobics classes, 
s w i m m i n g  laps, singles tennis, an d racquetball. A n y  activity that m a k e s  y o u  w o r k  a s  h a r d  a s  jo g g in g  
an d  lasts 2 0  m in u t e s at a time should b e  counted. T h e s e  types of activities usually increase y o u r  heart 
rate, a n d  m a k e  y o u  sweat, an d y o u  get out of breath. ( D o  n o t  c o u n t  w e ig h t  l if t in g .)
“ M o d e r a t e ”  exercise includes activities like brisk walking, gardening, s l o w  cycling, dancing, 
doubles tennis, or hard w o r k  around the house. A n y  activity that m a k e s  y o u  w o r k  a s  h a r d  a s  b r is k  
h v a lk in g  a n d  that lasts at least 3 0  m in u t e s at a time should be counted.
C irc le  O n e  
N u m b e r O n ly
1 .
CURRENT PHYSICAL ACTIVITY STATUS
I d o  not exercise or w a l k  regularly n o w ,  a n d  I d o  not intend to start in the near 
future.
2 . I d o  not exercise or w a l k  regularly, but I ha v e  been thinking of starting.
3. I a m  trying to start to exercise or walk, ( o r ) During the last m o n t h  I h a v e  started to
exercise or wa l k  o n  occasion ( o r  o n  w e e k e n d s  o n ly ) .
4. I h a v e  exercised or w a l k e d  infrequently ( o r  o n  w e e k e n d s  o n ly ) for over on e 
m o n t h .
5. I a m  do in g vigorous or m o de ra te exercise, less than 3 times per w e e k  ( o r  
m o d e r a t e  e x e r c is e  le s s  t h a n  2  h o u r s  p e r  w e e k ).
6 . I h a v e  been doing m o d e r a t e  exercise, 3 or m o r e  times per w e e k  ( o r  m o r e  th a n  2
h o u r s  p e r  w e e k ) for the last 1 - 6  mo nt hs .
7. I h a v e  b e e n  doing m o d e r a t e  exercise, 3 or m o r e  times per w e e k  ( o r  m o r e  th a n  2
h o u r s  p e r  w e e k ) for 7  m o n t h s  or more.
8 . I h a v e  been doing vigorous exercise, 3-5 times per w e e k  for 1-6 months.
9. I h a v e  b e e n  doing vigorous exercise, 3-5 times per w e e k  for 7 - 1 2  mo nt hs .
10. I h a v e  be e n  doing vigorous exercise, 3-5 times per w e e k  for ov er 12 months.
1 1 . I d o  vigorous exercise 6  or m o r e  times per week.
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T o  w h a t  e x t e n t  d o  th e  f o l l o w i n g  s i tu a t io n s  k e e p  y o u  f r o m  b e in g  a s  p h y s ic a l l y  a c t i v  
a s  v o u  w o u ld  l ik e ?
. BARRIERS T O  PHYSICAL ACTIVITY
P le a s e  circle th e  a n s w e r  th a t  b e s t  a p p l i e s  t o  y o u .
1. Being too busy
N o t  a t  a l l  A  l i t t l e  A  m o d e r a t e  a m o u n t
2. Not having a convenient or safe place to exercise 
N o t  a t  a l l  A  l i t t l e  A  m o d e r a t e  a m o u n t
3. Bad weather
N o t  a t  a l l  A  l i t t l e
4. Forgetting
N o t  a t  a l l  A  l i t t l e
A  m o d e r a t e  a m o u n t
A  m o d e r a t e  a m o u n t
5. Not having anyone to exercise with
N o t  a t  a l l  A  l i t t l e  A  m o d e r a t e  a m o u n t
6. The cost of exercise equipment, club membership
N o t  a t  a l l  A  l i t t l e  A  m o d e r a t e  a m o u n t
7. Fear of hurting myself
N o t  a t  a l i  A  l i t t l e A  m o d e r a t e  a m o u n t
A  g r e a t  d e a l
A  g r e a t  d e a l
A  g r e a t  d e a l
A  g r e a t  d e a l
A  g r e a t  d e a l
A  g r e a t  d e a l
A  g r e a t  d e a l
8. Not knowing what activities to do, or how much or how often to do them
N o t  a t  a l l  A  l i t t l e  A  m o d e r a t e  a m o u n t  A  g r e a t  d e a l
9. Not liking to exercise 
N o t  a t  a l l  A  l i t t l e
10. Mv health
A  m o d e r a t e  a m o u n t A  g r e a t  d e a l
N o t  a t  a l l A  l i t t l e A  m o d e r a t e  a m o u n t A  g r e a t  d e a l
CONFIDENCE A B O U T  D O I N G  THINGS
P le a s e  c ir c le  th e  n u m b e r  th a t  b e s t  a p p lie s  to  y o u .
How confident are you that over the next 3 months you will be able to
1. Take part in moderate intensity physical activity such as brisk walking 3 to 4 
times a week?
N o t  at all 1 2  3 4  5 6  7 8  9 10 Extremely
Confident Confident
2, Cut down on your intake of high fat food?
N o t  at all 1 2 3 4 5 6 7 8 9  1 0  Ex tr em el y
Confident Confident
SF-12 Health Survey D. Standard and Acute Forms ^  p. RS
S F - 1 2  H E A L T H  S U R V E Y  ( S T A N D A R D )
I N S T R U C T I O N S :  This questionnaire asks for your views about your health. This information will help keep 
track of h o w  you feei and h o w  well yo u are able to d o  your usual activities.
Please an sw er every question by marking o n e  box. If you are unsure about h o w  to answer, please give 
the best answer you can.
1. In general, would you say your health is:
□  □  □  □  □  
Excellent Ve r y  g o o d  G o o d  Fair P o o r
T h e  following items are about activities yo u might d o  during a typical day. D o e s  vour health n o w  limit you 
in these activities? If so, h o w  m u c h ?
Yes, Yes, No, No t
Limited Limited Limited
A  Lot A  Little At All
2. Mo de ra te activities, such as moving a  table, pushing a 
v a c u u m  cleaner, bowling, or playing golf □ □ □
3. Climbing several flights of stairs □ □ □
During the past 4  w e e k s , ha v e  you h a d  any of the following problems with your work or other regular daily 
activities as a result of vour physical health?
Y E S  N O
4. A c c o m p l i s h e d  less than you would like □ □
5. W e r e  limited in the kind of wo r k  or other activities □ □
Copyright© 1894 The Health Institute: 
New England Medical Center.
All rights reserved.
(SF-12 Standard US Version 1.0)
p. 86 W D. Standard and Acute Forms SF-12 Health Survey
During the past 4  w e e k s , have you ha d any of the following problems with your work or other regular daily 
activities as a resuit of anv emotional problems (such as feeling depressed or anxious)?
* Y E S NO
6. A c c o m p l i s h e d  less than you would like □ □
7. Didn't do work or other activities as carefully as usual □ □
8. During the past 4 w e e k s , h o w  m u c h  did pain interfere with your normal work (including both work 
outside the h o m e  and housework)?
□  □  □  □  □  
Not at all A little bit Moderately Quite a bit Extremely
T h e s e  questions are about h o w  you feel and h o w  things have been with you during the past 4  w e e k s . For 
each question, please give the o n e  a n sw er that c o m e s  closest to the w a y  you have been feeling. H o w  
m u c h  of the time during the past 4 w e e k s  -
9. H a v e  you felt calm and 
peaceful?
10. Did you have a lot of 
energy?
11. H a v e  you felt downhearted 
and blue?
All 
of the 
Time
□
□
□
Most 
of the 
Time
A Good 
Bit of 
the Time
Some 
of the 
Time
A Little 
of the 
Time
None 
of the 
Time
□ □ □ □ □
□ □ □ I I □
□ □ □ □ □
12. During the past 4 w e e k s , h o w  m u c h  of the time has your physical health or emotional problems 
interfered with your social activities (like visiting with friends, relatives, etc.)?
□  □  □  □  □
All of the time Most of the time Some of the time A little of the None of the time
time
Copyright O 1994 The Health Institute: 
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SELF-ASSESSMENT I
Please place an X in the column which you think most nearly applies to you.
S t r o n g l y
A g r e e
A g r e e D i s a g r e e S t r o n g l y
D i s a g r e e
1 . O n  the wh ol e, I a m  satisfied 
wi th myself.
2 . A t  times I think that I a m  n o  
g o o d  at all.
3. I feel that I h a v e  a  n u m b e r  o f  
g o o d  qualities.
4. I a m  able to d o  things as well 
as m o s t  people.
5. I feel I d o  not h a v e  m u c h  to b e  
p r o u d  of.
6 . I feel useless at times.
7. ** I feel that 1  a m  a  pe r s o n  o f  
w o r t h / a t  least o n  a n  equal 
pl an e wi th others.
8 . I w i s h  I could h a v e  m o r e  
respect for myself.
9. All in all I a m  inclined to feel 
that I a m  a  failure.
1 0 . I take a  positive attitude 
t o w a r d s  myself.
W E IG H T  HISTORY
1. Your present weight  ...................... Height ..........................
2. How do you feel your weight affects your daily activities? (circle one)
Not at all Sometimes interferes Often interferes Always interferes
3. W hat was the maximum weight (heaviest) you have been in the past 12 
months?
4. W hat was the minimum weight (lightest) you have been in the past 12 months?
5. A  number of d ifferent ways o f losing weight are listed below. Please indicate 
which methods you have used:
 _____________________________: M a x i m u m  . C o m m ents (e.g. length of tim e  weight
1 ____________________________ j : weight lost j loss maintained, a n y difficulties etc.)
sli mming club______________ ! y e s / n o ____________________________________________________________________________
weight w a t c h e r s __________1 yes/no
exercis e _______________________y e s / n o _______________________ _______________ ____________________
p i l l s ___________________________yes/no _____
.supervised diet_____________= yes/no _________________j
unsupervised diet___________ yes/no __________________________________________________________________
starvation diet______________ _yes/no^______
hy pnosis_______________________ yes/no _____________  _______ _____
other (pleasespecify) yes/no
6. W hich method did you use fo r the longest period of time?
7. W hat, i f  anything, usually goes wrong w ith  your weight loss programmes?
8. How often have you lost and regained 10 or more pounds in weight since 
puberty (excluding pregnancy and illness)? (circle one)
Never 1-2 times 3-5 times 6-9 times more than 10 times
BACKGROUND INFORMATION
Please tick the appropriate answer:
1. What is your marital status?
Married/Cohabiting Single Separated/Divorced Widowed.....
2. Do you work:
Full time Part time Neither, I am not working at the moment.......
3. What is (or was) your last occupation?..................................................
4. If you are not working at the moment, would you describe yourself 
as:
Unemployed Student Housewife/househusband.......Retired........
5. If applicable, what is (or was) your spouse’s or partner’s 
occupation?
6 . If he/she is not working at the moment would you describe your 
spouse/partner as:
Unemployed Student Housewife/househusband Retired.....
7. What kind of housing do you live in?
Own Rent Live in parents' house............................
8. Which of the following best describes you?
White Black African Black Caribbean Asian Other 
9. What is the highest qualification that you have obtained either 
while at school or since leaving school?
10. What medications or drugs are you taking at present?
11. Have you had any operations in the last 12 months?
12. GP’s name and address
Tel. No
THANK YOU FOR YOUR HELP
A p p e n d ix  2
Q u e s t io n n a ir e s  a d m in is t e r e d  a t D ia b e t e s  C e n tr e
EATING BEHAVIOUR
1. Each day, do you normally eat:
BREAKFAST NO YES
LUNCH NO YES
EVENING MEAL NO YES
SNACKS IN BETWEEN NO
YES
2. O ver the past three months, how often, on average, d id you "b inge", (e ither 
eating too much, not stopping when you knew you should, o r eating something 
you knew you should not eat)?
□  2 o r  more times per day
□  once per day
□  5-6  times per week
□  3-4  times per week
□  2  times per week
□  once per week
□  2-3 times per month
□  once per month
□  NEVER, or less than once per month
F a m ily  H is to r y
1. Has anyone in your immediate family (siblings/parents) had 
CHD? -  [ coronary heart diseaseJ 
[ ] NO
[ ] YES Who?_______________________
[ ] Absent 
[ ] 65 and over 
[ ] 55-64 
[ ] Under 55
2. Has anyone in your immediate family had a stroke? 
U N O
[ ] YES WHO?_______________________
[ ] Absent 
[ ] 65 and over 
[ ] 55-64 
[ ] Under 55
3. Is anyone in your immediate family overweight
[ ] NO
[ ] YES Specify WHO AGE DETAILS
4. Has anyone in your immediate family had diabetes?
[ ] NO
[ ]  YES Specify WHO AGE DETAILS
5. Did you have diabetes in pregnancy? 
[ ] NO
[ ] YES Details________
Health-Related Behaviour History
1. Have you ever smoked?
[ ] NO
[ ] YES Do you currently smoke?
[ ] NO When did you stop?
[ ] YES How many per day?
2. Do you drink alcohol?
[ 1 NO
[ ] YES Specify type____________________ amount and frequency.
[ ] Abstainer
[ ] 21 units or less per week 
[ ] 22-34 units per week
_____________________________________________r 1 units n^r wpelf---------------------------------
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C o r r e la t io n s  fo r  e a c h  M a n o v a
3.1. Correlations for Manova for primary outcome analysis for dietary behaviour 
Key to variables in correlational matrix:
KRSUB =  ICristal subscale ’substitute low-fat for high-fat foods'
KRMOD = Kristal subscale ’modify meat'
KRFRY = Kristal subscale 'avoid frying food'
KRFFV = Kristal subscale 'avoid adding fat as flavouring or seasoning to food1 
Daily estimate o f fat = Block Fat Screener estimated daily grams o f fat at Time 1 
(baseline)
BTOTF = Block Fat Screener estimated daily grams o f fat
T1 = Time 1 (baseline)
T2 — Time 2 (3 months)
T3 = Time 3 (6 months)
T4 = Time 4(1 year)
Correlations
Correlations
K R S U B  T1 K R M O D  T1 K R F R Y  T1 K R F F V  T1
K R S U B  T1 Pearson Correlation 1.000 .228* -.142 .094
Sig. (2-tailed) .022 .160 .350
N 100 100 100 100
K R M O D  T1 Pearson Correlation .228* 1.000 -.107 .010
Sig. (2-tailed) .022 .287 .925
N 100 100 100 100
K R F R Y _ T 1 Pearson Correlation -.142 -.107 1.000 -.181
Sig. (2-tailed) .160 .287 .071
N 100 100 100 100
K R F F V  T1 Pearson Correlation .094 .010 -.181 1.000
Sig. (2-tailed) .350 .925 .071
N 100 100 100 100
daily estimate of fat Pearson Correlation .163 .164 -.257** .191
Sig. (2-tailed) .105 .103 .010 .057
N 100 100 100 100
K R S U B  T2 Pearson Correlation .360** -.045 -.180 .041
Sig. (2-tailed) .000 .659 .073 .683
N 100 100 100 100
K R M O D  T2 Pearson Correlation .039 .389** .043 -.032
Sig. (2-tailed) .697 .000 .669 .754
N 100 100 100 100
K R F R Y J T 2 Pearson Correlation .008 -.021 .498** -.157
Sig. (2-tailed) .933 .837 .000 .120
N 100 100 100 100
K R F F V  T2 Pearson Correlation -.252* -.055 .125 .153
Sig. (2-tailed) .011 .589 .215 .128
N 100 100 100 100
B T O T F  T2 Pearson Correlation .221* .240* -.106 .140
Sig. (2-taiied) .027 .016 .295 .165
N 100 100 100 100
K R S U B  T3 Pearson Correlation .310** .075 -.176 .058
Sig. (2-tailed) .002 .465 .084 .570
N 98 98 98 98
K R M O D _ T 3 Pearson Correlation .177 .505** -.009 -.076
Sig. (2-tailed) .081 .000 .933 .456
N 98 98 98 98
K R F R Y  T3 Pearson Correlation -.012 -.117 .391** -.036
Sig. (2-tailed) .904 .252 .000 .723
N 98 98 98 98
K R F F V  T3 Pearson Correlation -.056 .102 .191 .295*v
Sig. (2-tailed) .587 .318 .059 .003
N 98 98 98 98
B T O T F J T 3 Pearson Correlation .229* .142 -.204* .176
Sig. (2-tailed) .024 .164 .045 .085
N 97 97 97 97
K R S U B  T4 Pearson Correlation .286** .026 -.090 .107
Sig. (2-tailed) .004 .797 .372 .288
N 100 100 100 100
K R M O D  T4 Pearson Correlation .054 .424** .055 -.072
Sig. (2-tailed) .592 .000 .587 .476
N 100 100 100 100
Correlations
K R S U B  T1 K R M O D  T1 K R F R Y  T1 K R F F V  T1
K R F R Y  T4 Pearson Correlation .037 -.014 .496** .078
Sig. (2-tailed) .716 .889 .000 .443
N 100 100 100 100
K R F F V  T4 Pearson Correlation -.190 -.076 .166 .215*
Sig. (2-tailed) .058 .453 .099 .032
N 100 100 100 100
B F T O T  T4 Pearson Correlation .238* .112 -.017 .156
Sig. (2-tai!ed) .017 .266 .866 .122
N 100 100 100 100
Correlations
daily estimate 
of fat K R S U B  T2 K R M O D _ T 2 K R F R Y  T2
K R S U B  T1 Pearson Correlation .163 .360** .039 .008
Sig. (2-tailed) .105 .000 .697 .933
N 100 100 100 100
K R M O D  T1 Pearson Correlation .164 -.045 .389** -.021
Sig. (2-tailed) .103 .659 .000 .837
N 100 100 100 100
K R F R Y  T1 Pearson Correlation -.257** -.180 .043 .498*’
Sig. (2-tailed) .010 .073 .669 .000
N 100 100 100 100
K R F F V  T1 Pearson Correlation .191 .041 -.032 -.157
Sig. (2-taiied) .057 .683 .754 .120
N 100 100 100 100
daily estimate of fat Pearson Correlation 1.000 .256* .143 -.202*
Sig. (2-tailed) .010 .156 .044
N 100 100 100 100
K R S U B  T2 Pearson Correlation .256* 1.000 .188 -.130
Sig. (2-tailed) .010 .061 .199
N 100 100 100 100
K R M O D  T2 Pearson Correlation .143 .188 1.000 -.047
Sig. (2-tailed) .156 .061 .641
N 100 100 100 100
K R F R Y  T2 Pearson Correlation -.202* -.130 -.047 1.000
Sig. (2-tailed) .044 .199 .641 .
N 100 100 100 100
K R F F V  T2 Pearson Correlation .125 .142 .191 -.061
Sig. (2-tailed) .215 .160 .057 .548
N 100 100 100 100
B T O T F  T2 Pearson Correlation .589** .306** .297** -.245*
Sig. (2-tailed) .000 .002 .003 .014
N 100 100 100 100
K R S U B  T3 Pearson Correlation .283** .686** .224* -.170
Sig. (2-tailed) .005 .000 .027 .093
N 98 98 98 98
K R M O D  T3 Pearson Correlation .201* .176 .628** -.100
Sig. (2-tailed) .047 .083 .000 .328
N 98 98 98 98
K R F R Y  T3 Pearson Correlation -.119 -.183 -.071 .453*’
Sig. (2-tailed) .241 .072 .487 .000
N 98 98 98 98
K R F F V  T3 Pearson Correlation .041 .170 .258* -.017
Sig. (2-tailed) .692 .093 .010 .865
N 98 98 98 98
B T O T F  T3 Pearson Correlation .604** .405** .213* -.270*’
Sig. (2-taiied) .000 .000 .036 .008
N 97 97 97 97
K R S U B  T4 Pearson Correlation .211* .539** .175 -.115
Sig. (2-tailed) .035 .000 .082 .253
N 100 100 100 100
K R M O D  T4 Pearson Correlation .099 .093 .572** -.045
Sig. (2-tailed) .329 .358 .000 .656
N 100 100 100 100
Correlations
daily estimate 
of fat K R S U B  T2 K R M O D  T2 K R F R Y  T2
K R F R Y _ T 4 Pearson Correlation -.168 -.222* -.093 .385*’
Sig. (2-tailed) .095 .026 .359 .000
N 100 100 100 100
K R F F V  T4 Pearson Correlation .042 .019 .185 -.051
Sig. (2-tailed) .675 .853 .066 .616
N 100 100 100 100
B F T O T _ T 4 Pearson Correlation .425** .196 .186 -.217*
Sig. (2-tailed) .000 .051 .063 .030
N 100 100 100 100
Correlations
K R F F V  T2 B T O T F  T2 K R S U B  T3 K R M O D  T3
K R S U B  T1 Pearson Correlation -.252* .221* .310 .177
Sig. (2-tailed) .011 .027 .002 .081
N 100 100 98 98
K R M O D  T1 Pearson Correlation -.055 .240* .075 .505*’
Sig. (2-tailed) .589 .016 .465 .000
N 100 100 98 98
K R F R Y  T1 Pearson Correlation .125 -.106 -.176 -.009
Sig. (2-tailed) .215 .295 .084 .933
N 100 100 98 98
K R F F V  T1 Pearson Correlation .153 .140 .058 -.076
Sig. (2-taiied) .128 .165 .570 .456
N 100 100 98 98
daily estimate of fat Pearson Correlation .125 .589** .283** .201*
Sig. (2-tailed) .215 .000 .005 .047
N 100 100 98 98
K R S U B  T2 Pearson Correlation .142 .306** .686** .176
Sig. (2-tailed) .160 .002 .000 .083
N 100 100 98 98
K R M O D  T2 Pearson Correlation .191 .297** .224* .628**
Sig. (2-tailed) .057 .003 .027 .000
N 100 100 98 98
K R F R Y  T2 Pearson Correlation -.061 -.245* -.170 -.100
Sig. (2-tailed) .548 .014 .093 .328
N 100 100 98 98
K R F F V  T2 Pearson Correlation 1.000 .091 .007 .182
Sig. (2-tailed) .365 .943 .073
N 100 100 98 98
B T O T F  T2 Pearson Correlation .091 1.000 .263** .278*’
Sig. (2-tailed) .365 * .009 .006
N 100. 100 98 98
K R S U B  T3 Pearson Correlation .007 .263** 1.000 .254*
Sig. (2-tailed) .943 .009 .012
N 98 98 98 98
K R M O D  T3 Pearson Correlation .182 .278** .254* 1.000
Sig. (2-tailed) .073 .006 .012
N 98 98 98 98
K R F R Y _ T 3 Pearson Correlation .020 -.185 -.223* -.077
Sig. (2-tailed) .844 .068 .028 .452
N 98 98 98 98
K R F F V  T3 Pearson Correlation .487** .112 .211* .267**
Sig. (2-tailed) .000 .271 .037 .008
N 98 98 98 98
B T O T F  T3 Pearson Correlation .123 .803** .479** .250*
Sig. (2-tailed) .232 .000 .000 .013
N 97 97 97 97
K R S U B  T4 Pearson Correlation .027 .215* .659** .287*’
Sig. (2-tailed) .789 .031 .000 .004
N 100 100 98 98
K R M O D  T4 Pearson Correlation .045 .252* .193 .712*’
Sig. (2-tailed) .659 .011 .057 .000
N 100 100 98 98
Correlations
K R F F V  T2 B T O T F  T2 K R S U B  T3 K R M O D  T3
K R F R Y  T4 Pearson Correlation -.006 -.198* -.166 -.114
Sig. (2-tailed) .950 .048 .102 .262
N 100 100 98 98
K R F F V  T4 Pearson Correlation .330** .016 .013 .160
Sig. (2-tailed) .001 .871 .898 .115
N 100 100 98 98
B F T O T _ T 4 Pearson Correlation -.005 .559** .374** .209*
Sig. (2-tailed) .964 .000 .000 .039
N 100 100 98 98
Correlations
K R F R Y  T3 K R F F V  T3 B T O T F  T3 K R S U B  T4
K R S U B _ T 1 Pearson Correlation -.012 -.056 .229* .286*’
Sig. (2-tailed) .904 .587 .024 .004
N 98 98 97 100
K R M O D _ T  1 Pearson Correlation -.117 .102 .142 .026
Sig. (2-tailed) .252 .318 .164 .797
N 98 98 97 100
K R F R Y _ T 1 Pearson Correlation .391** .191 -.204* -.090
Sig. (2-tailed) .000 .059 .045 .372
N 98 98 97 100
K R F F V T 1 Pearson Correlation -.036 .295** .176 .107
Sig. (2-tailed) .723 .003 .085 .288
N 98 98 97 100
daily estimate of fat Pearson Correlation -.119 .041 .604** .211*
Sig. (2-tailed) .241 .692 .000 .035
N 98 98 97 100
K R S U B _ T 2 Pearson Correlation -.183 .170 .405** .539*’
Sig. (2-tailed) .072 .093 .000 .000
N 98 98 97 100
K R M O D _ T 2 Pearson Correlation -.071 .258* .213* .175
Sig. (2-tailed) .487 .010 .036 .082
N 98 98 97 100
K R F R Y _ T 2 Pearson Correlation .453** -.017 -.270** -.115
Sig. (2-tailed) .000 .865 .008 .253
N 98 98 97 100
K R F F V J 2 Pearson Correlation .020 .487**1 .123 .027
Sig. (2-tailed) .844 .000 .232 .789
N 98 98 97 100
B T O T F _ T 2 Pearson Correlation -.185 .112 .803** .215*
Sig. (2-tailed) .068 .271 .000 .031
N 98. 98 97 100
K R S U B _ T 3 Pearson Correlation -.223* .211* .479** .659*’
Sig. (2-tailed) .028 .037 .000 .000
N 98 98 97 98
K R M O D _ T 3 Pearson Correlation I o .267** .250* .287*’
Sig. (2-tailed) .452 .008 .013 .004
N 98 98 97 98
K R F R Y „ T 3 Pearson Correlation 1.000 .197 -.181 -.075
Sig. (2-tailed) .052 .077 .463
N 98 98 97 98
K R F F V  T3 Pearson Correlation .197 1.000 .214* .190
Sig. (2-tailed) .052 .035 .061
N 98 98 97 98
B T O T F  T3 Pearson Correlation -.181 .214* 1.000 .300*’
Sig. (2-tailed) .077 .035 .003
N 97 97 97 97
K R S U B J T 4 Pearson Correlation -.075 .190 .300** 1.000
Sig. (2-tai!ed) .463 .061 .003
N 98 98 97 100
K R M O D _ T 4 Pearson Correlation -.063 .169 .272** .285*’
Sig. (2-taiied) .535 .097 .007 .004
N 98 98 97 100
Correlations
K R F R Y  T3 K R F F V  T3 B T O T F  T 3 K R S U B  T4
K R F R Y  T4 Pearson Correlation .391** .048 -.244* -.175
Sig. (2-tailed) .000 .640 .016 .081
N 98 98 97 100
K R F F V  T4 Pearson Correlation .057 .409** .047 .097
Sig. (2-tailed) .574 .000 .647 .338
N 98 98 97 100
B F T O T  T4 Pearson Correlation -.101 .144 .699** .207*
Sig. (2-tailed) .320 .156 .000 .039
N 98 98 97 100
Correlations
K R M O D  T 4 K R F R Y  T4 K R F F V  T4 B F T O T  T4
K R S U B  T1 Pearson Correlation .054 .037 -.190 .238*
Sig. (2-tailed) .592 .716 .058 .017
N 100 100 100 100
K R M O D  T1 Pearson Correlation .424** -.014 -.076 .112
Sig. (2-tailed) .000 .889 .453 .266
N 100 100 100 100
K R F R Y J H Pearson Correlation .055 .496** .166 -.017
Sig. (2-tailed) .587 .000 .099 .866
N 100 100 100 100
K R F F V  T1 Pearson Correlation -.072 .078 .215* .156
Sig. (2-tailed) .476 .443 .032 .122
N 100 100 100 100
daily estimate of fat Pearson Correlation .099 -.168 .042 .425*'
Sig. (2-tailed) .329 .095 .675 .000
N 100 100 100 100
K R S U B  T2 Pearson Correlation .093 -.222* .019 .196
Sig. (2-tailed) .358 .026 .853 .051
N 100 100 100 100
K R M O D  T2 Pearson Correlation .572** -.093 .185 .186
Sig. (2-tailed) .000 .359 .066 .063
N 100 100 100 100
K R F R Y _ T 2 Pearson Correlation -.045 .385** -.051 -.217*
Sig. (2-tailed) .656 .000 .616 .030
N 100 100 100 100
K R F F V  T2 Pearson Correlation .045 -.006 .330** -.005
Sig. (2-tailed) .659 .950 .001 .964
N 100 100 100 100
B T O T F _ T 2 Pearson Correlation .252* J CD CO
* .016 .559*'
Sig. (2-tailed) .011 .048 .871 .000
N 100 100 100 100
K R S U B  T3 Pearson Correlation .193 -.166 .013 .374*'
Sig. (2-tailed) .057 .102 .898 .000
N 98 98 98 98
K R M O D  T3 Pearson Correlation .712** -.114 .160 .209*
Sig. (2-tailed) .000 .262 .115 .039
N 98 98 98 98
K R F R Y  T3 Pearson Correlation -.063 .391** .057 -.101
Sig. (2-tailed) .535 .000 .574 .320
N 98 98 98 98
K R F F V  T3 Pearson Correlation .169 .048 .409** .144
Sig. (2-tai!ed) .097 .640 .000 .156
N 98 98 98 98
B T O T F  T3 Pearson Correlation .272** -.244* .047 .699*’
Sig. (2-tailed) .007 .016 .647 .000
N 97 97 97 97
K R S U B  T4 Pearson Correlation .285** -.175 .097 .207*
Sig. (2-tailed) .004 .081 .338 .039
N 100 100 100 100
K R M O D  T4 Pearson Correlation 1.000 -.130 .200* .354*'
Sig. (2-tailed) .198 .046 .000
N 100 100 100 100
Correlations
K R M O D  T4 K R F R Y  T 4 K R F F V  T 4 B F T O T  T4
K R F R Y _ T 4 Pearson Correlation -.130 1.000 .004 -.036
Sig. (2-tailed) .198 .965 .723
N 100 100 100 100
K R F F V _ T 4 Pearson Correlation .200* .004 1.000 .033
Sig. (2-tailed) .046 .965 .747
N 100 100 100 100
B F T O T _ T 4 Pearson Correlation .354** -.036 .033 1.000
Sig. (2-tailed) .000 .723 .747
N 100 100 100 100
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed).
3.2. Correlations for Manova for primary outcome analysis for BML/Waist
Key to variables in correlational matrix:
B M I = Body mass index 
WST = Waist circumference
T1 = Time 1 (baseline)
T2 = Time 2 (3 months)
T3 =  Time 3 (6 months)
T4 =  Time 4 (1 year)
Correlations
Correlations
B M L T 1 W S T  T1 B M L T 2 W S T  T2 BMI T3 W S T  T3
BMI T1 Pearson Correlation 1.000 .744** .989** .700** .982** .726*’
Sig. (2-tailed) .000 .000 .000 .000 .000
N 100 100 100 100 98 98
W S T  T1 Pearson Correlation .744 1.000 .743** .959** .753** .943*’
Sig. (2-taiied) .000 .000 .000 .000 .000
N 100 100 100 100 98 98
BMI T2 Pearson Correlation .989** .743** 1.000 .711** .989** .746*’
Sig. (2-tailed) .000 .000 .000 .000 .000
N 100 100 100 100 98 98
W S T  T2 Pearson Correlation .700** .959** .711** 1.000 .725** .958*’
Sig. (2-tailed) .000 .000 .000 .000 .000
N 100 100 100 100 98 98
BMI T3 Pearson Correlation .982** .753** .989** .725** 1.000 .756*’
Sig. (2-tailed) .000 .000 .000 .000 . .000
N 98 98 98 98 98 98
W S T  T3 Pearson Correlation .726** .943** .746** .958** .756** 1.000
Sig. (2-tailed) .000 .000 .000 .000 .000 •
N 98 98 98 98 98 98
BMI T4 Pearson Correlation .930** .740** .948** .736** .962** .769*’
Sig. (2-tailed) .000 .000 .000 .000 .000 .000
N 100 100 100 100 98 98
W S T T 4  . Pearson Correlation .674** .929** .690** .947** .713** .958*’
Sig. (2-tailed) .000 .000 .000 .000 .000 .000
N 100 100 100 100 98 98
Correlations
B M L T 4 W S T  T4
BM1„T1 Pearson Correlation .930** .674**
Sig. (2-tailed) .000 .000
N 100 100
W S T _ T  1 Pearson Correlation .740** .929**
Sig. (2-tailed) .000 .000
N 100 100
BMI_T2 Pearson Correlation .948** .690*’
Sig. (2-tailed) .000 .000
N 100 100
W S T _ T 2 Pearson Correlation .736** .947**
Sig. (2-tailed) .000 .000
N 100 100
B M L T 3 Pearson Correlation .962** .713**
Sig. (2-tailed) .000 .000
N 98 98
W S T _ T 3 Pearson Correlation .769** .958**
Sig. (2-tailed) .000 .000
N 98 98
BMI_T4 Pearson Correlation 1.000 .757**
Sig. (2-tailed) .000
N 100 100
W S T _ T 4 Pearson Correlation .757** 1.000
Sig. (2-tailed) .000
N 100 100
**. Correlation is significant at the 0.01 level (2-tailed).
3.3. Correlations for Manova for primary outcome analysis for Physiological variables
Key to variables in corre lational m a trix :
H b A lc  = Glycosylated haemoglobin 
HDL =  High density lipoprotein 
LDL = Low density lipoprotein 
TRIG = Triglycerides
T1 = Time 1 (baseline)
T2 = Time 2 (3 months)
T3 = Time 3 (6 months)
T4 =  Time 4 (1 year)
Correlations
cholesterol H b A l c H D L _ T 1 L D L _ T  1 T R I G  T1
cholesterol Pearson Correlation 1.000 .057 .251* .890** .171
Sig. (2-tailed) .576 .012 .000 .088
N 100 100 100 100 100
H b A l c Pearson Correlation .057 1.000 -.247* .024 .285*'
Sig. (2-taited) .576 .013 .816 .004
N 100 100 100 100 100
H D L _ T 1 Pearson Correlation .251* -.247* 1.000 .123 -.310*'
Sig. (2-tailed) .012 .013 .223 .002
N 100 100 100 100 100
L D L  T1 Pearson Correlation .890** .024 .123 1.000 -.146
Sig. (2-tailed) .000 .816 .223 .147
N 100 100 100 100 100
T R I G  T1 Pearson Correlation .171 .285** -.310** -.146 1.000
Sig. (2-tailed) .088 .004 .002 .147
N 100 100 100 100 100
C H O L  T2 Pearson Correlation
n
t 
' *£CD
j
.182 .123 .530** .260*'
Sig. (2-tailed) .000 .070 .221 .000 .009
N 100 100 100 100 100
H B A 1 C  T2 Pearson Correlation -.003 .860** -.208* -.020 .205*
Sig. (2-tailed) .973 .000 .038 .846 .041
N  . 100 100 100 100 100
H D L  T2 Pearson Correlation .116 -.284** .636**1 .017 -.203*
Sig. (2-tailed) .251 .004 .000 .869 .043
N 100 100 100 100 100
L D L  T2 Pearson Correlation .556** .146 .068 .522** .026
Sig. (2-tailed) .000 .148 .500 .000 .800
N 100 100 100 100 100
T R I G  T2 Pearson Correlation .080 .338** -.329** -.111 .745*'
Sig. (2-tailed) .428 .001 .001 .273 .000
N 100 100 100 100 100
C H O L  T3 Pearson Correlation .542** .112 .060 .450** .249*
Sig. (2-tailed) .000 .272 .555 .000 .014
N 98 98 98 98 98
H B A 1 C  T3 Pearson Correlation -.091 .824** -.233* -.103 .196
Sig. (2-tailed) .373 .000 .021 .316 .054
N 97 97 97 97 97
H D L  T3 Pearson Correlation .107 -.289** .704** .085 -.430*’
Sig. (2-tailed) .296 .004 .000 .404 .000
N 98 98 98 98 98
L D L  T3 Pearson Correlation .532** .085 -.058 .560** .004
Sig. (2-tailed) .000 .407 .570 .000 .970
N 98 98 98 98 98
T R I G  T3 Pearson Correlation .035 .210* -.237* -.158 .720*'
Sig. (2-tailed) .734 .038 .019 .120 .000
N 98 98 98 98 98
C H O L  T4 Pearson Correlation .538** .193 .116 .434** .202*
Sig. (2-tailed) .000 .054 .251 .000 .044
N 100 100 100 100 100
H B A 1 C  T4 Pearson Correlation .101 .660** -.127 .036 .281*’
Sig. (2-tailed) .316 .000 .208 .720 .005
N 100 100 100 100 100
H D L  T4 Pearson Correlation .204* -.204* .744** .135 -.388*'
Sig. (2-tailed) .042 .042 .000 .181 .000
N 100 100 100 100 100
Correlations
cholesterol H b A l c H D L  T1 L D L  T1 T R I G  T1
L D L  T4 Pearson Correlation .471** .216* -.010 .473** .050
Sig. (2-tailed) .000 .031 .922 .000 .623
N 100 100 100 100 100
T R I G  T4 Pearson Correlation .072 .232* -.270** -.104 .662*’
Sig. (2-tailed) .475 .020 .007 .302 .000
N 100 100 100 100 100
Correlations
C H O L _ T 2 H B A 1 C  T2 H D L _ T 2 L D L  T2 T R I G  T2
cholesterol Pearson Correlation .671** -.003 .116 .556** .080
Sig. (2-tailed) .000 .973 .251 .000 .428
N 100 100 100 100 100
H b A l c Pearson Correlation .182 .860** -.284** .146 .338*’
Sig. (2-tailed) .070 .000 .004 .148 .001
N 100 100 100 100 100
H D L _ T 1 Pearson Correlation .123 -.208* .636** .068 -.329*’
Sig. (2-tailed) .221 .038 .000 .500 .001
N 100 100 100 100 100
L D L  T1 Pearson Correlation .530** -.020 .017 .522** -.111
Sig. (2-tailed) .000 .846 .869 .000 .273
N 100 100 100 100 100
T R I G  T1 Pearson Correlation .260** .205* -.203* .026 .745*’
Sig. (2-tailed) .009 .041 .043 .800 .000
N 100 100 100 100 100
C H O L _ T 2 Pearson Correlation 1.000 .141 .027 .762** .276*’
Sig. (2-tailed) .162 .793 .000 .005
N 100 100 100 100 100
H B A 1 C _ T 2 Pearson Correlation .141 1.000 -.272** .119 .343*’
Sig. (2-tailed) .162 .006 .240 .000
N 100 100 100 100 100
H D L „ T 2 Pearson Correlation .027 -.272** 1.000 -.164 -.246*
Sig. (2-tailed) .793 .006 .103 .014
N 100 100 100 100 100
LD L _ T 2 Pearson Correlation .762**1 .119 -.164 1.000 -.113
Sig. (2-tailed) .000 .240 .103 .262
N 100 100 100 100 100
T R I G_T 2 Pearson Correlation .276** .343** -.246* -.113 1.000
Sig. (2-taiied) .005 .000 .014 .262
N 100 100 100 100 100
C H O L  T3 Pearson Correlation .781** . .072 -.028 .609** .245*
Sig. (2-tailed) .000 .478 .785 .000 .015
N 98 98 98 98 98
H B A 1 C _ T 3 Pearson Correlation .072 .870** -.238* .045 .321*’
Sig. (2-tailed) .484 .000 .019 .664 .001
N 97 97 97 97 97
H D L _ T 3 Pearson Correlation -.007 -.269** .726** -.031 -.469*’
Sig. (2-tailed) .942 .007 .000 .764 .000
N 98 98 98 98 98
L D L _ T 3 Pearson Correlation .682** .006 -.161 .718** -.088
Sig. (2-tailed) .000 .953 .114 .000 .389
N 98 98 98 98 98
T R I G _ T 3 Pearson Correlation .172 .235*
OOtof -.129 .821*’
Sig. (2-tailed) .091 .020 .120 .206 .000
N 98 98 98 98 98
C H O L _ T 4 Pearson Correlation .679** .163 .047 .519** .246*
Sig. (2-tailed) .000 .105 .644 .000 .014
N 100 100 100 100 100
H B A 1 C _ T 4 Pearson Correlation .147 .676** -.145 .053 .317*’
Sig. (2-tailed) .145 .000 .151 .600 .001
N 100 100 100 100 100
H D L _ T 4 Pearson Correlation .065 -.188 .704** .011 -.436*’
Sig. (2-tailed) .520 .061 .000 .915 .000
N 100 100 100 100 100
Correlations
C H O L  T2 H B A 1 C  T2 H D L  T2 L D L  T2 T R I G  T2
L D L _ T 4 Pearson Correlation .573** .151 -.108 .557** .042
Sig. (2-tailed) .000 .134 .285 .000 .676
N 100 100 100 100 100
TR I G _ T 4 Pearson Correlation .195 .269** -.128 -.083 .781*’
Sig. (2-tailed) .052 .007 .206 .411 .000
N 100 100 100 100 100
Correlations
C H O L  T3 H B A 1 C  T3 H D L  T3 L D L _ T 3 T R I G  T3
cholesterol Pearson Correlation .542** -.091 .107 .532** .035
Sig. (2-tailed) .000 .373 .296 .000 .734
N 98 97 98 98 98
H b A l c Pearson Correlation .112 .824** -.289** .085 .210*
Sig. (2-tailed) .272 .000 .004 .407 .038
N 98 97 98 98 98
H D L  T1 Pearson Correlation .060 -.233* .704** -.058 -.237*
Sig. (2-tailed) .555 .021 .000 .570 .019
N 98 97 98 98 98
L D L  T1 Pearson Correlation .450** -.103 .085 .560** -.158
Sig. (2-tailed) .000 .316 .404 .000 .120
N 98 97 98 98 98
T R I G  T1 Pearson Correlation .249* .196 -.430** .004 .720*'
Sig. (2-tailed) .014 .054 .000 .970 .000
N 98 97 98 98 98
C H O L _ T 2 Pearson Correlation .781 .072 -.007 .682** .172
Sig. (2-tailed) .000 .484 .942 .000 .091
N 98 97 98 98 98
H B A 1 C  T2 Pearson Correlation .072 .870 -.269** .006 .235*
Sig. (2-tailed) .478 .000 .007 .953 .020
N  . 98 97 98 98 98
H D L _ T 2 Pearson Correlation -.028 -.238* .726** -.161 -.158
Sig. (2-tailed) .785 .019 .000 .114 .120
N 98 97 98 98 98
L D L  T2 Pearson Correlation .609** .045 -.031 .718*1 -.129
Sig. (2-tailed) .000 .664 .764 .000 .206
N 98 97 98 98 98
T R I G _ T 2 Pearson Correlation .245* .321 -.469** -.088 .821*'
Sig. (2-tailed) .015 .001 .000 .389 .000
N 98 97 98 98 98
C H O L _ T 3 Pearson Correlation 1.000 • .017 -.016 .793** .300*'
Sig. (2-tailed) .867 .877 .000 .003
N 98 97 98 98 98
H B A 1 C  T3 Pearson Correlation .017 1.000 -.288** -.037 .215*
Sig. (2-tailed) .867 * .004 .715 .034
N 97 97 97 97 97
H D L  T3 Pearson Correlation -.016 -.288** 1.000 -.144 -.416*'
Sig. (2-tailed) .877 .004 .159 .000
N 98 97 98 98 98
L D L  T3 Pearson Correlation .793** -.037 -.144 1.000 -.177
Sig. (2-tailed) .000 .715 .159 .081
N 98 97 98 98 98
T R I G _ T 3 Pearson Correlation .300** .215* -.416** -.177 1.000
Sig. (2-tai!ed) .003 .034 .000 .081
N 98 97 98 98 98
C H O L _ T 4 Pearson Correlation .725** .135 -.039 .573** .251*
Sig. (2-tailed) .000 .186 .705 .000 .013
N 98 97 98 98 98
H B A 1 C  T4 Pearson Correlation .152 .692** -.197 .003 .302*’
Sig. (2-tailed) .135 .000 .052 .975 .003
N 98 97 98 98 98
H D L _ T 4 Pearson Correlation .011 -.199 .863** -.121 -.355*'
Sig. (2-tailed) .917 .051 .000 .236 .000
N 98 97 98 98 98
Correlations
C H O L  T3 H B A 1 C  T 3 H D L  T3 L D L _ T 3 T R I G  T3
L D L _ T 4 Pearson Correlation .632** .150 -.141 .693** .001
Sig. (2-tailed) .000 .143 .165 .000 .996
N 98 97 98 98 98
T R I G J T 4 Pearson Correlation .277** .236* -.442** -.067 .835*'
Sig. (2-tailed) .006 .020 .000 .514 .000
N 98 97 98 98 98
Correlations
C H O L  T4 H B A 1 C  T4 H D L _ T 4 L D L _ T 4 T R I G  T4
cholesterol Pearson Correlation .538** .101 .204* .471** .072
Sig. (2-tailed) .000 .316 .042 .000 .475
N 100 100 100 100 100
H b A l c Pearson Correlation .193 .660** -.204* .216* .232*
Sig. (2-tailed) .054 .000 .042 .031 .020
N 100 100 100 100 100
H D L _ T 1 Pearson Correlation .116 -.127 .744** -.010 -.270*’
Sig. (2-tailed) .251 .208 .000 .922 .007
N 100 100 100 100 100
L D L _ T  1 Pearson Correlation .434** .036 .135 .473** -.104
Sig. (2-tailed) .000 .720 .181 .000 .302
N 100 100 100 100 100
TRIG_T1 Pearson Correlation .202* .281** -.388** .050 .662*’
Sig. (2-tailed) .044 .005 .000 .623 .000
N 100 100 100 100 100
C H O L _ T 2 Pearson Correlation .679** .147 .065 .573** .195
Sig. (2-tailed) .000 .145 .520 .000 .052
N 100 100 100 100 100
H B A 1 C _ T 2 Pearson Correlation .163 .676** -.188 .151 .269*'
Sig. (2-tailed) .105 .000 .061 .134 .007
N 100 100 100 100 100
H D L _ T 2 Pearson Correlation .047 -.145 .704** -.108 -.128
Sig. (2-tailed) .644 .151 .000 .285 .206
N 100 100 100 100 100
L D L _ T 2 Pearson Correlation .519** .053 .011 .557** -.083
Sig. (2-tailed) .000 .600 .915 .000 .411
N 100 100 100 100 100
T R I G „ T 2 Pearson Correlation .246* .317** -.436** .042 .781*’
Sig. (2-tailed) .014 .001 .000 .676 .000
N 100 100 100 100 100
C H O L _ T 3 Pearson Correlation .725** . .152 .011 .632** .277*’
Sig. (2-tailed) .000 .135 .917 .000 .006
N 98 98 98 98 98
H B A 1 C _ T 3 Pearson Correlation .135 .692** -.199 .150 .236*
Sig. (2-taiied) .186 .000 .051 .143 .020
N 97 97 97 97 97
H D L _ T 3 Pearson Correlation -.039 -.197 .863** -.141 -.442*’
Sig. (2-tailed) .705 .052 .000 .165 .000
N 98 98 98 98 98
L D L T 3 Pearson Correlation .573** .003 -.121 ,693*J -.067
Sig. (2-tailed) .000 .975 .236 .000 .514
N 98 98 98 98 98
T R I G J T 3 Pearson Correlation .251* .302** -.355** .001 .835*’
Sig. (2-tailed) .013 .003 .000 .996 .000
N 98 98 98 98 98
C H O L _ T 4 Pearson Correlation 1.000 .288** .079 .880 .303*’
Sig. (2-tailed) . .004 .433 .000 .002
N 100 100 100 100 100
H B A 1 C _ T 4 Pearson Correlation .288** 1.000 -.112 .230* .346*'
Sig. (2-tailed) .004 .266 .021 .000
N 100 100 100 100 100
H D L _ T 4 Pearson Correlation .079 -.112 1.000 -.074 -.426*’
Sig. (2-tailed) .433 .266 .467 .000
N 100 100 100 100 100
Correlations
C H O L  T4 H B A 1 C  T4 H D L  T4 L D L  T4 T R I G  T4
L D L  T4 Pearson Correlation .880** .230* -.074 1.000 .019
Sig. (2-tailed) .000 .021 .467 .855
N 100 100 100 100 100
T R I G  T4 Pearson Correlation .303** .346** -.426** .019 1.000
Sig. (2-tailed) .002 .000 .000 .855
N 100 100 100 100 100
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed).
Key to variables in correlational m a trix :
SCDIE = Summary o f self-care 'Diet' subscale
SCPA = Summary o f self-care 'Physical Activity' subscale
T1 = Time 1 (baseline)
T2 =  Time 2 (3 months)
T3 = Time 3 (6 months)
T4 = Time 4 (1 year)
3.4. Correlations for Manova for primary outcome analysis for Summary o f diabetes
self-care activities
Correlations
Correlations
SC D IE_T 1 S C P A  T1 S C D I E  T2 S C P A  T2 S C D I E  T3
S C D I E  T1 Pearson Correlation 1.000 .251* .524** .229* .578*’
Sig. (2-tailed) .012 .000 .022 .000
N 100 100 100 100 98
S C P A  T1 Pearson Correlation .251* 1.000 .215* .593** .132
Sig. (2-tailed) .012 .032 .000 .196
N 100 100 100 100 98
S C D I E  T2 Pearson Correlation .524** .215* 1.000 .311** .488*’
Sig. (2-tailed) .000 .032 .002 .000
N 100 100 100 100 98
S C P A  T2 Pearson Correlation .229* .593** .311** 1.000 .314*’
Sig. (2-tailed) .022 .000 .002 .002
N 100 100 100 100 98
S C D I E _ T 3 Pearson Correlation .578** .132 .488** .314** 1.000
Sig. (2-tailed) .000 .196 .000 .002 .
N 98 98 98 98 98
S C P A  T3 Pearson Correlation .159 .447** .221* .747** .274*’
Sig. (2-tailed) .119 .000 .029 .000 .006
N 98 98 98 98 98
S C D I E _ T 4 Pearson Correlation .170 .162 .158 .171 .273*’
Sig. (2-tailed) .091 .107 .116 .089 .006
N 100 100 100 100 98
S C P A _ T 4 Pearson Correlation .123 .447** .252* .585** .108
Sig. (2-taiied) .223 .000 .011 .000 .289
N 100 100 100 100 98
Correlations
S C P A  T3 S C D I E  T4 S C P A  T4
S C D I E  T1 Pearson Correlation .159 .170 .123
Sig. (2-tailed) .119 .091 .223
N 98 100 100
S C P A „ T 1 Pearson Correlation .447** .162 .447*'
Sig. (2-tailed) .000 .107 .000
N 98 100 100
S C D I E  T2 Pearson Correlation .221* .158 .252*
Sig. (2-tailed) .029 .116 .011
N 98 100 100
S C P A  T2 Pearson Correlation .747** .171 .585*'
Sig. (2-tailed) .000 .089 .000
N 98 100 100
S C D I E  T3 Pearson Correlation .274** .273** .108
Sig. (2-tailed) .006 .006 .289
N 98 98 98
S C P A  T3 Pearson Correlation 1.000 .112 .627*'
Sig. (2-tailed) .270 .000
N 98 98 98
S C D I E  T4 Pearson Correlation .112 1.000 .416*'
Sig. (2-tailed) .270 * .000
N 98 100 100
S C P A  T4 Pearson Correlation .627** .416** 1.000
Sig. (2-tailed) .000 .000
N 98 100 100
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed).
3,5. Correlations for Manova for secondary outcome analysis for Personal models o f
diabetes, SF-12 Health Survey, Self-esteem Scale and the Binge Eating Scale
Key to variables in correlational m a trix :
Personal models o f diabetes:
PMSER = Personal models construct 'seriousness o f diabetes'
PMTRE = Personal models construct 'importance o f self-management'
SF-12 Health Survey:
SFPHT = SF-12 construct 'physical health'
SFMNT = SF-12 construct 'mental health'
Self-esteem Scale:
SETOT = Self-esteem total score
Binge Eating Scale:
BETOT =  Binge eating total score
T1 = Time 1 (baseline)
T2 =  Time 2 (3 months)
T3 = Time 3 (6 months)
T4 = Time 4 (1 year)
Correlations
Correlations
P M S E R _ T 1 P M T R E _ T  1 P M S E R  T2 P M T R E _ T 2 P M S E R  T3
P M S E R J 1 Pearson Correlation 1.000 .331** .694** .312** .757*’
Sig. (2-taiied) .001 .000 .002 .000
N 100 100 100 100 98
P M T R E _ T 1 Pearson Correlation .331** 1.000 .169 .625**1 .233*
Sig. (2-tailed) .001 .092 .000 .021
N 100 100 100 100 98
P M S E R _ T 2 Pearson Correlation .694** .169 1.000 .213* .638*’
Sig. (2-taiied) .000 .092 .034 .000
N 100 100 100 100 98
P M T R E J T 2 Pearson Correlation .312** .625** .213* 1.000 .235*
Sig. (2-tailed) .002 .000 .034 .020
N 100 100 100 100 98
P M S E R _ T 3 Pearson Correlation .757** .233* .638** .235* 1.000
Sig. (2-tailed) .000 .021 .000 .020
N 98 98 98 98 98
P M T R E _ T 3 Pearson Correlation .272** .606** .222* .649** .255*
Sig. (2-tailed) .007 .000 .028 .000 .011
N 98 98 98 98 98
P M S E R _ T 4 Pearson Correlation .550** .156 .434** .219* .641*’
Sig. (2-tailed) .000 .120 .000 .028 .000
N 100 100 100 100 98
P M T R E _ T 4 Pearson Correlation .007 .174 -.019 .253* .153
Sig. (2-tailed) .941 .083 .849 .011 .133
N 100 100 100 100 98
Correlations
P M T R E  T3 P M S E R  T4 P M T R E  T4
P M S E R _ T 1 Pearson Correlation ~ 2 7 2 * * .550**] TJ07
Sig. (2-tailed) .007 .000 .941
N 98 100 100
P M T R E _ T 1 Pearson Correlation .606** .156 .174
Sig. (2-tailed) .000 .120 .083
N 98 100 100
P M S ER__ T2 Pearson Correlation .222* .434** -.019
Sig. (2-tailed) .028 .000 .849
N 98 100 100
P M T R E _ T 2 Pearson Correlation .649** .219* .253*
Sig. (2-tailed) .000 .028 .011
N 98 100 100
P M S E R _ T 3 Pearson Correlation .255* .641** .153
Sig. (2-tailed) .011 .000 .133
N 98 98 98
P M T R E _ T 3 Pearson Correlation 1.000 .169 .392*’
Sig. (2-tailed) , .096 .000
N 98 98 98
P M S E R _ T 4 Pearson Correlation .169 1.000 .505*’
Sig. (2-tailed) .096 .000
N 98 100 100
P M T R E _ T 4 Pearson Correlation .392** .505** 1.000
Sig. (2-tailed) .000 .000
N 98 100 100
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed).
Correlations
Correlations
S F P H T  T1 S F M N T  T1 S F P H T  T2 S F M N T  T2 S F P H T  T3
S F P H T _ T 1 Pearson Correlation 1.000 -.205* .418** -.121 .487*'
Sig. (2-tailed) .041 .000 .232 .000
N 100 100 100 100 98
S F M N T  T1 Pearson Correlation -.205* 1.000 -.167 .572** -.162
Sig. (2-tailed) .041 .096 .000 .111
N 100 100 100 100 98
S F P H T T 2 Pearson Correlation .418** -.167 1.000 -.418** .525*'
Sig. (2-tailed) .000 .096 .000 .000
N 100 100 100 100 98
S F M N T _ T 2 Pearson Correlation -.121 .572** -.418** 1.000 -.110
Sig. (2-tailed) .232 .000 .000 .280
N 100 100 100 100 98
S F P H T _ T 3 Pearson Correlation .487** -.162 .525** -.110 1.000
Sig. (2-taiied) .000 .111 .000 .280
N 98 98 98 98 98
S F M N T _ T 3 Pearson Correlation -.009 .635** -.117 .599** -.190
Sig. (2-tailed) .930 .000 .250 .000 .061
N 98 98 98 98 98
S F P H T J T 4 Pearson Correlation .696** -.073 .494** -.018 .603*'
Sig. (2-tailed) .000 .468 .000 .858 .000
N 100 100 100 100 98
S F M N T J T 4 Pearson Correlation -.022 .665** -.142 .563** -.026
Sig. (2-tailed) .828 .000 .160 .000 .799
N 100 100 100 100 98
Correlations
S F M N T  T3 S F P H T  T4 S F M N T  T4
S F P H T J 1 Pearson Correlation -.009 .696** -.022
Sig. (2-tailed) .930 .000 .828
N 98 100 100
S F M N T T 1 Pearson Correlation .635** -.073 .665*’
Sig. (2-tailed) .000 .468 .000
N 98 100 100
S F P H T T 2 Pearson Correlation -.117 .494** -.142
Sig. (2-tailed) .250 .000 .160
N 98 100 100
S F M N T _ T 2 Pearson Correlation .599** -.018 .563*’
Sig. (2-tailed) .000 .858 .000
N 98 100 100
S F P H T _ T 3 Pearson Correlation -.190 .603** -.026
Sig. (2-tailed) .061 .000 .799
N 98 98 98
S F M N T _ T 3 Pearson Correlation 1.000 .007 .680*’
Sig. (2-tailed) .949 .000
N 98 98 98
S F P H T T 4 Pearson Correlation .007 1.000 -.029
Sig. (2-tailed) .949 .773
N  . 98 100 100
S F M N T J T 4 Pearson Correlation .680** -.029 1.000
Sig. (2-tailed) .000 .773
N 98 100 100
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed).
Correlations
Correlations
S E T O T  T1 S E T O T  T2 S E T O T  T3 S E T O T  T4
S E T O T  T1 Pearson Correlation 1.000 .778** .780** .756*’
Sig. (2-tailed) .000 .000 .000
N 100 100 98 100
S E T O T  T2 Pearson Correlation .778** 1.000 .764** .712“
Sig. (2-tailed) .000 .000 .000
N 100 100 98 100
S E T O T  T3 Pearson Correlation .780** .764“ 1.000 .747*’
Sig. (2-tailed) .000 .000 .000
N 98 98 98 98
S E T O T  T4 Pearson Correlation .756** .712** .747“ 1.000
Sig. (2-tailed) .000 .000 .000
N 100 100 98 100
**. Correlation is significant at the 0.01 level (2-tailed).
Correlations
Correlations
B E T O T  T1 B E T O T  T2 B E T O T _ T 3 B E T O T  T4
B E T O T  T1 Pearson Correlation 1.000 .827** .753** .753*'
Sig. (2-tailed) .000 .000 .000
N 99 98 97 93
B E T O T  T2 Pearson Correlation .827** 1.000 .844** .837*’'
Sig. (2-tailed) .000 .000 .000
N 98 99 98 94
B E T O T . T 3 Pearson Correlation .753** .844** 1.000 .835*’
Sig. (2-tailed) .000 .000 .000
N 97 98 98 94
B E T O T  T4 Pearson Correlation .753** .837** .835** 1.000
Sig. (2-tailed) .000 .000 .000
N 93 94 94 94
**. Correlation is significant at the 0.01 level (2-tailed).
3.6, Correlations for Manova for process analysis for changes in  dietary behaviour 
and physical activity
Key to variables in correlational matrix:
Dietary behaviour:
SOCF = Stages o f change for dietary fat reduction 
CONF2 =  Self-efficacy for reducing intake o f high fat food 
BHETO = Barriers to healthy eating total score
Physical activity:
PACE1 = Stages o f change for physical activity 
CONF1 =  Self-efficacy for participating in physical activity 
BPATO = Barriers to physical activity total score
T1 = Time 1 (baseline)
T2 =  Time 2 (3 months)
T3 = Time 3 (6 months)
T4 = Time 4 (1 year)
Correlations
Correlations
S O C F  T1 C O N F 2  T1 B H E T O  T1 S O C F  T2 C O N F 2  T2
S O C F  T1 Pearson Correlation 1.000 .111 -.155 .479** .170
Sig. (2-tailed) .272 .125 .000 .090
N 100 100 100 100 100
C O N F 2 _ T 1 Pearson Correlation .111 1.000 -.097 .173 .370*’
Sig. (2-tailed) .272 .337 .086 .000
N 100 100 100 100 100
B H E T O _ T 1 Pearson Correlation -.155 -.097 1.000 -.253* -.155
Sig. (2-tailed) .125 .337 .011 .125
N 100 100 100 100 100
S O C F  T2 Pearson Correlation .479** .173 -.253* 1.000 .346*'
Sig. (2-tailed) .000 .086 .011 .000
N 100 100 100 100 100
C O N F 2  T2 Pearson Correlation .170 .370** -.155 .346** 1.000
Sig. (2-tailed) .090 .000 .125 .000
N 100 100 100 100 100
B H E T O _ T 2 Pearson Correlation -.173 -.097 .618** -.236* -.189
Sig. (2-tailed) .086 .335 .000 .018 .059
N 100 100 100 100 100
S O C F  T3 Pearson Correlation .381** .208* -.268** .572** .271*'
Sig. (2-tailed) .000 .039 .008 .000 .007
N 98 98 98 98 98
C O N F 2 _ T 3 Pearson Correlation .275*^ .440** -.293** .431** .579*’
Sig. (2-tailed) .006 .000 .003 .000 .000
N 98 98 98 98 98
B H E T O  T3 Pearson Correlation -.213*
C
O
in,r*“r .673** -.342** -.206*
Sig. (2-tailed) .035 .132 .000 .001 .042
N 98 98 98 98 98
S O C F _ T 4 Pearson Correlation .239* .244* -.266** .492** .380*'
Sig. (2-tailed) .016 • .015 .007 .000 .000
N 100 100 100 100 100
C O N F 2  T4 Pearson Correlation .054 .280** .055 .349** .286*'
Sig. (2-tailed) .595 .005 .588 .000 .004
N 100 100 100 100 100
B H E T O  T4 Pearson Correlation -.152 -.215* .619** -.292** -.261*’
Sig. (2-tailed) .131 .031 .000 .003 .009
N 100 100 100 100 100
Correlations
B H E T O  T2 S O C F  T3 C O N F 2  T3 B H E T O J T 3 S O C F  T4
S O C F  T1 Pearson Correlation -.173 .381** .275** -.213* .239*
Sig. (2-tailed) .086 .000 .006 .035 .016
N 100 98 98 98 100
C O N F 2  T1 Pearson Correlation -.097 .208* .440** -.153 .244*
Sig. (2-tailed) .335 .039 .000 .132 .015
N 100 98 98 98 100
B H E T O _ T 1 Pearson Correlation .618** -.268** -.293** .673*J -.266*’
Sig. (2-tailed) .000 .008 .003 .000 .007
N 100 98 98 98 100
S O C F  T2 Pearson Correlation -.236* .572** .431** -.342** .492*’
Sig. (2-tailed) .018 .000 .000 ,001 .000
N 100 98 98 98 100
C O N F 2 _ T 2 Pearson Correlation -.189 .271** .579** -.206* .380*’
Sig. (2-tailed) .059 .007 .000 .042 .000
N 100 98 98 98 100
B H E T O _ T 2 Pearson Correlation 1.000 -.369** -.258* .777** -.298*’
Sig. (2-tailed) .000 .010 .000 .003
N 100 98 98 98 100
S O C F  T3 Pearson Correlation -.369** 1.000 .483** -.356** .558*’
Sig. (2-tailed) .000 .000 .000 .000
N 98 98 98 98 98
C O N F 2  T3 Pearson Correlation -.258* .483** 1.000 -.389** .431*’
Sig. (2-taiied) .010 .000 .000 .000
N 98 98 98 98 98
B H E T O  T3 Pearson Correlation .777*1 -.356** -.389** 1.000 -.331*’
Sig. (2-tailed) .000 .000 .000 .001
N 98 98 98 98 98
S O C F  T4 Pearson Correlation -.298** .558** .431** -.331** 1.000
Sig. (2-tailed) .003 .000 .000 .001
N 100 98 98 98 100
C O N F 2  T4 Pearson Correlation -.053 . .386** .453** -.075 .430*’
Sig. (2-tailed) .597 .000 .000 .464 .000
N 100 98 98 98 100
B H E T O _ T 4 Pearson Correlation .688** -.398** -.369** .774** -.371*’
Sig. (2-tailed) .000 .000 .000 .000 .000
N 100 98 98 98 100
Correlations
C O N F 2  T4 B H E T O  T4
S O C F _ T 1 Pearson Correlation .054 -.152
Sig. (2-tailed) .595 .131
N 100 100
C O N F 2  T1 Pearson Correlation .280** -.215*
Sig. (2-tailed) .005 .031
N 100 100
B H E T O  T1 Pearson Correlation .055 .619“
Sig. (2-tailed) .588 .000
N 100 100
S O C F  T2 Pearson Correlation .349** -.292“
Sig. (2-tailed) .000 .003
N 100 100
C O N F 2 _ T 2 Pearson Correlation .286** -.261“
Sig. (2-tailed) .004 .009
N 100 100
B H E T O  T2 Pearson Correlation -.053 .688*’
Sig. (2-tailed) .597 .000
N 100 _x O o
S O C F _ T 3 Pearson Correlation .386** -.398“
Sig, (2-tailed) .000 .000
N. 98 98
C O N F 2  T3 Pearson Correlation .453**1 -.369*’
Sig. (2-tailed) .000 .000
N 98 98
B H E T O  T3 Pearson Correlation -.075 .774*’
Sig. (2-tailed) .464 .000
N 98 98
S O C F _ T 4 Pearson Correlation .430**
*COr
Sig. (2-tailed) .000 .000
N 100 100
C O N F 2 _ T 4 Pearson Correlation 1.000 - -.199*
Sig. (2-tailed) , .047
N 100 100
B H E T O  T4 Pearson Correlation CD CD
* 1.000
Sig. (2-tailed) .047
N 100 100
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
Correlations
Correlations
PACE1__T1 C O N F 1 _ T 1 B P A T O  T1 P A C E 1  T2 C O N F 1  T2
P A C E 1  T1 Pearson Correlation 1.000 .422** -.255* .532** .322*'
Sig. (2-taiied) .000 .010 .000 .001
N 100 100 100 100 100
C O N F 1 _ T 1 Pearson Correlation .422** 1.000 -.133 .297** .596*'
Sig. (2-tailed) .000 .187 .003 .000
N 100 100
oo
100 100
B P A T O  T1 Pearson Correlation -.255* -.133 1.000 -.329** -.069
Sig. (2-tailed) .010 .187 .001 .498
N 100 100 100 100 100
P A C E 1 J T 2 Pearson Correlation .532** .297** -.329** 1.000 .350*'
Sig. (2-tailed) .000 .003 .001 .000
N 100 100 100 100 100
C O N F 1  T2 Pearson Correlation .322** .596** -.069 .350** 1.000
Sig. (2-tailed) .001 .000 .498 .000
N 100 100 100 100 100
B P A T O  T2 Pearson Correlation -.315** -.282** .577** -.484** -.198*
Sig. (2-tailed) .001 .005 .000 .000 .048
N 100 100 100 100 100
P A C E 1  T3 Pearson Correlation .545** .318** -.251* .647** .366*'
Sig. (2-tailed) .000 .001 .013 .000 .000
N 98 98 98 98 98
C O N F 1  T3 Pearson Correlation .313** .296** -.266** .472** .547*'
Sig. (2-tailed) .002 .003 .008 .000 .000
N 98 98 98 98 98
B P A T O  T3 Pearson Correlation -.276** -.261** .594** -.368** -.174
Sig. (2-tailed) .006 .009 .000 .000 .086
N 98 98 98 98 98
P A C E 1  T4 Pearson Correlation .582** .399** -.261*1 .485*1 .353*’
Sig. (2-tailed) .000 .000 .009 .000 .000
N 100 100 100 100 100
C O N F 1  T4 Pearson Correlation .374** .452** -.125 .354** .507*'
Sig. (2-tailed) .000 .000 .215 .000 .000
N 100 100 100 100 100
B P A T O  T 4 Pearson Correlation -.164 -.316** .312** -.290** -.295*'
Sig. (2-tailed) .103 .001 .002 .003 .003
N 100 100 100 100 100
Correlations
B P A T O  T2 P A C E 1  T3 C O N F 1 .  T3 B P A T O  T3 P A C E 1 J T 4
P A C E 1  T1 Pearson Correlation -.315“ .545“ .313“ -.276“ .582*’
Sig. (2-tailed) .001 .000 .002 .006 .000
N 100 98 98 98 100
C O N F 1  T1 Pearson Correlation -.282“ .318“ .296“ -.261“ .399*’
Sig. (2-tailed) .005 .001 .003 .009 .000
N 100 98 98 98 100
B P A T O  T1 Pearson Correlation .577“ -.251* -.266“ .594** -.261*’
Sig. (2-tailed) .000 .013 .008 .000 .009
N
ooT—
98 98 98 100
P A C E 1  T2 Pearson Correlation -.484“ .647** .472** -.368** .485*’
Sig. (2-tailed) .000 .000 .000 .000 .000
N 100 98 98 98 100
C O N F 1  T2 Pearson Correlation -.198* .366** .547“ -.174 .353*’
Sig. (2-tailed) .048 .000 .000 .086 .000
N 100 98 98 98 _x o o
B P A T O  T2 Pearson Correlation 1.000 -.491“ -.320“ .792** -.333*’
Sig. (2-tailed) .000 .001 .000 .001
N 100 98 98 98 100
P A C E 1  T3 Pearson Correlation -.491“ 1.000 .599** -.508** .567*’
Sig. (2-tailed) .000 .000 .000 .000
N 98 98 98 98 98
C O N F 1  T3 Pearson Correlation -.320“ .599“ 1.000 -.426“ .451*’
Sig. (2-tailed) .001 .000 .000 .000
N 98 98 98 98 98
B P A T O  T3 Pearson Correlation .792** -.508“ -.426“ 1.000 -.400*’
Sig. (2-tailed) .000 .000 .000 .000
N 98 98 98 98 98
P A C E 1  T4 Pearson Correlation -.333“ .567** .451“ -.400“ 1.000
Sig. (2-tailed) .001 .000 .000 .000
N 100 98 98 98 100
C O N F 1  T4 Pearson Correlation -.273“ .440“ .555“ -.326“ .493“
Sig. (2-tailed) .006 .000 .000 .001 .000
N 100 98 98 98 100
B P A T O  T4 Pearson Correlation .456“ -.399“ .530** -.411“
Sig. (2-tailed) .000 .000 .000 .000 .000
N 100 98 98 98 100
Correlations
C O N F 1  T4 B P A T O  T4
P A C E 1 _ T 1 Pearson Correlation .374** -.164
Sig. (2-tailed) .000 .103
N 100 100
C O N F 1 _ T 1 Pearson Correlation .452** -.316*’
Sig. (2-tailed) .000 .001
N 100 100
B P A T O J H Pearson Correlation -.125 .312*’
Sig. (2-tailed) .215 .002
N 100 100
P A C E 1 _ T 2 Pearson Correlation .354** -.290*’
Sig. (2-tailed) .000 .003
N 100 100
C O N F 1 _ T 2 Pearson Correlation .507** -.295*’
Sig. (2-tailed) .000 .003
N 100 100
B P A T O _ T 2 Pearson Correlation -.273** .456*’
Sig. (2-tailed) .006 .000
N 100 100
P A C E 1  13 Pearson Correlation .440** -.414*’
Sig. (2-tailed) .000 .000
N. 98 98
C O N F 1 _ T 3 Pearson Correlation .555** -.399*’
Sig. (2-tailed) .000 .000
N 98 98
B P A T O _ T 3 Pearson Correlation -.326** .530*’
Sig. (2-tailed) .001 .000
N 98 98
P A C E 1 _ T 4 Pearson Correlation .493** -.411*’
Sig. (2-taiied) .000 .000
N 100 100
C O N F 1  T4 Pearson Correlation 1.000 -.407*’
Sig. (2-tailed) .000
N 100 100
B P A T O _ T 4 Pearson Correlation -.407*1 1.000
Sig. (2-tailed) .000
N 100 100
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
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This questionnaire is pa rt o f an ongoing research project related to psychological 
in tervention to im prove lifestyle self-management in patients w ith  Type 2 
diabetes. Thank you fo r taking the time to complete it. A ll in form ation w ill be 
treated in strictest confidence. I f  you have any questions or would like some 
more in form ation, please do not hesitate to contact me.
M A R IE  C L A R K  
D E P A R TM E N T OF PSYCHOLOGY 
Ext. 2970
Attitudes
Below are some statements about diabetes. Each numbered statement finishes the 
sentence “In  general, I  believe that...” You may believe that a statement is true for 
one person but not for another person or may be true one time but not be true another 
time. M ark the answer that you believe is true most of the time or is true for most 
people. Place a check m ark in the box below the word or phrase that is closest to 
your opinion about each statement. It is important that you answer every statement.
Note: The term “health care professionals” in this survey refers to doctors, nurses, 
and dietitians.
In general, I believe that:
Strongly Strongly
Agree Agree Neutral Disagree Disagree
1. ...health care professionals who 
treat people with diabetes should 
be trained to communicate w ell
with their patients. CH □  □  CH CH
2. ...people who do not need to take 
insulin  to treat their diabetes have
a pretty m ild disease. CH CH CH CH CH
3. ...there is not much use in trying to 
have good blood sugar control 
because the com plications of
diabetes w ill happen anyway. CH CH CH CH CH
4. ...diabetes affects almost every
part of a diabetic person’s life . CH CH CH CH CH
5. ...the important decisions regarding 
daily diabetes care should be made
by the person with diabetes. D  O  . CH . CH CH
6. ...health care professionals should 
be taught how d aily  diabetes care
affects patients’ lives. D  □  □  □  □
Strongly Strongly
Agree Agree Neutral Disagree Disagree
In general, I believe that:
7. ...older people with Type II* 
diabetes do not usually get
complications. CD CH CD CD CH
8. ...keeping the blood sugar close to 
normal can help to prevent the
complications of diabetes. CD CH CD CD CD
9. ...most people can enjoy life  and
still keep tight blood sugar control. CD CD CD CD CD.
10. ...health care professionals should 
help patients make informed
choices about their care plans. CD CD CH CH CD
1 1 . ...it is important for the nurses 
and dietitians who teach people 
with diabetes to leam
counseling sk ills. CD CD CD CD CD
12. ...people whose diabetes is treated 
by just a diet do not have to worry 
about getting many long-term
complications. CD CD CD CD CH
13. ...almost everyone with diabetes 
should do whatever it takes to keep
their blood sugar close to norm al. CH CH CD CH CD
14. ...the emotional effects of diabetes
are pretty sm all. CD CH CD CD CD
* Type I I  diabetes usually begins after age 40. Many patients are overweight and weight loss is often 
an important part o f the treatment. Insulin and/or diabetes pills are sometimes used in the treatment. 
Type I I  diabetes is also called noninsulin-dependent diabetes mellitus or N ID D M ; formerly it  was 
called “ adult diabetes.”
Strongly Strongly
Agree Agree Neutral Disagree Disagree
In general, I believe that:
15. ...people with diabetes should 
have the final say in  setting their
blood glucose goals. □  □  □  □  □
16. ...blood sugar testing is not needed
for people with Type 31* diabetes. □  □  □  □  □
17 . ...low blood sugar reactions make 
tight control too risky for most
people. □  □  □  □
18. ...health care professionals should 
leam  how to set goals with patients,
not just tell them what to do. CH CH CH CH CH
19. ...diabetes is hard because you
never get a break from it. CH CH CH CH CH
20. ...the person with diabetes is the 
most important member of the
diabetes care team. CH CH CH CH CH
2 1 . ...to do a good job, diabetes 
educators should leam  a lot about
being teachers □  □  □  □  □
22. ...Type II* diabetes is a very
serious disease. □  □  □  □  □
23. ...having diabetes changes a
person’s outlook on life. □  □  □  □  □
Type II  diabetes usually begins after age 40. Many patients are overweight and weight loss is 
often an important part o f the treatment. Insulin and/or diabetes pills are sometimes used in 
the treatment. Type I I  diabetes is also called noninsulin-dependent diabetes mellitus or 
NIDDM ; formerly it was called “ adult diabetes.”
In general, I believe that:
Strongly Strongly
Agree Agree Neutral Disagree Disagree
24. ...people who have Type IT  
diabetes w ill probably not get
much payoff from tight control __
of their blood sugars. □  □  □  □  □
25. ...people with diabetes should 
learn a lot about the disease so that 
they can be in charge of their own
diabetes care. D  □  O  □  □
26. ...Type IT  is as serious as . • _
Type It diabetes. D  O  □  □  D
27. ...tight control is too much work. D  D  □  □  □
28. ...a person with diabetes can lead
a norm al life . □  □  □  □  □
29. ...what the patient does has more 
effect on the outcome of diabetes 
care than anything a health
professional does. D  O  D  D  □
30. ...tight control of blood sugar 
makes sense only for people
with Type It diabetes. D  D  D  D  D
Type I I  diabetes usually begins after age 40. Many patients are overweight and weight loss is often 
an important part o f the treatment. Insulin and/or diabetes pills are sometimes used in the treatment 
Type I I  diabetes is also called noninsulin-dependent diabetes mellitus or N IDDM ; formerly it was 
called “ adult diabetes.”
^Type I  diabetes usually begins before age 40 and always requires insulin as part o f the treatment 
Patients are usually not overweight Type I  diabetes is also called insulin-dependent diabetes mellitus 
or IDDM ; formerly it  was called “ juvenile diabetes.”
Strongly Strongly
Agree Agree Neutral Disagree Disagree
In general, I believe that:
3 L  ...it is frustrating for people with 
diabetes to take care of their
disease. O O O  O  O
32. ...people with diabetes have a right
to decide how hard they w ill work _  __ _
to control their blood sugar. CH O  CH LH □
33. ...people who take diabetes p ills  
should be as concerned about their 
blood sugar as people who take
insulin. □  □  □  □  □
34. ...people with diabetes have the
right not to take good care of their _
diabetes. □  □  □  □  □
35. ...support from fam ily and friends
is important in dealing with _
diabetes. 0  0  1111 O  O
The fo llo w in g  questions are about yo u  personally.
Age:...........yrs Profession:
Are you: Male.... Female.
White/Black African/Black Carribean/Asian/Other, 
(please circle)
About your work.
How long have you been involved in diabetes care?.
How much o f you r w o rk  time is devoted to diabetes care?
0-24% 25-49% 50-74% 75-100%
W hat k ind  o f setting do you w ork in (e.g. primary/community/secondary care)?
Have you ever attended a special tra in ing  course for health professionals 
involved in  diabetes care?
Yes. No.
If 'Yes', please give details:.
How do you rate the treatment of diabetes compared to.
Diabetes easier 
Hypertension 1 2 3 4 5 6
Hyperlipidemia 1 2 3 4 5 6
Angina 1 2 3 4 5 6
Arthritis 1 2 3 4 5 6
Heart Failure 1 2 3 4 5 6
Diabetes harder 
8 9 10
8 9 10
8 9 10
8 9 10
10
Treatment o f  hyperglycemia in diabetes is effective in preventing diabetes 
complications such as retinopathy, nephropathy and foot ulcers
Strongly agree Strongly disagree
1 2 3 4 5 6 7 8 9  10
I  feel confident that my therapeutic actions/advice result in improved diabetic 
outcomes
Strongly agree Strongly disagree
1 2 3 4 5 6 7 8 9  10
I  have adequate time and resources to effectively treat my diabetic patients
Strongly agree Strongly disagree
1 2 3 4 5 6  7 8 9  10
I f  we wanted to discuss w ith  you some o f your answers to this questionnaire, 
would you be happy fo r us to contact you?
Yes  N o.............
If 'Yes', please give us the following details:
Name:............................................................................................
Address:........................................ ................................................
Please sta te  to w hat ex ten t y o u  agree w ith the fo llow ing  statem ents........
Evening:
Telephone: Day:........
T H A N K  YO U FO R YO UR HELP
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This questionnaire is pa rt o f an ongoing research project related to psychological 
in tervention to im prove lifestyle self-management in patients w ith  Type 2 
diabetes. Thank you fo r taking the time to complete it. AU in form ation w ill be 
treated in  strictest confidence. I f  you have any questions or would like some 
more in form ation, please do not hesitate to contact me.
M A R IE  C L A R K  
D E P A R TM E N T OF PSYCHO LOG Y 
Ext. 2970
Attitudes
Below are some statements about diabetes. Each numbered statement finishes the 
sentence “In general, I  believe that...” You may believe that a statement is true for 
one person but not for another person or may be true one time but not be-true another 
time. Marie the answer that you believe is true most of the time or is true for most 
people. Place a check m ark in the box below the word or phrase that is closest to 
your opinion about each statement. It is important that you answer every statement.
Note: The term “health care professionals” in this survey refers to doctors, nurses, 
and dietitians.
In general, I believe that:
Strongly Strongly
Agree Agree Neutral Disagree Disagree
1. ...health care professionals who 
treat people with diabetes should 
be trained to communicate w ell
with their patients. CU CH CH O  O
2. ...people who do not need to take 
insulin  to treat their diabetes have
a pretty m ild disease. CH O  CH □  CH
3. ...there is not much use in  trying to 
have good blood sugar control 
because the com plications of
diabetes w ill happen anyway. CH CH CH CH CH
4. ...diabetes affects almost every
part of a diabetic person’s life . CH O  CH O  O
5. ...the important decisions regarding 
daily diabetes care should be made
by die person with diabetes. CH 0 - 0  . CH CH
6. ...health care professionals should 
be taught how d aily  diabetes care
affects patients’ lives. O D O  O  O
Strongly Strongly
Agree Agree Neutral Disagree Disagree
In general, I believe that:
7. ...older people with Type IX* 
diabetes do not usually get
complications. * CH EH CD CD CH
8. ...keeping the blood sugar close to
normal can help to prevent the __ _
complications of diabetes. CD CD CD CD CD
9. ...most people can enjoy life  and
still keep tight blood sugar control. CD CD CD
10. ...health care professionals should 
help patients make informed
choices about their care plans. D  CD CD C H . CH
1 1 . ...it is important for the nurses 
and dietitians who teach people 
with diabetes to leam
counseling sk ills. CD CD CD CD CD
12. ...people whose diabetes is treated 
by just a diet do not have to worry 
about getting many long-term
com plications. CD CD CH CH CH
13. ...almost everyone with diabetes 
should do whatever it takes to keep
their blood sugar close to norm al. CD CH CD CD CD
14. ...the emotional effects of diabetes
are pretty sm all. CH CH □  □  □
* Type I I  diabetes usually begins after age 40. Many patients are overweight and weight loss is often 
an important part o f the treatment. Insulin and/or diabetes pills are sometimes used in the treatment. 
Type I I  diabetes is also called noninsulin-dependent diabetes mellitus or N ID D M ; form erly i t  was 
called “ adult diabetes.”
Strongly Strongly
Agree Agree Neutral Disagree Disagree
In general, I  believe that:
15. ...people with diabetes should 
have the final say in  setting their
blood glucose goals. □  □  □  □  □
16. ...blood sugar testing is not needed
for people with Type IX* diabetes. CD D  D  CH D
17 . ...low  blood sugar reactions make 
tight control too risky for most
people. □  □  □  □  . O *
18. ...health care professionals should 
leam  how to set goals with patients,
not just tell them what to do. CH CD CH CH CH
19. ...diabetes is hard because you
never get a break from it. □  □  □  □  O
20. ...the person with diabetes is the 
most important member of the
diabetes care team. CH CH CH CH CH
2 1 . ...to do a good job, diabetes 
educators should leam a lot about
being teachers CH CH CH CH D
22. ...Type II* diabetes is a very _
serious disease. □  □  □  □  □
23. ...having diabetes changes a
person’s outlook on life. O D D  CH CH
Type I I  diabetes usually begins after age 40, Many patients are overweight and weight loss is 
often an important part o f the treatment. Insulin and/or diabetes pills are sometimes used in 
the treatment. Type I I  diabetes is also called noninsulin-dependent diabetes m ellitus or 
N IDDM ; formerly it  was called “ adult diabetes.”
Strongly Strongly
Agree Agree Neutral Disagree Disagree
In general, I believe that:
24. ...people who have Type IP  
diabetes w ill probably not get 
much payoff from tight control
of their blood sugars. CD O  D  D  D
25. ...people with diabetes should 
learn a lot about the disease so that 
they can be in charge of their own
diabetes care. □  □  □  □  □
26. ...Type IP  is as serious as . • '
Type P  diabetes. CH CH CH CH CH
27. ...tight control is too much work. CH CH CH CH CH
28. ...a person with diabetes can lead
a norm al life . CH CH CH CH CH
29. ...what the patient does has more 
effect on the outcome of diabetes 
care than anything a health
professional does. D  CD □  CH CH
30. ...tight control of blood sugar 
makes sense only for people
with Type P  diabetes. CH CH CD CD CD
Type I I  diabetes usually begins after age 40. Many patients are overweight and weight loss is often 
an important part o f the treatment. Insulin and/or diabetes pills are sometimes used in the treatment 
Type I I  diabetes is also called noninsulin-dependent diabetes mellitus or N IDDM ; formerly it  was 
called “ adult diabetes.”
tType I  diabetes usually begins before age 40 and always requires insulin as part o f the treatment 
Patients are usually not overweight. Type I  diabetes is also called insulin-dependent diabetes mellitus 
or IDDM ; formerly it  was called “juvenile diabetes.”
In  general, I  believe that:
Strongly Strongly
Agree Agree Neutral Disagree Disagree
3 1. . . . i t  is  f r u s t r a t in g  f o r  p e o p l e  w i th  
d ia b e te s  to  ta k e  c a r e  o f  t h e i r
d i s e a s e .  □  □  □  □  □
3 2 . . . .p e o p le  w ith  d i a b e te s  h a v e  a  r ig h t  
to  d e c id e  h o w  h a r d  t h e y  w i l l  w o r k
to  c o n t r o l  th e i r  b l o o d  s u g a r .  CH CH CH CH CH
3 3 . . . .p e o p le  w h o  ta k e  d i a b e t e s  p i l l s  
s h o u ld  b e  a s  c o n c e r n e d  a b o u t  t h e i r  
b lo o d  s u g a r  a s  p e o p le  w h o  ta k e
in s u l in .  CH CH CH CH CH
3 4 . . . .p e o p le  w i th  d i a b e t e s  h a v e  th e  
r i g h t  n o t  to  t a k e  g o o d  c a r e  o f  th e i r
d ia b e te s .  CH CD CH CH CH
3 5 . . . . s u p p o r t  f r o m  f a m i l y  a n d  f r ie n d s  
is  im p o r ta n t  in  d e a l in g  w i th
d ia b e te s .  CH CH CH CH CH
T h e  f o l l o w i n g  q u e s t io n s  a r e  a b o u t  y o u  p e r s o n a l ly . . . . .  
A g e :............ y rs  H e ig h t: .. . ........  W e ig h t:.
O c c u p a tio n :..........................................................
( I f  unem ployed, give previous occupation)
A re  y o u : M ale ...............................  Female.
W hite/B lack A frican/B lack Carribean/A sian/O ther. 
(please circle)
W h a t  k in d  o f  h o u s in g  do you  live in ?  O w n R en t O th er.........
A b o u t  y o u r  h e a l th  ..... .
H o w  lo n g  ago  w e re  y o u  d iag n o sed  as h av in g  d ia b e te s?   ................ y e a rs
W h a t  d ia b e te s  m e d ica tio n  a re  yo u  ta k in g  now  -
In s u lin .........................................................H o w  long ago did
you begin taking
your insulin?.....................................
Tablets
B o th  Insulin and T a b le ts .........................H ow  long ago did
you begin taking 
insulin w ith tablets?.
N one
H a v e  y o u  ev e r a t te n d e d  a  d iab e te s  p a t ie n t  ed u c a tio n  p ro g ra m m e  /a  series o f  
c la sse s /g ro u p ?
Y es  N o ............
I f  Y es ', p lease give details
H o w  w o u ld  y o u  r a te  y o u r  u n d e r s ta n d in g  o f d iab e te s  a n d  its t r e a tm e n t?
P o o r E xcellent
1 2 3 4 5 6 7 8 9  10
I f  w e  w a n te d  to  d iscuss w ith  y o u  som e o f y o u r  an sw ers  to  th is  q u e s tio n n a ire , 
w o u ld  y o u  b e  h a p p y  fo r  us to  c o n ta c t  y o u ?
Y es  N o ................
I f 'Y e s p l e a s e  g iv e  u s  th e  f o l l o w i n g  d e ta ils :
N a m e :...........................................................................................................
A d d re s s : .......................................................................................................
T e lep h o n e : D a y :.........
E v en in g :
T H A N K  Y O U  F O R  Y O U R  H E L P
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